academic journal | Q737498 |
society journal | Q73364223 |
scientific journal | Q5633421 |
P6981 | ACNP journal ID | 12569 |
2107212 | ||
P1159 | CODEN | DADEDV |
P8375 | Crossref journal ID | 1268 |
P1250 | Danish Bibliometric Research Indicator (BFI) SNO/CNO | 6706 |
P5963 | Elsevier journal ID | drug-and-alcohol-dependence |
P1058 | ERA Journal ID | 13492 |
P236 | ISSN | 0376-8716 |
1879-0046 | ||
P7363 | ISSN-L | 0376-8716 |
P1277 | JUFO ID | 54838 |
P1144 | Library of Congress Control Number (LCCN) (bibliographic) | 75647592 |
P4730 | Mir@bel journal ID | 21814 |
P1055 | NLM Unique ID | 7513587 |
P243 | OCLC control number | 01847307 |
P856 | official website | http://www.elsevier.com/wps/find/journaldescription.cws_home/506052/description#description |
http://www.sciencedirect.com/science/journal/03768716 | ||
P10283 | OpenAlex ID | S109998069 |
S4210226263 | ||
P3181 | OpenCitations bibliographic resource ID | 5791 |
P7662 | Scilit journal ID | 324097 |
P1156 | Scopus source ID | 26380 |
P495 | country of origin | Switzerland | Q39 |
P1240 | Danish Bibliometric Research Indicator level | 1 | |
P571 | inception | 1975-01-01 | |
P8875 | indexed in bibliographic review | Scopus | Q371467 |
Science Citation Index Expanded | Q104047209 | ||
P407 | language of work or name | English | Q1860 |
Dutch | Q7411 | ||
P921 | main subject | substance dependence | Q3378593 |
alcohol dependence | Q4713263 | ||
P123 | publisher | Elsevier BV | Q746413 |
P1476 | title | Drug and Alcohol Dependence | |
Drug and alcohol dependence |
Q39383006 | "Don't think I'm going to leave you over it": Accounts of changing hepatitis C status among couples who inject drugs. |
Q33606433 | "Drinking buddies" and alcohol dependence symptoms among African American men and women in Baltimore, MD. |
Q39234943 | "Experimenting" with drugs: a critical evaluation |
Q57071112 | "Feeling confident and equipped": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City |
Q91311073 | "Flakka" use among high school seniors in the United States |
Q36595767 | "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment |
Q104685798 | "I actually finally feel like the cigarettes aren't controlling me." - Interviews with participants smoking very low nicotine content cigarettes during a residential study |
Q89729207 | "I cannot live without my vape": Electronic cigarette user-identified indicators of vaping dependence |
Q36788050 | "I just wanted to tell you that loperamide WILL WORK": a web-based study of extra-medical use of loperamide |
Q96113389 | "It's not just injecting drugs": Supervised consumption sites and the social determinants of health |
Q36745385 | "It's not smoke. It's not tar. It's not 4000 chemicals. Case closed": Exploring attitudes, beliefs, and perceived social norms of e-cigarette use among adult users |
Q44417201 | "King hit" fatalities in Australia, 2000-2012: the role of alcohol and other drugs |
Q36507042 | "Not getting tanked": definitions of moderate drinking and their health implications |
Q90200235 | "Phantom smokers": Young cigarillo users who do not identify as smokers |
Q35673227 | "Ready, willing, and (not) able" to change: young adults' response to residential treatment |
Q98721641 | "Residual blood THC levels in frequent cannabis users after over four hours of abstinence: A systematic review." |
Q28270706 | "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference |
Q100430479 | "That person stopped being human": Intersecting HIV and substance use stigma among patients and providers in South Africa |
Q38498674 | "The drug user": a semantic source for built-in treatment failure |
Q31096493 | "Those edibles hit hard": Exploration of Twitter data on cannabis edibles in the U.S. |
Q30991496 | "Time for dabs": Analyzing Twitter data on marijuana concentrates across the U.S. |
Q45155513 | "Unplugged": a school-based randomized control trial to prevent and reduce adolescent substance use in the Czech Republic |
Q90202474 | "You can see those concentric rings going out": Emergency personnel's experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire |
Q47196325 | "You got to love rosin: Solventless dabs, pure, clean, natural medicine." Exploring Twitter data on emerging trends in Rosin Tech marijuana concentrates |
Q57818127 | #drunktwitter: Examining the relations between alcohol-related Twitter content and alcohol willingness and use among underage young adults |
Q44049022 | 'Diagnostic orphans' among young adult cannabis users: persons who report dependence symptoms but do not meet diagnostic criteria |
Q51222518 | 'Hangover' effects the morning after marijuana smoking. |
Q57163334 | 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs |
Q28374221 | 'Research' versus 'real-world' patients: representativeness of participants in clinical trials of treatments for cocaine dependence |
Q43421704 | 'Unstandard' ways of answering standard questions: protocol analysis in alcohol survey research |
Q70792182 | (+)-Amphetamine oral 'drug taking behavior' in naive and tolerant rats |
Q89026965 | (-)-Stepholidine reduces cue-induced reinstatement of cocaine seeking and cocaine self-administration in rats |
Q72568879 | (-)-alpha-Acetylmethadol for treatment of chronic pain patients who abuse opioids |
Q51850212 | (--)-alpha-Acetylmethadol effects on alcohol and diazepam use, sexual function and cardiac function. |
Q34236794 | 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice |
Q40065068 | 1-alpha-acetylmethadol (LAAM), methadone and morphine abstinence in dependent rats: EEG and behavioral correlates |
Q36198746 | 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment |
Q42275272 | 12-lead and continuous ECG recordings of subjects during inpatient administration of smoked cocaine |
Q50862751 | 12h abstinence-induced right anterior insula network pattern changes in young smokers. |
Q43241999 | 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel |
Q71736713 | 1983 perspectives on the pharmacotherapy of opiate addiction |
Q35017074 | 3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection |
Q35167166 | 30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California |
Q44048997 | 4-MTA: a new synthetic drug on the dance scene. |
Q48384152 | 5-Hydroxyindoleacetic acid and 5-hydroxytryptophol levels in rat brain: effects of ethanol, pyrazole, cyanamide and disulfiram treatment |
Q37326437 | A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial |
Q34021824 | A "refugee paradox" for substance use disorders? |
Q36951096 | A 10-year study of factors associated with alcohol treatment use and non-use in a U.S. population sample. |
Q51637252 | A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation. |
Q41469476 | A Closeness to Divorce Scale for wives of alcoholics |
Q70300308 | A French experiment: a law for alcoholics presumed to be dangerous |
Q45029062 | A MAOA gene*cocaine severity interaction on impulsivity and neuropsychological measures of orbitofrontal dysfunction: preliminary results |
Q47751667 | A Multiple Indicators Multiple Causes (MIMIC) model of internal barriers to drug treatment in China |
Q37036723 | A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal |
Q98721645 | A Population Study of Prescribed Opioid-based Pain Reliever Use among Individuals with Mood and Anxiety Disorders in Canada |
Q36541145 | A Rasch model analysis of evidence-based treatment practices used in the criminal justice system |
Q51877452 | A Swedish drug abuse warning network. |
Q57663526 | A Twitter-based survey on marijuana concentrate use |
Q40081710 | A behavioral approach to drug abuse |
Q31926080 | A behavioral economic analysis of polydrug abuse in alcoholics: asymmetrical substitution of alcohol and cocaine |
Q48414312 | A behavioral economic measure of demand for alcohol predicts brief intervention outcomes |
Q45068079 | A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers |
Q71736706 | A birds eye view of the present state of drug abuse in Japan |
Q99346819 | A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial |
Q49923119 | A call to end the epidemic of adolescent E-cigarette use. |
Q47566328 | A case-control study of driving-while-impaired offenders |
Q71389903 | A clinical sociology approach to treatment of deviants: the case of drug addicts |
Q36982251 | A cluster analysis of drug use and sexual HIV risks and their correlates in a sample of African-American crack cocaine smokers with HIV infection |
Q53400300 | A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers. |
Q28143101 | A cocaine analog, 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway |
Q51540637 | A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. |
Q51239874 | A cognitive behavioral analysis of relaxation training in drug abusers |
Q53419738 | A commentary on the proposed changes in DSM-III concept of alcohol dependence. |
Q44555322 | A community based study of patterns of psychoactive substance use among street children in a local government area of Nigeria |
Q91124480 | A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial |
Q52006749 | A community survey of adverse effects of cannabis use. |
Q41384478 | A comparative analysis of two methods for the study of alcohol intake in Mexico |
Q37013041 | A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals |
Q44324655 | A comparison of 7-day recall with two summary measures of alcohol use. |
Q44283701 | A comparison of African American and non-Hispanic Caucasian cocaine-abusing outpatients |
Q40523181 | A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States |
Q30422321 | A comparison of a specialist women's alcohol and other drug treatment service with two traditional mixed-sex services: client characteristics and treatment outcome |
Q39294512 | A comparison of alcohol and drug use patterns of homosexual and heterosexual men: the San Francisco Men's Health Study |
Q39405021 | A comparison of alcohol consumption between lesbians and heterosexual women in an urban population |
Q44068309 | A comparison of alcohol, tobacco and drug use as determined from household and school surveys |
Q31035854 | A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department. |
Q44094296 | A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months |
Q73652635 | A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia |
Q38689238 | A comparison of bone quality and its determinants in young opioid-dependent women with healthy control group |
Q31926090 | A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule |
Q44587175 | A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics |
Q36337438 | A comparison of delay discounting among smokers, substance abusers, and non-dependent controls. |
Q49010418 | A comparison of disulfiram acceptors and refusers on selected demographic and clinical characteristics |
Q45109755 | A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. |
Q92721892 | A comparison of longitudinal modelling approaches: Alcohol and cannabis use from adolescence to young adulthood |
Q37675350 | A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis |
Q100758556 | A comparison of product dependence among cigarette only, ENDS only, and dual users: Findings from Wave 3 (2015-2016) of the PATH study |
Q40158685 | A comparison of recidivism rates for alcoholic detox residents referred to treatment facilities |
Q43803499 | A comparison of recovering alcoholic and non-alcoholic smokers |
Q34748679 | A comparison of subjective, psychomotor and physiological effects of a novel muscarinic analgesic, LY297802 tartrate, and oral morphine in occasional drug users |
Q35981674 | A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs |
Q48802259 | A comparison of the catecholamine releasing effect of the khat alkaloids (-)-cathinone and (+)-norpseudoephedrine |
Q45284807 | A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. |
Q60632065 | A comparison of the harms associated with the injection of heroin and amphetamines |
Q46449710 | A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys |
Q70153607 | A comparison of the structure of two models of treatment for alcoholism |
Q92407546 | A comparison of the utility of urine- and hair testing in detecting self-reported drug use among young adult opioid users |
Q41708820 | A comparison of three methods of measuring the type and quantity of services provided during substance abuse treatment |
Q71064395 | A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts |
Q43859250 | A comparison of treatment effectiveness of nonaddict and exaddict professionals in an adolescent treatment program |
Q51159853 | A comparison of two treatment interventions aimed at lowering anxiety levels and alcohol consumption amongst alcohol abusers. |
Q93596346 | A comparison of young drinking offenders with other adolescents |
Q48438062 | A complete analysis of NMDA receptor subunits in periaqueductal grey and ventromedial medulla of morphine tolerant mice |
Q35673184 | A comprehensive assessment of neurocognition in middle-aged chronic cigarette smokers. |
Q33834838 | A comprehensive guide to the application of contingency management procedures in clinical settings |
Q52382305 | A comprehensive model of predictors of suicide attempt in heavy drinkers: Results from a national 3-year longitudinal study. |
Q38415244 | A comprehensive review of the effects of mixing caffeinated energy drinks with alcohol |
Q27312072 | A comprehensive study of sensorimotor cortex excitability in chronic cocaine users: Integrating TMS and functional MRI data |
Q91311689 | A computational model of the Cambridge gambling task with applications to substance use disorders |
Q46646393 | A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task |
Q93346644 | A content analysis of JUUL discussions on social media: Using Reddit to understand patterns and perceptions of JUUL use |
Q38842889 | A content analysis of tweets about high-potency marijuana |
Q41640325 | A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users |
Q39385958 | A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids |
Q43925605 | A controlled trial of buprenorphine treatment for opium dependence: the first experience from Iran. |
Q44331658 | A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence. |
Q45989984 | A controlled trial of fluoxetine in crack cocaine dependence. |
Q44026076 | A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users |
Q70905546 | A critical evaluation of the obstetric use of alcohol in preterm labor |
Q37703072 | A cross-lagged path analysis of five intrapersonal determinants of smoking cessation. |
Q88571522 | A cross-national study of the population-level association between alcohol consumption and suicide rates |
Q35032617 | A cross-national study on Mexico-US migration, substance use and substance use disorders |
Q92225559 | A current re-examination of racial/ethnic disparities in the use of substance abuse treatment: Do disparities persist? |
Q36754360 | A daily calendar analysis of substance use and dating violence among high risk urban youth. |
Q52317958 | A daily diary study of stressful and positive events, alcohol use, and addiction severity among heavy drinking sexual minority men. |
Q90416087 | A day-by-day prospective analysis of stress, craving and risk of next day alcohol intake during alcohol use disorder treatment |
Q42359320 | A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment |
Q50623620 | A descriptive epidemiology of substance use and substance use disorders in Nigeria during the early 21st century |
Q45065333 | A developmental etiological model for drug abuse in men. |
Q72070515 | A discriminant function analysis of various interferon parameters among alcoholics and heavy smokers |
Q40515911 | A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers |
Q36090479 | A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence |
Q113876987 | A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept |
Q45193441 | A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin |
Q35489643 | A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. |
Q43506065 | A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence |
Q36890264 | A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence |
Q48700054 | A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms |
Q48583578 | A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence |
Q51901560 | A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. |
Q34653718 | A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence |
Q33653805 | A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers |
Q52601290 | A fMRI study on the impact of advertising for flavored e-cigarettes on susceptible young adults. |
Q50896299 | A family history and direct interview study of the familial aggregation of substance abuse: the adolescent substance abuse study. |
Q36345352 | A family history of substance dependence obscures the group differences in brain function associated with HIV-1 and ART. |
Q54356414 | A feeding regime for the study of the interaction of ethanol and aging. |
Q46292676 | A follow-up study of heroin addicts five years after first admission to a methadone treatment program |
Q61142509 | A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions |
Q34748883 | A generalized matching law analysis of cocaine vs. food choice in rhesus monkeys: effects of candidate 'agonist-based' medications on sensitivity to reinforcement |
Q35842989 | A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. |
Q44448289 | A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence |
Q44888915 | A haplotype analysis is consistent with the role of functional HTR1B variants in alcohol dependence. |
Q58121252 | A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder |
Q30440748 | A history of alternative reinforcement reduces stimulus generalization of ethanol-seeking in a rat recovery model |
Q35690496 | A hyper-connected but less efficient small-world network in the substance-dependent brain |
Q39200507 | A laboratory-based evaluation of exercise plus contingency management for reducing cigarette smoking |
Q39160965 | A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses? |
Q36942668 | A latent class analysis of underage problem drinking: evidence from a community sample of 16-20 year olds |
Q112577407 | A lay-counsellor delivered brief psychological treatment for men with comorbid Alcohol Use Disorder and depression in primary care: Secondary analysis of data from a randomized controlled trial |
Q41202599 | A lifetime history of alcohol use disorder increases risk for chronic medical conditions after stable remission |
Q37331522 | A longitudinal examination of alcohol, marijuana, and cigarette perceived norms among middle school adolescents |
Q91246766 | A longitudinal examination of daily patterns of cannabis and alcohol co-use among medicinal and recreational veteran cannabis users |
Q58044404 | A longitudinal examination of the impact of childhood emotional abuse on cannabis use trajectories among community youth |
Q39219137 | A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults |
Q57482309 | A longitudinal investigation of the association between cannabis use and alcohol use among people living with HIV |
Q62671084 | A longitudinal mediational study of the stability of alexithymia among alcohol treatment seekers |
Q53200684 | A longitudinal study of cotinine in long-term daily users of e-cigarettes. |
Q44026083 | A longitudinal study of developmental trajectories to young adult cigarette smoking |
Q47249541 | A longitudinal study of electronic cigarette use and onset of conventional cigarette smoking and marijuana use among Mexican adolescents |
Q52100811 | A longitudinal study of health risks associated with alcohol abuse in young navy men. |
Q88296999 | A longitudinal study of risk perceptions and e-cigarette initiation among college students: Interactions with smoking status |
Q43647894 | A longitudinal study of the order of onset of alcohol dependence and major depression |
Q38655762 | A longitudinal study of the reciprocal relationship between ever smoking and urgency in early adolescence |
Q40342675 | A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine |
Q42680120 | A mathematical model of HIV transmission in NSW prisons |
Q38234162 | A meta-analysis of ear-acupuncture, ear-acupressure and auriculotherapy for cigarette smoking cessation. |
Q34677189 | A meta-analysis of the relationship between trait mindfulness and substance use behaviors |
Q91056921 | A mixed-methods assessment of the impact of the opioid epidemic on first responder burnout |
Q48395762 | A morphological comparison of the regional distribution of methadone in human and rat brain as demonstrated by immunofluorescence |
Q56888121 | A multi-level analysis of emergency department data on drinking patterns, alcohol policy and cause of injury in 28 countries |
Q35876082 | A multi-level analysis of the impact of neighborhood structural and social factors on adolescent substance use. |
Q52318218 | A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users. |
Q43842925 | A multicenter randomized evaluation of methadone medical maintenance |
Q40963918 | A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients |
Q43476053 | A multicentre study to introduce naltrexone for opiate dependence in Spain |
Q33775198 | A multidimensional assessment of the validity and utility of alcohol use disorder severity as determined by item response theory models |
Q34851016 | A multistudy analysis of the effects of early cocaine abstinence on sleep |
Q42616342 | A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins |
Q37149192 | A national study of substance use behaviors among NCAA male athletes who use banned performance enhancing substances |
Q90507437 | A nationally representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids |
Q31799466 | A naturalistic study on ending blind dosing in a methadone maintenance clinic in Israel |
Q95806278 | A new Associate Editor for Drug and Alcohol Dependence: Dr. Adam Leventhal |
Q30575430 | A new criterion for acquisition of nicotine self-administration in rats |
Q35037041 | A new definition of early age at onset in alcohol dependence |
Q74610603 | A new editor looks to the past and future of Drug and Alcohol Dependence |
Q73700444 | A new recruiting strategy to allow estimates of response rates in studies with people who inject drugs |
Q48963853 | A note on the characteristics of alcohol abusers with controlled drinking aspirations |
Q44759843 | A note on the use of statistical models in epidemiologic research on illicit drug use. |
Q36546257 | A novel application of propensity score matching to estimate Alcoholics Anonymous' effect on drinking outcomes |
Q59355783 | A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study |
Q34176665 | A parallel process growth mixture model of conduct problems and substance use with risky sexual behavior |
Q93371596 | A parent-oriented alcohol prevention program "Effekt" had no impact on adolescents' alcohol use: Findings from a cluster-randomized controlled trial in Estonia |
Q44448295 | A partner's drug-using status impacts women's drug treatment outcome |
Q39947017 | A peer-led mobile outreach program and increased utilization of detoxification and residential drug treatment among female sex workers who use drugs in a Canadian setting |
Q33872457 | A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys |
Q41900406 | A pharmacological comparison of 3-methoxy-4,5-methylenedioxyamphetamine and LSD in the dog |
Q39155382 | A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal |
Q38741494 | A pilot investigation of acute inhibitory control training in cocaine users |
Q44336437 | A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose |
Q30426188 | A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users |
Q40068924 | A pilot replication of QUIT, a randomized controlled trial of a brief intervention for reducing risky drug use, among Latino primary care patients |
Q47635717 | A pilot study of loss aversion for drug and non-drug commodities in cocaine users |
Q91231036 | A pilot study to examine the acceptability and health effects of electronic cigarettes in HIV-positive smokers |
Q44448282 | A pilot trial of olanzapine for the treatment of cocaine dependence |
Q34649737 | A pilot trial of topiramate for the treatment of cocaine dependence |
Q44342350 | A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. |
Q35417660 | A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence |
Q37462555 | A placebo-controlled trial of buspirone for the treatment of marijuana dependence |
Q34091611 | A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period |
Q37030113 | A placebo-controlled trial of modafinil for nicotine dependence |
Q43597899 | A plan aimed at the prevention and treatment of drug dependence |
Q35607184 | A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men. |
Q64986122 | A possible link between morphine and alcohol preferences in rat. |
Q70398702 | A possible role of antithrombin III in venous thrombosis among alcoholics |
Q41548119 | A possible role of catecholamines and (Na+ + K+)ATPase in the ethanol withdrawal syndrome |
Q70667338 | A possible role of the parasympathetic system in the alcohol withdrawal syndrome |
Q73316253 | A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States |
Q92811437 | A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients |
Q36628375 | A preliminary experimental investigation of peer influence on risk-taking among adolescent smokers and non-smokers. |
Q44852811 | A preliminary investigation of early smoking initiation and nicotine dependence in Korean adults |
Q38963927 | A preliminary longitudinal study of white matter alteration in cocaine use disorder subjects. |
Q58702818 | A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder |
Q34980314 | A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine |
Q30440262 | A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence |
Q39217119 | A preliminary report on crime and addiction within a community-wide population of narcotic addicts |
Q70398673 | A preliminary report: nutritional levels and cognitive performance in chronic alcohol abusers |
Q35952369 | A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO |
Q42724123 | A preliminary study of longitudinal neuroadaptation associated with recovery from addiction |
Q35812912 | A preliminary study of the neural effects of behavioral therapy for substance use disorders |
Q48887779 | A preliminary study of the problem-solving strategies of detoxified long-term alcoholics |
Q96591736 | A preliminary validation of the adolescent e-cigarette consequences questionnaire |
Q44676228 | A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed? |
Q46070934 | A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation |
Q52265924 | A prospective assessment of opiate addiction treatment protocols for inpatients with HIV-related syndromes. |
Q34577163 | A prospective population based study of changes in alcohol use and binge drinking after a mass traumatic event |
Q37308121 | A prospective study of familial conflict, psychological stress, and the development of substance use disorders in adolescence |
Q34614361 | A prospective study of marijuana use change and cessation among adolescents |
Q88515473 | A prospective study of newly incident cannabis use and cannabis risk perceptions: Results from the United States Monitoring the Future study, 1976-2013 |
Q93342478 | A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife |
Q46045863 | A prospective study of risk and protective factors for substance use among impoverished women living in temporary shelter settings in Los Angeles County |
Q24647351 | A prospective study of risk drinking: at risk for what? |
Q98509866 | A prospective study of the association between rate of nicotine metabolism and alcohol use in tobacco users in the United States |
Q43041836 | A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus |
Q59256216 | A qualitative investigation comparing sexual effects of alcohol and marijuana among adults |
Q35048123 | A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China |
Q36912594 | A quasi-experimental study examining New York State's tobacco-free regulation: effects on clinical practice behaviors. |
Q42611131 | A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system |
Q44337497 | A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence |
Q44345951 | A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence |
Q39009581 | A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release |
Q36711454 | A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release |
Q92575307 | A randomized clinical trial of motivational interviewing plus skills training vs. Relaxation plus education and 12-Steps for substance using incarcerated youth: Effects on alcohol, marijuana and crimes of aggression |
Q93189170 | A randomized controlled trial and economic evaluation of the Parents Under Pressure program for parents in substance abuse treatment |
Q91056927 | A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders |
Q34176604 | A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention. |
Q90722342 | A randomized controlled trial of a manual-only treatment for reduction and cessation of problematic caffeine use |
Q34631482 | A randomized controlled trial of intensive referral to 12-step self-help groups: one-year outcomes |
Q53594572 | A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. |
Q39657856 | A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users |
Q34030894 | A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry |
Q36248803 | A randomized controlled trial of the effects of working memory training in methadone maintenance patients |
Q34114588 | A randomized controlled trial of two primary school intervention strategies to prevent early onset tobacco smoking |
Q46652344 | A randomized controlled trial to influence client language in substance use disorder treatment |
Q36619657 | A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence |
Q36678007 | A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management. |
Q30578204 | A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification. |
Q97876353 | A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms |
Q46333726 | A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults |
Q46708584 | A randomized placebo-controlled trial of gabapentin for cocaine dependence |
Q30537387 | A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders |
Q46977188 | A randomized study of the effect of anonymity, quasi-anonymity, and Certificates of Confidentiality on postpartum women's disclosure of sensitive information |
Q33651514 | A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. |
Q37392151 | A randomized trial of contingency management for adolescent marijuana abuse and dependence |
Q36579283 | A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans |
Q34091629 | A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit |
Q44686653 | A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence |
Q44049015 | A randomized, double-blind, placebo-controlled safety study of high-dose dextromethorphan in methadone-maintained male inpatients |
Q31799450 | A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence |
Q50198759 | A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release |
Q40273771 | A rationale for opiate withdrawal symptomatology |
Q52505251 | A reconsideration of the relevance of recent animal studies for development of treatment procedures for alcoholics. |
Q35694145 | A reexamination of medical marijuana policies in relation to suicide risk |
Q91441412 | A repeated cross-sectional study of factors associated with pregabalin-positive poisoning deaths in Ireland |
Q44836258 | A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers |
Q36162226 | A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation |
Q36803299 | A retrospective and prospective analysis of trading sex for drugs or money in women substance abuse treatment patients |
Q38710339 | A retrospective review of unintentional opioid overdose risk and mitigating factors among acutely injured trauma patients. |
Q40283152 | A review of alcohol's effects on sex and reproduction |
Q37302772 | A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment. |
Q27312296 | A review of pharmacogenetic studies of substance-related disorders |
Q34535899 | A review of the additive health risk of cannabis and tobacco co-use |
Q39504084 | A review of the effects of repeated administration of selected phenylethylamines |
Q30239098 | A review: Fentanyl and non-pharmaceutical fentanyls |
Q44344897 | A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain |
Q44026057 | A screening trial of amantadine as a medication for cocaine dependence |
Q69056383 | A search for degeneration in the circumventricular area of ethanol-treated mice |
Q42991077 | A serotonin transporter polymorphism (5-HTTLPR) predicts the development of adolescent alcohol use. |
Q37614742 | A simulative comparison of respondent driven sampling with incentivized snowball sampling--the "strudel effect". |
Q35876092 | A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm |
Q51627961 | A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. |
Q45173593 | A sociological theory of the diffusion and social setting of opiate addiction |
Q36066920 | A stage I pilot study of acceptance and commitment therapy for methadone detoxification |
Q47308855 | A state-wide assessment: marital stability and client outcomes |
Q68800036 | A study of drug abuse in rural areas of Punjab (India) |
Q72433464 | A study of hospitalized surgical patients on methadone maintenance |
Q69748689 | A study of sex differences in cognitive impairment in alcoholics using traditional and computer-based tests |
Q43844635 | A study of street heroin lots for the presence of the hepatitis B surface antigen |
Q104130692 | A study of the effectiveness of naltrexone in preventing recurrence of methadone poisoning in opioid-naive children |
Q42205250 | A study of the mediator spectrum of delta-9 tetrahydrocanabinol effects on cerebral bioelectric activity |
Q59780354 | A study on the TNF-α system in Caucasian Spanish patients with alcoholic liver disease |
Q51290406 | A study on the personality characteristics of Iranian addicts. |
Q50730930 | A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. |
Q50626212 | A survey of nonmedical use of tranquilizers, stimulants, and pain relievers among college students: patterns of use among users and factors related to abstinence in non-users. |
Q35552364 | A survey study to characterize use of Spice products (synthetic cannabinoids). |
Q34334521 | A syndemic including cigarette smoking and sexual risk behaviors among a sample of MSM in Shanghai, China |
Q103834910 | A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys |
Q36380061 | A systematic literature review of tobacco use among adults 15 years and older in sub-Saharan Africa |
Q114190317 | A systematic review and behaviour change technique analysis of remotely delivered alcohol and/or substance misuse interventions for adults |
Q99622438 | A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders |
Q88728502 | A systematic review of community-based interventions to improve oral chronic disease medication regimen adherence among individuals with substance use disorder |
Q34992482 | A systematic review of evidence on the association between cocaine use and seizures. |
Q38778365 | A systematic review of injecting-related injury and disease among people who inject drugs |
Q96680244 | A systematic review of opioid overdose interventions delivered within emergency departments |
Q92113307 | A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions |
Q92391391 | A systematic review of stakeholder perceptions of supervised injection facilities |
Q129750376 | A systematic review of task-sharing interventions for substance use and substance use disorder in low- and middle-income countries |
Q35741502 | A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction |
Q34380750 | A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization |
Q38725058 | A systematic review of the motivations for the non-medical use of prescription drugs in young adults |
Q44322235 | A systems approach to care pathways into in-patient alcohol detoxification: outcomes from a retrospective study. |
Q37470235 | A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. |
Q50715004 | A taxonomy of small hostels for alcoholics. |
Q36935694 | A test of alcohol dose effects on multiple behavioral measures of impulsivity. |
Q33972637 | A test of the DSM-5 severity scale for alcohol use disorder |
Q35723292 | A translational behavioral model of mood-based impulsivity: Implications for substance abuse |
Q44430861 | A tripartite of HIV-risk for African American women: the intersection of drug use, violence, and depression. |
Q31926110 | A twin study on sensation seeking, risk taking behavior and marijuana use. |
Q37621846 | A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone. |
Q45247391 | A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs |
Q36586100 | A vaccine against methamphetamine attenuates its behavioral effects in mice |
Q48695594 | A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. |
Q37619204 | A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine |
Q46944259 | A walk through the history of research in drug abuse trends and fads. The Nathan B. Eddy Award address given at CPDD 2005: part II. |
Q45421878 | A web-based survey on mephedrone |
Q98782356 | A within-person comparison of the subjective effects of higher vs. lower-potency cannabis |
Q52171035 | A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. |
Q36406999 | A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances |
Q35983512 | ADAPTA: A pilot randomised controlled trial of an alcohol-focused intervention versus a healthy living intervention for problem drinkers identified in a general hospital setting |
Q38664612 | ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation. |
Q47306773 | AIDS among drug users in Europe |
Q51902219 | AIDS research in the NIDA Clinical Trials Network: emerging results. |
Q53653756 | ANAPC1 and SLCO3A1 are associated with nicotine dependence: meta-analysis of genome-wide association studies. |
Q99357872 | ART uptake and adherence among women who use drugs globally: A scoping review |
Q59698505 | AUDIT and AUDIT-C as screening instruments for alcohol problem use in adolescents |
Q46036314 | AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey. |
Q84512723 | Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal |
Q46692203 | Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance |
Q103024476 | Abnormal organization of inhibitory control functional networks in future binge drinkers |
Q44959429 | Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire |
Q41280875 | Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program |
Q42276662 | Absence of acute cocaine interactions with the MAO-B inhibitor selegiline |
Q37652906 | Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment |
Q51004187 | Abstaining and carousing: substance use among adolescents in the Western Isles of Scotland. |
Q45946601 | Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. |
Q44070864 | Abstinence at intake for marijuana dependence treatment predicts response |
Q41460519 | Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum |
Q51055346 | Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum. |
Q44049003 | Abstinence reinforcement maintenance contingency and one-year follow-up |
Q71595757 | Abstinence-induced changes in plasma apolipoprotein levels of alcoholics |
Q98776076 | Abstinence-reinforcing contingency management improves HIV viral load suppression among HIV-infected people who use drugs: A randomized controlled trial |
Q35413458 | Abstinence-related changes in sleep during treatment for cocaine dependence |
Q72426594 | Abstracts 5th Biennial International Symposium on Alcoholism. June 9-13, 1980, Cardiff, Wales |
Q46985229 | Abuse deterrent formulations and the Controlled Substances Act (CSA). |
Q36674756 | Abuse liability and reinforcing efficacy of oral tramadol in humans |
Q43918545 | Abuse liability and the regulatory control of therapeutic drugs: untested assumptions |
Q40587223 | Abuse liability assessment of CNS drugs: conclusions, recommendations, and research priorities |
Q43055981 | Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats. |
Q46712098 | Abuse liability assessment of atomoxetine in a drug-abusing population |
Q101571361 | Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers |
Q103722843 | Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system |
Q51911194 | Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. |
Q52313952 | Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount. |
Q34051406 | Abuse liability of oxycodone as a function of pain and drug use history |
Q34749168 | Abuse liability of the dietary supplement dimethylamylamine |
Q37291137 | Abuse liability studies of opioid agonist-antagonists in humans |
Q40339532 | Abuse of prescription drugs and the risk of addiction |
Q52238302 | Abuse potential and pharmacological comparison of tramadol and morphine. |
Q39593297 | Abuse potential evaluation of inhalants |
Q42541323 | Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification. |
Q57137141 | Accelerated repetitive transcranial magnetic stimulation does not influence grey matter volumes in regions related to alcohol relapse: An open-label exploratory study |
Q36420087 | Accentuating effects of nicotine on ethanol response in mice with high genetic predisposition to ethanol-induced locomotor stimulation |
Q91384326 | Acceptability and willingness to pay for contingency management interventions among parents of young adults with problematic opioid use |
Q33912772 | Acceptability of a safer injection facility among injection drug users in San Francisco. |
Q58427992 | Acceptability of audio computer-assisted self-interview (ACASI) among substance abusers seeking treatment in Rio de Janeiro, Brazil |
Q67290324 | Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts |
Q100295813 | Acceptability of real-time video counselling compared to other behavioural interventions for smoking cessation in rural and remote areas |
Q49968039 | Acceptance and patterns of personal vaporizer use in Australia and the United Kingdom: Results from the International Tobacco Control survey. |
Q37381975 | Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care |
Q35613251 | Access to a running wheel decreases cocaine-primed and cue-induced reinstatement in male and female rats. |
Q44342833 | Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition? |
Q37154026 | Access to drug and alcohol treatment among a cohort of street-involved youth. |
Q43685938 | Access to medical care and service utilization among injection drug users with HIV/AIDS. |
Q39976461 | Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling |
Q37224938 | Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. |
Q44434945 | Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting |
Q91207264 | Accidental drug overdose deaths in Connecticut, 2012-2018: The rise of polysubstance detection? |
Q57297866 | Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder |
Q30405512 | Acculturation, drinking and social settings among U.S. Hispanics |
Q36536828 | Accumbens functional connectivity during reward mediates sensation-seeking and alcohol use in high-risk youth |
Q35920029 | Accuracy of alcohol diagnosis among DWI offenders referred for screening |
Q36621480 | Accuracy of hospital discharge data: five alcohol-related diseases |
Q40384864 | Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients. |
Q41470045 | Acetaldehyde adducts with serum proteins are not responsible for decreased drug binding in alcoholic patients |
Q46205904 | Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission. |
Q34102402 | Acetylcodeine, an impurity of illicitly manufactured heroin, elicits convulsions, antinociception, and locomotor stimulation in mice |
Q49122169 | Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers |
Q37470214 | Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment |
Q36516563 | Acquisition of cocaine self-administration in ovariectomized female rats: effect of estradiol dose or chronic estradiol administration |
Q90256488 | Active cannabis marketing and adolescent past-year cannabis use |
Q39242280 | Acupuncture fails to improve treatment outcome in alcoholics |
Q26766272 | Acupuncture for substance use disorders: A systematic review and meta-analysis |
Q45068077 | Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans |
Q42605845 | Acute administration of vinpocetine, a phosphodiesterase type 1 inhibitor, ameliorates hyperactivity in a mice model of fetal alcohol spectrum disorder |
Q35965680 | Acute alcohol consumption elevates serum bilirubin: an endogenous antioxidant |
Q69544909 | Acute alcohol ingestion reduces heart rate variability |
Q92352149 | Acute alcohol intake alters resting state functional connectivity of nucleus accumbens with pain-related corticolimbic structures |
Q96028249 | Acute alcohol use in Australian coronial suicide cases, 2010-2015 |
Q38711806 | Acute and chronic alcohol use correlated with methods of suicide in a Swiss national sample |
Q92297339 | Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial |
Q43503059 | Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms |
Q91072378 | Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects |
Q37163680 | Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study |
Q91306996 | Acute cocaine administration alters permeability of blood-brain barrier in freely-moving rats- Evidence using miniaturized fluorescence microscopy |
Q36582340 | Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans |
Q36646392 | Acute disinhibiting effects of alcohol as a factor in risky driving behavior |
Q37109407 | Acute effects of alcohol on inhibitory control and information processing in high and low sensation-seekers |
Q47706748 | Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses |
Q44049010 | Acute effects of oral cocaine on inhibitory control of behavior in humans |
Q34995538 | Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study |
Q68134267 | Acute ethanol effects on sensory/motor function in baboons with a history of chronic ethanol ingestion |
Q57838896 | Acute harms associated with inhalant misuse: Co-morbidities and trends relative to age and gender among ambulance attendees |
Q52505761 | Acute heroin abstinence in man. III. Effect upon waking and slow wave sleep. |
Q52506317 | Acute heroin abstinence in man: I. Changes in behavior and sleep. |
Q71358712 | Acute heroin abstinence in man: II. Alterations in rapid eye movement (REM) sleep |
Q70824881 | Acute heroin abstinence in man: IV. Sleep--waking state contingencies |
Q36869525 | Acute myocardial infarction in young adults who abuse amphetamines |
Q44330127 | Acute opioid withdrawal is associated with increased neural activity in reward-processing centers in healthy men: A functional magnetic resonance imaging study |
Q35952259 | Acute oral administration of the novel, competitive and selective glucocorticoid receptor antagonist ORG 34517 reduces the severity of ethanol withdrawal and related hypothalamic-pituitary-adrenal axis activation |
Q68241298 | Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone |
Q51451513 | Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis. |
Q37351342 | Acute responses to nicotine and smoking: implications for prevention and treatment of smoking in lower SES women |
Q48436120 | Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: a microdialysis study in the rat. |
Q51715032 | Acute scopolamine poisoning after sniffing adulterated cocaine. |
Q92731461 | Acute stressors and clinical characteristics differentiate death by suicide, accident, or natural causes among illicit and prescription opiate users |
Q51091137 | Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects. |
Q48794569 | Acute subjective responses to paroxetine in normal volunteers |
Q48120269 | Acute tolerance in inbred and selected lines of mice |
Q44375889 | Acute tolerance to the cardiovascular effects of nicotine |
Q45081259 | Acute tolerance to the cardiovascular effects of volatilized cocaine free base in rats |
Q48120284 | Adaptation to ethanol-induced fluidization of brain lipid bilayers |
Q35828039 | Adapting judicial supervision to the risk level of drug offenders: discharge and 6-month outcomes from a prospective matching study |
Q44730108 | Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'. |
Q48120292 | Adaptive changes in membrane lipid composition and fluidity as the basis for ethanol tolerance |
Q39296785 | Adaptive changes in the dopamine system produced by chronic ethanol feeding |
Q39296794 | Adaptive changes in the responsiveness of adenylate cyclase to catecholamines |
Q44152875 | Adaptive sampling in research on risk-related behaviors |
Q32033759 | Addiction and imaging of the living human brain |
Q35841679 | Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods study |
Q114190354 | Addiction onset and offset characteristics and public stigma toward people with common substance dependencies: A large national survey experiment |
Q90192249 | Addiction resistance to alcohol: What about heavy drinkers who avoid alcohol problems? |
Q36074960 | Addiction resistance: Definition, validation and association with mastery |
Q46580354 | Addiction severity assessment tool: development of a self-report measure for clients in substance abuse treatment |
Q38505382 | Addicts' attitudes toward drugs: a semantic-differential study |
Q39704143 | Additional metabolic correlates of l-α-acetylmethadol (LAAM)-induced cellular tolerance and physical dependence: The role of the hepatic microsomal electron transport system |
Q93152839 | Additive effectiveness of contingency management on cognitive behavioural treatment for smokers with depression: Six-month abstinence and depression outcomes |
Q35909531 | Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. |
Q51734666 | Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder. |
Q100733762 | Addressing opioid overdose deaths: The vision for the HEALing communities study |
Q90616270 | Addressing the nexus of risk: Biobehavioral outcomes from a cluster randomized trial of the Women's Health CoOp Plus in Pretoria, South Africa |
Q50422046 | Addressing the public health concerns of Fetal Alcohol Spectrum Disorder: Impact of stigma and health literacy |
Q100510116 | Adherence to buprenorphine: An analysis of prescription drug monitoring program data |
Q46566316 | Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care. |
Q50673273 | Admissions for drug and alcohol-related problems in Nigerian psychiatric care facilities in one year |
Q38914748 | Adolescent Community Reinforcement Approach implementation and treatment outcomes for youth with opioid problem use. |
Q82856203 | Adolescent alcohol and cannabis use in relation to peer and school factors. Results of multilevel analyses |
Q46794282 | Adolescent alcohol use and adult alcohol disorders: a two-part random-effects model with diagnostic outcomes |
Q40164881 | Adolescent alcohol use and alcohol use disorders in Mexico City |
Q40868921 | Adolescent alcohol use development and young adult outcomes |
Q58437117 | Adolescent binge drinking and risky health behaviours: Findings from northern Russia |
Q33653144 | Adolescent cannabis use increases risk for cocaine-induced paranoia |
Q68503886 | Adolescent drug taking: role of family and peers |
Q44861561 | Adolescent drug use, health and personality |
Q39213103 | Adolescent drug using groups in Chicago parks |
Q57177968 | Adolescent dual-product users: Acquisition and situational use of cigarettes and cigars |
Q36098792 | Adolescent exposure to nicotine results in reinforcement enhancement but does not affect adult responding in rats |
Q91673296 | Adolescent exposures to traditional and novel psychoactive drugs, reported to National Poison Data System (NPDS), 2007-2017 |
Q45800238 | Adolescent illicit drug use and subsequent academic and psychosocial adjustment: an examination of socially-mediated pathways |
Q91415792 | Adolescent menthol cigarette use and risk of nicotine dependence: Findings from the national Population Assessment on Tobacco and Health (PATH) study |
Q104571667 | Adolescent nicotine and marijuana vaping activity and the use of other illicit substances |
Q48276499 | Adolescent nicotine exposure sensitizes cue-induced reinstatement of cocaine seeking in rats bred for high and low saccharin intake. |
Q30494884 | Adolescent outpatient treatment and continuing care: main findings from a randomized clinical trial |
Q57815852 | Adolescent recanting of alcohol use: A longitudinal investigation of time-varying intra-individual predictors |
Q36010131 | Adolescent smokers rate delayed rewards as less certain than adolescent nonsmokers |
Q88728504 | Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations |
Q38733072 | Adolescent smoking experimentation as a predictor of daily cigarette smoking |
Q30997844 | Adolescent substance use and educational attainment: An integrative data analysis comparing cannabis and alcohol from three Australasian cohorts |
Q46493170 | Adolescent substance use and hospital presentations: a record linkage assessment of 12-month outcomes. |
Q90721225 | Adolescent treatment admissions for marijuana following recreational legalization in Colorado and Washington |
Q51995354 | Adolescent versus adult onset and the development of substance use disorders in males. |
Q49923123 | Adolescents and e-cigarettes: Objects of concern may appear larger than they are. |
Q31037235 | Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research |
Q93124503 | Adolescents' awareness of the nicotine strength and e-cigarette status of JUUL e-cigarettes |
Q34091507 | Adolescents' expectancies for smoking to regulate affect predict smoking behavior and nicotine dependence over time |
Q71865397 | Adolescents' experiences of smoking cessation |
Q90378748 | Adolescents' smoking environment under weak tobacco control: A mixed methods study for Portugal |
Q38653983 | Adolescents, alcohol, and marijuana: Context characteristics and problems associated with simultaneous use. |
Q57429564 | Adoption, reach and effectiveness of computer-based, practitioner delivered and combined smoking interventions in general medical practices: A three-arm cluster randomized trial |
Q26852192 | Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders |
Q51839535 | Adulterants in heroin/cocaine: implications concerning heroin-associated nephropathy. |
Q69720034 | Adults at risk: a comparison of heavy drinkers in three areas of Britain |
Q35109298 | Adults with a family history of alcohol related problems are more impulsive on measures of response initiation and response inhibition |
Q91654338 | Advanced visualizations to interpret prescription drug monitoring program information |
Q35158688 | Advances in neurobiological research related to interventions in adolescents with substance use disorders: research to practice |
Q44348351 | Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder |
Q92413250 | Adverse childhood experiences and MSM marijuana use |
Q44448320 | Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis |
Q89391129 | Adverse effects of GHB-induced coma on long-term memory and related brain function |
Q34420578 | Adverse effects of stimulant drugs in a community sample of drug users. |
Q46698611 | Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender |
Q51248684 | Adverse reactions and seeking medical treatment among student cannabis users. |
Q64118266 | Adverse symptoms users attribute to e-cigarettes: Results from a national survey of US adults |
Q43802396 | Adversity among drug users: relationship to impulsivity |
Q37036769 | Aerobic exercise decreases the positive-reinforcing effects of cocaine |
Q57137130 | Affect and cannabis use in daily life: a review and recommendations for future research |
Q91572562 | Affect, motivation, temptation, and drinking among alcohol-dependent outpatients trying to maintain abstinence: An Ecological Momentary Assessment study |
Q51270255 | Affective changes in male and female methadone patients. |
Q44555326 | Affiliation with deviant peers among children of substance dependent fathers from pre-adolescence into adolescence: associations with problem behaviors |
Q35653149 | African American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patients |
Q70870008 | After how many detoxications is rehabilitation probable? |
Q79426432 | Age and sex differences in factors associated with the onset of cannabis use: a cohort study |
Q35545429 | Age and sex effects levels of choline compounds in the anterior cingulate cortex of adolescent methamphetamine users |
Q60641795 | Age and working memory predict delay discounting in adolescents in treatment for cannabis use disorders |
Q91886332 | Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: A focus on young adults |
Q46520068 | Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia |
Q96771435 | Age disparities in six-month treatment retention for opioid use disorder |
Q40189226 | Age of first drunkenness and risks for all-cause mortality: A 27-year follow-up from the epidemiologic catchment area study. |
Q92078175 | Age of initiation and transition times to tobacco dependence: Early onset and rapid escalated use increase risk for dependence severity |
Q24653863 | Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders |
Q52646592 | Age sensitive associations of adolescent substance use with amygdalar, ventral striatum, and frontal volumes in young adulthood. |
Q91211478 | Age trends in alcohol use behavior patterns among U.S. adults ages 18-65 |
Q47682907 | Age trends in rates of substance use disorders across ages 18-90: Differences by gender and race/ethnicity |
Q37541137 | Age, period and cohort trends in drug abuse hospitalizations within the total Swedish population (1975-2010). |
Q27312598 | Age, period, and cohort effects in heavy episodic drinking in the US from 1985 to 2009 |
Q40635860 | Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015. |
Q48429071 | Age-dependent susceptibility of rat cerebellar Purkinje cells to ethanol exposure |
Q40311787 | Age-period-cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys |
Q35216241 | Age-related differences in cigarette smoking among whites and African-Americans: evidence for the crossover hypothesis |
Q38722131 | Age-related patterns in nonmedical prescription opioid use and disorder in the US population at ages 12-34 from 2002 to 2014. |
Q88737526 | Age-related prevalence and twelve-month incidence of illicit drug use in a cohort of Australian gay and bisexual men: Results from the Flux Study |
Q73045435 | Age-specific patterns of hallucinogen use in the US population: an analysis using generalized additive models |
Q36328453 | Age-varying associations between substance use behaviors and depressive symptoms during adolescence and young adulthood |
Q47568032 | Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification. |
Q30981440 | Aggregate and event-level associations between substance use and sexual behavior among gay and bisexual men: Comparing retrospective and prospective data |
Q91195615 | Aggression and violence at ambulance attendances where alcohol, illicit and/or pharmaceutical drugs were recorded: A 5-year study of ambulance records in Victoria, Australia |
Q43647884 | Aggressive behavior and opportunities to purchase drugs |
Q43803509 | Aggressive responding of male heroin addicts under methadone treatment: psychometric and neuroendocrine correlates |
Q35017248 | Agitated depression in substance dependence |
Q35875524 | Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons |
Q52047167 | Agreement between DSM-III and III-R substance use disorders. |
Q39639987 | Agreement between head of household informant and self-report in a community survey of substance use in India. |
Q46966070 | Alcohol abuse among high school students in Benin City, Nigeria |
Q39242274 | Alcohol abuse and dependence in an urban primary care clinic in Nigeria |
Q54795650 | Alcohol abuse in a rural community in India. Part I: Epidemiological study. |
Q70709838 | Alcohol abuse in a rural community in India. Part II: characteristics of alcohol users |
Q50708133 | Alcohol abuse: A case study of secondary school students in a rural area of Benin district, Nigeria |
Q77893784 | Alcohol abusers who want to quit smoking: implications for clinical treatment |
Q36639727 | Alcohol and HIV sexual risk behaviors among injection drug users |
Q53925930 | Alcohol and Islamic faith. |
Q59187178 | Alcohol and STI risk: Evidence from a New Zealand longitudinal birth cohort |
Q46588038 | Alcohol and benzodiazepines in falls: an epidemiological view |
Q48405814 | Alcohol and benzodiazepines: recent mechanistic studies |
Q40303383 | Alcohol and cardiovascular disorders |
Q47626475 | Alcohol and depression: Evidence from the 2014 health survey for England. |
Q91961465 | Alcohol and disgust: An intimate relationship |
Q35004424 | Alcohol and distraction interact to impair driving performance |
Q36497581 | Alcohol and drinking cultures in Vietnam: A review |
Q33653734 | Alcohol and drug involvement after adolescent treatment and functioning during emerging adulthood |
Q39870839 | Alcohol and drug involvement in motorcycle driver injuries in the city of Sao Paulo, Brazil: Analysis of crash culpability and other associated factors |
Q30427301 | Alcohol and drug use among young adults driving to a drinking location |
Q39481254 | Alcohol and drug use patterns have declined between generations of younger gay-bisexual men in San Francisco |
Q94953649 | Alcohol and marijuana co-use: Consequences, subjective intoxication, and the operationalization of simultaneous use |
Q33740870 | Alcohol and marijuana use in early adulthood for at-risk men: time-varying associations with peer and partner substance use. |
Q35195803 | Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty |
Q92413973 | Alcohol and parenthood: An integrative analysis of the effects of transition to parenthood in three Australasian cohorts |
Q46244170 | Alcohol and substance screening and brief intervention for detainees kept in police custody. A feasibility study |
Q40053532 | Alcohol and substance use diagnoses among HIV-positive patients receiving care in NYC clinic settings |
Q38130783 | Alcohol and the methylome: design and analysis considerations for research using human samples |
Q41350345 | Alcohol and the validation of experimental aggression paradigms: the Taylor reaction time procedure |
Q45893832 | Alcohol and tobacco use and heart rate reactivity to a psychosocial stressor in an adolescent population |
Q33674062 | Alcohol and tobacco use disorder comorbidity in young adults and the influence of romantic partner environments |
Q33968477 | Alcohol and tobacco use disorders in a general population: short-term and long-term associations from the St. Louis epidemiological catchment area study |
Q34240324 | Alcohol and tobacco use patterns among heterosexually and homosexually experienced California women |
Q44189343 | Alcohol attentional bias as a predictor of alcohol abusers' treatment outcome |
Q41190647 | Alcohol consumption across the lifecycle in Australia, 1985-1988. |
Q104506540 | Alcohol consumption among French physicians: A cross-sectional study |
Q35570894 | Alcohol consumption among HIV-positive pregnant women in KwaZulu-Natal, South Africa: prevalence and correlates |
Q44623858 | Alcohol consumption among high-risk Thai youth after raising the legal drinking age. |
Q69661606 | Alcohol consumption among university students in Spain |
Q93076121 | Alcohol consumption among university students in the night-time economy in the UK: A three-wave longitudinal study |
Q46314692 | Alcohol consumption amongst South African farm workers: a challenge for post-apartheid health sector transformation |
Q93008277 | Alcohol consumption and S-Klotho plasma levels in sedentary healthy middle-aged adults: A cross sectional study |
Q78170768 | Alcohol consumption and alcohol dependence in adults in New York State |
Q43270939 | Alcohol consumption and all-cause mortality among elderly in Finland |
Q69444353 | Alcohol consumption and casualties; drinking in the event |
Q91211470 | Alcohol consumption and consequences in adolescents in 68 low and middle-income countries - a multi-country comparison of risks by sex |
Q35040590 | Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection |
Q99413409 | Alcohol consumption and incidence of sleep disorder: A systematic review and meta-analysis of cohort studies |
Q46490314 | Alcohol consumption and injury in the general population: from a national sample |
Q49311403 | Alcohol consumption and morbidity in the Canada Health Survey: inter-beverage differences |
Q69487485 | Alcohol consumption and physical symptoms in a Mexican American population |
Q30486253 | Alcohol consumption and quitting smoking in the International Tobacco Control (ITC) Four Country Survey |
Q39368021 | Alcohol consumption and rates of alcoholism in Greece |
Q67575074 | Alcohol consumption and rates of personal violence in Australia |
Q50645629 | Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder |
Q35004487 | Alcohol consumption associated with collegiate American football pre-game festivities |
Q39318215 | Alcohol consumption during pregnancy among Southern city women |
Q39810966 | Alcohol consumption in Mozambique: regular consumption, weekly pattern and binge drinking |
Q40099388 | Alcohol consumption in very old age and its association with survival: A matter of health and physical function. |
Q43728930 | Alcohol consumption patterns and health care costs in an HMO. |
Q34258900 | Alcohol consumption patterns in HIV-infected adults with alcohol problems. |
Q69749000 | Alcohol consumption, cigarette sales and mortality in the United Kingdom: an analysis of the period 1970-1985 |
Q50137881 | Alcohol consumption, gender and self-reported hypertension |
Q92749378 | Alcohol demand assessed daily: Validity, variability, and the influence of drinking-related consequences |
Q45000228 | Alcohol dependence and the alcohol Stroop paradigm: evidence and issues |
Q54703330 | Alcohol dependence, family history, and D2 dopamine receptor function as neuroendocrinologically assessed with apomorphine. |
Q47314660 | Alcohol drinking among Moslem and Druze adolescents in Israel in 1990. |
Q46699896 | Alcohol drinking and cigarette smoking: an exploration of the association in middle-aged men and women |
Q48922136 | Alcohol drinking habits and attitudes of the adult Jewish population in Israel 1987. |
Q48269458 | Alcohol drinking in the rat induced by acute intracerebral infusion of two tetrahydroisoquinolines and a β-carboline |
Q104286952 | Alcohol excise taxes as a percentage of retail alcohol prices in 26 OECD countries |
Q43570038 | Alcohol expectancies and motives in a substance abusing male treatment sample |
Q90719549 | Alcohol expectancies change in early to middle adolescence as a function of the exposure to parental alcohol use |
Q89714500 | Alcohol expectancies mediate the association between the neural response to emotional words and alcohol consumption |
Q60767609 | Alcohol expectancies, drinking refusal self-efficacy and drinking behaviour in Asian and Australian students |
Q52172088 | Alcohol exposure therapy: generalisation and changes in responsivity. |
Q44332696 | Alcohol high risk drinking, abuse and dependence among tobacco smoking medical care patients and the general population |
Q91092285 | Alcohol impairs hippocampal function: From NMDA receptor synaptic transmission to mitochondrial function |
Q34258650 | Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes |
Q52412994 | Alcohol incidence in rural drivers: characteristics of a population and clues for countermeasures. |
Q35973172 | Alcohol intoxication and sexual risk behaviors among rural-to-urban migrants in China |
Q35134404 | Alcohol involvement as a function of co-occurring alcohol use disorders and major depressive episode: evidence from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q87946039 | Alcohol metabolism in hangover sensitive versus hangover resistant social drinkers |
Q47250683 | Alcohol misuse and criminal offending: findings from a 30-year longitudinal study |
Q43202741 | Alcohol misuse and functional impairment in the UK Armed Forces: a population-based study |
Q48439280 | Alcohol misuse and psychosocial outcomes in young adulthood: results from a longitudinal birth cohort studied to age 30 |
Q48460881 | Alcohol misuse and relationship breakdown: findings from a longitudinal birth cohort |
Q45355598 | Alcohol misuse and violent behavior: findings from a 30-year longitudinal study. |
Q40497437 | Alcohol misuse in the United Kingdom Armed Forces: A longitudinal study |
Q39305819 | Alcohol misuse, risky sexual behaviors, and HIV or syphilis infections among Chinese men who have sex with men. |
Q88006731 | Alcohol mixed with energy drinks and arrhythmias |
Q37284392 | Alcohol mixed with energy drinks: Associations with risky drinking and functioning in high school |
Q44430872 | Alcohol outcome expectancies and risk for alcohol use problems in women with and without a family history of alcoholism |
Q43170832 | Alcohol pharmacokinetics, decision making and folk wisdom: a reply to Moxnes and Jensen (2009). |
Q70724462 | Alcohol policy measures and the consumption of alcoholic beverages in Finland, 1950 - 1975 |
Q51627956 | Alcohol pretreatment alters the metabolic pattern and accelerates cocaine metabolism in pigs. |
Q43949492 | Alcohol prevention among adolescents: a French experiment |
Q36600135 | Alcohol problem recognition and help seeking in adolescents and young adults at varying genetic and environmental risk |
Q37164860 | Alcohol problems as a signal for sensitivity to nicotine dependence and future smoking |
Q60639191 | Alcohol research with transgender populations: A systematic review and recommendations to strengthen future studies |
Q91832400 | Alcohol screening and assessment measures for young people: A systematic review and meta-analysis of validation studies |
Q37693443 | Alcohol stigma and persistence of alcohol and other psychiatric disorders: a modified labeling theory approach |
Q80139333 | Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q101454830 | Alcohol type and ideal cardiovascular health among adults of the Multi-Ethnic Study of Atherosclerosis |
Q43263920 | Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland |
Q41043692 | Alcohol use among Latino migrant workers in South Florida |
Q40003354 | Alcohol use among Native Americans compared to whites: Examining the veracity of the 'Native American elevated alcohol consumption' belief |
Q38667606 | Alcohol use among Nigerian youths: the need for drug education and alcohol policy |
Q52871704 | Alcohol use among adolescents in São Paulo, Brazil. |
Q53990830 | Alcohol use among black youths in a rural community |
Q45942043 | Alcohol use among primary care patients: comparing an HMO with county clinics and the general population. |
Q45161018 | Alcohol use among university students in Lebanon: prevalence, trends and covariates. The IDRAC University Substance Use Monitoring Study (1991 and 1999). |
Q34333650 | Alcohol use and HIV risk behaviors among HIV-infected hospitalized patients in St. Petersburg, Russia. |
Q46525380 | Alcohol use and HIV risk taking among Chinese MSM in Beijing |
Q36060646 | Alcohol use and abuse among rural Zimbabwean adults: a test of a community-level intervention |
Q72658677 | Alcohol use and abuse in the frail, homebound elderly: a clinical analysis of 103 persons |
Q90631195 | Alcohol use and binge drinking among U.S. men, pregnant and non-pregnant women ages 18-44: 2002-2017 |
Q91992876 | Alcohol use and binge drinking among men who have sex with men in China: Prevalence and correlates |
Q47799757 | Alcohol use and bipolar disorders: Risk factors associated with their co-occurrence and sequence of onsets. |
Q53421440 | Alcohol use and change over time in firearm safety among families with young children. |
Q39219152 | Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents |
Q39787926 | Alcohol use and its consequences in South India: views from a marginalised tribal population |
Q104685805 | Alcohol use and mental health during COVID-19 lockdown: A cross-sectional study in a sample of UK adults |
Q39756946 | Alcohol use and misuse in urban Mexican men and women: an epidemiologic perspective |
Q38623733 | Alcohol use and receipt of alcohol screening and brief intervention in a representative sample of sexual minority and heterosexual adults receiving health care |
Q51222666 | Alcohol use and trait anxiety in the general population. |
Q37619188 | Alcohol use and trauma exposure among male and female veterans before, during, and after military service |
Q44958403 | Alcohol use by healthcare professionals |
Q69126793 | Alcohol use by violent and property offenders |
Q88882756 | Alcohol use disorder and associated physical health complications and treatment amongst individuals with and without opioid dependence: A case-control study |
Q91211494 | Alcohol use disorder in sexual minority adults: Age- and sex- specific prevalence estimates from a national survey, 2015-2017 |
Q33836115 | Alcohol use disorder, contexts of alcohol use, and the risk of HIV transmission among South African male patrons of shebeens |
Q119830486 | Alcohol use disorder: An analysis of the evidence underpinning clinical practice guidelines |
Q87296982 | Alcohol use disorders among surgical patients: unplanned 30-days readmissions, length of hospital stay, excessive costs and mortality |
Q64120828 | Alcohol use disorders associated with an increased risk of mesenteric ischemia: A nationwide cohort study |
Q44189354 | Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being |
Q40198020 | Alcohol use disorders in Iran: Prevalence, symptoms, correlates, and comorbidity. |
Q45023652 | Alcohol use disorders in patients with obsessive-compulsive disorder: the importance of appropriate dual-diagnosis |
Q34359115 | Alcohol use from ages 9 to 16: A cohort-sequential latent growth model |
Q91209384 | Alcohol use in late adolescence and early adulthood: The role of generalized anxiety disorder and drinking to cope motives |
Q89845195 | Alcohol use in young adults associated with cortical gyrification |
Q93372405 | Alcohol use severity and age moderate the effects of brief interventions in an emergency department randomized controlled trial |
Q35613109 | Alcohol use, alcohol problems, and depressive symptomatology among newly married couples |
Q51854440 | Alcohol withdrawal syndromes - prediction from detailed medical and drinking histories. |
Q72125546 | Alcohol withdrawal: delayed distribution of intubated ethanol in rats having seizures |
Q52395199 | Alcohol, AIDS risks and commercial sex: some preliminary results from a Scottish study. |
Q68641080 | Alcohol, AIDS risks and sex industry clients: results from a Scottish study |
Q36455019 | Alcohol, drugs, and condom use among drug offenders: an event-based analysis |
Q41265651 | Alcohol, sex and risks of HIV infection |
Q43413852 | Alcohol, tobacco and cannabis: 12-year longitudinal associations with antecedent social context and personality |
Q68035105 | Alcohol, tobacco and illicit drug use amongst nurses: a Scottish study |
Q33648174 | Alcohol, tobacco, and drug use among emergency department patients |
Q91994135 | Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co- and tri-use |
Q103722808 | Alcohol- and speeding-related fatal crashes among novice drivers age 18-20 not fully licensed at the time of the crash |
Q46576074 | Alcohol-attentional bias and motivational structure as independent predictors of social drinkers' alcohol consumption |
Q37724993 | Alcohol-dependent individuals discount sex at higher rates than controls |
Q70376974 | Alcohol-induced hypogonadism: reversal after ethanol withdrawal |
Q39195435 | Alcohol-related blackouts across 55 weeks of college: Effects of European-American ethnicity, female sex, and low level of response to alcohol |
Q39401001 | Alcohol-related cognitions in children (aged 2-10) and how they are shaped by parental alcohol use: A systematic review |
Q52098223 | Alcohol-related morbidity among older career navy men. |
Q43934777 | Alcoholic beverage type, recall period effects and functional disability: evidence from the 1983 NHIS. |
Q34288845 | Alcoholic myopathy: biochemical mechanisms |
Q52301070 | Alcoholic women treated by behaviorally orientated therapy: An 18-month follow-up study |
Q58671411 | Alcoholics' beliefs about abuse: Causes, effects and treatment |
Q40332116 | Alcoholism and violence |
Q67501395 | Alcoholism in women |
Q69953059 | Alcoholism--assessment and diagnosis |
Q46753803 | Alcoholism: Illness beliefs and resource allocation preferences of the public. |
Q43131150 | Alcopops, alcohol consumption and alcohol-related problems in a sample of German adolescents: is there an alcopop-specific effect? |
Q101474690 | Alexithymia and pain experience among patients using methadone-maintenance therapy |
Q62671114 | Alexithymia in alcohol dependent patients is partially mediated by alcohol expectancy |
Q35690351 | Alexithymia level and response to computer-based training in cognitive behavioral therapy among cocaine-dependent methadone maintained individuals |
Q45961157 | All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study. |
Q100431599 | All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors |
Q48481649 | All-cause mortality in criminal justice clients with substance use problems--a prospective follow-up study |
Q46073205 | Allelic association of the D2 dopamine receptor gene with cocaine dependence |
Q51589387 | Alpha 1-adrenergic receptor antagonist blocks acute cocaine action on the compound action potential of the auditory nerve in the chinchilla. |
Q36629050 | Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers |
Q96769558 | Alpha-tACS effect on inhibitory control and feasibility of administration in community outpatient substance use treatment |
Q52001438 | Alprazolam-reinforced medication use in outpatients with anxiety. |
Q89165064 | Alteration in the concentrations of Interleukin-7 (IL-7), Interleukin-10 (IL-10) and Granulocyte Colony Stimulating Factor (G-CSF) in alcohol-dependent individuals without liver disease, during detoxification therapy |
Q47358343 | Alteration of α-N-acetylgalactosaminidase (nagalase) concentration in alcohol-dependent individuals without liver disease, during the detoxification therapy. |
Q48490036 | Alterations in catecholamine metabolism partially corrected during amphetamine-dependence |
Q47670975 | Alterations in functional brain networks associated with loss-chasing in gambling disorder and cocaine-use disorder |
Q48974193 | Alterations in serotonin1B (5HT1B) receptor subtypes in the brain of ethanol-treated rats |
Q30316093 | Alterations of neuronal precursor cells in stages of human adult neurogenesis in heroin addicts |
Q46535060 | Alterations of the vascular basal lamina in the cerebral cortex in drug abuse: a combined morphometric and immunohistochemical investigation. |
Q39296789 | Altered activation of tyrosine hydroxylation by γ-butyrolactone following chronic ethanol treatment |
Q39822301 | Altered activity-based sleep measures in rhesus monkeys following cocaine self-administration and abstinence |
Q37364369 | Altered affective response in marijuana smokers: an FMRI study |
Q50090210 | Altered attentional control strategies but spared executive functioning in chronic cannabis users |
Q45193430 | Altered brain tissue composition in heavy marijuana users |
Q47626021 | Altered functional connectivity to stressful stimuli in prenatally cocaine-exposed adolescents |
Q51240650 | Altered mood and norepinephrine metabolism following withdrawal from alcohol. |
Q27312468 | Altered neural correlates of reward and loss processing during simulated slot-machine fMRI in pathological gambling and cocaine dependence |
Q51059601 | Altered oxidative stress/antioxidant status in blood of alcoholic subjects is associated with alcoholic liver disease. |
Q29396303 | Altered risk-related processing in substance users: Imbalance of pain and gain |
Q35661147 | Altered white matter in cocaine-dependent subjects with traumatic brain injury: A diffusion tensor imaging study |
Q77893769 | Alternative definitions of high risk for impaired driving: the overlap of high volume, frequent heavy drinking and alcohol dependence |
Q115217230 | Alternative model of personality disorders traits predict residential addictions treatment completion |
Q51593046 | Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. |
Q51571420 | Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial. |
Q51683092 | Amantadine may facilitate detoxification of cocaine addicts |
Q51770464 | Amantadine: evaluation of reinforcing properties and effect on cocaine self-injection in baboons. |
Q40158682 | Ambulatory detoxification of heroin addicts: A follow-up study |
Q36930257 | Among long-term crack smokers, who avoids and who succumbs to cocaine addiction? |
Q43489288 | Among patients with unhealthy alcohol use, those with HIV are less likely than those without to receive evidence-based alcohol-related care: A national VA study. |
Q91282963 | Among whom is cigarette smoking declining in the United States? The impact of cannabis use status, 2002-2015 |
Q48887789 | Amphetamine withdrawal and sleep disturbance |
Q39450400 | Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia |
Q40875742 | Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study |
Q91885051 | Amygdala-orbitofrontal functional connectivity mediates the relationship between sensation seeking and alcohol use among binge-drinking adults |
Q33491972 | An IRT-based measure of alcohol trait severity and the role of traitedness in trait validity: a reanalysis of Project MATCH data |
Q38889385 | An Initial evaluation of law enforcement overdose training in Rhode Island |
Q52009078 | An Internet-based abstinence reinforcement treatment for cigarette smoking. |
Q36146886 | An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes |
Q42543514 | An acute dose of nicotine enhances cue-induced cocaine craving |
Q52264305 | An addiction treatment program in Laos: The first year's experience |
Q71502543 | An adoption study of DSM-IIIR alcohol and drug dependence severity |
Q42117832 | An alcohol contact program: training for increased security of alcoholics in trial situations |
Q104559335 | An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis |
Q51824356 | An analysis of naltrexone and naloxone's possible agonistic actions in the dog. |
Q38430372 | An analysis of racial and sex differences for smoking among adolescents in a juvenile correctional center |
Q101474692 | An analysis of within-subject and population level risk related to substance use and mental health outcomes among adolescents in the PATH study |
Q73434103 | An approach to the medical marijuana controversy |
Q41340468 | An assessment of MDPV-induced place preference in adult Sprague-Dawley rats |
Q50073652 | An assessment of the utilization of the preclinical rodent model literature in clinical trials of putative therapeutics for the treatment of alcohol use disorders |
Q44032022 | An association between smoking habits and blood pressure in normotensive Japanese men: a 5-year follow-up study |
Q41506426 | An attempt to improve the identification of alcohol-dependent patients in a teaching general hospital |
Q90673218 | An ecological momentary assessment study examining posttraumatic stress disorder symptoms, prenatal bonding, and substance use among pregnant women |
Q113876985 | An ecological momentary assessment study of outcome expectancies and smoking lapse in daily life |
Q35875513 | An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness |
Q39667394 | An enumeration method of determining the prevalence of users and operatives of cocaine and heroin in Central Harlem |
Q42015049 | An epidemiologic investigation of marijuana- and cocaine-related palpitations |
Q90202472 | An ethnographic decision model of the initiation of gabapentin misuse among prescription and/or illicit opioid (mis)user |
Q51270369 | An evaluation of a behaviour therapy programme as an intervention treatment for the fear of withdrawal with heroin-dependent persons. |
Q90218762 | An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain |
Q46588052 | An evaluation of the reinforcing effects of memantine in cocaine-dependent humans |
Q44701200 | An evaluation of workshop training in motivational interviewing for addiction and mental health clinicians |
Q35844371 | An examination of associations between social norms and risky alcohol use among African American men who have sex with men. |
Q44394315 | An examination of indirect risk of exposure to HIV among wives of substance-abusing men. |
Q44867143 | An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats |
Q24635217 | An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program |
Q47645212 | An examination of the cocaine relapse process |
Q89470148 | An examination of the extent to which mood and context are associated with real-time alcohol consumption |
Q41648991 | An examination of the relationship between drinking status after treatment and the self-evaluation of the alcoholic |
Q37107296 | An exploratory randomized controlled trial of a novel high-school-based smoking cessation intervention for adolescent smokers using abstinence-contingent incentives and cognitive behavioral therapy |
Q43116767 | An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R) |
Q58121503 | An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI |
Q68046820 | An increase of collagen biosynthesis precedes other symptoms of ethanol-induced liver damage in rats |
Q44668420 | An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride). |
Q34490604 | An initial meta-analysis of Acceptance and Commitment Therapy for treating substance use disorders |
Q34765512 | An initial trial of a computerized behavioral intervention for cannabis use disorder |
Q74610612 | An innovative approach to reducing cannabis use in a subset of methadone maintenance clients |
Q30571255 | An integrated data analysis approach to investigating measurement equivalence of DSM nicotine dependence symptoms |
Q38721006 | An intensive assessment of alcohol use and emergency department utilization in homeless alcohol-dependent adults |
Q46011639 | An interaction between DAT1 and having an alcoholic father predicts serious alcohol problems in a sample of males. |
Q37346405 | An internet-based abstinence reinforcement smoking cessation intervention in rural smokers. |
Q45068064 | An internet-based survey method for college student drinking research |
Q64135882 | An intervention trial targeting methadone maintenance treatment providers to improve clients' treatment retention in China |
Q38699064 | An inventory of methods suitable to assess additive-induced characterising flavours of tobacco products |
Q103825511 | An investigation of the link between prenatal alcohol exposure and sleep problems across childhood |
Q34096938 | An item response theory analysis of nicotine dependence symptoms in recent onset adolescent smokers |
Q85920989 | An iterative model for in vitro laboratory assessment of tamper deterrent formulations |
Q37334774 | An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers |
Q37562096 | An overview of the emergence of disparities in smoking prevalence, cessation, and adverse consequences among women |
Q92878161 | Anabolic androgenic steroid dependence is associated with executive dysfunction |
Q115217236 | Anabolic androgenic steroids, antisocial personality traits, aggression and violence |
Q34433056 | Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. |
Q35995035 | Anabolic steroid abuse among teenage girls: an illusory problem? |
Q46658160 | Anabolic steroid use among gay and bisexual men living in Australia and New Zealand: Associations with demographics, body dissatisfaction, eating disorder psychopathology, and quality of life |
Q46017603 | Anabolic steroid use and body image psychopathology in men: Delineating between appearance- versus performance-driven motivations. |
Q72533802 | Anabolic steroid users identified by needle and syringe exchange contact |
Q41719770 | Anabolic steroids and cardiovascular risk: A national population-based cohort study |
Q73815814 | Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users |
Q92673248 | Anabolic-androgenic steroids and the risk of imprisonment |
Q37700823 | Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain |
Q35737627 | Analyses related to the development of DSM-5 criteria for substance use related disorders: 1. Toward amphetamine, cocaine and prescription drug use disorder continua using Item Response Theory |
Q37128303 | Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients |
Q39702106 | Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria |
Q39162968 | Analysis of alcohol use disorders from the Nathan Kline Institute-Rockland Sample: Correlation of brain cortical thickness with neuroticism. |
Q36457296 | Analysis of epidemiological data on agonist-antagonist analgesics |
Q74163418 | Analysis of risk taking in adults with a history of high risk behavior |
Q91990649 | Analysis of substance use and its outcomes by machine learning I. Childhood evaluation of liability to substance use disorder |
Q90728751 | Analysis of substance use and its outcomes by machine learning: II. Derivation and prediction of the trajectory of substance use severity |
Q44333135 | Analysis of the antinociceptive actions of the kappa-opioid agonist enadoline (CI-977) in neonatal and adult rats: comparison to kappa-opioid receptor mRNA ontogeny |
Q52541378 | Analysis of the distribution of peripheral blood lymphocyte subsets associated with chronic ethanol treatment in rats with a disturbed circadian cycle. |
Q43890409 | Analysis of the reinforcing and subjective effects of different doses of nitrous oxide using a free-choice procedure |
Q91180500 | Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage |
Q44958382 | Analyzing the acquisition of drug self-administration using growth curve models |
Q67020054 | Animal models for human behavior: Some critical remarks and clinical objections |
Q69126804 | Animal models of chronic alcohol ingestion: the liquid diet |
Q35110020 | Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation. |
Q48382193 | Anionic glycerophospholipids in platelets from alcoholics |
Q48768590 | Antagonism of AND and AND-OR drug mixture discriminations in rats. |
Q52194486 | Antagonism of the response rate-decreasing effects of meperidine and morphine by beta-funaltrexamine and naltrexone in squirrel monkeys. |
Q36421449 | Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis |
Q98187018 | Antagonizing serotonin 2A (5-HT2A) receptors attenuates methamphetamine-induced reward and blocks methamphetamine-induced anxiety-like behaviors in adult male rats |
Q35005766 | Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment |
Q35179519 | Antecedents and consequences of marijuana use trajectories over the life course in an African American population |
Q34687295 | Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts |
Q43629591 | Antecedents of narcotic use and addiction. A study of 898 Vietnam veterans |
Q90110137 | Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE |
Q43270095 | Antibody response to hepatitis B vaccine in substance use disorder patients |
Q96680914 | Anticipated use of a supervised drug consumption site among syringe services program clients in King County, Washington: Assessing the role of opioid overdose and injection behavior |
Q91402440 | Anticipation of monetary reward in amygdala, insula, caudate are predictors of pleasure sensitivity to d-Amphetamine administration |
Q39588712 | Anticipatory reward processing among cocaine-dependent individuals with and without concurrent methadone-maintenance treatment: Relationship to treatment response |
Q50636476 | Anticipatory stress restores decision-making deficits in heavy drinkers by increasing sensitivity to losses |
Q69579975 | Antigenical alterations of hepatocyte membrane in rats after long-term administration of ethanol and carbon tetrachloride |
Q42633341 | Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology. |
Q51080822 | Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. |
Q68046833 | Antioxidant and free radical-scavenging enzymes in chronically ethanol-consuming rats: controversy over hepatic lipid peroxidation |
Q50114681 | Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy |
Q44037089 | Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in Central Asia |
Q40659916 | Antisense confirmation of mu- and kappa-opioid receptor mediation of morphine's effects on body temperature in rats |
Q44857260 | Antisocial behavioral syndromes among residential drug abuse treatment clients |
Q45111122 | Antisocial behavioral syndromes among residential drug abuse treatment clients |
Q37077891 | Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q51546174 | Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjects. |
Q40714128 | Antisocial personality disorder and cocaine dependence: their effects on behavioral and electroencephalographic measures of time estimation |
Q51639834 | Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. |
Q36881038 | Antisocial personality disorder is associated with receipt of physical disability benefits in substance abuse treatment patients |
Q42603477 | Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy |
Q60632066 | Antisocial personality disorder, psychopathy and injecting heroin use |
Q44849075 | Anxiety and anger among abusers of different substances |
Q33725094 | Anxiety and depressive symptoms and affective patterns of tobacco withdrawal |
Q46474496 | Anxiety disorders among patients with co-occurring bipolar and substance use disorders |
Q33828124 | Anxiety disorders and risk for alcohol use disorders: the moderating effect of parental support |
Q34021889 | Anxiety sensitivity as an amplifier of subjective and behavioral tobacco abstinence effects |
Q39486632 | Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents. |
Q35854864 | Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. |
Q68606732 | Apolipoprotein distribution in plasma HDL subfractions in alcohol consumers |
Q91207272 | Appeal of JUUL among adolescents |
Q33819375 | Applicability of Type A/B alcohol dependence in the general population |
Q52042495 | Application of a synthetic analogue of leu-enkephalin (Dalargin) in alcohol withdrawal |
Q27312152 | Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids |
Q46197360 | Application of the Relapse Risk Scale to alcohol-dependent individuals in Japan: comparison with stimulant abusers |
Q48266114 | Application of the conditioned taste aversion paradigm to assess discriminative stimulus properties of psychostimulants in rats |
Q93213622 | Application of vested interest theory to prevention of non-medical prescription stimulant and marijuana use: Unforeseen benefits of attitude-behavior inconsistency |
Q40669031 | Applying behavioral concepts and principles to the treatment of cocaine dependence |
Q58571355 | Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populations |
Q33895605 | Are adolescent smokers dependent on nicotine? A review of the evidence |
Q47749454 | Are area-level effects just a proxy for school-level effects? Socioeconomic differences in alcohol consumption patterns among Swedish adolescents |
Q72231608 | Are benzodiazepines a risk factor for road accidents? 'Benzodiazepine/Driving' Collaborative Group |
Q38657265 | Are brief alcohol interventions targeting alcohol use efficacious in military and veteran populations? A meta-analysis |
Q39518233 | Are community level prescription opioid overdoses associated with child harm? A spatial analysis of California zip codes, 2001-2011 |
Q53230428 | Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria. |
Q44026065 | Are drunk-driving offenders referred for screening accurately reporting their drug use? |
Q35962535 | Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas |
Q35646727 | Are genetic variants for tobacco smoking associated with cannabis involvement? |
Q36299239 | Are homeschooled adolescents less likely to use alcohol, tobacco, and other drugs? |
Q46588023 | Are judicial status hearings a "key component" of drug court? Six and twelve months outcomes |
Q72876494 | Are men or women more likely to stop drinking because of alcohol problems? |
Q88571519 | Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse? |
Q58828679 | Are personality disorders or ADHD linked to cocaine-induced psychosis in cocaine-dependent patients? |
Q93219827 | Are posttraumatic stress and depressive symptoms pathways to smoking relapse after a natural disaster? |
Q49151915 | Are psychotic experiences among detained juvenile offenders explained by trauma and substance use? |
Q41227267 | Are the effects of chronic ethanol administration on erythrocyte membrane mediated by changes in plasma lipids? |
Q35570781 | Are there income differences in the impact of a national reimbursement policy for smoking cessation treatment and accompanying media attention? Findings from the International Tobacco Control (ITC) Netherlands Survey |
Q92391352 | Are traumatic dental injuries greater in alcohol or illicit drugs consumers? A systematic review and meta-analysis |
Q87374430 | Are users' most recent drug purchases representative? |
Q94953644 | Are we missing opioid-related deaths among people with HIV? |
Q38689444 | Area-level disadvantage and alcohol use disorder in northern Mexico |
Q51910312 | Arrest history as an indicator of adolescent/young adult substance use and HIV risk. |
Q44394312 | Arrests and convictions for cannabis related offences in a New Zealand birth cohort |
Q52277495 | Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction. |
Q51004655 | Asian American and Pacific Islander substance use treatment admission trends. |
Q44852813 | Asking about quantity and frequency of alcohol consumption before asking the CAGE questions produces lower ratings on the CAGE test |
Q52315120 | Aspects of alcohol use disorder affecting social cognition as assessed using the Mini Social and Emotional Assessment (mini-SEA). |
Q52264496 | Aspects of the psychopathology and pathophysiology of addiction |
Q28199537 | Aspirin or amiloride for cerebral perfusion defects in cocaine dependence |
Q38893803 | Assessing 30-day quantity-frequency of U.S. adolescent cigarette smoking as a predictor of adult smoking 14 years later |
Q35132188 | Assessing abuse liability in clinical trials |
Q99202438 | Assessing alcohol consumption through wastewater-based epidemiology: Spain as a case study |
Q35875438 | Assessing contributions of nucleus accumbens shell subregions to reward-seeking behavior |
Q34625628 | Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients |
Q38607383 | Assessing electronic cigarette effects and regulatory impact: Challenges with user self-reported device power. |
Q31047887 | Assessing geographical differences in illicit drug consumption--A comparison of results from epidemiological and wastewater data in Germany and Switzerland. |
Q100422784 | Assessing how the history of e-cigarette and cigarette use are associated with the developmental course of marijuana use in a sample of United States adolescents |
Q30983647 | Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial |
Q60121420 | Assessing nicotine dependence in adolescent E-cigarette users: The 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence Item Bank for electronic cigarettes |
Q52313356 | Assessing phosphatidylethanol (PEth) levels reflecting different drinking habits in comparison to the alcohol use disorders identification test - C (AUDIT-C). |
Q91233436 | Assessing reciprocal association between drunkenness, drug use, and delinquency during adolescence: Separating within- and between-person effects |
Q44152867 | Assessing reliability of categorical substance use measures with latent class analysis |
Q34511089 | Assessing sleep in opioid dependence: A comparison of subjective ratings, sleep diaries, and home polysomnography in methadone maintenance patients |
Q35633016 | Assessing teen smoking patterns: the weekend phenomenon |
Q47977738 | Assessing the association between the use of NRT for smoking reduction and attempts to quit smoking using propensity score matching |
Q51143354 | Assessing the behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. |
Q52192547 | Assessing the helping alliance and its impact in the treatment of opiate dependence. |
Q91705229 | Assessing the impacts of minimum legal drinking age laws on police-reported violent victimization in Canada from 2009 to 2013 |
Q36439054 | Assessing the long-term impact of drug court participation on recidivism with generalized estimating equations |
Q58808202 | Assessing the longitudinal stability of latent classes of substance use among gay, bisexual, and other men who have sex with men |
Q92170983 | Assessing the motivational effects of ethanol in mice using a discrete-trial current-intensity intracranial self-stimulation procedure |
Q47425459 | Assessing tobacco beliefs among youth using item response theory models |
Q90800181 | Assessing tobacco use in an African population: Serum and urine cotinine cut-offs from South Africa |
Q34708716 | Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals |
Q38708643 | Assessment methods and schedules for collecting daily process data on substance use related health behaviors: A randomized control study. |
Q36845718 | Assessment of a formulation designed to be crush-resistant in prescription opioid abusers |
Q36515914 | Assessment of abuse liability of stimulant drugs in humans: a methodological survey |
Q39937803 | Assessment of addiction severity among ritual users of ayahuasca |
Q38463908 | Assessment of attentional bias and mood in users and non-users of anabolic-androgenic steroids |
Q89499842 | Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine |
Q36842356 | Assessment of co-occurring depression and substance use in an ethnically diverse patient sample during behavioral health intake interviews |
Q37372674 | Assessment of cocaine and other drug dependence in the general population: "gated" versus "ungated" approaches |
Q40925739 | Assessment of coercive and noncoercive pressures to enter drug abuse treatment |
Q87129787 | Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users |
Q44340869 | Assessment of nalmefene glucuronide as a selective gut opioid antagonist. |
Q36567029 | Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement |
Q57299911 | Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice |
Q47828594 | Assessment of ropinirole as a reinforcer in rhesus monkeys. |
Q70450070 | Assessment of serum autoantibody status in chronic alcoholic patients--is it useful? |
Q69020534 | Assessment of specific drug disorders in a sample of substance abuse patients: a comparison of the DIS and the SADS-L procedures |
Q45030505 | Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor |
Q89515969 | Assessment of the completeness of intervention reporting of randomized clinical trials for alcohol use disorders: Effect of the TIDieR checklist and guide |
Q34248350 | Assessment of the opiate properties of two constituents of a toxic illicit drug mixture |
Q35473808 | Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women |
Q48026773 | Association between breath alcohol concentration and waterpipe lounge patrons' carbon monoxide exposure: A field investigation. |
Q90672396 | Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012-2017 |
Q38161132 | Association between depression and non-fatal overdoses among drug users: a systematic review and meta-analysis |
Q77462269 | Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern California |
Q104607635 | Association between energy drink consumption and substance use in adolescence: A systematic review of prospective cohort studies |
Q89656951 | Association between genetic variants in CYP2E1 and CTRC genes and susceptibility to alcoholic pancreatitis: A systematic review and meta-analysis |
Q38893360 | Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs. |
Q80812106 | Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients |
Q89138678 | Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine |
Q39690752 | Association between injection practices and duration of injection among recently initiated injection drug users |
Q52059144 | Association between intravenous drug use and early misbehavior. |
Q41688399 | Association between monoamine oxidase gene polymorphisms and smoking behavior: A meta-analysis |
Q86811458 | Association between nicotine replacement therapy use in pregnancy and smoking cessation |
Q35882669 | Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention |
Q46763442 | Association between non-medical and prescriptive usage of opioids |
Q104571672 | Association between observing peers vaping on campus and E-cigarette use and susceptibility in middle and high school students |
Q44563739 | Association between parental and individual psychiatric/substance use disorders and smoking stages among Puerto Rican adolescents |
Q62583541 | Association between polygenic risk for tobacco or alcohol consumption and liability to licit and illicit substance use in young Australian adults |
Q107001902 | Association between post-traumatic stress disorder and alcohol-related hospitalizations among World Trade Center Health Registry enrollees |
Q89804010 | Association between preference for using alcohol beverage-named e-liquids and alcohol use among high school youth |
Q37455559 | Association between prescription drug misuse and injection among runaway and homeless youth |
Q58633724 | Association between prescription opioid use and frequent emergency department use |
Q36971316 | Association between problematic alcohol use and reactivity to uncertain threat in two independent samples |
Q38701857 | Association between process measures and mortality in individuals with opioid use disorders. |
Q46554813 | Association between psychiatric disorders and smoking stages among Latino adolescents |
Q38596882 | Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis |
Q89937856 | Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV |
Q53165666 | Association of CYP2A6 gene polymorphisms with cigarette consumption: a meta-analysis. |
Q52290614 | Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment. |
Q48430072 | Association of THR105Ile, a functional polymorphism of histamine N-methyltransferase (HNMT), with alcoholism in German Caucasians |
Q28200994 | Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence |
Q46805721 | Association of a D2S2944 allele with depression specifically among those with substance abuse or antisocial personality |
Q35957877 | Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies |
Q44351470 | Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis |
Q38279718 | Association of anxiety disorders with the risk of smoking behaviors: a meta-analysis of prospective observational studies |
Q34980273 | Association of attention-deficit/hyperactivity disorder and conduct disorder with early tobacco and alcohol use |
Q48394365 | Association of baseline characteristics and motivation to change among patients seeking treatment for substance dependence |
Q36952343 | Association of candidate genes with antisocial drug dependence in adolescents |
Q37047038 | Association of cannabis use with opioid outcomes among opioid-dependent youth |
Q44360020 | Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine |
Q91645686 | Association of current and past opioid use disorders with health-related quality of life and employment among US adults |
Q93057417 | Association of electronic cigarette vaping and subsequent smoking relapse among former smokers |
Q38711811 | Association of elevated ambient temperature with death from cocaine overdose |
Q57163331 | Association of exercise with smoking-related symptomatology, smoking behavior and impulsivity in men and women |
Q103798448 | Association of fatty acid ethyl esters in meconium with behavior during childhood |
Q48443250 | Association of functional DBH genetic variants with alcohol dependence risk and related depression and suicide attempt phenotypes: results from a large multicenter association study |
Q37435852 | Association of major depression with subtypes of nicotine dependence found among adult daily smokers: a latent class analysis |
Q43156162 | Association of polymorphism in alcohol dehydrogenase and interaction with other genetic risk factors with alcoholic liver cirrhosis |
Q43198858 | Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians |
Q98172042 | Association of prenatal alcohol exposure with preadolescent alcohol sipping in the ABCD study® |
Q46512132 | Association of prenatal cocaine exposure, childhood maltreatment, and responses to stress in adolescence |
Q37349982 | Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals |
Q39726904 | Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City |
Q46089073 | Association of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorder |
Q63352093 | Association of thirty-year alcohol consumption typologies and fatty liver: Findings from a large population cohort study |
Q98299679 | Association of transphobic discrimination and alcohol misuse among transgender adults: Results from the U.S. Transgender Survey |
Q91166861 | Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders |
Q37067963 | Associations among state and local organizational contexts: Use of evidence-based practices in the criminal justice system |
Q35661896 | Associations among types of impulsivity, substance use problems and neurexin-3 polymorphisms |
Q36689676 | Associations between LGBTQ-affirmative school climate and adolescent drinking behaviors |
Q34511082 | Associations between abstinence in adolescence and economic and educational outcomes seven years later among high-risk youth |
Q92255134 | Associations between adolescent cannabis use frequency and adult brain structure: A prospective study of boys followed to adulthood |
Q38403306 | Associations between butane hash oil use and cannabis-related problems |
Q128711247 | Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019 |
Q50198766 | Associations between childhood ADHD, gender, and adolescent alcohol and marijuana involvement: A causally informative design |
Q35111943 | Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom. |
Q41634372 | Associations between deployment, military rank, and binge drinking in active duty and Reserve/National Guard US servicewomen |
Q43591435 | Associations between dieting and smoking-related behaviors in young women |
Q96762368 | Associations between digital technology and substance use among U.S. adolescents: Results from the 2018 Monitoring the Future survey |
Q91456738 | Associations between drug use patterns and viral load suppression among HIV-positive individuals who use support services in New York City |
Q51380087 | Associations between energy drink consumption and alcohol use behaviors among college students. |
Q51069416 | Associations between exposure to stressful life events and alcohol use disorder in a longitudinal birth cohort studied to age 30 |
Q91566382 | Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada |
Q52630681 | Associations between opioid and nicotine dependence in nationally representative samples of United States adult daily smokers. |
Q44339909 | Associations between pain clinic density and distributions of opioid pain relievers, drug-related deaths, hospitalizations, emergency department visits, and neonatal abstinence syndrome in Florida |
Q52588615 | Associations between pain intensity and urge to smoke: Testing the role of negative affect and pain catastrophizing. |
Q91297937 | Associations between polygenic risk for tobacco and alcohol use and liability to tobacco and alcohol use, and psychiatric disorders in an independent sample of 13,999 Australian adults |
Q45071079 | Associations between polysubstance use and psychiatric problems in a criminal justice population in Sweden |
Q101241553 | Associations between reasons for vaping and current vaping and smoking status: Evidence from a UK based cohort |
Q51807569 | Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service. |
Q36249023 | Associations of adolescent cannabis use with academic performance and mental health: A longitudinal study of upper middle class youth. |
Q33750970 | Associations of glutamate decarboxylase genes with initial sensitivity and age-at-onset of alcohol dependence in the Irish Affected Sib Pair Study of Alcohol Dependence |
Q41335065 | Associations of lifetime abstention and past and current alcohol use with late-life mental health: a propensity score analysis |
Q100502062 | Associations of prenatal alcohol exposure and offspring harmful alcohol use: findings from the Raine Study |
Q41714966 | Associations of substance use patterns with attempted suicide among persons who inject drugs: can distinct use patterns play a role? |
Q93008296 | Associations of the Stoptober smoking cessation program with information seeking for smoking cessation: A Google trends study |
Q36857705 | Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial |
Q51735563 | Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial. |
Q37267821 | Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study |
Q44186906 | Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. |
Q44701180 | Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors. |
Q43875765 | Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS). |
Q36914536 | Attempts to stop or reduce marijuana use in non-treatment seekers |
Q46655779 | Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women |
Q36342901 | Attendance, drug use patterns, and referrals made from North America's first supervised injection facility |
Q30389584 | Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: race and gender differences |
Q42545342 | Attention and memory in illicit amphetamine users |
Q42541327 | Attention and memory in illicit amphetamine users: comparison with non-drug-using controls |
Q36279189 | Attention deficit/hyperactivity disorder symptoms and depression symptoms as mediators in the intergenerational transmission of smoking |
Q36708913 | Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD |
Q127174958 | Attention-deficit/hyperactivity disorder combined subtype exacerbates opioid use disorder consequences: Mediation by impulsive phenotypes |
Q50541142 | Attentional bias and executive control in treatment-seeking substance-dependent adolescents: A cross-sectional and follow-up study |
Q34778595 | Attentional bias in addictive behaviors: a review of its development, causes, and consequences |
Q91203276 | Attentional bias in opioid users: A systematic review and meta-analysis |
Q47614687 | Attentional bias toward alcohol stimuli as a predictor of treatment retention in cocaine dependence and alcohol user patients |
Q91384314 | Attentional bias towards cannabis cues in cannabis users: A systematic review and meta-analysis |
Q43155294 | Attentional bias, inhibitory control and acute stress in current and former opiate addicts |
Q33547757 | Attentional functioning in abstinent cocaine abusers |
Q35914931 | Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons |
Q48428627 | Attenuation of the effects of chronic ethanol administration in the brain lipid content of the developing rat by an oil enriched in gamma linolenic acid |
Q28296936 | Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome |
Q54773981 | Attitude towards alcohol, church attendance and denominational identity |
Q39662574 | Attitudes about alcohol: a general review |
Q46894906 | Attitudes of Nigerian medical students towards use and abuse of tobacco, alcohol and drugs |
Q35595876 | Attitudes of North Carolina law enforcement officers toward syringe decriminalization |
Q47337748 | Attitudes of a sector of the Arab-Muslim population in Kuwait towards alcohol and drug misuse: an objective appraisal |
Q40234395 | Attitudes of high school students toward drug education |
Q39291337 | Attitudes of urban South Africans towards drinking and drunkenness |
Q41353263 | Attitudes toward alcoholism among Italian future teachers and health professionals |
Q69616649 | Attitudes toward alcoholism in volunteer therapist aides: do they change? |
Q58633948 | Attitudes toward and preferences for health research among drug users and non-drug users |
Q113185712 | Attitudes toward computer interventions for partner abuse and drug use among women in the emergency department |
Q34890135 | Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention |
Q91333856 | Attitudes, beliefs, and knowledge of substance use amongst youth in the Eastern Mediterranean region: A systematic review |
Q71064391 | Attributions of causality for drinking behavior made by alcoholics and by normal drinkers |
Q34233108 | Atypical frontal lobe activity during verbal working memory in youth with a family history of alcoholism |
Q36553593 | Atypical neural activity during inhibitory processing in substance-naïve youth who later experience alcohol-induced blackouts |
Q41369804 | Audiogenic seizures during ethanol withdrawal can be blocked by a delta opioid agonist |
Q50608178 | Audiometric configuration in patients being treated for alcoholism |
Q92207216 | Auditing the AUDIT: A systematic review of cut-off scores for the Alcohol Use Disorders Identification Test (AUDIT) in low- and middle-income countries |
Q40358187 | Auditory effects of chronic alcoholism |
Q60636284 | Australian clinician attitudes towards contingency management: Comparing down under with America |
Q50516925 | Autobiographical memory compromise in individuals with alcohol use disorders: Towards implications for psychotherapy research. |
Q57163346 | Automatic visual-spatial perspective taking in alcohol-dependence: A study with happy emotional faces |
Q68252101 | Autonomic and peripheral neuropathy in chronic alcoholic liver disease |
Q47897399 | Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice. |
Q36976173 | Autosomal linkage analysis for cannabis use behaviors in Australian adults |
Q35621950 | Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysis |
Q36692583 | Availability of buprenorphine on the Internet for purchase without a prescription. |
Q35147373 | Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation |
Q37443574 | Availability of tobacco products associated with use of marijuana cigars (blunts). |
Q46633706 | Aversion therapy of cannabis dependence in Nigeria |
Q49119530 | Aversive effects of naltrexone in subjects not dependent on opiates |
Q37123181 | Avoidance of cigarette pack health warnings among regular cigarette smokers |
Q48554077 | Avoiding the ingestion of cytotoxic concentrations of ethanol may reduce the risk of cancer associated with alcohol consumption |
Q60145904 | BSAFER: A Web intervention for women in the ED with drug use and IPV |
Q71736711 | Back to fundamentalism |
Q34061029 | Baclofen administration for the treatment of affective disorders in alcoholic patients |
Q88626650 | Baclofen and naltrexone effects on alcohol self-administration: Comparison of treatment initiated during abstinence or ongoing alcohol access in baboons |
Q46675644 | Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats |
Q34546977 | Baclofen prevents MDMA-induced rise in core body temperature in rats |
Q56502185 | Baclofen, a GABA B Agonist, reduces risk-taking and reveals the relationship between brain responses to drug cues and risk-taking in cocaine-addicted patients |
Q56806164 | Bangkok 2016: From overly punitive to deeply humane drug policies |
Q66990156 | Barbiturate tolerance and hypersensitivity of arterial smooth muscle |
Q104693992 | Barriers and facilitators to PDMP IS Success in the US: A systematic review |
Q99571504 | Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study |
Q91258287 | Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists-The practitioner experience |
Q39820916 | Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. |
Q51916114 | Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. |
Q38979653 | Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis. |
Q91609680 | Barriers to seeking help for physicians with substance use disorder: A review |
Q40564657 | Bars and nightclubs associated with higher HIV prevalence. |
Q51571948 | Basal plasma beta-endorphin in prepubertal sons of alcoholics and drug addicts: lack of association with problem behaviors. |
Q42632359 | Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT). |
Q40765113 | Baseline prediction of 7-month cocaine abstinence for cocaine dependence patients |
Q39653626 | Bayesian inference for the distribution of grams of marijuana in a joint |
Q51187306 | Beer intoxication and physical aggression in males. |
Q40397525 | Behavior in cocaine-exposed infants and children: association versus causality |
Q41493387 | Behavioral and biochemical effects of intracerebrally injected alkaloids |
Q52212592 | Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives. |
Q80440697 | Behavioral and economic perspectives in drug abuse research |
Q42625437 | Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence |
Q34525273 | Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties. |
Q31076658 | Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes |
Q44448273 | Behavioral and subjective effects of marijuana following partial sleep deprivation. |
Q48102767 | Behavioral approach and orbitofrontal cortical activity during decision-making in substance dependence. |
Q37346434 | Behavioral assessment of impulsivity in pathological gamblers with and without substance use disorder histories versus healthy controls |
Q39184637 | Behavioral characterization of opioid mixed agonist-antagonists |
Q34441050 | Behavioral components of impulsivity predict alcohol consumption in adults with ADHD and healthy controls |
Q37640779 | Behavioral disinhibition in mice bred for high drinking in the dark (HDID) and HS controls increases following ethanol |
Q34792063 | Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial |
Q46829527 | Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial |
Q33303279 | Behavioral economic analysis of drug preference using multiple choice procedure data |
Q37300384 | Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply |
Q43485342 | Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply |
Q115217238 | Behavioral economic demand in opioid treatment: Predictive validity of hypothetical purchase tasks for heroin, cocaine, and benzodiazepines |
Q92302293 | Behavioral economic demand metrics for abuse deterrent and abuse potential quantification |
Q38760443 | Behavioral economic substitution between conventional cigarettes and e-cigarettes differs as a function of the frequency of e-cigarette use. |
Q51657107 | Behavioral economics and drug choice: effects of unit price on cocaine self-administration by monkeys. |
Q40791207 | Behavioral economics of drug self-administration: an introduction |
Q40791213 | Behavioral economics: a novel experimental approach to the study of drug dependence |
Q45014738 | Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration |
Q51142696 | Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. |
Q43571804 | Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats |
Q44405433 | Behavioral effects of salsolinol and ethanol on mice selected for sensitivity to alcohol-induced sleep time |
Q35793724 | Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers |
Q96773480 | Behavioral inhibition and reward processing in college binge drinkers with and without marijuana use |
Q39707921 | Behavioral methods for the assessment of alcohol tolerance and dependence |
Q39820255 | Behavioral pharmacology of buprenorphine |
Q51666132 | Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination. |
Q33446068 | Behavioral problems and the occurrence of tobacco, cannabis, and coca paste smoking in Chile: evidence based on multivariate response models for school survey data |
Q77893756 | Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture |
Q48739532 | Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment |
Q40480292 | Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. |
Q73405958 | Behavioral self-regulation: correlates and 2 year follow-ups for boys at risk for substance abuse |
Q104691626 | Behavioral symptoms of child mental disorders and lifetime substance use in adolescence: A within-family comparison of US siblings |
Q39714312 | Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. |
Q26829749 | Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter |
Q27014879 | Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism |
Q34337286 | Behavioural activation as predictor of substance use: mediating and moderating role of attitudes and social relationships |
Q90851131 | Being old fashioned in a modern world: Gender role attitudes moderate the relation between role conflicts and alcohol use of parents |
Q38724071 | Belgian experience with direct acting antivirals in people who inject drugs |
Q77893779 | Beliefs about smoking cessation among out-of-school youth |
Q51115769 | Beliefs about steroids: user vs. non-user comparisons. |
Q43230453 | Beliefs about the empirical support of drug abuse treatment interventions: a survey of outpatient treatment providers |
Q91112663 | Beliefs and attitudes regarding prenatal marijuana use: Perspectives of pregnant women who report use |
Q70578349 | Beliefs and opinions about drugs and their users as predictors of drug-user status of adolescents in post-revolutionary Iran |
Q92290187 | Beneficial effects of motivational interviewing case management: A latent class analysis of recovery capital among sober living residents with criminal justice involvement |
Q34560105 | Benefit-risk ratio of agonist-antagonist analgesics |
Q39397760 | Benzodiazepine and sedative use/abuse by methadone maintenance clients |
Q42207652 | Benzodiazepine antagonist, CGS-8216, in diazepam- or pentobarbital-dependent and non-dependent rats |
Q45068060 | Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome |
Q35489297 | Benzodiazepine dependence among multidrug users in the club scene |
Q68046858 | Benzodiazepine dependence--aetiological factors, time course, consequences and withdrawal symptomatology: a study of five cases |
Q67650016 | Benzodiazepine dependence: detoxification under standardized conditions |
Q36810459 | Benzodiazepine prescription for patients in opioid maintenance treatment in Norway |
Q45401403 | Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence |
Q42937874 | Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. |
Q67522811 | Benzodiazepine use and HIV risk-taking behaviour among injecting drug users |
Q36090290 | Benzodiazepine use as an independent risk factor for HIV infection in a Canadian setting |
Q37565076 | Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes |
Q38896255 | Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study |
Q72456131 | Benzodiazepines and drug abuse: Clinical observations in chemically dependent persons before and during abstinence |
Q38840230 | Benzylpiperazine: "A messy drug". |
Q51928103 | Best friends and alcohol consumption in adolescence: a within-family analysis. |
Q42533948 | Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation |
Q47285576 | Betel nut chewing associated with increased risk of arterial stiffness |
Q34996324 | Betel nut chewing during pregnancy, Madang province, Papua New Guinea |
Q91489843 | Between- and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference |
Q35577669 | Beyond income: material resources among drug users in economically-disadvantaged New York City neighborhoods. |
Q114671050 | Beyond pharmacotherapy: Emerging data that non-invasive brain stimulation may be an efficacious strategy for decreasing drug craving in substance-dependent individuals |
Q37196194 | Beyond quitting: predictors of teen smoking cessation, reduction and acceleration following a school-based intervention |
Q89123511 | Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons |
Q69890069 | Bidirectional cross-tolerance between methadone (mu)- and ethylketocyclazocine (kappa)-tolerant rats |
Q43162032 | Bill Pollin Era at NIDA (1979-1985). |
Q29395159 | Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors |
Q91028765 | Binge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine release |
Q36845682 | Binge drinking among Brazilian students: a gradient of association with socioeconomic status in five geo-economic regions |
Q36084782 | Binge drinking and risky sexual behavior among HIV-negative and unknown HIV status men who have sex with men, 20 US cities |
Q37107093 | Binge drinking and sleep problems among young adults |
Q40003347 | Binge drinking and subsequent depressive symptoms in young women in Australia |
Q36882901 | Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals |
Q58578114 | Binge drinking is associated with reduced quality of life in young students: A pan-European study |
Q50737764 | Binge drinking trajectory and neuropsychological functioning among university students: a longitudinal study. |
Q42711020 | Binge toluene exposure alters glutamate, glutamine and GABA in the adolescent rat brain as measured by proton magnetic resonance spectroscopy |
Q44418200 | Biochemical and behavioral changes in rats during and after chronic d-amphetamine exposure |
Q44570828 | Biochemical resistance to development of morphine-dependence in rats: biogenic amines, its receptors and antibodies |
Q70398658 | Biofeedback treatment of narcotic addiction: a double-blind study |
Q52560963 | Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. |
Q36507771 | Biological research on drug abuse and addiction in Hispanics: current status and future directions |
Q48960482 | Biorhythm of core temperature in depressive and non-depressive alcoholics |
Q43803504 | Biphasic dose-related effects of morphine on dopamine release |
Q39505925 | Birth order and hospitalization for alcohol and narcotics use in Sweden |
Q33913570 | Bitter and sweet components of ethanol taste in humans |
Q37171680 | Blood alcohol concentrations among bar patrons: A multi-level study of drinking behavior |
Q71099421 | Blood beta-carotene status in chronic alcoholics--a good biochemical marker for malnutrition |
Q51287720 | Blood glucose and lipid concentrations after overload are not associated with the risk of alcohol relapse. |
Q34610855 | Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure |
Q51633277 | Blunted oral body temperature response to MK-212 in cocaine addicts. |
Q102996784 | Blunted prefrontal signature of proactive inhibitory control in cocaine use disorder |
Q27312497 | Blunted striatal responses to favorite-food cues in smokers |
Q92556856 | Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults |
Q40146708 | Body mass index, body dissatisfaction and adolescent smoking initiation. |
Q35088372 | Border effects on DSM-5 alcohol use disorders on both sides of the U.S.-Mexico border |
Q42624436 | Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). |
Q38969373 | Bowling alone, dying together: The role of social capital in mitigating the drug overdose epidemic in the United States |
Q42211323 | Brachial and lumbar plexitis as a reaction to heroin |
Q33686438 | Brain activation during the Stroop task in adolescents with severe substance and conduct problems: A pilot study |
Q47758011 | Brain activation in response to craving- and aversion-inducing cues related to alcohol in patients with alcohol dependence |
Q35690343 | Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. |
Q46651936 | Brain catalase mediates potentiation of social recognition memory produced by ethanol in mice. |
Q48182194 | Brain growth during ethanol-induced hypoplasia |
Q36451266 | Brain hydration during alcohol withdrawal in alcoholics measured by magnetic resonance imaging |
Q33323106 | Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice |
Q37219197 | Brain macrostructural and microstructural abnormalities in cocaine dependence |
Q42452777 | Brain membrane disordering related to acute ethanol administration in naive and short-term ethanol-intoxicated rats |
Q47653954 | Brain monoamines and free choice ethanol consumption in rats |
Q35287414 | Brain perfusion in polysubstance users: relationship to substance and tobacco use, cognition, and self-regulation |
Q48114237 | Brain self-stimulation, locomotor activity and tissue concentrations of ethanol in male rats |
Q47381358 | Brain substrates of early (4h) cigarette abstinence: Identification of treatment targets. |
Q57815347 | Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis |
Q70484348 | Breaking the 'detox-loop' for alcoholics with social detoxification |
Q70709847 | Brief Minnesota Multiphasic Personality Inventory scales to screen for substance abuse |
Q46870061 | Brief alcohol intervention for general hospital inpatients: a randomized controlled trial |
Q50762499 | Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment. |
Q43282952 | Brief counseling for reducing sexual risk and bacterial STIs among drug users--results from project RESPECT. |
Q68504809 | Brief history of control, prevention and treatment of drug dependence in Japan |
Q83352864 | Brief history of the Drug Evaluation Committee (DEC) and its role in the college on problems of drug dependence |
Q43281925 | Brief intervention in general hospital for problematic prescription drug use: 12-month outcome |
Q91375666 | Brief interventions for cannabis use in emerging adults: A systematic review, meta-analysis, and evidence map |
Q40546008 | Brief measures of sensation seeking for screening and large-scale surveys |
Q35074631 | Brief motivational feedback improves post-incarceration treatment contact among veterans with substance use disorders |
Q45193436 | Brief motivational intervention at a clinic visit reduces cocaine and heroin use. |
Q44349242 | Brief overdose education is sufficient for naloxone distribution to opioid users |
Q44762915 | Brief psycho-education affects circadian variability in nicotine craving during cessation |
Q47339641 | Bringing perspective to illicit markets: estimating the size of the U.S. marijuana market |
Q30430845 | Bringing the real world into the laboratory: personal smoking and nonsmoking environments |
Q50030807 | Broken lives: Fights, fractures, and motor vehicle accidents among heroin users entering detoxification |
Q46333528 | Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels |
Q67353180 | Building a standardized alcoholism interview schedule |
Q47603633 | Building abstinent networks is an important resource in improving quality of life. |
Q91777296 | Building the community: Endogenous network formation, homophily and prosocial sorting among therapeutic community residents |
Q38677300 | Bullying involvement and adolescent substance use: A multilevel investigation of individual and neighbourhood risk factors. |
Q39494290 | Buprenorphine |
Q42027327 | Buprenorphine alone and in combination with naloxone in non-dependent humans. |
Q39113302 | Buprenorphine and cocaine effects on social behavior of monkeys |
Q34598914 | Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial |
Q41209394 | Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. |
Q43813287 | Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series |
Q44200709 | Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine |
Q34051572 | Buprenorphine as new treatment for heroin dependence |
Q36248890 | Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners |
Q44448287 | Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study. |
Q34288852 | Buprenorphine for opiate addiction: potential economic impact |
Q46596047 | Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management |
Q41454559 | Buprenorphine infrequently found in fatal overdose in New York City. |
Q34615753 | Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy |
Q91729260 | Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence |
Q44344544 | Buprenorphine physician supply: Relationship with state-level prescription opioid mortality |
Q43842940 | Buprenorphine prescription by general practitioners in a French region. |
Q96155653 | Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study |
Q44347846 | Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing |
Q44342354 | Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing. |
Q43571815 | Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes |
Q44345946 | Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome |
Q44349294 | Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome |
Q44574571 | Buprenorphine versus methadone maintenance: a cost-effectiveness analysis |
Q48792198 | Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis |
Q36527454 | Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial |
Q40983954 | Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients |
Q44331745 | Buprenorphine: a controlled clinical trial in the treatment of opioid dependence |
Q52027578 | Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. |
Q35124202 | Buprenorphine: how to use it right |
Q36014571 | Bupropion SR for the treatment of smokeless tobacco use. |
Q34044583 | Bupropion attenuates methamphetamine self-administration in adult male rats |
Q35298970 | Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial |
Q35661041 | Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. |
Q47610819 | Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine |
Q36249079 | Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial |
Q39550370 | Butorphanol |
Q43505922 | Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine |
Q44049026 | Bystander resuscitation attempts at heroin overdose: does it improve outcomes? |
Q33931558 | C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis. |
Q44794868 | CANDIS treatment program for cannabis use disorders: findings from a randomized multi-site translational trial |
Q99604396 | COVID-19 survey among people who use drugs in three cities in Norway |
Q44596358 | CPDD Policy statement. Standards for drug abuse treatment providers |
Q92023740 | CR-19-0950: Event-related responses to alcohol-related stimuli in Mexican-American young adults: Relation to age, gender, comorbidity and "dark side" symptoms |
Q24644404 | Caffeinated energy drinks--a growing problem |
Q33948512 | Caffeine antagonism of alcohol-induced driving impairment |
Q35281275 | Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine |
Q43890369 | Caffeine dependence in teenagers |
Q42214928 | Caffeine increases the motivation to obtain non-drug reinforcers in rats. |
Q72874083 | Caffeine self-administration and withdrawal: incidence, individual differences and interrelationships |
Q48405794 | Caffeine--an atypical drug of dependence |
Q69444357 | Calcitonin and prolactin serum levels in heroin addicts: study on a methadone treated group |
Q93659093 | Calcitonin serum levels in heroin addicts: effects of methadone and clonidine detoxication treatments |
Q45083000 | Calcium agonists and antagonists of the dihydropyridine type: effect on nicotine-induced antinociception and hypomotility |
Q33912521 | Can 12-step group participation strengthen and extend the benefits of adolescent addiction treatment? A prospective analysis |
Q39559440 | Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere |
Q40509693 | Can brain games help smokers quit?: Results of a randomized clinical trial |
Q40780152 | Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs? |
Q37505027 | Can intranasal drug use reduce HCV infection among injecting drug users? |
Q36729404 | Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? |
Q37282169 | Can the school context moderate the protective effect of parental support on adolescents' alcohol trajectories in urban Chicago? |
Q35122016 | Can we design and replicate clinical trials with a multiple drug focus |
Q51637256 | Can you trust patient self-reports of drug use during treatment? |
Q52700732 | Candidate mechanisms for inhibition of neurotransmitter release by narcotic analgesics and endorphins |
Q53113293 | Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity. |
Q48556919 | Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network. |
Q48166054 | Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol |
Q45086799 | Cannabinoid receptors in developing rats: detection of mRNA and receptor binding |
Q52070389 | Cannabis and cognitive functions: a prospective study. |
Q34323045 | Cannabis and depression: an integrative data analysis of four Australasian cohorts. |
Q48405803 | Cannabis and endogenous cannabinoid systems. |
Q93076111 | Cannabis and tobacco use and co-use: Trajectories and correlates from early adolescence to emerging adulthood |
Q52187770 | Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. |
Q35952146 | Cannabis effects on driving lateral control with and without alcohol |
Q89649702 | Cannabis labelling and consumer understanding of THC levels and serving sizes |
Q91411140 | Cannabis legalization, tobacco prevention policies, and Cannabis use in E-cigarettes among youth |
Q35287207 | Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts |
Q27312420 | Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005-2010. |
Q97687094 | Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization |
Q90000180 | Cannabis use among youth in the United States, 2004-2016: Faster rate of increase among youth with depression |
Q46776764 | Cannabis use and adult ADHD symptoms |
Q41612149 | Cannabis use and alcohol problems among adults and students |
Q51907586 | Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. |
Q48933696 | Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: A TRAILS study |
Q43067543 | Cannabis use and educational achievement: findings from three Australasian cohort studies. |
Q115217232 | Cannabis use and obesity-traits: A Mendelian randomization study |
Q91211492 | Cannabis use and physical activity among 89,777 adolescents aged 12-15 years from 21 low- and middle-income countries |
Q100745888 | Cannabis use and the risk of anxiety and depression in women: A comparison of three Swedish cohorts |
Q91166873 | Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016 |
Q46905530 | Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescents |
Q90507504 | Cannabis use disorders among adults in the United States during a time of increasing use of cannabis |
Q37164865 | Cannabis use during a voluntary quit attempt: an analysis from ecological momentary assessment |
Q58583618 | Cannabis use during alcohol treatment is associated with alcohol-related problems one-year post-treatment |
Q90116437 | Cannabis use during pregnancy in the United States: The role of depression |
Q28291328 | Cannabis use in a drug and alcohol clinic population |
Q38243168 | Cannabis use in adolescence and risk of future disability pension: a 39-year longitudinal cohort study |
Q104611951 | Cannabis use in college: Genetic predispositions, peers, and activity participation |
Q98244558 | Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial |
Q98579191 | Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment |
Q104506620 | Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis |
Q96018543 | Cannabis use prevalence among individuals with diabetes: The National Survey on Drug Use and Health, 2005-2018 |
Q99346821 | Cannabis use, other drug use, and risk of subsequent acute care in primary care patients |
Q30340967 | Cannabis use, sport practice and other leisure activities at the end of adolescence. |
Q35112935 | Cannabis withdrawal in adolescent treatment seekers |
Q43270705 | Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients |
Q34091534 | Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers |
Q35875536 | Cannabis, cigarettes, and their co-occurring use: Disentangling differences in default mode network functional connectivity |
Q49115363 | Cannabis: Finally a therapeutic agent? |
Q91804558 | Capturing habitualness of drinking and smoking behavior in humans |
Q48794577 | Carbamazepine and cocaine-cue reactivity |
Q51603066 | Carbamazepine treatment for cocaine dependence. |
Q51124391 | Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. |
Q73861205 | Carbohydrate deficient transferrin in detecting relapse in alcohol dependence |
Q30481230 | Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users |
Q91004181 | Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats |
Q40553866 | Cardiovascular effects of cocaine in humans: laboratory studies |
Q51750630 | Cardiovascular effects of ethanol in anaesthetized, conscious and pithed rats. |
Q42631946 | Carisoprodol tolerance and precipitated withdrawal. |
Q92811419 | Cartoon-based e-cigarette marketing: Associations with susceptibility to use and perceived expectations of use |
Q31384390 | Carvedilol affects the physiological and behavioral response to smoked cocaine in humans |
Q43274020 | Case histories in pharmaceutical risk management |
Q36431241 | Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations |
Q39392403 | Casualties in Acapulco: results of a study on alcohol use and emergency room care |
Q37100834 | Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain |
Q70616749 | Catecholamines and metabolites in cerebrospinal fluid of teetotallers and sober alcoholics |
Q40470601 | Categorical perception of emotional facial expressions in alcohol-dependence. |
Q90130185 | Caudate reactivity to smoking cues is associated with increased responding to monetary reward in nicotine-dependent individuals |
Q97439234 | Causal relationships between substance use and insomnia |
Q44620683 | Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000 |
Q46950539 | Cause of casualty and drinking patterns: an emergency room study of unintentional injuries |
Q104741916 | Causes of death among U.S. Veterans with a prior nonfatal opioid overdose |
Q90457195 | Causes of hospital admission and mortality among 6683 people who use heroin: A cohort study comparing relative and absolute risks |
Q36248928 | Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice |
Q36786516 | Celebrating the history of NIDA (2003-present) |
Q39426592 | Cell phone-based ecological momentary assessment of substance use context for Latino youth in outpatient treatment: Who, what, when and where |
Q48150283 | Central nervous system myelination in rats exposed to ethanol in utero |
Q66985009 | Central neurons are depressed by iontophoretic and micropressure application of ethanol and tetrahydropapaveroline |
Q39803333 | Central serotonergic mechanisms and development of morphine dependence |
Q48983085 | Cerebral atrophy and slow wave sleep of abstinent chronic alcoholics |
Q43842921 | Cerebral blood flow pulsatility deficits in HIV+ poly substance abusers: differences associated with antiviral medications |
Q46675737 | Cerebral blood flow velocity and erythrocyte deformability in heavy alcohol drinkers at the acute stage and two weeks after withdrawal |
Q37396982 | Cerebral gray matter volumes and low-frequency fluctuation of BOLD signals in cocaine dependence: duration of use and gender difference. |
Q34631150 | Cerebral metabolism and mood in remitted opiate dependence |
Q44094321 | Cerebral perfusion defects in combined cocaine and alcohol dependence |
Q36936189 | Cessation of alcohol consumption decreases rate of nicotine metabolism in male alcohol-dependent smokers |
Q40758658 | Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors |
Q44487804 | Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions |
Q35088386 | Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS. |
Q37004432 | Challenging expectancies to prevent nonmedical prescription stimulant use: a randomized, controlled trial |
Q90016542 | Change in alcohol and other drug use during five years of continuous opioid substitution treatment |
Q38826178 | Change in motives among frequent cannabis-using adolescents: Predicting treatment outcomes |
Q96946786 | Change in opioid policies in New England emergency departments, 2014 vs 2018 |
Q35997336 | Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity. |
Q37337204 | Change over time in alcohol consumption in control groups in brief intervention studies: systematic review and meta-regression study. |
Q42937877 | Changes at drug and alcohol dependence |
Q45131263 | Changes in HIV-related behaviors among heterosexual alcoholics following addiction treatment |
Q37016757 | Changes in PTSD symptomatology during acute and protracted alcohol and cocaine abstinence |
Q90323786 | Changes in adolescent smoking with implementation of local smoke-free policies in Indonesia: Quasi-experimental repeat cross-sectional analysis of national surveys of 2007 and 2013 |
Q35088294 | Changes in alcohol consumption: United States, 2001-2002 to 2012-2013. |
Q69748704 | Changes in alcohol problems as a result of changing alcohol consumption: a natural experiment |
Q45032800 | Changes in alcohol use after traumatic experiences: the impact of combat on Army National Guardsmen. |
Q88957971 | Changes in alcohol use associated with changes in HIV disease severity over time: A national longitudinal study in the Veterans Aging Cohort |
Q39324894 | Changes in alcohol use following the transition to motherhood: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q41439587 | Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). |
Q43144780 | Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. |
Q28326837 | Changes in benzodiazepine-receptor activity modify morphine withdrawal syndrome in mice |
Q48466218 | Changes in brain gray matter in abstinent heroin addicts |
Q90077878 | Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal |
Q70724457 | Changes in cholinergic function in rat brain late in abstinence after chronic barbital treatment |
Q48120865 | Changes in cigarette and alcohol use during cannabis abstinence. |
Q49833352 | Changes in dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence |
Q43774571 | Changes in dopamine receptor responsivity during alcohol detoxification may predict relapse |
Q47994689 | Changes in drinking behavior among control group participants in early intervention studies targeting unhealthy alcohol use recruited in general hospitals and general practices. |
Q39407581 | Changes in drinking patterns during and after pregnancy among mothers of children with fetal alcohol syndrome: A study in three districts of South Africa |
Q37379197 | Changes in feeding and locomotion induced by amphetamine analogs in rats |
Q92160658 | Changes in fentanyl demand following naltrexone, morphine, and buprenorphine in male rats |
Q44033331 | Changes in hepatic and serum gamma-glutamyltransferase activities following chronic ethanol intake in rats |
Q39985561 | Changes in illicit drug consumption patterns in 2009 detected by wastewater analysis. |
Q68046825 | Changes in locomotor-activity patterns as a measure of spontaneous morphine withdrawal: no effect of clonidine |
Q39450396 | Changes in network characteristics and HIV risk behavior among injection drug users |
Q41364763 | Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011. |
Q47691475 | Changes in nonhuman primate brain function following chronic alcohol consumption in previously naïve animals |
Q102377605 | Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program |
Q44448286 | Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia |
Q35223794 | Changes in protective behavioral strategies and alcohol use among college students |
Q37433660 | Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review |
Q33723650 | Changes in resting functional connectivity during abstinence in stimulant use disorder: a preliminary comparison of relapsers and abstainers. |
Q70510456 | Changes in serum LH and FSH following preovulatory administration of ethanol in rats |
Q44411585 | Changes in short-term prognosis-a comparison between Swedish amphetamine and opiate abusers |
Q46869464 | Changes in smoking behaviours from late childhood to adolescence: 4 years later |
Q47196231 | Changes in smoking status among a longitudinal cohort of gay, bisexual, and other men who have sex with men in Vancouver, Canada |
Q40609786 | Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. |
Q94548444 | Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting |
Q68046841 | Changes in sulfhydryl compounds in plasma, liver and brain after acute and chronic acetaldehyde administration in rats |
Q61602140 | Changes in supervised drug-injecting practices following a community-based educational intervention: A longitudinal analysis |
Q70398661 | Changes in the frequency of alcohol intoxication associated with mortality |
Q47611321 | Changes in the perception of alcohol-related stigma in Germany over the last two decades |
Q35633198 | Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques |
Q44334744 | Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. |
Q30412977 | Changes in the α4β2* nicotinic acetylcholine system during chronic controlled alcohol exposure in nonhuman primates |
Q91211463 | Changes in urban and rural cigarette smoking and cannabis use from 2007 to 2017 in adults in the United States |
Q43890379 | Changes in use of crack cocaine after drug misuse treatment: 4-5 year follow-up results from the National Treatment Outcome Research Study (NTORS). |
Q97561746 | Changes over time in young adults' harmful alcohol consumption: A cross-temporal meta-analysis using the AUDIT |
Q35618781 | Changing motives for use: outcomes from a cognitive-behavioral intervention for marijuana-dependent adults |
Q47989310 | Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures |
Q43890375 | Changing patient characteristics with increased methadone maintenance availability |
Q51873143 | Changing patterns of first injection across key periods of the French Harm Reduction Policy: PrimInject, a cross sectional analysis. |
Q71473807 | Changing patterns of soft drug use prior to and during pregnancy: a prospective study |
Q39281135 | Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys |
Q91144800 | Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada |
Q103834909 | Characteristics and circumstances of death related to buprenorphine toxicity in Australia |
Q90220875 | Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia |
Q91195605 | Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids |
Q91072388 | Characteristics and current clinical practices of opioid treatment programs in the United States |
Q99590257 | Characteristics associated with denial of problem drinking among two generations of individuals with alcohol use disorders |
Q35300643 | Characteristics associated with the diversion of controlled medications among adolescents |
Q52271061 | Characteristics of 68 chronic phencyclidine abusers who sought treatment |
Q46321208 | Characteristics of DSM-IV alcohol diagnostic orphans: drinking patterns, physical illness, and negative life events |
Q43453410 | Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing |
Q40358105 | Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability |
Q48473591 | Characteristics of adults seeking medical marijuana certification |
Q67488748 | Characteristics of attenders to community based alcohol treatment centre with special reference to sex difference |
Q52896340 | Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. |
Q34479322 | Characteristics of clinicians likely to refer clients to 12-Step programs versus a diversity of post-treatment options |
Q43912249 | Characteristics of developmentally early alcohol use disorder symptom reports: a prospective-longitudinal community study |
Q47654805 | Characteristics of drinking events associated with heavy episodic drinking among adolescents in the United States. |
Q47178443 | Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use. |
Q35589591 | Characteristics of drug users who witness many overdoses: implications for overdose prevention. |
Q44419175 | Characteristics of drug-related hospital separations in Australia |
Q43515105 | Characteristics of injection drug using parents who retain their children |
Q45000232 | Characteristics of men with substance use disorder consequent to illicit drug use: comparison of a random sample and volunteers |
Q58581265 | Characteristics of patients with substance use disorder before and after the Affordable Care Act |
Q33670755 | Characteristics of people who initiate injection drug use later in life |
Q34616956 | Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study |
Q46302144 | Characteristics of self-inflicted drug overdose deaths in North Carolina |
Q36619730 | Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration |
Q51169741 | Characteristics of women receiving mandated treatment for alcohol or polysubstance dependence in Massachusetts. |
Q45105113 | Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems |
Q48120314 | Characterization of brain acetaldehyde oxidizing systems in the mouse |
Q36936196 | Characterization of comorbid PTSD in treatment-seeking alcohol dependent inpatients: Severity and personality trait differences |
Q92731441 | Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky |
Q73045430 | Characterization of the decline in alcohol consumption by aminopeptidase inhibition |
Q57202946 | Characterizing JUUL-related posts on Twitter |
Q37298826 | Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers |
Q30578444 | Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients using modified materials |
Q57815349 | Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada |
Q92557194 | Characterizing latent classes of social support among persons who inject drugs |
Q33810775 | Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users. |
Q40123985 | Characterizing marijuana concentrate users: A web-based survey |
Q35660989 | Characterizing opioid withdrawal during double-blind buprenorphine detoxification |
Q36328256 | Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients |
Q89362533 | Characterizing peer roles in an overdose crisis: Preferences for peer workers in overdose response programs in emergency shelters |
Q94472460 | Characterizing profiles of polysubstance use among high school students in Baltimore, Maryland: A latent class analysis |
Q40068687 | Characterizing substance use and mental health profiles of cigar, blunt, and non-blunt marijuana users from the National Survey of Drug Use and Health. |
Q96762372 | Characterizing the polytobacco behaviors of sexual minority young adult college students |
Q44730083 | Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers |
Q48430914 | Characterizing white matter changes in cigarette smokers via diffusion tensor imaging |
Q44138261 | Chasing the dragon, related to the impaired lung function among heroin users |
Q44090085 | Cheese: an old drug in a new wrapper |
Q36987705 | Chemical aversion treatment of alcohol dependence |
Q44345098 | Chemical dependency treatment and employment outcomes: results from the 'ADATSA' program in Washington State |
Q51738919 | Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. |
Q51741819 | Child injury deaths linked with adult alcohol consumption: A time series analysis. |
Q35785626 | Child maltreatment increases sensitivity to adverse social contexts: neighborhood physical disorder and incident binge drinking in Detroit |
Q74224867 | Child sexual abuse as a predictor of psychiatric co-morbidity and its implications for drug and alcohol treatment |
Q37164824 | Childhood abuse and neglect and transitions in stages of alcohol involvement among women: a latent transition analysis approach. |
Q35861274 | Childhood adversity, serotonin transporter (5-HTTLPR) genotype, and risk for cigarette smoking and nicotine dependence in alcohol dependent adults |
Q46693255 | Childhood and adolescent antecedents of drug and alcohol problems: A longitudinal study |
Q37522428 | Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students |
Q46380862 | Childhood hyperactivity-inattention symptoms and smoking in adolescence |
Q92481052 | Childhood language development and later alcohol use behaviors |
Q39459620 | Childhood misbehavior and the risk of injecting drug use. |
Q37282493 | Childhood or adolescent parental divorce/separation, parental history of alcohol problems, and offspring lifetime alcohol dependence |
Q48443242 | Childhood physical abuse, non-suicidal self-harm and attempted suicide amongst regular injecting drug users |
Q50754835 | Childhood physical neglect associated with executive functions impairments in crack cocaine-dependent women. |
Q35196450 | Childhood physical punishment and the onset of drinking problems: evidence from metropolitan China |
Q35083953 | Childhood predictors of first chance to use and use of cannabis by young adulthood |
Q40460140 | Childhood risk categories for adolescent substance involvement: a general liability typology. |
Q43144779 | Childhood sexual abuse and adolescent substance use: a latent class analysis |
Q35946033 | Childhood sexual abuse and the course of alcohol dependence development: findings from a female twin sample |
Q92749390 | Childhood social context in relation to alcohol expectancy through early adolescence: A latent profile approach |
Q43186817 | Childhood trauma and dissociation in patients with alcohol dependence, drug dependence, or both-A multi-center study |
Q104691625 | Childhood trauma and post-trauma environment affect fear memory and alcohol use differently in male and female mice |
Q99731882 | Childhood trauma, alexithymia, and mental states recognition among individuals with alcohol use disorder and healthy controls |
Q36983018 | Childhood weight status and timing of first substance use in an ethnically diverse sample. |
Q47335456 | Children's brain activation during risky decision-making: A contributor to substance problems? |
Q52266685 | Chlordiazepoxide vs. methadone in opiate withdrawal: a preliminary double blind trial. |
Q34850262 | Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome |
Q43774555 | Chloroephedrine: contaminant of methamphetamine synthesis with cardiovascular activity |
Q68916207 | Choice of blind methadone dose increases by methadone maintenance patients |
Q36935300 | Choice of nitrous oxide and its subjective effects in light and moderate drinkers |
Q36528682 | Choice of sevoflurane and its subjective and psychomotor effects in light and moderate drinkers |
Q36721872 | Choice to view cocaine images predicts concurrent and prospective drug use in cocaine addiction |
Q48863542 | Cholinergic activity in hippocampus in chronic alcoholism |
Q35846758 | Choosing a behavioral therapy platform for pharmacotherapy of substance users |
Q44360028 | Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement |
Q48650854 | Chronic administration of and dependence on halazepam, diazepam, and nordiazepam in the dog |
Q37323419 | Chronic alcohol consumption from adolescence-to-adulthood in mice--effect on growth and social behavior |
Q34507740 | Chronic alcohol consumption impairs visuo-spatial associative memory in periadolescent rhesus monkeys. |
Q39866334 | Chronic alcoholic cardiomyopathy: Fact or fiction? |
Q71196807 | Chronic alcoholism and myocardial disease |
Q34584457 | Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA). |
Q41448888 | Chronic cannabis consumption: suggestions for future research |
Q39480335 | Chronic cannabis takers: Some temperamental characteristics |
Q91166876 | Chronic childhood adversity and speed of transition through stages of alcohol involvement |
Q50729787 | Chronic childhood adversity and stages of substance use involvement in adolescents. |
Q91568664 | Chronic cocaine administration upregulates FKBP5 in the extended amygdala of male and female rats |
Q44279652 | Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions |
Q48495942 | Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males |
Q44229582 | Chronic ethanol abuse and membrane fluidity changes in liver disease |
Q36421415 | Chronic ethanol self-administration in macaques shifts dopamine feedback inhibition to predominantly D2 receptors in nucleus accumbens core |
Q43890403 | Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels |
Q35501675 | Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users |
Q46136208 | Chronic ingestion of ethanol increases stimulation-induced voluntary activity in the rat. |
Q35287737 | Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens. |
Q51569284 | Chronic lead exposure attenuates sensitization to the locomotor-stimulating effects of cocaine. |
Q46114959 | Chronic morphine treatment induces over-expression of HSP70 in mice striatum related with abnormal ubiquitin-proteasome degradation |
Q70972527 | Chronic nicotine exposure in rat: A behavioural and biochemical study of tolerance |
Q89845184 | Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization |
Q44994527 | Chronic opiate treatment enhances both cocaine-reinforced and cocaine-seeking behaviors following opiate withdrawal. |
Q70643971 | Chronic opiate use during methadone detoxification: effects of a dose increase treatment |
Q39596506 | Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy |
Q88503817 | Chronic restraint stress during withdrawal increases vulnerability to drug priming-induced cocaine seeking via a dopamine D1-like receptor-mediated mechanism |
Q46627187 | Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. |
Q35083923 | Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders |
Q50083707 | Cigarette craving and stressful social interactions: The roles of state and trait social anxiety and smoking to cope |
Q36817785 | Cigarette craving is associated with blunted reward processing in nicotine-dependent smokers |
Q50085563 | Cigarette cues capture attention of smokers and never-smokers, but for different reasons. |
Q36739529 | Cigarette reduction: an intervention for adolescent smokers |
Q37002799 | Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture |
Q37239301 | Cigarette smokers discount past and future rewards symmetrically and more than controls: is discounting a measure of impulsivity? |
Q52291703 | Cigarette smokers show steeper discounting of both food and cigarettes than money. |
Q40609791 | Cigarette smoking and alcohol use as predictors of disability retirement: A population-based cohort study |
Q34827624 | Cigarette smoking and short-term addiction treatment outcome. |
Q44634543 | Cigarette smoking and solvent use among Japanese adolescents |
Q37081185 | Cigarette smoking and the lifetime alcohol involvement continuum |
Q36961530 | Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes |
Q39822592 | Cigarette smoking in young adults: the influence of the HTR2A T102C polymorphism and punishment sensitivity. |
Q46128862 | Cigarette smoking is associated with amplified age-related volume loss in subcortical brain regions |
Q57299714 | Cigarette smoking is associated with cortical thinning in anterior frontal regions, insula and regions showing atrophy in early Alzheimer's Disease |
Q47973686 | Cigarette smoking quit rates among adults with and without alcohol use disorders and heavy alcohol use, 2002-2015: A representative sample of the United States population |
Q35951822 | Cigarette smoking status in pathological gamblers: association with impulsivity and cognitive flexibility |
Q44041198 | Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls |
Q88882744 | Cigarette use trajectories in young adults: Analyses of predictors across system levels |
Q35000302 | Cigarette, marijuana, and alcohol use and prior drug treatment among newly homeless young adults in New York City: Relationship to a history of foster care |
Q33877682 | Cigarettes, alcohol, marijuana, other risk behaviors, and American youth |
Q52676139 | Cigarillo sales in legalized marijuana markets in the U.S. |
Q49009177 | Circadian rhythm of REM sleep of chronic alcoholics during alcohol withdrawal |
Q48334764 | Circumstances and toxicology of sudden or unnatural deaths involving alprazolam |
Q36816919 | Circumstances of initiation into new-type drug use among adults in Shanghai: are there differences by types of first new-type drug used? |
Q39722651 | Circumstances of witnessed drug overdose in New York City: implications for intervention |
Q39708852 | Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. |
Q58121254 | Civil commitment experiences among opioid users |
Q36936224 | Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach |
Q120499454 | Classifying youth substance use with non-invasive questions |
Q34021956 | Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug? |
Q44340670 | Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia. |
Q46945763 | Client consensus on beliefs about abstinence: effects on substance abuse treatment outcomes |
Q70150506 | Clinical and biochemical heterogeneity of alcoholism: the role of family history and alexithymia |
Q39299798 | Clinical and demographic features of patients admitted to a new chemical dependency program in New York City |
Q38126657 | Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports |
Q35124190 | Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? |
Q52266334 | Clinical and prognostic value of serum procollagen levels in chronic alcoholic liver disease. |
Q92918846 | Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review |
Q36689601 | Clinical characteristics of alcohol combined with other substance use disorders in an American Indian community sample |
Q37379413 | Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders |
Q37351611 | Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder |
Q34092133 | Clinical effectiveness of attentional bias modification training in abstinent alcoholic patients |
Q35124199 | Clinical efficacy of buprenorphine: comparisons to methadone and placebo |
Q44924185 | Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients |
Q51145177 | Clinical evaluation of a citric acid inhaler for smoking cessation. |
Q38590259 | Clinical evaluation of a naltrexone sustained-release preparation |
Q43537616 | Clinical experience with T's and B's. |
Q35822376 | Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review |
Q39729077 | Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. |
Q37548578 | Clinical features of registry-ascertained alcohol use disorders that reflect familial risk |
Q44138226 | Clinical impairment of benzodiazepines--relation between benzodiazepine concentrations and impairment in apprehended drivers |
Q43898786 | Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines |
Q39466533 | Clinical observations of agonist-antagonist analgesic dependence |
Q28335780 | Clinical pharmacological studies with 6-azidomorphine |
Q41737283 | Clinical pharmacology of oral cotinine |
Q39136308 | Clinical trial in post-addicts with oxilorphan (Levo-BC2605): A new narcotic antagonist |
Q72658691 | Clinical trials using ascorbic acid aerosol to aid smoking cessation |
Q39741052 | Clinical use of appetite suppressants |
Q47766630 | Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disorders. |
Q91066751 | Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder |
Q70905522 | Clinical--correctional interface in drug abuse treatment--the Milwaukee model |
Q30403930 | Clinician and service user perceptions of implementing contingency management: a focus group study. |
Q47596465 | Clinician identification of elevated symptoms of depression among individuals seeking treatment for substance misuse. |
Q47651261 | Clinician-delivered contingency management increases engagement and attendance in drug and alcohol treatment |
Q39525906 | Clonidine and the treatment of the opiate withdrawal syndrome |
Q72523427 | Clonidine suppression of the alcohol withdrawal syndrome |
Q35690285 | Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan |
Q39231143 | Cluster randomised trial of the effectiveness of motivational interviewing for universal prevention. |
Q91121308 | Cluster randomized stepped-wedge trial of a multi-level HIV prevention intervention to decrease amphetamine-type stimulants and sexual risk in Cambodian female entertainment and sex workers |
Q52051337 | Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. |
Q73128966 | Clusters of drug involvement in Panama: results from Panama's 1996 National Youth Survey |
Q96773478 | Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retention |
Q71617354 | Co-factors affecting substance abuse among homosexual men: an investigation within a midwestern gay community |
Q36339173 | Co-ingestion of prescription opioids and other drugs among high school seniors: results from a national study |
Q34625779 | Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain |
Q34398157 | Co-morbid post-traumatic stress disorder in a substance misusing clinical population. |
Q36400119 | Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand |
Q47682540 | Co-occurrence of alcohol use disorder and behavioral addictions: relevance of impulsivity and craving. |
Q40172455 | Co-occurrence of tobacco product use, substance use, and mental health problems among adults: Findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) Study |
Q46698624 | Co-occurring DSM-IV drug abuse in DSM-IV drug dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q35661044 | Co-occurring psychiatric and drug use disorders among sexual minority men with lifetime alcohol use disorders. |
Q64129534 | Co-occurring substance use and mental disorders among adults with opioid use disorder |
Q91415783 | Co-use of alcohol, tobacco, and licit and illicit controlled substances among pregnant and non-pregnant women in the United States: Findings from 2006 to 2014 National Survey on Drug Use and Health (NSDUH) data |
Q92046373 | Co-use of tobacco and marijuana among young people experiencing homelessness in Los Angeles County |
Q44783315 | Cocaine abuse among heroin addicts in Spain |
Q41041110 | Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. |
Q33625523 | Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory |
Q44835337 | Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding |
Q42691274 | Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients |
Q38790503 | Cocaine and ethanol target 26S proteasome activity and gene expression in neuroblastoma cells. |
Q41252984 | Cocaine behavioral economics: from the naturalistic environment to the controlled laboratory setting |
Q60641796 | Cocaine decreases preference for condom use as function of delayed condom availability and STI risk |
Q40133505 | Cocaine dependence modulates the effect of HIV infection on brain activation during intertemporal decision making |
Q51974909 | Cocaine dependence with and without comorbid depression: a comparison of patient characteristics. |
Q91384320 | Cocaine dependence: "Side effects" and syndrome formation within 1-12 months after first cocaine use |
Q51569291 | Cocaine does not affect prostacyclin, thromboxane or prostaglandin E production in human umbilical veins. |
Q37145523 | Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy |
Q41640358 | Cocaine self-administration and reinstatement in female rats selectively bred for high and low voluntary running. |
Q28372725 | Cocaine self-administration in monkeys: effects on the acquisition and performance of response sequences |
Q36729413 | Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition |
Q51614405 | Cocaine use and HIV risk behavior in methadone maintenance patients. |
Q51696979 | Cocaine use and dependence in young adults: associated psychiatric disorders and personality traits. |
Q36779169 | Cocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the Epidemiologic Catchment Area surveys |
Q97678970 | Cocaine use and overdose mortality in the United States: Evidence from two national data sources, 2002-2018 |
Q34431083 | Cocaine use and risk of stroke: a systematic review |
Q42691313 | Cocaine use and risky injection and sexual behaviors |
Q39646555 | Cocaine use disorders and suicidal ideation |
Q36678744 | Cocaine use during pregnancy and health outcome after 10 years. |
Q42678205 | Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system |
Q38746499 | Cocaine use may modify HIV/ART-associated myocardial steatosis and hepatic steatosis. |
Q42676868 | Cocaine users with antisocial personality improve HIV risk behaviors as much as those without antisocial personality |
Q42043310 | Cocaine withdrawal alters the reward omission effect and enhances traits of negative urgency in rats across multiple days of testing |
Q31528675 | Cocaine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy? |
Q51696986 | Cocaine, social behavior, and alcohol-solution drinking in monkeys. |
Q30401809 | Cocaine-, caffeine-, and stress-evoked cocaine reinstatement in high vs. low impulsive rats: treatment with allopregnanolone |
Q98244557 | Cocaine-Induced Sensitization is Linked to Distal Chromosome 6 Region in Congenic Mouse Model |
Q30570256 | Cocaine-associated odor cue re-exposure increases blood oxygenation level dependent signal in memory and reward regions of the maternal rat brain |
Q91725334 | Cocaine-related alterations in fronto-parietal gray matter volume correlate with trait and behavioral impulsivity |
Q45234110 | Cocaine-related fatalities in New South Wales, Australia 1993-2002. |
Q30581979 | Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments |
Q37787505 | Cochrane systematic reviews in the field of addiction: what's there and what should be. |
Q44809233 | Cochrane systematic reviews: time for an introduction and appraisal |
Q48871063 | Cognition and impulsivity in adults with attention deficit hyperactivity disorder with and without cocaine and/or crack dependence. |
Q48932960 | Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment |
Q48946688 | Cognitions and alcohol-influenced performance: The impact of reinforcement contingencies |
Q44786447 | Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study |
Q38425584 | Cognitive and affective theory of mind abilities in alcohol-dependent patients: the role of autobiographical memory. |
Q48057984 | Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine use. |
Q44687309 | Cognitive behavioral smoking cessation during alcohol detoxification treatment: a randomized, controlled trial |
Q44836285 | Cognitive bias and drug craving in recreational cannabis users |
Q34683122 | Cognitive bias for alcohol-related information in inferential processes |
Q71812197 | Cognitive capacity in female adolescent substance abusers |
Q87837091 | Cognitive control in young heavy drinkers: An ERP study |
Q35673255 | Cognitive control links alcohol use, trait disinhibition, and reduced cognitive capacity: Evidence for medial prefrontal cortex dysregulation during reward-seeking behavior |
Q70905525 | Cognitive deficit in middle-aged alcoholics |
Q36717843 | Cognitive deficits in long-term anabolic-androgenic steroid users |
Q36724630 | Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome |
Q89729214 | Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence |
Q40387821 | Cognitive deficits predict low treatment retention in cocaine dependent patients. |
Q36179654 | Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study |
Q44049005 | Cognitive functioning among infants of alcoholic fathers. |
Q48728366 | Cognitive functioning of alcoholic females: an exploratory study |
Q52247840 | Cognitive functioning of alcoholics and its relationship with prognosis. |
Q41349333 | Cognitive group therapy for wives of alcoholics--a pilot study |
Q42671252 | Cognitive impairment and chronic alcohol abuse: a neuropsychological study |
Q61777375 | Cognitive impairment associated with cocaine use: The role of co-existent alcohol abuse/dependence |
Q44026538 | Cognitive impairment in methadone maintenance patients |
Q92019162 | Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand |
Q44555348 | Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment |
Q38420830 | Cognitive impairments in sober alcoholics: performance on selective and divided attention tasks |
Q34980201 | Cognitive manifestations of drinking-smoking associations: preliminary findings with a cross-primed Stroop task |
Q46081119 | Cognitive mediators and disparities in the relation between teen depressiveness and smoking |
Q50531824 | Cognitive predictors of problem drinking and AUDIT scores among college students |
Q91005669 | Cognitive reappraisal moderates the relationship between PTSD symptoms and alcohol use over time in post-9/11 U.S. military veterans |
Q51012551 | Cognitive recovery during and after treatment for volatile solvent abuse. |
Q38666568 | Cognitive remediation improves executive functions, self-regulation and quality of life in residents of a substance use disorder therapeutic community |
Q34760944 | Cohort trends in prevalence and spousal concordance for smoking |
Q44794138 | Coincident posttraumatic stress disorder and depression predict alcohol abuse during and after deployment among Army National Guard soldiers. |
Q36886025 | Collecting substance use data with an anonymous mailed survey |
Q90485681 | College attendance type and subsequent alcohol and marijuana use in the U.S. |
Q78008556 | College on Problems of Drug Dependence 64th Annual Scientific Meeting. June 8-13, 2002. Quebec City, Quebec, Canada. Abstracts |
Q71865414 | College on Problems of Drug Dependence Policy on Administering Drugs with Abuse Potential in Human Research |
Q35084350 | College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement |
Q73624031 | College on Problems of Drug Dependence. 62nd Annual Scientific Meeting. June 17-22, 2000. San Juan, Puerto Rico. Abstracts |
Q50622619 | College on problems of drug dependence meeting, Puerto Rico (June 1996) marijuana use and dependence |
Q73807175 | College on problems of drug dependence. 63rd annual scientific meeting. June 16-21, 2001, Scottsdale, Arizona. Abstracts |
Q83145168 | College on the problems of drug dependence. Highlights from the 67th annual meeting |
Q36496182 | College student use of Salvia divinorum |
Q42724118 | College students' perceptions and knowledge of hookah use. |
Q43182664 | College students' readiness to reduce binge drinking: criterion validity of a brief measure |
Q35594934 | Collegial ethics: what, why and how |
Q115217250 | Colocalization of association signals at nicotinic acetylcholine receptor genes between schizophrenia and smoking traits |
Q40330145 | Combination of ALDH2 and ADH1B polymorphisms is associated with smoking initiation: A large-scale cross-sectional study in a Japanese population |
Q33269643 | Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. |
Q44050496 | Combinations of oxazepam and metyrapone attenuate cocaine and methamphetamine cue reactivity |
Q39788413 | Combined Goal Management Training and Mindfulness meditation improve executive functions and decision-making performance in abstinent polysubstance abusers. |
Q46623247 | Combined exposure to tobacco smoke and ethanol during adolescence leads to short- and long-term modulation of anxiety-like behavior |
Q73795239 | Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study |
Q46861313 | Combining psychometric and biometric measures of substance use. |
Q100501576 | Combustible cigarette use and other risky behavior by adult e-cigarette users in a 2019 survey |
Q57842212 | Commentary |
Q39645273 | Commentary on, 'Internal reliability of measures of substance-related cognitive bias'. |
Q37570004 | Commitment strength, alcohol dependence and HealthCall participation: effects on drinking reduction in HIV patients |
Q89804001 | Common and distinct brain activity associated with risky and ambiguous decision-making |
Q36946406 | Common and specific liability to addiction: approaches to association studies of opioid addiction |
Q48405808 | Common aspects of the action of nicotine and other drugs of abuse |
Q34546657 | Common genetic influences on the timing of first use for alcohol, cigarettes, and cannabis in young African-American women |
Q52014345 | Common genetic mechanisms in alcohol, drug, and mental disorder comorbidity. |
Q24603044 | Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective |
Q38693991 | Common liability to drug addictions: theory, research, practice |
Q47688679 | Commonly used stimulants: Sleep problems, dependence and psychological distress |
Q46872177 | Community actions against alcohol drinking in Slovenia--a Delphi study |
Q100722997 | Community dashboards to support data-informed decision-making in the HEALing communities study |
Q100570132 | Community engagement to implement evidence-based practices in the HEALing communities study |
Q37216834 | Community program therapist adherence and competence in motivational enhancement therapy |
Q28142954 | Community reinforcement training for family and significant others of drug abusers: a unilateral intervention to increase treatment entry of drug users |
Q39678811 | Community-based approaches to highway safety: health promotion and drinking-driving |
Q36619293 | Comorbid depression, antisocial personality, and substance dependence: Relationship with delay discounting |
Q43685942 | Comorbid disruptive behavior disorder symptoms and their relationship to adolescent alcohol use disorders |
Q58123016 | Comorbid social phobia does not predict the outcome in alcohol use disorder outpatient treatment |
Q62017642 | Comorbid social phobia does not predict the outcome in alcohol use disorder outpatient treatment |
Q35181256 | Comorbidity and temporal relations of alcohol and cannabis use disorders from youth through adulthood |
Q44634738 | Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q34370995 | Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey |
Q40358097 | Comorbidity between alcohol dependence and illicit drug dependence in adolescents with antisocial behavior and matched controls |
Q34090165 | Comorbidity between patterns of substance use dependence and psychiatric syndromes |
Q52000664 | Comorbidity of drug dependence and other mental disorders: a two-phase study of prevalence at outpatient treatment centres in Italy. |
Q37164894 | Comorbidity of posttraumatic stress disorder with alcohol dependence among US adults: results from National Epidemiological Survey on Alcohol and Related Conditions |
Q35917730 | Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey |
Q113185713 | Comparative efficacy of a computer-based HIV testing video intervention in sites of varying HIV prevalence |
Q45907295 | Comparative epidemiology of betel nut use versus ecstasy use among Taiwanese adolescents: Findings from a national survey |
Q40816087 | Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin |
Q57101477 | Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study |
Q52278618 | Comparative neurobiological effects of ibogaine and MK-801 in rats. |
Q44334707 | Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users |
Q30525634 | Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders. |
Q44343140 | Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence |
Q52838676 | Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: a cross-sectional survey of drug using prisoners. |
Q46649468 | Comparative psychometric study of a range of hazardous drinking measures administered online in a youth population |
Q42655336 | Comparing HIV-related syringe-sharing behaviors among female IDU engaging versus not engaging in commercial sex. |
Q48136025 | Comparing abrupt and gradual smoking cessation: a randomized trial |
Q35940943 | Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence. |
Q38782542 | Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States |
Q51567259 | Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. |
Q44049018 | Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task |
Q96160521 | Comparing cannabis use motive item performance between American Indian and White youth |
Q47275280 | Comparing daily drivers of problem drinking among older and younger adults: An electronic daily diary study using smartphones |
Q44283711 | Comparing homeless and domiciled pregnant substance dependent women on psychosocial characteristics and treatment outcomes |
Q40821315 | Comparing levels of cocaine cue reactivity in male and female outpatients |
Q101409228 | Comparing mortality and healthcare utilization in the year following a paramedic-attended non-fatal overdose among people who were and were not transported to hospital: A prospective cohort study using linked administrative health data |
Q34607700 | Comparing overdose mortality associated with methadone and buprenorphine treatment |
Q98563546 | Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians |
Q90897192 | Comparing state, regional, and local variation in concurrent opioid and benzodiazepine use |
Q52684858 | Comparing substance use and mental health outcomes among sexual minority and heterosexual women in probability and non-probability samples. |
Q90873803 | Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study |
Q91512019 | Comparing the predictive capability of self-report and medically-verified non-fatal overdose in adults released from prison: A prospective data linkage study |
Q43238456 | Comparing the predictive validity of five cigarette dependence questionnaires |
Q47645470 | Comparing the predictive validity of the four-factor and five-factor (bifactor) measurement structures of the drinking motives questionnaire. |
Q90077880 | Comparing the reward value of cigarettes and food during tobacco abstinence and nonabstinence |
Q46712093 | Comparing the validity of the Cigarette Dependence Scale and the Fagerström Test for Nicotine Dependence. |
Q67781895 | Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification |
Q47393983 | Comparison between the WHO and NIAAA criteria for binge drinking on drinking features and alcohol-related aftermaths: Results from a cross-sectional study among eight emergency wards in France |
Q39331220 | Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients. |
Q40273761 | Comparison of a physical dependence on t-butanol and ethanol |
Q93351013 | Comparison of age of first drink and age of first intoxication as predictors of substance use and mental health problems in adulthood |
Q36230162 | Comparison of alcohol impairment of behavioral and attentional inhibition |
Q40258800 | Comparison of beliefs about e-cigarettes' harms and benefits among never users and ever users of e-cigarettes. |
Q33564574 | Comparison of categorical alcohol dependence versus a dimensional measure for predicting weekly alcohol use in heavy drinkers |
Q35957344 | Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence |
Q36960396 | Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence |
Q51826991 | Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding. |
Q48172478 | Comparison of impulsivity and working memory in cocaine addiction and pathological gambling: Implications for cocaine-induced neurotoxicity |
Q51210197 | Comparison of intravenously administered methadone, morphine and heroin. |
Q36635305 | Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder |
Q52278073 | Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. |
Q42209807 | Comparison of peripheral and central administration of naloxone in precipitating abstinence in morphine-dependent rats |
Q27312121 | Comparison of provider-documented and patient-reported brief intervention for unhealthy alcohol use in VA outpatients |
Q44730087 | Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders |
Q38411955 | Comparison of self-reported alcohol use with the alcohol biomarker phosphatidylethanol among young people in northern Tanzania |
Q37419872 | Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts |
Q53821183 | Comparison of the MoCA and BEARNI tests for detection of cognitive impairment in in-patients with alcohol use disorders. |
Q34403222 | Comparison of the behavioral effects of gamma-hydroxybutyric acid (GHB) and its 4-methyl-substituted analog, gamma-hydroxyvaleric acid (GHV). |
Q35925627 | Comparison of the characteristics of long-term users of electronic cigarettes versus nicotine replacement therapy: A cross-sectional survey of English ex-smokers and current smokers |
Q38764828 | Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats |
Q44903003 | Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization |
Q51425631 | Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. |
Q44049006 | Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users |
Q89956986 | Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients |
Q58180777 | Comparison of tobacco, alcohol and illegal drug usage among school students in three Pacific Island societies |
Q48334736 | Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone |
Q51799393 | Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery. |
Q78170773 | Comparison of urinary 5-hydroxytryptophol, breath ethanol, and self-report for detection of recent alcohol use during outpatient treatment: a study on methadone patients |
Q39340363 | Comparison of γ-glutamyltransferase and questionnaire test as alcohol indicators in different risk groups |
Q30805892 | Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients |
Q36896517 | Comparisons of three nicotine dependence scales in a multiethnic sample of young adult menthol and non-menthol smokers. |
Q33966758 | Competing values among criminal justice administrators: The importance of substance abuse treatment |
Q46681024 | Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine |
Q41594650 | Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study. |
Q44672973 | Comprehensive deficits in performance of an attentional task produced by co-administering alcohol and nicotine to rats |
Q51913202 | Comprehensive mathematical modeling in drug addiction sciences. |
Q36016324 | Computer adaptive testing of liability to addiction: identifying individuals at risk. |
Q30544630 | Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care: one year outcomes |
Q104287083 | Computer- vs. nurse practitioner-delivered brief intervention for adolescent marijuana, alcohol, and sex risk behaviors in school-based health centers |
Q87884231 | Computer-delivered indirect screening and brief intervention for drug use in the perinatal period: A randomized trial |
Q56747415 | Computers in community-based drug and alcohol clinical settings: are they acceptable to respondents? |
Q44245073 | Concentration-dependent conditioned place preference to inhaled toluene vapors in rats |
Q45157519 | Conceptual issues in understanding the relationship between suicidal behavior and substance use during adolescence |
Q101131156 | Concomitant drugs with buprenorphine user deaths |
Q52572219 | Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: Using the prescription behavior surveillance system. |
Q33806385 | Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients |
Q31870786 | Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents |
Q47778119 | Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study |
Q33553988 | Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth |
Q35017089 | Concordance between self-reports and archival records of physician visits: a case-control study comparing individuals with and without alcohol use disorders in the community |
Q47778132 | Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. |
Q35754704 | Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA |
Q52278076 | Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS). |
Q41608838 | Concurrent and prospective associations between bullying victimization and substance use among Australian adolescents. |
Q36094629 | Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey |
Q41198341 | Concurrent and simultaneous use of alcohol with cocaine: results of national survey |
Q46262574 | Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome |
Q36772222 | Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition |
Q49968056 | Concurrent nicotine and tobacco product use among homeless smokers and associations with cigarette dependence and other factors related to quitting. |
Q44283687 | Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both? |
Q88457370 | Concurrent use of alcohol with other drugs and DSM-5 alcohol use disorder comorbid with other drug use disorders: Sociodemographic characteristics, severity, and psychopathology |
Q35090740 | Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths |
Q37414069 | Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. |
Q44343846 | Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients |
Q93140239 | Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids |
Q35231680 | Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population |
Q43884121 | Conditioned suppression of behavior maintained by cocaine self-administration |
Q51296350 | Conditioning of narcotic abstinence symptoms in human subjects |
Q51575883 | Conditions sufficient for the production of oral cocaine or lidocaine self-administration in preference to water. |
Q44337032 | Condom use rates for specific sexual behaviors among opioid abusers entering treatment |
Q59187280 | Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: Results of a 25-year longitudinal study |
Q43849679 | Conduct disorder and HIV risk behaviors among runaway and homeless adolescents |
Q96591741 | Conduct disorder and attention-deficit/hyperactivity disorder as risk factors for prescription opioid use |
Q37204895 | Conduct problem trajectories and alcohol use and misuse in mid to late adolescence |
Q39967682 | Conducting a respondent-driven sampling survey with the use of existing resources in Sydney, Australia. |
Q35017158 | Conference on abuse liability and appeal of tobacco products: conclusions and recommendations |
Q44448730 | Conference on abuse liability assessment of CNS drugs |
Q59488287 | Conference on drug formulations and abuse liability |
Q44489153 | Confidence interval estimation in R-DAS. |
Q92570568 | Confirmed marijuana use and lymphocyte count in black people living with HIV |
Q38603605 | Confirmed marijuana use and lymphocyte count in black people living with HIV. |
Q57141602 | Congregation sites for youthful multiple drug users: locations for epidemiological research and intervention |
Q44138245 | Consequences of monosodium glutamate or goldthioglucose arcuate nucleus lesions on ethanol-induced locomotion. |
Q52569441 | Considering high alcohol and violence neighborhood context using daily diaries and GPS: A pilot study among people living with HIV. |
Q92209271 | Considering the impact of vaping-associated pulmonary illness reports on e-cigarette harm perceptions and tobacco use patterns |
Q49451199 | Consistency between adolescent reports and adult retrospective reports of adolescent marijuana use: explanations of inconsistent reporting among an African American population. |
Q47671298 | Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment |
Q51597145 | Construct validity of the abuse-dependence distinction as measured by DSM-IV criteria for different psychoactive substances. |
Q33401423 | Construct, concurrent and predictive validity of the URICA: data from two multi-site clinical trials |
Q35915690 | Constructing evidence-based treatment strategies using methods from computer science |
Q91103283 | Construction trade and extraction workers: A population at high risk for drug use in the United States, 2005-2014 |
Q92773802 | Contagion models for the transmission of drug abuse among propinquity-of-rearing defined acquaintances: A Swedish national study |
Q101241558 | Content analysis of instagram posts by leading cannabis vaporizer brands |
Q91207293 | Context matters: On the importance of context-specific analysis for the use of screening questionnaires |
Q38609914 | Context-dependent effects of rimonabant on ethanol-induced conditioned place preference in female mice |
Q90130169 | Contexts of alcohol use: A latent class analysis among Argentinean college students |
Q48404422 | Contextual renewal of cocaine seeking in rats and its attenuation by the conditioned effects of an alternative reinforcer |
Q35966159 | Contextual risks linking parents' adolescent marijuana use to offspring onset |
Q38688566 | Contingency Management interventions for non-prescribed drug use during treatment for opiate addiction: A systematic review and meta-analysis |
Q30506043 | Contingency management delivered by community therapists in outpatient settings |
Q35301317 | Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor |
Q87758347 | Contingency management for smoking cessation among treatment-seeking patients in a community setting |
Q100422772 | Contingency management for the treatment of methamphetamine use disorder: A systematic review |
Q51767196 | Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. |
Q52171036 | Contingency management in outpatient methadone treatment: a meta-analysis. |
Q30421552 | Contingency management in substance abuse treatment: a structured review of the evidence for its transportability |
Q129674351 | Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth |
Q35126834 | Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use |
Q47973677 | Contingency management treatment in cocaine using methadone maintained patients with and without legal problems |
Q46588056 | Contingency management treatments that reinforce completion of goal-related activities: participation in family activities and its association with outcomes |
Q39977354 | Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children |
Q52260948 | Contingent methadone delivery: effects on illicit-opiate use. |
Q52212591 | Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. |
Q49014479 | Contingent methadone take-home privileges: effects on compliance with fee payment schedules |
Q51468085 | Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients. |
Q48703235 | Continued heroin use during methadone treatment: relationships between frequency of use and reasons reported for heroin use. |
Q38169337 | Continuing care for patients with alcohol use disorders: a systematic review |
Q47260055 | Continuity of drunk and drugged driving behaviors four years post-college. |
Q37397242 | Continuous exposure to dizocilpine facilitates escalation of cocaine consumption in male Sprague-Dawley rats |
Q47772475 | Continuous exposure to dizocilpine facilitates the acquisition and escalation of cocaine consumption in male Sprague-Dawley rats |
Q33443466 | Continuous in-the-field measurement of heart rate: Correlates of drug use, craving, stress, and mood in polydrug users |
Q88737539 | Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes |
Q31926076 | Continuous, categorical, and time to event cocaine use outcome variables: degree of intercorrelation and sensitivity to treatment group differences |
Q100392220 | Contrasting effects of adolescent and early-adult ethanol exposure on prelimbic cortical pyramidal neurons |
Q36227275 | Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats |
Q46491046 | Contrasting predictors of readiness for substance abuse treatment in adults and adolescents: a latent variable analysis of DATOS and DATOS-A participants |
Q91568678 | Contribution of cannabis-related cues to concurrent reinforcer choice in humans |
Q39467260 | Contributions of the social context to the development of adolescent substance use: a multivariate latent growth modeling approach |
Q44345962 | Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients |
Q39784966 | Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users |
Q44809251 | Convergent and concurrent validity of the Contemplation Ladder and URICA scales |
Q28372730 | Convulsive status epilepticus following abrupt high-dose benzodiazepine discontinuation |
Q34269061 | Coping and emotion regulation profiles as predictors of nonmedical prescription drug and illicit drug use among high-risk young adults |
Q49311429 | Coping strategies and relapse in alcohol abuse |
Q114015654 | Copycat and lookalike edible cannabis product packaging in the United States |
Q44730180 | Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations |
Q37435533 | Correlated outcomes of a pilot intervention for people injecting drugs and their family members in Vietnam |
Q52558630 | Correlates and subgroups of injecting drug use in UK gay and bisexual men: Findings from the 2014 Gay Men's Sex Survey. |
Q52689772 | Correlates and trends in youth co-use of marijuana and tobacco in the United States, 2005-2014. |
Q68266978 | Correlates of DSM-III-R alcohol dependence in treatment and general populations |
Q41234852 | Correlates of HIV infection among female sex workers in Vietnam: injection drug use remains a key risk factor. |
Q104139899 | Correlates of Non-fatal, Opioid Overdose among Women Who Use Opioids in Dar es Salaam, Tanzania |
Q37189835 | Correlates of alcohol use among methadone-maintained adults |
Q98155446 | Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients |
Q35581029 | Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia |
Q40371913 | Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia. |
Q44568658 | Correlates of attempted suicide among young injection drug users in a multi-site cohort |
Q91572577 | Correlates of cannabis and other illicit drugs use among secondary school adolescents in Nigeria |
Q39788286 | Correlates of consistent condom use with main partners by partnership patterns among young adult male injection drug users from five US cities. |
Q40278024 | Correlates of driving under the influence of cannabis |
Q42227459 | Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort. |
Q37116421 | Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population |
Q88580312 | Correlates of frequent alcohol consumption among middle-aged and older men and women in Russia: A multilevel analysis of the PrivMort retrospective cohort study |
Q46160037 | Correlates of heavy drinking and alcohol related problems among men and women in drug treatment programs |
Q31798863 | Correlates of heavy substance use among young gay and bisexual men: The San Francisco Young Men's Health Study |
Q42630444 | Correlates of hepatitis C virus infection in homeless men: a latent variable approach |
Q43570025 | Correlates of initiation to cannabis use: a 5-year follow-up of 15-19-year-old adolescents |
Q36404702 | Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities |
Q40757023 | Correlates of injection drug use among individuals admitted to public and private drug treatment facilities in Turkey |
Q37346408 | Correlates of later-onset cannabis use in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). |
Q67416073 | Correlates of methadone patients' lengths of stay for first and second admissions |
Q35040493 | Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment |
Q39200741 | Correlates of nicotine dependence among adolescent waterpipe smokers |
Q35568662 | Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of U.S. college students |
Q36525439 | Correlates of overdose risk perception among illicit opioid users |
Q88413006 | Correlates of poly-tobacco use among youth and young adults: Findings from the Population Assessment of Tobacco and Health study, 2013-2014 |
Q34391661 | Correlates of polysomnographic sleep changes in cocaine dependence: self-administration and clinical outcomes |
Q34170252 | Correlates of prescription drug market involvement among young adults |
Q87870045 | Correlates of prescription opioid misuse among Black adults: Findings from the 2015 National Survey on Drug Use and Health |
Q44026534 | Correlates of received and expressed violence persistence following substance abuse treatment |
Q36362007 | Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system |
Q34959214 | Correlates of risky injection practices among past-year injection drug users among the US general population |
Q41751767 | Correlates of selling sex among male injection drug users in New York City |
Q44171444 | Correlates of smoking among young adults: the role of lifestyle, attitudes/beliefs, demographics, and exposure to anti-tobacco media messaging |
Q90954536 | Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis |
Q36164850 | Correlates of tobacco dependence and motivation to quit among young people receiving mental health treatment |
Q40762414 | Correlates of use of alcohol mixed with energy drinks among youth across 10 US metropolitan areas |
Q38954055 | Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. |
Q114671049 | Correlation between PFC gyrification and white matter integrity in young cannabis users |
Q90077879 | Correlation between interleukin-6 levels and methadone maintenance therapy outcomes |
Q64988950 | Correlation of cytokines, BDNF levels, and memory function in patients with opioid use disorder undergoing methadone maintenance treatment. |
Q92168840 | Correlations between sex-related hormones, alcohol dependence and alcohol craving |
Q46873707 | Correspondence between proxy and self-reports on smoking in a full family study |
Q83819684 | Corrigendum |
Q42345994 | Corrigendum to "A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans" [Drug Alcohol Depend. 128 (2013) 222-229] |
Q90659038 | Corrigendum to "A repeated cross-sectional study of factors associated with pregabalin-positive poisoning deaths in Ireland" [Drug Alcohol Depend. 206 (2020) 107741] |
Q90591252 | Corrigendum to "Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder" [Drug Alcohol Depend. 186 (2018) 171-174] |
Q100422786 | Corrigendum to "Age disparities in six-month treatment retention for opioid use disorder" [Drug Alcohol Depend. 213 (2020) 108130] |
Q50216512 | Corrigendum to "Assessing geographical differences in illicit drug consumption-A comparison of results from epidemiological and wastewater data in Germany and Switzerland" [Drug Alcohol Depend. 161 (2016) 189-199]. |
Q90881335 | Corrigendum to "Assessing nicotine dependence in adolescent E-cigarette users: The 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence Item Bank for electronic cigarettes" [Drug Alcohol Depend. 188 (2018) 60- |
Q100446760 | Corrigendum to "Causal relationships between substance use and insomnia" [Drug Alcohol Dependence 214 (2020) 108151] |
Q88119154 | Corrigendum to "Cognition and impulsivity in adults with attention deficit hyperactivity disorder with and without cocaine and/or crack dependence" [Drug Alcohol Depend. 160 (2016) 97-104] |
Q42354381 | Corrigendum to "Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients" [Drug Alcohol Depend. 140 (2014) 213-216]. |
Q90163483 | Corrigendum to "Concurrent nicotine and tobacco product use among homeless smokers and associations with cigarette dependence and other factors related to quitting" [Drug Alcohol Depend. 185 (2018) 133-140] |
Q44597285 | Corrigendum to "Do drinking-age laws have an impact on crime? Evidence from Canada, 2009-2013" [Drug Alcohol Depend. 167 (2016) 67-74]. |
Q92604379 | Corrigendum to "Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal" [Drug Alcohol Depend. 170 (2017) 43-50] |
Q92692604 | Corrigendum to "Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample" [Drug Alcohol Depend. 187 (2018) 358-362] |
Q91652021 | Corrigendum to "Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis" [Drug Alcohol Depend. 185 (2018) 322-327] |
Q96634955 | Corrigendum to "Harmful alcohol use among acutely ill hospitalized medical patients in Oslo and Moscow: A cross-sectional study" [Drug Alcohol Depend. 204 (2019) 107588] |
Q92944488 | Corrigendum to "Heated tobacco products: Cigarette complements, not substitutes" [Drug and Alcohol Depend. 204 (2019) 107576] |
Q90269831 | Corrigendum to "Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study" [Drug Alcohol Depend. 162 (2016) 245-250] |
Q42331891 | Corrigendum to "Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse" [Drug and Alcohol Dependence 152 (2015) 93-101]. |
Q49968047 | Corrigendum to "Marijuana and tobacco co-use among a nationally representative sample of US pregnant and non-pregnant women: 2005-2014 National Survey on Drug Use and Health findings" [Drug Alcohol Depend. 177 (2017) 130-135]. |
Q58701357 | Corrigendum to "Marijuana use by middle-aged and older adults in the United States, 2015-2016" [Drug Alcohol Depend. 191 (2018) 374-381] |
Q42359091 | Corrigendum to "National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009" [Drug Alcohol Depend. 146 (2015) 17-23]. |
Q57064837 | Corrigendum to "Pharmacotherapy for amphetamine dependence: A systematic review" [Drug Alcohol Depend. 191 (2018) 309-337] |
Q47579902 | Corrigendum to "Prescribing of benzodiazepines and opioids to individuals with substance use disorders" [Drug Alcohol Depend. 178 (2017) 223-230]. |
Q50151541 | Corrigendum to "Subjective experiences at first use of cigarette, e-cigarettes, hookah, and cigar products among Texas adolescents" [Drug Alcohol Depend. 173/1 (2017) 10-16]. |
Q89938213 | Corrigendum to "The impact of alcohol policies on alcohol-attributable diseases in Taiwan-A population-based study" [Drug Alcohol Depend. 180 (2017) 103-112] |
Q90163488 | Corrigendum to "The moderating effect of perceived social support on the relation between heaviness of smoking and quit attempts among adult homeless smokers" [Drug and Alcohol Depend. 190 (2018) 128-132] |
Q47568263 | Corrigendum to "Trends in insurance coverage and treatment among persons with opioid use disorders following the affordable care act" [Drug Alcohol. Depend. 179 (2017) 271-274]. |
Q54758806 | Corrigendum to Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies [Drug Alcohol Depend. 173 (2017) 92-98]. |
Q58392019 | Corrigendum to ‘Exposure to the Lebanon War of 2006 and effects on alcohol use disorders: The moderating role of childhood maltreatment’ [Drug Alcohol Depend. 134 (2014) 296–303] |
Q58435814 | Corrigendum to “Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review” Drug and Alcohol Dependence 148 (2015) 1–20 |
Q59488280 | Corrigendum to “Nicotine metabolism and CYP2A6 activity in a population of black African descent: Impact of gender and light smoking” [Drug Alcohol Depend. 89/1 (2007) 24–33] |
Q63433287 | Corrigendum to “Spousal resemblance for smoking: Underlying mechanisms and effects of cohort and age” [Drug Alcohol Depend. 153 (2015) 221–228] |
Q57046966 | Corrigendum to “The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study” [Drug Alcohol Depend. 152C (2015) 264–271] |
Q89658036 | Corrigendum to “Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking” |
Q87940092 | Corrigendum to: "Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in Europe" [Drug Alcohol Dependence 179 (2017) 299-308] |
Q37087887 | Cortical activation deficits during facial emotion processing in youth at high risk for the development of substance use disorders |
Q48440997 | Cortical excitability in tramadol dependent patients: A transcranial magnetic stimulation study |
Q114671047 | Cortical gyrification in children with attention deficit-hyperactivity disorder and prenatal alcohol exposure |
Q36090358 | Cortical thinness and volume differences associated with marijuana abuse in emerging adults |
Q48962708 | Cortisol and beta-endorphin response in alcoholics and alcohol abusers following a high naloxone dosage |
Q37105100 | Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients |
Q100382404 | Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail |
Q97565159 | Cost and cost-effectiveness of three strategies for implementing motivational interviewing for substance misuse on medical inpatient units |
Q42058785 | Cost and cost-effectiveness of three strategies for training clinicians in motivational interviewing. |
Q36421418 | Cost-effectiveness analysis of a continuing care intervention for cocaine-dependent adults |
Q39672107 | Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. |
Q31046185 | Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial |
Q39355057 | Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam |
Q34551982 | Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. |
Q52686909 | Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. |
Q44595168 | Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics |
Q31061872 | Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial |
Q57493284 | Cost-effectiveness of naloxone kits in secondary schools |
Q35944736 | Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs |
Q39722855 | Cost-effectiveness of screening and referral to an alcohol health worker in alcohol misusing patients attending an accident and emergency department: a decision-making approach |
Q37373571 | Cost-effectiveness of the strong African American families-teen program: 1-year follow-up |
Q73405946 | Cost-effectiveness of treatment for drug-abusing pregnant women |
Q52277867 | Costs and benefits of treatment for cocaine addiction in DATOS. |
Q77367038 | Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting |
Q35250493 | Could a continuous measure of individual transmissible risk be useful in clinical assessment of substance use disorder? Findings from the National Epidemiological Survey on Alcohol and Related Conditions |
Q35745825 | Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers |
Q37173261 | Country of origin, age of drinking onset, and drinking patterns among Mexican American young adults |
Q46105498 | Coupons attract high-risk untreated heroin users into detoxification |
Q88503816 | Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder |
Q58322667 | Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission |
Q64134329 | Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team |
Q48794586 | Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts |
Q50793263 | Craving and illicit heroin use among patients in heroin-assisted treatment. |
Q91092270 | Craving and opioid use disorder: A scoping review |
Q52910357 | Craving despite extremely high methadone dosage. |
Q90568186 | Craving is impermanent and it matters: Investigating craving and cannabis use among young adults with problematic use interested in reducing use |
Q36477976 | Craving predicts time to cocaine relapse: further validation of the Now and Brief versions of the cocaine craving questionnaire |
Q43647890 | Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis |
Q47419998 | Craving versus control: Negative urgency and neural correlates of alcohol cue reactivity |
Q36335935 | Craving: consensus of status and agenda for future research |
Q70567080 | Crime and drug use among applicants for methadone maintenance |
Q51674388 | Criminality in a sample of drug abusers in Greece. |
Q33700811 | Critical issues in adolescent substance use assessment |
Q40752435 | Cross validation of the prognostic and diagnostic utility of tobacco craving in a general and a pregnant sample of treatment-seeking smokers |
Q94587317 | Cross-Generational THC Exposure Alters Heroin Reinforcement in Adult Male Offspring |
Q87443395 | Cross-border activities and association with current methamphetamine use among Chinese injection drug users (IDUs) in a China-Myanmar border region |
Q34510933 | Cross-border drug injection relationships among injection drug users in Tijuana, Mexico |
Q98469980 | Cross-country and historical variation in alcohol consumption among older men and women: Leveraging recently harmonized survey data in 21 countries |
Q47613028 | Cross-cultural examination of college drinking culture in Spain, Argentina, and USA: Measurement invariance testing of the College Life Alcohol Salience Scale |
Q91869831 | Cross-cultural examination of different personality pathways to alcohol use and misuse in emerging adulthood |
Q47706704 | Cross-cultural patterns of the association between varying levels of alcohol consumption and the common mental disorders of depression and anxiety: secondary analysis of the WHO Collaborative Study on Psychological Problems in General Health Care |
Q96123721 | Cross-fading motives for simultaneous alcohol and marijuana use: Associations with young adults' use and consequences across days |
Q43808437 | Cross-generational effects on gender differences in psychoactive drug abuse and dependence |
Q47330199 | Cross-lagged relations between motives and substance use: Can use strengthen your motivation over time? |
Q91066741 | Cross-sectional associations of food insecurity with smoking cigarettes and heavy alcohol use in a population-based sample of adults |
Q54265638 | Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015. |
Q93227852 | Cross-sectional surveys of financial harm associated with others' drinking in 15 countries: Unequal effects on women? |
Q51009505 | Cross-system agreement among demographic subgroups: DSM-III, DSM-III-R, DSM-IV and ICD-10 diagnoses of alcohol use disorders. |
Q38711802 | Cross-validation of short forms of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R). |
Q37107238 | Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
Q89052396 | Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada |
Q36083410 | Crystal methamphetamine use among female street-based sex workers: Moving beyond individual-focused interventions |
Q39080675 | Crystal methamphetamine use and HIV medical outcomes among HIV-infected men who have sex with men accessing support services in New York |
Q51748161 | Crystal methamphetamine use and its correlates in women engaged in sex work in a developing country setting. |
Q80163472 | Crystal methamphetamine: a source of added sexual risk for Hispanic men who have sex with men? |
Q52244715 | Cue exposure as an assessment technique in the management of a heroin addict: case report. |
Q90873808 | Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study |
Q98776073 | Cue-elicited functional connectivity of the periaqueductal gray and tonic cocaine craving |
Q41640409 | Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias |
Q51690464 | Cue-evoked arousal in cocaine users: a study of variance and predictive value |
Q60030997 | Cue-induced cocaine craving increases with aripiprazole treatment in methadone-maintenance patients |
Q35293033 | Cultural competence in outpatient substance abuse treatment: measurement and relationship to wait time and retention |
Q47334819 | Cultural differences in the perception of magazine alcohol advertisements by Israeli Jewish, Moslem, Druze and Christian high school students |
Q40571419 | Cultural model of self-stigma among Chinese with substance use problems. |
Q38696502 | Cumulative contextual risk at birth and adolescent substance initiation: Peer mediation tests. |
Q36478382 | Cumulative lifetime adversities and alcohol dependence in adolescence and young adulthood |
Q50347785 | Curbing the DUI offender's self-efficacy to drink and drive: A laboratory study |
Q38954578 | Current FDA regulatory guidance on the conduct of drug discrimination studies for NDA review: Does the scientific literature support recent recommendations? |
Q89859372 | Current cannabis use and smoking cessation among treatment seeking combustible smokers |
Q38757594 | Current forms of inhibitory training produce no greater reduction in drinking than simple assessment: A preliminary study. |
Q30401556 | Current major depression is associated with greater sensitivity to the motivational effect of both negative mood induction and abstinence on tobacco-seeking behavior |
Q97597715 | Current marijuana use among women of reproductive age |
Q33895580 | Current models of nicotine dependence: what is known and what is needed to advance understanding of tobacco etiology among youth |
Q98299675 | Current reporting of usability and impact of mHealth interventions for substance use disorder: A systematic review |
Q70910552 | Current strategies for the treatment of alcohol dependence in the United States |
Q71736697 | Current trends in biologic research on alcoholism |
Q35901448 | Customizing treatment to the patient: adaptive treatment strategies |
Q40105603 | Cyclic adenosine 3′,5′-monophosphate, adenylate cyclase and physical dependence on ethanol: Studies with tranylcypromine |
Q40285357 | Cyclic nucleotides and ethanol tolerance and dependence |
Q40285364 | Cyclic nucleotides in the development of alcohol tolerance and dependence: A commentary |
Q43912920 | Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. |
Q68937223 | Cynomolgus monkeys and morphine tolerance and dependence |
Q34582678 | Cytisine for smoking cessation: a research agenda |
Q44332707 | Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses |
Q43326108 | Cytokine levels in acute alcoholic hepatitis: a sequential study. |
Q31799392 | Cytotoxic effect of alcohol-withdrawal on primary cultures of cortical neurones |
Q37469098 | D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation |
Q28240383 | D.L. Davies and 'Normal drinking in recovered alcohol addicts': the genesis of a paper |
Q43857324 | DBS of nucleus accumbens on heroin seeking behaviors in self-administering rats |
Q37098589 | DEVELOPMENT AND VALIDATION OF 'SURE': A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE. |
Q128582265 | DNA methylation at DLGAP2 and risk for relapse in alcohol dependence during acamprosate treatment |
Q33796934 | DRD2 and DRD4 in relation to regular alcohol and cannabis use among adolescents: Does parenting modify the impact of genetic vulnerability? The TRAILS study |
Q46524937 | DRD2 genotypes and substance use in adolescent children of alcoholics |
Q34715407 | DRD4 and susceptibility to peer influence on alcohol use from adolescence to adulthood |
Q95789066 | DSM-5 SUD diagnoses: changes, reactions, remaining open questions |
Q37619195 | DSM-5 cannabis use disorder: a phenotypic and genomic perspective |
Q58552712 | DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults |
Q37092076 | DSM-5 latent classes of alcohol users in a population-based sample: results from the São Paulo Megacity Mental Health Survey, Brazil |
Q38655356 | DSM-5 substance use disorders among adult primary care patients: Results from a multisite study. |
Q40976438 | DSM-III, DSM-IV and ICD-10 as severity scales for drug dependence |
Q51048293 | DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: results from the Mental Health Supplement to the Ontario Health Survey. |
Q35954396 | DSM-IV alcohol abuse and dependence criteria characteristics for recent onset adolescent drinkers |
Q51915404 | DSM-IV alcohol dependence and abuse: further evidence of validity in the general population. |
Q44356429 | DSM-IV alcohol dependence and drug abuse/dependence in a treatment sample of whites, blacks and Mexican Americans |
Q37362791 | DSM-IV criteria-based clinical subtypes of cannabis use disorders: results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). |
Q38667083 | Daily associations between cannabis motives and consumption in emerging adults |
Q37587964 | Daily associations between emotional functioning and alcohol involvement: Moderating effects of response inhibition and gender |
Q72658697 | Daily cigarette consumption in early adulthood: age of smoking initiation and duration of smoking |
Q35690479 | Daily co-occurrence of alcohol use and high-risk sexual behavior among heterosexual, heavy drinking emergency department patients |
Q100514242 | Daily heroin injection and psychiatric disorders: A cross-sectional survey among People Who Inject Drugs (PWID) in Haiphong, Vietnam |
Q43270704 | Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence |
Q31138737 | Daily nicotine patch wear time predicts smoking abstinence in socioeconomically disadvantaged adults: An analysis of ecological momentary assessment data. |
Q46011644 | Daily ratings measures of alcohol craving during an inpatient stay define subtypes of alcohol addiction that predict subsequent risk for resumption of drinking. |
Q30832763 | Data compatibility in the addiction sciences: an examination of measure commonality |
Q90097532 | Data quality considerations when using county-level opioid overdose death rates to inform policy and practice |
Q90110144 | Data quality considerations when using county-level opioid overdose death rates to inform policy and practice: A reply |
Q30930855 | Data triangulation in the context of opioids monitoring via wastewater analyses. |
Q90515844 | Dating violence victimization and substance use: The role of a serotonin transporter gene polymorphism (5HTTLPR) |
Q36803607 | Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy |
Q33177654 | Deaths associated with inhalant abuse in Virginia from 1987 to 1996. |
Q31077101 | Deaths by unintentional illicit drug overdose in Italy, 1984-2000. |
Q43632173 | Deaths of clients in methadone treatment in Texas: 1994-2002. |
Q35893572 | Debating the Controlled Substances Act. |
Q44049020 | Decision biases and persistent illicit drug use: an experimental study of distributed choice and addiction |
Q47750026 | Decision making measured by the Iowa Gambling Task in alcohol use disorder and gambling disorder: a systematic review and meta-analysis |
Q90849087 | Decision making of individuals with heroin addiction receiving opioid maintenance treatment compared to early abstinent users |
Q50668158 | Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study |
Q39524231 | Decision-making deficits are still present in heroin abusers after short- to long-term abstinence |
Q37222813 | Decision-making in long-term cocaine users: Effects of a cash monetary contingency on Gambling task performance |
Q91421153 | Decision-making skills as a mediator of the #Tamojunto school-based prevention program: Indirect effects for drug use and school violence of a cluster-randomized trial |
Q33603875 | Decisional balance proportion: quantifying qualitative data to represent motivation to change among treatment-seeking smokers. |
Q43922790 | Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tablets |
Q52678640 | Decline in the perceived risk of cigarette smoking between 2006 and 2015: Findings from a U.S. nationally representative sample. |
Q46449732 | Decomposing the total variation in a nested random effects model of neighborhood, household, and individual components when the dependent variable is dichotomous: implications for adolescent marijuana use. |
Q35102483 | Deconstructing the architecture of alcohol abuse and dependence symptoms in a community sample of late adolescent and emerging adult women: an item response approach |
Q52015216 | Decrease in alcohol tolerance: clinical significance in alcohol dependence |
Q44026544 | Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. |
Q46777513 | Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users |
Q39636797 | Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin). |
Q36609285 | Decreased frontal lobe phosphocreatine levels in methamphetamine users. |
Q69444360 | Decreased serum selenium and magnesium levels in drunkenness arrestees |
Q51790787 | Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. |
Q51580640 | Decreased striatal dopamine transporters in codeine-containing cough syrup abusers. |
Q66972161 | Decreasing acetaldehyde levels with 4-methylpyrazole does not increase voluntary ethanol drinking by rats |
Q45066391 | Decreasing sensitivity of clinical alcohol screening with the AUDIT-C after repeated negative screens in VA clinics |
Q30451392 | Deepened extinction of cocaine cues |
Q37493567 | Default mode network activity in male adolescents with conduct and substance use disorder. |
Q38246578 | Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis |
Q33942710 | Deficits in default mode network activity preceding error in cocaine dependent individuals |
Q99209499 | Deficits in recognizing female facial expressions related to social network in cocaine-addicted men |
Q40412433 | Deficits in response inhibition associated with chronic methamphetamine abuse |
Q48601976 | Defining strategies for promoting product through 'drink responsibly' messages in magazine ads for beer, spirits and alcopops. |
Q91421144 | Definition of a 'standard joint equivalent': Comment on "Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity" |
Q38695993 | Definitions of non-abstinent and abstinent categories in alcoholism treatment outcome classifications: a review and proposal |
Q57137182 | Delay discounting and e-cigarette use: An investigation in current, former, and never cigarette smokers |
Q39289879 | Delay discounting by depressed and non-depressed adolescent smokers and non-smokers |
Q46346344 | Delay discounting by the children of smokers and nonsmokers |
Q34167648 | Delay discounting differentiates pre-adolescents at high and low risk for substance use disorders based on family history |
Q44340922 | Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users |
Q41657313 | Delay to first treatment contact for alcohol use disorder. |
Q36494775 | Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence |
Q37339496 | Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment |
Q90672411 | Deletion of the serotonin transporter perturbs BDNF signaling in the central amygdala following long-access cocaine self-administration |
Q38762090 | Delivery of nicotine aerosol to mice via a modified electronic cigarette device. |
Q101409229 | Delta resting-state functional connectivity in the cognitive control network as a prognostic factor for maintaining abstinence: An eLORETA preliminary study |
Q33624781 | Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol |
Q28139393 | Demographic and substance use factors related to violent and accidental injuries: results from an emergency room study |
Q39097610 | Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005-2014. |
Q46711092 | Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities |
Q46497647 | Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study |
Q51726055 | Demonstration of naturalistic methods for cocaine smoking by human volunteers. |
Q35661068 | Denial in methamphetamine users: Associations with cognition and functional connectivity in brain. |
Q69914153 | Dependence characteristics and risk assessment of agonist-antagonist analgesics |
Q37035912 | Dependence levels in users of electronic cigarettes, nicotine gums and tobacco cigarettes |
Q72579382 | Dependence liability of the benzodiazepines |
Q56453851 | Dependence on amphetamines increases Parkinson's disease: Effect of gender |
Q43909036 | Dependence symptoms but no diagnosis: diagnostic 'orphans' in a 1992 national sample |
Q39467254 | Dependence symptoms but no diagnosis: diagnostic 'orphans' in a community sample |
Q44934073 | Dependent and problem drinking over 5 years: a latent class growth analysis |
Q24613776 | Depressed mood and the effect of two universal first grade preventive interventions on survival to the first tobacco cigarette smoked among urban youth |
Q45109739 | Depressed smokers and stage of change: implications for treatment interventions |
Q38756418 | Depression among current, former, and never smokers from 2005 to 2013: The hidden role of disparities in depression in the ongoing tobacco epidemic |
Q46489633 | Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking |
Q42256383 | Depression during methadone withdrawal: no role for beta-phenylethylamine |
Q96616391 | Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder |
Q46535066 | Depression syndromes with risk of alcohol dependence in adulthood: a latent class analysis |
Q92236196 | Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis |
Q36689325 | Depression, posttraumatic stress, and alcohol misuse in young adult veterans: The transdiagnostic role of distress tolerance |
Q48847168 | Depressive mood and tobacco use: moderating effects of gender and emotional attention |
Q51443890 | Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence. |
Q92008112 | Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSM |
Q48107423 | Depressive symptoms and the implicit evaluation of alcohol: the moderating role of coping motives |
Q52083005 | Depressive symptoms differentiating between heroin addicts and alcoholics. |
Q43619992 | Depressive symptoms modulate the subjective and physiological response to cocaine in humans |
Q34619877 | Depressive symptoms, negative urgency and substance use initiation in adolescents |
Q90507477 | Depressive symptoms, ruminative thinking, marijuana use motives, and marijuana outcomes: A multiple mediation model among college students in five countries |
Q90329432 | Derivation and validation of a multivariable model, the alcohol withdrawal triage tool (AWTT), for predicting severe alcohol withdrawal syndrome |
Q57400145 | Deriving phenotypes for molecular genetic studies of substance use disorders: A family study approach |
Q39397764 | Descriptive analysis of cocaine use of methadone patients |
Q44448292 | Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients |
Q51726060 | Desipramine effects on cocaine self-administration by rhesus monkeys. |
Q40420112 | Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. |
Q34551285 | Desomorphine (Krokodil): An overview of its chemistry, pharmacology, metabolism, toxicology and analysis |
Q101137509 | Detachment, peer pressure, and age of first substance use as gateways to later substance use |
Q35519490 | Detecting initiation or risk for initiation of substance use before high school during pediatric well-child check-ups |
Q43842938 | Detecting smoking following smoking cessation treatment |
Q71039633 | Detection and quantitation of phencyclidine in rat parotid saliva and plasma |
Q36689382 | Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users. |
Q71538291 | Detection of alcohol problems in primary care outpatients under different conditions |
Q69917416 | Detection of blood benzodiazepines in injured people. Relationship with alcoholism |
Q92713464 | Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing |
Q30352138 | Determinants of 12-step group affiliation and moderators of the affiliation-abstinence relationship. |
Q34091441 | Determinants of alcohol consumption in HIV-uninfected injection drug users |
Q93198409 | Determinants of alcohol use among people living with HIV initiating isoniazid preventive therapy in Ethiopia |
Q40066558 | Determinants of hazardous drinking among black South African men who have sex with men. |
Q46588032 | Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy |
Q92575312 | Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia |
Q43033248 | Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician |
Q34066503 | Determinants of waterpipe smoking initiation among school children in Irbid, Jordan: a 4-year longitudinal analysis |
Q40628071 | Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine. |
Q70023629 | Determination of beta-endorphin in alcoholic patients in the acute stage of intoxication: relation with naloxone therapy |
Q47238649 | Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts |
Q40866388 | Detoxification from methadone maintenance: Double-blind comparison of two methods |
Q47356785 | Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project |
Q47735144 | Detrimental effects of self-administered methamphetamine during pregnancy on offspring development in the rat. |
Q35896960 | Developing adaptive treatment strategies in substance abuse research |
Q101241552 | Development and Validation of a Prediction Model of Prescription Tranquilizer Misuse Based on a Nationally Representative United States Sample |
Q38194773 | Development and impact of prescription opioid abuse deterrent formulation technologies |
Q38770889 | Development and initial validation of a cessation fatigue scale |
Q38545975 | Development and initial validation of a marijuana cessation expectancies questionnaire |
Q44138252 | Development and psychometric properties of the Verona Service Satisfaction Scale for methadone-treated opioid-dependent patients (VSSS-MT). |
Q47841612 | Development and validation of a Brief Assessment of Recovery Capital (BARC-10) for alcohol and drug use disorder |
Q42655324 | Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM). |
Q91893477 | Development and validation of a risk predictive model for student harmful drinking-A longitudinal data linkage study |
Q52299481 | Development and validation of a self-rating scale for betel quid chewers based on a male-prisoner population in Taiwan: the Betel Quid Dependence Scale. |
Q57482312 | Development and validation of a virtual agent to screen tobacco and alcohol use disorders |
Q34990905 | Development and validation of the Alcoholics Anonymous Intention Measure (AAIM). |
Q50918418 | Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan. |
Q39250261 | Development and validation of the cannabis refusal self-efficacy questionnaire (CRSEQ) in adult cannabis users in treatment. |
Q50467499 | Development and validation of the scale to assess satisfaction with medications for addiction treatment-methadone for heroin addiction (SASMAT-METHER). |
Q43629872 | Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation |
Q43426755 | Development of a Readiness Ruler for use with alcohol brief interventions |
Q38397991 | Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale |
Q68514166 | Development of a citric acid aerosol as a smoking cessation aid |
Q91691932 | Development of a novel alcohol and nicotine concurrent access (ANCA) self-administration procedure in baboons |
Q60641798 | Development of a prospective memory training program for substance use treatment |
Q48552416 | Development of a therapeutic vaccine for the treatment of cocaine addiction |
Q42426966 | Development of a translational model to screen medications for cocaine use disorder I: Choice between cocaine and food in rhesus monkeys |
Q38857284 | Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. |
Q51554852 | Development of an adherence/competence rating scale for individual drug counseling. |
Q67019750 | Development of cellular tolerance to lethality and analgesia concurrent with physical dependence following repeated oral administration of LAAM |
Q70658848 | Development of dependence on levorphanol in rats by oral intake of the drug -- the influence of taste on drinking behaviour in rats physically dependent on levorphanol |
Q59540411 | Development of error processing in children of alcoholics |
Q48323778 | Development of morphine tolerance under tonic control of brain oxytocin. |
Q44329967 | Development of opioid formulations with limited diversion and abuse potential |
Q34421428 | Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients |
Q52272860 | Development of sexual behavior in prenatally ethanol-exposed rats. |
Q52002810 | Development of substance use and psychiatric comorbidity in an epidemiologic study of white and American Indian young adolescents the Great Smoky Mountains Study. |
Q38204524 | Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT). |
Q39651489 | Development of the caffeine withdrawal symptom questionnaire: caffeine withdrawal symptoms cluster into 7 factors |
Q40218274 | Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users |
Q90026182 | Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City |
Q52285156 | Developmental and generational trends in alcohol, cannabis and tobacco use--a ten year cohort analysis. |
Q24652233 | Developmental epidemiological courses leading to antisocial personality disorder and violent and criminal behavior: effects by young adulthood of a universal preventive intervention in first- and second-grade classrooms |
Q37351714 | Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk |
Q44620669 | Developmental exposure to cadmium alters responsiveness to cocaine in the rat |
Q33935951 | Developmental lead exposure alters methamphetamine self-administration in the male rat: acquisition and reinstatement |
Q35928523 | Developmental momentum toward substance dependence: natural histories and pliability of risk factors in youth experiencing chronic stress. |
Q34076883 | Developmental sources of variation in liability to adolescent substance use disorders |
Q40668445 | Developmental trajectories of cigarette use from early adolescence into young adulthood |
Q37040009 | Developmental trajectories of criteria of nicotine dependence in adolescence |
Q57071114 | Developmental trajectories of externalizing behavior from ages 4 to 12: Prenatal cocaine exposure and adolescent correlates |
Q34290148 | Developmentally inspired drug prevention: middle school outcomes in a school-based randomized prevention trial |
Q68213002 | Dexamethasone suppression test in alcohol withdrawal: relationship to depression and liver function |
Q40727443 | Diagnosed alcohol dependence and criminal sentencing among British Columbian Aboriginal offenders. |
Q47611048 | Diagnosing ADHD during active substance use: Feasible or flawed? |
Q44584626 | Diagnostic accuracy of a two-item screen for drug use developed from the alcohol, smoking and substance involvement screening test (ASSIST). |
Q31870729 | Diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders |
Q51651391 | Diagnostic concordance of substance use disorders in DSM-III, DSM-IV and ICD-10. |
Q35850737 | Diagnostic criteria for cannabis withdrawal syndrome |
Q44447075 | Diagnostic efficiency of the AUDIT-C in U.S. veterans with military service since September 11, 2001. |
Q43842928 | Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of alcohol and drug diagnoses. |
Q69873004 | Diagnostic of alcoholism: how useful is the combination of gamma glutamyl transferase with different biochemical markers? |
Q37089302 | Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample |
Q90037055 | Diagnostic performance of the Alcohol Use Disorders Identification Test (AUDIT) in detecting DSM-5 alcohol use disorders in the General population |
Q46493166 | Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). |
Q39427272 | Diagnostic tests for alcoholism in primary health care: compared efficacy of different instruments |
Q34133136 | Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder |
Q49053331 | Diary gives more accurate information about alcohol consumption than questionnaire |
Q51802981 | Diazepam and methadone blood levels following concurrent administration of diazepam and methadone. |
Q44747685 | Diazepam use among methadone maintenance patients: Patterns and dosages |
Q50432041 | Did the dependent coverage expansion increase risky substance use among young adults? |
Q71196815 | Dietary choices and likelihood of abstinence among alcoholic patients in an outpatient clinic |
Q70450063 | Dietary choices of recovering alcoholics |
Q39724007 | Dietary supplementation with fish oil prevents high fat diet-induced enhancement of sensitivity to the locomotor stimulating effects of cocaine in adolescent female rats |
Q43728924 | Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry |
Q44003373 | Differences between juvenile offenders with and without substance use problems in the prevalence and impact of risk and protective factors for criminal recidivism |
Q31926141 | Differences between methamphetamine users and cocaine users in treatment |
Q41629348 | Differences in HIV risk behaviors among people who inject drugs by gender and sexual orientation, San Francisco, 2012. |
Q37357494 | Differences in IV alcohol-induced dopamine release in the ventral striatum of social drinkers and nontreatment-seeking alcoholics |
Q57137173 | Differences in alcohol cognitions, consumption, and consequences among first-time DUI offenders who co-use alcohol and marijuana |
Q50933301 | Differences in alcohol use and alcohol-related problems among fraternity and sorority members. |
Q35952082 | Differences in alcohol use and alcohol-related problems between transgender- and nontransgender-identified young adults. |
Q91712120 | Differences in alcohol use between younger and older people: Results from a general population study |
Q51246146 | Differences in attitudes towards drug taking among drug addicts: implications for treatment. |
Q47615106 | Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: Results from a national adult sample. |
Q47345041 | Differences in biomarkers of crack-cocaine adolescent users before/after abstinence |
Q36502348 | Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task |
Q50610175 | Differences in happiness between smokers, ex-smokers and never smokers: cross-sectional findings from a national household survey |
Q51273659 | Differences in heroin addicts seeking inpatient detoxification, ambulatory detoxification, or methadone maintenance |
Q39705783 | Differences in impulsivity and sexual risk behavior among inner-city crack/cocaine users and heroin users |
Q88358595 | Differences in nicotine dependence, smoke exposure and consumer characteristics between smokers of machine-injected roll-your-own cigarettes and factory-made cigarettes |
Q98384662 | Differences in patient-reported and observer-rated opioid withdrawal symptom etiology, time course, and relationship to clinical outcome |
Q58566057 | Differences in protective factors among U.S. Veterans with posttraumatic stress disorder, alcohol use disorder, and their comorbidity: Results from the National Health and Resilience in Veterans Study |
Q47621511 | Differences in reporting of perceived acute effects of alcohol use, marijuana use, and simultaneous alcohol and marijuana use. |
Q47995474 | Differences in self-reported and behavioral measures of impulsivity in recreational and dependent cocaine users |
Q43620000 | Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. |
Q87868688 | Differences in time to injection onset by drug in California: Implications for the emerging heroin epidemic |
Q36979752 | Differences in time to onset of smoking and nicotine dependence by race/ethnicity in a Midwestern sample of adolescents and young adults from a high risk family study |
Q31870699 | Different control of GH secretion by gamma-amino- and gamma-hydroxy-butyric acid in 4-year abstinent alcoholics |
Q115162873 | Different drugs come with different motives: Examining motives for substance use among people who engage in polysubstance use undergoing methadone maintenance therapy (MMT) |
Q40474478 | Different genes influence toluene- and ethanol-induced locomotor impairment in C. elegans. |
Q58585989 | Different socioeconomic backgrounds between hazardous drinking and heavy episodic drinking: Prevalence by sociodemographic factors in a Japanese general sample |
Q41089496 | Different versions of the Alcohol Use Disorders Identification Test (AUDIT) as screening instruments for underage binge drinking |
Q37087740 | Differential activation of the anterior cingulate cortex and caudate nucleus during a gambling simulation in persons with a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project |
Q71132355 | Differential alcohol use patterns and personality traits among three Alcoholics Anonymous attendance level groups: further considerations of the affiliation profile |
Q37586875 | Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120. |
Q96166932 | Differential changes in quitting smoking by daily cigarette consumption and intention to quit after the introduction of a tobacco tax increase and pictorial cigarette pack warnings in Korea, 2013-2017 |
Q39478038 | Differential contributions of family and peer factors to the etiology of narcotic addiction |
Q37281980 | Differential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys |
Q43925616 | Differential effects of alcohol, cocaine, and opioid abuse on event-related potentials recorded during a response competition task |
Q48191797 | Differential effects of chronic ethanol on apomorphine-induced locomotion, climbing and aggression in rats |
Q27312201 | Differential effects of cocaine exposure on the abundance of phospholipid species in rat brain and blood |
Q51563045 | Differential effects of cocaine, alcohol, and nicotine dependence on olfactory evoked potentials. |
Q34973799 | Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice |
Q52300221 | Differential effects of intermittent and continuous exposure to novel environmental stimuli on the development of amphetamine-induced behavioral sensitization in mice: implications for addiction. |
Q47815260 | Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice |
Q40123991 | Differential effects of perceived stress on alcohol consumption in moderate versus heavy drinking HIV-infected women. |
Q44487821 | Differential effects of saccharin supplementation on alcohol and water consumption by Wistar rats from different sources |
Q37283346 | Differential expression and functional role of cannabinoid genes in alcohol users |
Q52150820 | Differential expression of α-synuclein splice variants in the brain of alcohol misusers: Influence of genotype. |
Q95658371 | Differential implications of persistent, remitted, and late-onset ADHD symptoms for substance abuse in women and men: A twin study from ages 11 to 24 |
Q59540414 | Differential incentive processing in youth before and after substance use initiation |
Q92464930 | Differential pathways into smoking among sexual orientation and social class groups in England: A structural equation model |
Q38977593 | Differential profiles of drug-addicted patients according to gender and the perpetration of intimate partner violence. |
Q44340419 | Differential regulation of brain opioid receptors following repeated cocaine administration to guinea pigs |
Q57117737 | Differential relationships between cannabis consumption and sleep health as a function of HIV status |
Q92236190 | Differential responses to infant faces in relation to maternal substance use: An exploratory study |
Q35147153 | Differential reward network functional connectivity in cannabis dependent and non-dependent users |
Q63313861 | Differential risk of racial admixture for substance abuse: A longitudinal analysis |
Q38845847 | Differential sensitivity to learning from positive and negative outcomes in cocaine users. |
Q74137204 | Differential tolerance to morphine's immunomodulatory effects following continuous administration |
Q91691336 | Differentially classified methamphetamine-using men who have sex with men: A latent class analysis |
Q46007435 | Differentials and trends in emergency department visits due to alcohol intoxication and co-occurring conditions among students in a U.S. public university. |
Q46392247 | Differentials in the treatment of black female heroin addicts |
Q38948053 | Differentiating patterns of prescription stimulant medical and nonmedical use among youth 10-18 years of age. |
Q48490040 | Differentiation of alcoholics high and low in childhood hyperactivity |
Q70450073 | Differentiation of the analgesic effects of THIP and morphine using three mouse strains |
Q40515918 | Difficult temperament, acute alcohol intoxication, and aggressive behavior |
Q48286043 | Difficulties in emotion regulation and impulse control during cocaine abstinence |
Q36930511 | Difficulties in emotional regulation and substance use disorders: a controlled family study of bipolar adolescents |
Q66972158 | Difficulties in measuring human acetaldehyde levels |
Q37309003 | Diffusion tensor imaging in cocaine dependence: regional effects of cocaine on corpus callosum and effect of cocaine administration route |
Q35877143 | Dimensionality of DSM-IV nicotine dependence in a national sample: an item response theory application |
Q37156806 | Dimensionality of lifetime alcohol abuse, dependence and binge drinking |
Q44612522 | Dimensions of marihuana experience |
Q43009165 | Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users |
Q101378079 | Diminished cortical response to risk and loss during risky decision making in alcohol use disorder |
Q34148073 | Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol |
Q52267492 | Diploma in addiction behaviour |
Q52242358 | Diploma in addiction behaviour: update. |
Q40050661 | Directly alcohol-attributable mortality by industry and occupation in a Spanish Census cohort of economically active population. |
Q35633045 | Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence |
Q30497684 | Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial |
Q91893488 | Discharge against medical advice from hospitalizations for substance use disorders: The potential impact of the Affordable Care Act |
Q41052792 | Discharge patterns of residents from halfway houses for male alcoholics |
Q44080139 | Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study |
Q47228043 | Discordant reporting of nonmedical amphetamine use among Adderall-using high school seniors in the US. |
Q44555329 | Discounting of money, health, and freedom in substance abusers and controls |
Q40863984 | Discrepancies in addressing overdose prevention through prescription monitoring programs |
Q39318474 | Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever |
Q34961111 | Discrimination and alcohol-related problems among college students: a prospective examination of mediating effects |
Q91804536 | Discrimination learning in oxycodone-treated nonhuman primates |
Q53087323 | Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine. |
Q44448279 | Discriminative stimulus effects of (-)-ephedrine in rats: analysis with catecholamine transporter and receptor ligands. |
Q46564368 | Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo |
Q51099663 | Discriminative stimulus effects of alcohol in humans. |
Q50996720 | Discriminative stimulus effects of cocaine in female versus male rats. |
Q52058710 | Discriminative stimulus effects of combinations of pentobarbital and ethanol in rhesus monkeys. |
Q31870754 | Discriminative stimulus effects of panadiplon (U-78875), a partial agonist at the benzodiazepine site, in pentobarbital-trained rhesus monkeys |
Q52217403 | Discriminative stimulus effects of phencyclidine: pharmacologically specific interactions with delta 9- and delta 8-tetrahydrocannabinol. |
Q52260276 | Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons. |
Q41832637 | Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone |
Q52261458 | Discriminative stimulus properties of phenylisopropylamine derivatives. |
Q42680744 | Discriminative-stimulus effects of modafinil in cocaine-trained humans |
Q35181608 | Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats |
Q89845187 | Disordered eating is associated with non-medical use of prescription stimulants among college students |
Q45268378 | Disorders of sexual desire in a sample of women alcoholics |
Q123299581 | Disorders through organizational change |
Q33341371 | Disparate cocaine-induced locomotion as a predictor of choice behavior in rats trained in a delay-discounting task |
Q38129553 | Disparities in Latino substance use, service use, and treatment: implications for culturally and evidence-based interventions under health care reform |
Q91384304 | Disparities in adult cigarette smoking and smokeless tobacco use by sexual identity |
Q40082800 | Disparities in drinking patterns and risks among ethnic majority and minority groups in China: The roles of acculturation, religion, family and friends |
Q91757113 | Disparities in opioid related mortality between United States counties from 2000 to 2014 |
Q60501012 | Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity |
Q36115969 | Displays of dabbing marijuana extracts on YouTube |
Q48282213 | Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys |
Q88650788 | Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms |
Q52317444 | Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications. |
Q33903788 | Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers |
Q48742453 | Dissociation between subjective and behavioral responses after cocaine stimuli presentations |
Q73434121 | Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats |
Q48022442 | Distinct behavioral and immunoendocrine parameters during crack cocaine abstinence in women reporting childhood abuse and neglect. |
Q91092288 | Distinct effects of cocaine and cocaine + cannabis on neurocognitive functioning and abstinence: A six-month follow-up study |
Q34850920 | Distinctive characteristics of methamphetamine users presenting at public clinics: steep rise in South Carolina, United States, 2000-2005 |
Q35757407 | Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists |
Q38771287 | Distinguishing subpopulations of marijuana users with latent profile analysis |
Q44620677 | Distribution of deaths by unintentional illicit drug overdose in Italy based on periodicity over time, 1984–2000 |
Q33280696 | Distributive syringe sharing among young adult injection drug users in five U.S. cities |
Q89462348 | Disturbances of postural sway components in cannabis users |
Q42538809 | Disulfiram effects on acute cocaine administration |
Q35792934 | Disulfiram effects on responses to intravenous cocaine administration |
Q36517347 | Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol |
Q37074102 | Divergent marijuana trajectories among men: Socioeconomic, relationship, and life satisfaction outcomes in the mid-30s |
Q93631318 | Diverging trends in youthful and adult alcohol consumption: a result of preventive programs? |
Q36568562 | Diverse HIV epidemics among people who inject drugs in Thailand: evidence from respondent-driven sampling surveys in Bangkok and Chiang Mai. |
Q48960697 | Diverse autonomic regulation of pupillary function and the cardiovascular system during alcohol withdrawal |
Q84812155 | Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians |
Q49148498 | Divided attention task performance and subjective effects following alcohol and placebo: differences between women with and without a family history of alcoholism |
Q36496567 | Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users? |
Q114190320 | Do alcohol policies affect everyone equally? An assessment of the effects of state policies on education-related patterns of alcohol use, 2011–2019 |
Q37155093 | Do brief interventions which target alcohol consumption also reduce cigarette smoking? Systematic review and meta-analysis |
Q57670322 | Do consumers substitute between cannabis and opium? Evidence from British India |
Q36306212 | Do consumers substitute opium for hashish? An economic analysis of simultaneous cannabinoid and opiate consumption in a legal regime |
Q46144874 | Do drinking-age laws have an impact on crime? Evidence from Canada, 2009-2013. |
Q42679031 | Do drug users in China who frequently receive detoxification treatment change their risky drug use practices and sexual behavior? |
Q36734705 | Do early experiences with cannabis vary in cigarette smokers? |
Q35966318 | Do environmental cues prompt attempts to stop smoking? A prospective natural history study |
Q33541919 | Do hallucinogens cause residual neuropsychological toxicity? |
Q46176088 | Do law enforcement interactions reduce the initiation of injection drug use? An investigation in three North American settings. |
Q93346638 | Do maternal knowledge and paternal knowledge of children's whereabouts buffer differently against alcohol use? A longitudinal study among Finnish boys and girls |
Q89803998 | Do men who have sex with men who report alcohol and illicit drug use before/during sex (chemsex) present moderate/high risk for substance use disorders? |
Q89391133 | Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid |
Q69677289 | Do persistent morphine effects involve interactions with the genome? |
Q58812576 | Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy? |
Q46847449 | Do primary care physicians' own AUDIT scores predict their use of brief alcohol intervention? A cross-sectional survey |
Q46489619 | Do research payments precipitate drug use or coerce participation? |
Q59360764 | Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder? |
Q36269756 | Do smokers with alcohol problems have more difficulty quitting? |
Q39211606 | Do survivors respond differently when alcohol abuse complicates suicide? Findings from the psychological autopsy study in Estonia |
Q92998547 | Do tobacco industry websites target content to specific demographic groups? |
Q45263540 | Do trauma history and PTSD symptoms influence addiction relapse context? |
Q34615910 | Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? |
Q51798407 | Do young people benefit from AA as much, and in the same ways, as adult aged 30+? A moderated multiple mediation analysis. |
Q52591571 | Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries. |
Q36680988 | Does Alcoholics Anonymous work differently for men and women? A moderated multiple-mediation analysis in a large clinical sample |
Q34279700 | Does active referral by a doctor or 12-Step peer improve 12-Step meeting attendance? Results from a pilot randomised control trial. |
Q40090086 | Does areca nut use lead to dependence? |
Q51914880 | Does assigning a representative payee reduce substance abuse? |
Q37652922 | Does beverage type and drinking context matter in an alcohol-related injury? Evidence from emergency department patients in Latin America |
Q43195432 | Does binge drinking in teenagers affect their everyday prospective memory? |
Q39636117 | Does calling alcoholism an illness make a difference? The public image of alcoholism in Italy |
Q77989951 | Does clinical case management improve outpatient addiction treatment |
Q35985023 | Does co-morbid depression alter the inverse relationship between obesity and substance use disorders? |
Q28266046 | Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes |
Q35660973 | Does comparing alcohol use along a single dimension obscure within-group differences? Investigating men's hazardous drinking by sexual orientation and race/ethnicity |
Q40369801 | Does contingency management affect motivation to change substance use? |
Q37345565 | Does delay discounting play an etiological role in smoking or is it a consequence of smoking? |
Q92774321 | Does e-cigarette experimentation increase the transition to daily smoking among young ever-smokers in France? |
Q50633522 | Does early socio-economic disadvantage predict comorbid alcohol and mental health disorders? |
Q88157829 | Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood |
Q35866473 | Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? Results from the national epidemiological survey on alcohol and related conditions |
Q34179902 | Does heavy adolescent marijuana use lead to criminal involvement in adulthood? Evidence from a multiwave longitudinal study of urban African Americans |
Q36090462 | Does laboratory cue reactivity correlate with real-world craving and smoking responses to cues? |
Q38803771 | Does marijuana "blunt" smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking |
Q43571812 | Does multisite sampling improve patient heterogeneity in drug misuse research? |
Q47731006 | Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in Europe |
Q38532377 | Does physical activity protect against drug abuse vulnerability? |
Q35980539 | Does quitting smoking during pregnancy have a long-term impact on smoking status? |
Q47370029 | Does recovery-oriented treatment prompt heroin users prematurely into detoxification and abstinence programmes? Qualitative study. |
Q39275433 | Does resilience moderate the associations between parental problem drinking and adolescents' internalizing and externalizing behaviors? A study of Korean adolescents |
Q38845948 | Does substance use moderate the association of neighborhood disadvantage with perceived stress and safety in the activity spaces of urban youth? |
Q36069581 | Does the "gateway" sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy |
Q47587736 | Does the biopsychosocial-spiritual model of addiction apply in an Islamic context? A qualitative study of Jordanian addicts in treatment |
Q39403285 | Does the familial transmission of drinking patterns persist into young adulthood? A 10-year follow up. |
Q39141587 | Does the pattern of amphetamine use prior to incarceration predict later psychosis?--a longitudinal study of amphetamine users in the Swedish criminal justice system. |
Q37557867 | Does treatment fidelity predict client outcomes in 12-Step Facilitation for stimulant abuse? |
Q38177927 | Does urine drug abuse screening help for managing patients? A systematic review |
Q44341104 | Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects |
Q43259945 | Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals |
Q52272665 | Dopamine D2 receptor gene Taq I 'A' locus map including 'A4' variant: relevance for alcoholism and drug abuse. |
Q28374214 | Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys |
Q46591374 | Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats |
Q33809050 | Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO. |
Q48597719 | Dopamine neurotoxicity in cortical neurons |
Q45284817 | Dopamine receptor regulation of ethanol intake and extracellular dopamine levels in the ventral pallidum of alcohol preferring (P) rats |
Q60619404 | Dopamine receptor responsivity in alcoholic patients before and after detoxification |
Q36930260 | Dopamine transporter levels in cocaine dependent subjects |
Q74137210 | Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: association with behavioral signs |
Q47943228 | Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge |
Q50773926 | Dopaminergic involvement in effort-based but not impulsive reward processing in smokers. |
Q73154607 | Dorothy Hatsukami and the sponsorship of Drug and Alcohol Dependence by the College on Problems of Drug Dependence |
Q41640381 | Dorsal anterior cingulate glutamate is associated with engagement of the default mode network during exposure to smoking cues |
Q33975160 | Dose related risk of motor vehicle crashes after cannabis use. |
Q47830942 | Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. |
Q51181542 | Dose-response relationship between tobacco or alcohol consumption and the development of diabetes mellitus in Japanese male workers. |
Q47445066 | Dose-response relationships between exercise intensity, cravings, and inhibitory control in methamphetamine dependence: An ERPs study |
Q42280650 | Double jeopardy through social marginalization: HIV risk among Tajik male labor migrants in Moscow |
Q41747240 | Double trouble: Exploring the association between waterpipe tobacco smoking and the nonmedical use of psychoactive prescription drugs among adolescents |
Q38414947 | Double trouble: Psychiatric comorbidity and opioid addiction-all-cause and cause-specific mortality |
Q37079341 | Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence |
Q34158675 | Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. |
Q42546661 | Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal |
Q31926146 | Double-blind randomized trial of buprenorphine and methadone in opiate dependence |
Q52274889 | Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital. |
Q52289396 | Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence. |
Q37281826 | Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence. |
Q43774545 | Drink and drugs: from medical students to doctors |
Q37260465 | Drinkers and bettors: investigating the complementarity of alcohol consumption and problem gambling |
Q36867035 | Drinkers' memory bias for alcohol picture cues in explicit and implicit memory tasks |
Q47611841 | Drinking and driving among American youth: beliefs and behaviors |
Q43570046 | Drinking and driving: pre-driving attitudes and perceptions among Brazilian youth |
Q70398699 | Drinking and drug use among Ontario Indian students |
Q47655710 | Drinking and heavy drinking by students in 18 countries |
Q52279038 | Drinking and smoking as concurrent predictors of illicit drug use and positive drug attitudes in adolescents. |
Q33767546 | Drinking and stress: an examination of sex and stressor differences using IVR-based daily data |
Q72612372 | Drinking and unemployment: contrasting patterns among men and women |
Q73795234 | Drinking as a risk factor for sustained smoking |
Q43791647 | Drinking behaviour and social change among youths in Nigeria--a study of two cities |
Q40198034 | Drinking despite health problems among individuals with liver disease across the United States |
Q36816469 | Drinking drivers and drug use on weekend nights in the United States |
Q52277496 | Drinking in the Swedish gay and lesbian community. |
Q37537240 | Drinking motives as prospective predictors of outcome in an intervention trial with heavily drinking HIV patients. |
Q40591979 | Drinking pattern during midlife and risk of developing depression during 28 years of follow-up: A prospective cohort study |
Q88484298 | Drinking patterns and adherence to "low-risk" guidelines among community-residing older adults |
Q40233468 | Drinking patterns and alcohol problems among Hispanics in the U.S.: a review |
Q33541916 | Drinking patterns and problems, drug use and health services utilization: a comparison of two regions in the US general population |
Q41137123 | Drinking patterns and problems: a comparison of emergency room populations in the United States and Spain |
Q35661032 | Drinking problems and mortality risk in the United States |
Q40422801 | Drinking refusal self-efficacy questionnaire-revised (DRSEQ-R): a new factor structure with confirmatory factor analysis |
Q36663528 | Drinking to cope with negative emotions moderates alcohol use disorder treatment response in patients with co-occurring anxiety disorder. |
Q95924661 | Drinking to death: Hyponatraemia induced by synthetic phenethylamines |
Q90669086 | Drinking to go out or going out to drink? A longitudinal study of alcohol in night-time entertainment districts |
Q38550440 | Drinking to have fun and to get drunk: motives as predictors of weekend drinking over and above usual drinking habits |
Q35088330 | Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans |
Q37660374 | Drinking, smoking, and educational achievement: cross-lagged associations from adolescence to adulthood |
Q47226904 | Drivers with alcohol use disorders and their risks of crash involvement |
Q44578997 | Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions |
Q91027560 | Driving under the influence of cannabis among medical cannabis patients with chronic pain |
Q36509285 | Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial |
Q35160234 | Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial |
Q51771785 | Drug Stroop: Mechanisms of response to computerized cognitive behavioral therapy for cocaine dependence in a randomized clinical trial. |
Q53254186 | Drug abuse and HIV/AIDS: international research lessons and imperatives. |
Q71035539 | Drug abuse and affluence in five countries: a study of economic and health conditions, 1960-1975 |
Q45157501 | Drug abuse and suicidal behavior |
Q31032665 | Drug abuse in France: a review of statistical data |
Q72080919 | Drug abuse in Jordan: an exploratory study |
Q41469469 | Drug abuse in a farm community; a brief appraisal of a research work |
Q51855685 | Drug abuse in the United States: the past decade. |
Q50769666 | Drug abuse scientists should use social media to engage the public because their primary translational product is information. |
Q51168717 | Drug abuse strategies. |
Q33856563 | Drug abuse treatment as an HIV prevention strategy: a review |
Q48737379 | Drug abuse treatment retention and process effects on follow-up outcomes |
Q41470140 | Drug abuse trends among German youth |
Q44253859 | Drug abuse, methadone treatment, and health services use among injection drug users with AIDS. |
Q52711550 | Drug abuse: a manifestation of the cyclic nature of human behavior |
Q48405870 | Drug addiction research: moving toward the 21st century |
Q58365709 | Drug addicts and renal lesions |
Q33452387 | Drug addicts attending specialised institutions: towards a drug addiction data bank? |
Q39346184 | Drug addicts seeking treatment after the Iranian Revolution: a clinic-based study |
Q85383368 | Drug and Alcohol Dependence Fellowship |
Q78170776 | Drug and alcohol consumption and sexual risk behaviour among young adults: results from a national survey |
Q42606463 | Drug and alcohol treatment among privately insured patients: rate of specialty substance abuse treatment and association with cost-sharing |
Q30354209 | Drug and alcohol-impaired driving among electronic music dance event attendees |
Q60144148 | Drug and tobacco use during pregnancy transmit genetic influences on developmental risk for substance use |
Q71137846 | Drug attitudes and discrimination between drugs among a group of English schoolchildren |
Q101131157 | Drug checking identifies counterfeit alprazolam tablets |
Q90669082 | Drug checking services at music festivals and events in a Canadian setting |
Q70450066 | Drug counselors' perceptions of clients: demographic, personality and psychopathology correlates |
Q35238099 | Drug dealing cessation among a cohort of drug users in Vancouver, Canada |
Q67963098 | Drug dependence and personality disorder: its relationship to the treatment of drug dependence |
Q41384490 | Drug dependence units in England and Wales. The results of a national survey |
Q43864898 | Drug dependence, crime and personality among female addicts |
Q28344318 | Drug dependence, parenting responsibilities, and treatment history: why doesn't mom go for help? |
Q52072839 | Drug dependence: benefit-risk ratio assessment of agonist-antagonist analgesics. |
Q43070756 | Drug dependence: stress and dysregulation of brain reward pathways |
Q28281999 | Drug discrimination studies |
Q69444341 | Drug findings in 'Driving Under the Influence of Drugs' cases: a problem of illicit drug use |
Q35842847 | Drug fluency: a potential marker for cocaine use disorders |
Q38886126 | Drug involvement during and after college: Estimates of opportunity and use given opportunity |
Q90457199 | Drug overdose mortality among residents of single room occupancy buildings in San Francisco, California, 2010-2017 |
Q57817823 | Drug screening and changing marijuana policy: Validation of new single question drug screening tools |
Q90110134 | Drug screening during pregnancy: Urine dip cups measure up |
Q43721965 | Drug spend and acquisitive offending by substance misusers |
Q44809237 | Drug test feasibility in a general population household survey |
Q51766369 | Drug use among alcoholism detoxification patients: prevalence and impact on alcoholism treatment. |
Q72091323 | Drug use among non-students in three countries |
Q39437567 | Drug use among street children in southern Brazil |
Q44283699 | Drug use among two American Indian populations: prevalence of lifetime use and DSM-IV substance use disorders |
Q36039426 | Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care. |
Q51696982 | Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment. |
Q42597970 | Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia |
Q40958172 | Drug use and childhood-, military- and post-military trauma exposure among women and men veterans |
Q36658120 | Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings. |
Q71132359 | Drug use and drug problems among teenagers in a household sample |
Q37334745 | Drug use and other risk factors related to lower body mass index among HIV-infected individuals |
Q31156392 | Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey |
Q42688156 | Drug use and risk of HIV/AIDS on the Mexico-USA border: a comparison of treatment admissions in both countries |
Q43571783 | Drug use and sport--a commentary on: Injury, pain and prescription opioid use among former National Football League football players by Cottler et al. |
Q37204921 | Drug use disorders and post-traumatic stress disorder over 25 adult years: role of psychopathology in relational networks |
Q44069915 | Drug use expectancies among nonabstinent community cocaine users |
Q40464430 | Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California. |
Q36846607 | Drug use in the social networks of heroin and cocaine users before and after drug cessation |
Q57077162 | Drug use opportunities and the transition to drug use among adolescents from the Mexico City Metropolitan Area |
Q39694890 | Drug use opportunities as opportunities for drug use prevention: Bogotá, Colombia a case in point |
Q43777853 | Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). |
Q36295888 | Drug use patterns in young adulthood and post-college employment. |
Q35875932 | Drug use patterns predict risk of non-fatal overdose among street-involved youth in a Canadian setting |
Q46588028 | Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis |
Q37087802 | Drug use related problems among nonmedical users of prescription stimulants: a web-based survey of college students from a Midwestern university. |
Q72676368 | Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients |
Q52278004 | Drug use, self report and urinalysis. |
Q95314500 | Drug use, sexual risk, and structural vulnerability among female sex workers in two urban centers of the Dominican Republic: The EPIC study |
Q58633730 | Drug users and non-drug users both favor uncommon informed consent practices |
Q33625219 | Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives |
Q38574122 | Drug users' spiritual beliefs, locus of control and the disease concept in relation to Narcotics Anonymous attendance and six-month outcomes |
Q58633737 | Drug users’ advice on enrollment and retention in health research |
Q48405857 | Drug-activation of brain reward pathways |
Q48916835 | Drug-reinforced responding: rapid determination of dose-response functions |
Q34980340 | Drug-related deaths and the sales of needles through pharmacies |
Q31870944 | Drug-related emergencies and drug-related deaths in Vienna, 1995-1997. |
Q90105935 | Drug-related mortality after discharge from treatment: A record-linkage study of substance abuse clients in Texas, 2006-2012 |
Q70870015 | Drug-related mortality in an inner city area |
Q37282186 | Drug-related stimuli impair inhibitory control in cocaine abusers. |
Q52306831 | Drug-seeking behavior in the dog: Lack of effect of prior passive dependence on morphine |
Q41594656 | Drugged driving, a review based on the experience in Norway |
Q48728349 | Drugs and homicide: a theory |
Q30328470 | Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. |
Q46221271 | Drugs of abuse found in fatally injured drivers in Los Angeles County |
Q40728555 | Drugs on a medical campus I. Drug use among medical undergraduates |
Q39570794 | Drugs on a medical campus. II. Drug use among faculty members |
Q41473361 | Drugs on a medical campus. III. Drug use among nursing and paramedical personnel |
Q50786694 | Drunk versus drugged: how different are the drivers? |
Q41699593 | Drunkenness and its association with health risk behaviors among adolescents and young adults in three Asian cities: Hanoi, Shanghai, Taipei |
Q45922828 | Drunker than intended: misperceptions and information treatments. |
Q90329436 | Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year |
Q43197505 | Dual use of anabolic-androgenic steroids and narcotics in Sweden |
Q91272641 | Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care |
Q104070784 | Dyadic associations between relationship quality and risk of opioid use among couples receiving methadone for opioid use disorder |
Q35684512 | Dynamics in the costs of criminality among opioid dependent individuals |
Q31870967 | Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users |
Q37502107 | E-cigarette advertising exposure and implicit attitudes among young adult non-smokers |
Q93370773 | E-cigarette devices used by high-school youth |
Q50138546 | E-cigarette use and quantity of cigarette smoking among adolescent cigarette smokers: A finite mixture model analysis |
Q93346651 | E-cigarette use and respiratory disorder in an adult sample |
Q39798307 | E-cigarette use and subsequent cigarette and marijuana use among Hispanic young adults |
Q90566466 | E-cigarette use frequency and motivations among current users in middle school |
Q91211475 | E-cigarette use is associated with a self-reported diagnosis of prediabetes in never cigarette smokers: Results from the behavioral risk factor surveillance system survey |
Q40509700 | E-cigarettes, conventional cigarettes, and dual use in Korean adolescents and university students: Prevalence and risk factors. |
Q91665852 | E-cigarettes-An unintended illicit drug delivery system |
Q33624714 | EEG spectral phenotypes: heritability and association with marijuana and alcohol dependence in an American Indian community study |
Q43641310 | Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample |
Q36082767 | Early adolescent psychopathology as a predictor of alcohol use disorders by young adulthood |
Q30683555 | Early adolescent substance use in Mexican origin families: Peer selection, peer influence, and parental monitoring |
Q47558433 | Early age at childhood parental incarceration and STI/HIV-related drug use and sex risk across the young adult lifecourse in the US: Heightened vulnerability of black and Hispanic youth |
Q47237785 | Early age of e-cigarette use onset mediates the association between impulsivity and e-cigarette use frequency in youth |
Q46700844 | Early alcohol experiences and adolescent mental health: a population-based study in Taiwan. |
Q45193449 | Early alcohol or tobacco onset and transition to other drug use among students in the state of Morelos, Mexico |
Q39578666 | Early clinical manifestations of cannabis dependence in a community sample |
Q35661085 | Early emerging nicotine dependence symptoms in adolescence predict daily smoking in young adulthood |
Q35793010 | Early experience with racial discrimination and conduct disorder as predictors of subsequent drug use: a critical period hypothesis |
Q37040028 | Early exposure to stimulant medications and substance-related problems: The role of medical and nonmedical contexts. |
Q39437572 | Early family adversity as a precursor to narcotic addiction |
Q63358417 | Early life trauma, neurocognitive functioning, and substance use |
Q30665750 | Early onset and recent drug use among children of parents with alcohol problems: data from a national epidemiologic survey |
Q39716784 | Early onset inhalant use and risk for opiate initiation by young adulthood |
Q41735750 | Early onset of cannabis use: does personality modify the relation with changes in perceived parental involvement? |
Q35638721 | Early onset problem behaviors and alcohol, tobacco, and other substance use disorders in young adulthood |
Q50142562 | Early onset tobacco cigarette smokers exhibit deficits in response inhibition and sustained attention |
Q39356817 | Early predictors of age at first use of alcohol, marijuana, and cigarettes |
Q72658673 | Early smoking initiation and nicotine dependence in a cohort of young adults |
Q44360031 | Early-onset cannabis use and cognitive deficits: what is the nature of the association? |
Q40966694 | Early-onset drug use and risk of later drug problems |
Q52278411 | Early-onset of illicit substance use is associated with greater axis-II comorbidity, not with axis-I comorbidity. |
Q95651839 | Eating disorders in a community-based sample of women with alcohol use disorder and nicotine dependence |
Q48408284 | Ecological assessment of executive functions in substance dependent individuals |
Q44910543 | Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: a comparison of feasibility and validity |
Q38338253 | Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review |
Q97561755 | Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study |
Q93015900 | Economic demand analysis of within-session dose-reduction during nicotine self-administration |
Q45961576 | Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment. |
Q31061435 | Economic manifestations of opiate addiction: evidence from historical data from colonial Indonesia |
Q52276810 | Ecstasy (MDMA) dependence. |
Q34122199 | Ecstasy use among US adolescents from 1999 to 2008. |
Q60630740 | Ecstasy use in Australia: patterns of use and associated harm |
Q36113949 | Education inequality and use of cigarettes, alcohol, and marijuana |
Q37380191 | Educational attainment and smoking among women: risk factors and consequences for offspring |
Q33950655 | Educational attainment is not a good proxy for cognitive function in methamphetamine dependence |
Q88069337 | Educational differences in alcohol consumption and heavy drinking: An age-period-cohort perspective |
Q37390639 | Educational disadvantage and cigarette smoking during pregnancy |
Q67025748 | Effect of 1,5-dicaffeylquinic acid (Cynarine) on cholesterol levels in serum and liver of acute ethanol-treated rats |
Q66972157 | Effect of 4-methylpyrazole and abstinence on ethanol elimination in an alcoholic |
Q37157553 | Effect of a "pill mill" law on opioid prescribing and utilization: The case of Texas |
Q34022084 | Effect of a primary care based brief intervention trial among risky drug users on health-related quality of life |
Q46380300 | Effect of acetaldehyde on skeletogenesis in rats |
Q48925026 | Effect of acute injections of ethanol on lipid and protein-bound sialic acid in mice of different ages |
Q41963251 | Effect of alcohol and glucose infusion on pituitary-gonadal hormones in normal females |
Q68046816 | Effect of alcohol content on beer consumption by rats |
Q66972155 | Effect of alpha- and beta-blockers on ethanol metabolism |
Q52260947 | Effect of amphetamine on sucrose-reinforced lever pressing: interaction with food deprivation. |
Q98182374 | Effect of bile duct ligation-induced liver dysfunction on methamphetamine pharmacokinetics in male and female rats |
Q45195547 | Effect of chronic acetaldehyde intoxication on ethanol tolerance and membrane fatty acids |
Q68671011 | Effect of chronic ethanol feeding on glutathione and glutathione-related enzyme activities in rat liver |
Q43685930 | Effect of chronic ethanol ingestion and exercise training on skeletal muscle in rat. |
Q34154872 | Effect of cocaine on structural changes in brain: MRI volumetry using tensor-based morphometry |
Q40553871 | Effect of cocaine on vagal tone: a common factors approach |
Q70754039 | Effect of colchicine on lactate production by isolated hepatocytes in rats treated with carbon tetrachloride and ethanol |
Q50147432 | Effect of electronic brief intervention on uptake of specialty treatment in hospital outpatients with likely alcohol dependence: Pilot randomized trial and qualitative interviews |
Q90873798 | Effect of electronic screening and brief intervention on hazardous or harmful drinking among adults in the hospital outpatient setting: A randomized, double-blind, controlled trial |
Q57420413 | Effect of ethanol infusion on plasma cortisol, corticotrophin, β-lipotrophin, growth hormone and prolactin, and its modification by naloxone |
Q40285370 | Effect of ethanol on cyclic nucleotides in vivo: Consequences of controlling motor and respiratory changes |
Q48269489 | Effect of ethanol on dop amine synthesis in rat striatal synaptosomes |
Q54378211 | Effect of ethanol on hepatic iron, copper, zinc and manganese contents in the male albino mouse. |
Q69748696 | Effect of ethanol on liver cell-development in the male albino mouse |
Q69367850 | Effect of ethanol on the maturation of the spontaneous transmitter release by regenerated nerve endings |
Q69890072 | Effect of ethanol on the spontaneous transmitter release by nerve endings in the process of maturation |
Q41163520 | Effect of experimental analogs of contingency management treatment on cocaine seeking behavior |
Q43774548 | Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans |
Q51470282 | Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats. |
Q38993475 | Effect of immigration background and country-of-origin contextual factors on adolescent substance use in Spain |
Q37273924 | Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. |
Q91740598 | Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial |
Q42652497 | Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers |
Q68503882 | Effect of lesions of the dorsalis raphe nuclei on the initiation of alcohol preference in rats |
Q90672385 | Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal |
Q48454654 | Effect of long-term nicotine treatment on [3H]nicotine binding sites in the rats brain |
Q92137255 | Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program |
Q43884125 | Effect of maternal methionine pre-treatment on alcohol-induced exencephaly and axial skeletal dysmorphogenesis in mouse fetuses |
Q93213618 | Effect of menstrual cycle on ethanol drinking in rhesus monkeys |
Q69748683 | Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients |
Q52722226 | Effect of methamphetamine exposure on the plasma levels of endothelial-derived microparticles. |
Q36058177 | Effect of motivational interviewing on reduction of alcohol use. |
Q91402444 | Effect of nicotine lozenge use prior to smoking cue presentation on craving and withdrawal symptom severity |
Q52249967 | Effect of nimodipine on drinking behavior measured in the runway: comparison and interaction with (+/-)-amphetamine. |
Q47672363 | Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers |
Q41470040 | Effect of pimozide on home cage ethanol drinking in the rat: dependence on drinking session length |
Q90000187 | Effect of positive urine fentanyl screen on attitudes toward heroin use |
Q72629326 | Effect of pre-treatment with aspirin on alcohol-induced neural tube defects in the TO mouse fetuses |
Q68345282 | Effect of propylthiouracil on liver cell development in the male albino mouse: protective effect against ethanol-induced alterations |
Q34448716 | Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans |
Q53580440 | Effect of religion and religiosity on alcohol use in a college student sample. |
Q71132357 | Effect of repeated oral propoxyphene administration on analgesia, toxicity and microsomal metabolism in the mouse |
Q40356622 | Effect of risperidone on acute methamphetamine-induced hyperthermia in rats |
Q44348977 | Effect of selective antagonism of mu(1)-, mu(1/2)-, mu(3)-, and delta-opioid receptors on the locomotor-stimulating actions of ethanol. |
Q45193447 | Effect of the combination of naltrexone and baclofen, on acquisition of alcohol drinking behavior in alcohol-preferring rats |
Q42937666 | Effect of the threat of a disulfiram-ethanol reaction on cue reactivity in alcoholics |
Q36421534 | Effect of traumatic event reexposure and PTSD on substance use disorder treatment response |
Q122947936 | Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trial |
Q71241961 | Effect of two iron-chelators, desferrioxamine and diethylenetriaminepentaacetic acid, on the development of tolerance to the physical dependence on ethanol in mice |
Q41531511 | Effect of variation in BDNF Val(66)Met polymorphism, smoking, and nicotine dependence on symptom severity of depressive and anxiety disorders |
Q47784195 | Effective active vaccination against methamphetamine in female rats. |
Q36332865 | Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial. |
Q93076116 | Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone |
Q47929855 | Effectiveness of a Dutch community-based alcohol intervention: Changes in alcohol use of adolescents after 1 and 5 years |
Q93198430 | Effectiveness of a brief information, motivation and behavioral skills program on stage transitions and lapse for individuals who use ketamine |
Q44934089 | Effectiveness of a brief-intervention and continuity of care in enhancing attendance for treatment by adolescent substance users |
Q58633912 | Effectiveness of ambassador plus navigator vs. navigator alone to enroll current drug users in health studies |
Q40132747 | Effectiveness of brief alcohol interventions for general practice patients with problematic drinking behavior and comorbid anxiety or depressive disorders |
Q52650504 | Effectiveness of community psychosocial and pharmacological treatments for alcohol use disorder: A national observational cohort study in England. |
Q42662184 | Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women |
Q35704036 | Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews |
Q92464937 | Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs |
Q40122556 | Effectiveness of prize-based contingency management in a methadone maintenance program in China |
Q43571809 | Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity |
Q40045227 | Effectiveness of psychotherapeutic counseling in methadone maintenance |
Q97074376 | Effectiveness of the use of implementation intentions on reduction of substance use: A meta-analysis |
Q44345866 | Effectiveness of treatment for opioid use disorder: A national, five-year, prospective, observational study in England |
Q44242945 | Effectiveness of very low-cost contingency management in a community adolescent treatment program |
Q37018136 | Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys |
Q39403292 | Effects of 21-day d-amphetamine and risperidone treatment on cocaine vs food choice and extended-access cocaine intake in male rhesus monkeys |
Q44809242 | Effects of 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats |
Q41640386 | Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability |
Q44375260 | Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol |
Q36090475 | Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys |
Q39724020 | Effects of 7-day repeated treatment with the 5-HT2A inverse agonist/antagonist pimavanserin on methamphetamine vs. food choice in male rhesus monkeys |
Q46591378 | Effects of GABAergic modulators on food and cocaine self-administration in baboons |
Q51663466 | Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. |
Q92998540 | Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults |
Q36090344 | Effects of MAO inhibition and a combination of minor alkaloids, β-carbolines, and acetaldehyde on nicotine self-administration in adult male rats |
Q70179714 | Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms |
Q35148515 | Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats. |
Q46315143 | Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. |
Q35690272 | Effects of a strategy to improve offender assessment practices: Staff perceptions of implementation outcomes |
Q24645268 | Effects of a universal classroom behavior management program in first and second grades on young adult behavioral, psychiatric, and social outcomes |
Q34761967 | Effects of a universal classroom behavior program in first and second grades on young adult problem outcomes |
Q46377859 | Effects of abstinence and chronic cigarette smoking on white matter microstructure in alcohol dependence: Diffusion tensor imaging at 4T. |
Q48792214 | Effects of access to a running wheel on food, water and ethanol intake in rats bred to accept ethanol |
Q35875875 | Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats |
Q45242927 | Effects of acute and chronic administration of Δ9-tetrahy-drocannabinol or cocaine on ethanol intake in a rat model |
Q48428634 | Effects of acute and repeated alcohol ingestion on hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal functioning in normal males |
Q27312372 | Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice |
Q48929928 | Effects of acute cannabis use and short-term deprivation on plasma prolactin and dopamine-beta-hydroxylase in long-term users |
Q60619469 | Effects of acute cannabis use on urinary neurotransmitter metabolites and cyclic nucleotides in man |
Q48665411 | Effects of acute combined serotonin and dopamine depletion on cue-induced drinking intention/desire and cognitive function in patients with alcohol dependence |
Q51538896 | Effects of acute daily administration of diazepam on spatial learning and working memory. |
Q68046843 | Effects of acute doses of ethanol administered at pre-implantation stages on fetal development in the mouse |
Q39346856 | Effects of acute doses of ethanol on pre- and postnatal development in the mouse |
Q42482256 | Effects of acute ethanol exposure on class I HDACs family enzymes in wild-type and BDNF(+/-) mice |
Q51347141 | Effects of acute nicotine and alcohol on the rating of attractiveness in social smokers and alcohol drinkers. |
Q93371564 | Effects of acute treatments with the serotonin 2A antagonist M100907 alone or in combination with the serotonin 2C agonist WAY163909 on methamphetamine self-administration in rhesus monkeys |
Q45000243 | Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders |
Q52175873 | Effects of alcohol cues on cognitive processing in heavy and light drinkers. |
Q47331171 | Effects of alcohol on disinhibition towards alcohol-related cues |
Q37394592 | Effects of alcohol on psychomotor performance and perceived impairment in heavy binge social drinkers |
Q71035544 | Effects of alcohol rehabilitation treatment on health and performance of Navy enlisted men |
Q31870807 | Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo |
Q48503654 | Effects of an oil enriched in gamma linolenic acid on locomotor activity and behaviour in the Morris Maze, following in utero ethanol exposure in rats |
Q41639294 | Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food |
Q52318328 | Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. |
Q40932405 | Effects of apomorphine and apomorphine-L-dopa-carbidopa on alcohol post-intoxication symptoms |
Q36328505 | Effects of artificial sweeteners on breath alcohol concentrations in male and female social drinkers |
Q48360740 | Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: comparison with alteration of [3H]DAMGO binding to rat brain sections |
Q50183877 | Effects of buprenorphine and an alternative nondrug reinforcer, alone and in combination on smoked cocaine self-administration in monkeys. |
Q44348671 | Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts |
Q44724854 | Effects of buprenorphine in heroin addicts |
Q37204791 | Effects of bupropion on cognitive performance during initial tobacco abstinence |
Q58044437 | Effects of childhood trauma on psychopathology, risky sex, aggression, and emotion dysregulation among inpatient substance users |
Q48215410 | Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys |
Q71993961 | Effects of chronic alcohol intake on the vasopressin content in the hypothalamic paraventricular and supraoptic nuclei of the mouse. An immunohistochemical and morphometric study |
Q30377582 | Effects of chronic binge-like ethanol consumption on cocaine self-administration in rhesus monkeys. |
Q51554924 | Effects of chronic cocaine use on physical health: a prospective study in a general population sample. |
Q44394309 | Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys |
Q44836266 | Effects of chronic ethanol administration and ethanol withdrawal on cyclic guanosine 3',5'-monophosphate (cGMP) levels in the rat brain. |
Q51707815 | Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. |
Q44934092 | Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys |
Q44349211 | Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials |
Q51823644 | Effects of chronic treatment with diazepam, phenobarbital, or amphetamine on naloxone-precipitated morphine withdrawal. |
Q93596342 | Effects of cigarette rod length on puff volume and carbon monoxide delivery in cigarette smokers |
Q37219168 | Effects of cocaine esterase following its repeated administration with cocaine in mice |
Q51563040 | Effects of cocaine on human and goat isolated cerebral arteries. |
Q43619996 | Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers |
Q51654020 | Effects of cocaine self-administration on ethanol, food and water intake in the rat. |
Q35903378 | Effects of cold pressor pain on the abuse liability of intranasal oxycodone in male and female prescription opioid abusers |
Q40095199 | Effects of combined alcohol and benzodiazepine: A review |
Q35447235 | Effects of d-amphetamine in human models of information processing and inhibitory control |
Q44555331 | Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. |
Q69953056 | Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice |
Q48432227 | Effects of differential rearing on amphetamine-induced c-fos expression in rats |
Q51544267 | Effects of dopaminergic drugs on food- and cocaine-maintained responding. IV: Continuous cocaine infusions. |
Q88737535 | Effects of electronic cigarette liquid solvents propylene glycol and vegetable glycerin on user nicotine delivery, heart rate, subjective effects, and puff topography |
Q43529492 | Effects of environmental enrichment on nicotine-induced sensitization and cross-sensitization to d-amphetamine in rats |
Q51093831 | Effects of ethanol and nitrous oxide, alone and in combination, on mood, psychomotor performance and pain reports in healthy volunteers. |
Q69416645 | Effects of ethanol and propylthiouracil on hepatic iron and copper contents in the male albino mouse |
Q44165916 | Effects of ethanol and toluene on fixed-ratio performance in short sleep and long sleep mice |
Q69416639 | Effects of ethanol in vitro on some parameters of the immune response |
Q47128518 | Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement |
Q52247841 | Effects of ethanol on human fractionated response times. |
Q52220215 | Effects of ethanol on human free-operant cooperative responding. |
Q54287879 | Effects of ethanol on phospholipid acylation in rat erythrocytes: a model for a biochemical approach to membrane adaptation. |
Q68046853 | Effects of ethanol withdrawal on ethanol-reinforced responding in rhesus monkeys |
Q94591927 | Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats |
Q34091561 | Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers |
Q88790073 | Effects of exposure to anti-vaping public service announcements among current smokers and dual users of cigarettes and electronic nicotine delivery systems |
Q91124490 | Effects of familial and non-familial warmth during childhood and adolescence on sexual-orientation disparities in alcohol use trajectories and disorder during emerging adulthood |
Q36932158 | Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. |
Q36952858 | Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats |
Q50976776 | Effects of genetic variants of ADH1B and ALDH2 and social network on continued alcohol drinking among young adolescents in Taiwan. |
Q52298732 | Effects of group exposure on single injection-induced behavioral sensitization to drugs of abuse in mice. |
Q44394303 | Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine |
Q44347094 | Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers |
Q44672957 | Effects of identification and usefulness of the Lie Scale of the Drug Use Screening Inventory (DUSI-R) in the assessment of adolescent drug use. |
Q40590031 | Effects of in-utero opiate exposure: new paradigms for old questions |
Q94500687 | Effects of incentives on viral suppression in people living with HIV who use cocaine or opiates |
Q51534288 | Effects of information on the reinforcing, subjective, and psychomotor effects of nitrous oxide in healthy volunteers. |
Q67694354 | Effects of initial tolerance on acquired tolerance to alcohol in two selectively bred rat strains |
Q34443267 | Effects of item sequence on the performance of the AUDIT in general practices |
Q48272810 | Effects of long-term ethanol consumption on GABAergic neurons in the mouse hippocampus: a quantitative immunocytochemical study |
Q46282660 | Effects of lorcaserin (Belviq®) on nicotine- and food-maintained responding in non-human primates |
Q92930002 | Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder |
Q64125982 | Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing |
Q51129550 | Effects of marijuana history on the subjective, psychomotor, and reinforcing effects of nitrous oxide in humans. |
Q52251274 | Effects of marijuana on the task-elicited physiological response. |
Q33442559 | Effects of marijuana use on impulsivity and hostility in daily life |
Q45093583 | Effects of mazindol on behavior maintained or occasioned by cocaine |
Q68249653 | Effects of methadone on alcohol consumption and growth in mice |
Q35609720 | Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase. |
Q58053740 | Effects of morphine in postaddict humans: a meta-analysis |
Q69056386 | Effects of morphine on rat kidney glomerular podocytes: a scanning electron microscopic study |
Q92070235 | Effects of motivation phase intervention components on quit attempts in smokers unwilling to quit: A factorial experiment |
Q39736323 | Effects of motivational interviewing training on mental health therapist behavior |
Q48678914 | Effects of naloxone on ethanol dependence in rats, |
Q51099160 | Effects of naltrexone on cue-elicited craving for alcohol and cocaine. |
Q57484483 | Effects of neuromodulation on cognitive performance in individuals exhibiting addictive behaviors: A systematic review |
Q92413232 | Effects of nicotine and THC vapor inhalation administered by an electronic nicotine delivery system (ENDS) in male rats |
Q35875970 | Effects of nicotine and minor tobacco alkaloids on intracranial-self-stimulation in rats. |
Q89918231 | Effects of nicotine exposure on oral methamphetamine self-administration, extinction, and drug-primed reinstatement in adolescent male and female rats |
Q52276115 | Effects of nicotine on methadone self-administration in humans. |
Q50138553 | Effects of nicotine-containing and "nicotine-free" e-cigarette refill liquids on intracranial self-stimulation in rats |
Q92751372 | Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers |
Q44070878 | Effects of oral THC maintenance on smoked marijuana self-administration |
Q37343634 | Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial |
Q47903083 | Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice |
Q39408410 | Effects of parental alcohol rules on risky drinking and related problems in adolescence: Systematic review and meta-analysis |
Q50952331 | Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers. |
Q51571417 | Effects of phentermine and cocaine on fenfluramine-induced depletion of serotonin in mouse brain. |
Q28371784 | Effects of phenytoin on cocaine self-administration in humans |
Q42068136 | Effects of postnatal administration of ethanol on the M. gastrocnemius of the albino mouse. |
Q42977801 | Effects of practitioner-delivered brief counseling and computer-generated tailored letters on cigarettes per day among smokers who do not quit--a quasi-randomized controlled trial |
Q52262582 | Effects of prenatal alcohol exposure on behavior of aged rats. |
Q35875541 | Effects of prenatal cocaine exposure on early sexual behavior: Gender difference in externalizing behavior as a mediator. |
Q37614746 | Effects of prenatal cocaine/polydrug exposure on substance use by age 15. |
Q46372779 | Effects of prenatal morphine treatment of rats on mortality, bodyweight and analgesic response in the offspring |
Q33333771 | Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats |
Q52171034 | Effects of prolonged ethanol exposure on neurophysiological measures during an associative learning paradigm. |
Q68503874 | Effects of provocation and alcohol on human aggressive behavior |
Q46243429 | Effects of reinforcer magnitude and alternative reinforcer delay on preference for alcohol during a multiple-choice procedure |
Q51586022 | Effects of remoxipride, an atypical antipsychotic, on cocaine self-administration in the rat using fixed- and progressive-ratio schedules of reinforcement. |
Q34120202 | Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers |
Q62897833 | Effects of reward and punishment on learning from errors in smokers |
Q43199062 | Effects of risk perception of marijuana use on marijuana use and intentions to use among adolescents in Bogotá, Colombia |
Q91142160 | Effects of romantic involvement on substance use among young sexual and gender minorities |
Q52245445 | Effects of secobarbital on human aggressive and non-aggressive responding. |
Q51739850 | Effects of self-reported drug use and antisocial behavior on evoked potentials in adolescents. |
Q33932225 | Effects of sleep deprivation on sleep homeostasis and restoration during methadone-maintenance: a [31]P MRS brain imaging study |
Q59705621 | Effects of smoked marijuana on social interaction in small groups |
Q43093808 | Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis |
Q57429944 | Effects of smoking cessation on health care use: Is elevated risk of hospitalization among former smokers attributable to smoking-related morbidity? |
Q48762348 | Effects of some phenylethylamines in rhesus monkeys trained to discriminate (+)-amphetamine from saline |
Q39458411 | Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice |
Q48131309 | Effects of stress and alcohol cues in men with and without problem gambling and alcohol use disorder |
Q44339095 | Effects of sublingually given naloxone in opioid-dependent human volunteers |
Q39346664 | Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology. |
Q63375719 | Effects of the 5-HT1B receptor agonist CP 94253 on methamphetamine self-administration |
Q50646749 | Effects of the Campus Watch intervention on alcohol consumption and related harm in a university population |
Q47383106 | Effects of the benzodiazepine GABAA α1-preferring antagonist 3-isopropoxy-β-carboline hydrochloride (3-ISOPBC) on alcohol seeking and self-administration in baboons |
Q34167669 | Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats |
Q36870910 | Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine |
Q91800178 | Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys |
Q48821440 | Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys |
Q42439387 | Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women |
Q93175684 | Effects of time-varying changes in tobacco and alcohol use on depressive symptoms following pharmaco-behavioral treatment for smoking and heavy drinking |
Q44348683 | Effects of tizanidine administration on precipitated opioid withdrawal signs in rats |
Q37650592 | Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study |
Q44848060 | Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients |
Q38803765 | Effects of transcranial direct current stimulation on craving, heart-rate variability and prefrontal hemodynamics during smoking cue exposure. |
Q31926121 | Effects of urine testing frequency on outcome in a methadone take-home contingency program. |
Q88642608 | Effects of varenicline on subjective craving and relative reinforcing value of cigarettes |
Q93371588 | Effects of voluntary memberships and volunteering on alcohol and tobacco use across the life course: Findings from the German Socio-Economic Panel |
Q37282128 | Effects of working memory load, a history of conduct disorder, and sex on decision making in substance dependent individuals |
Q36803217 | Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls |
Q50804168 | Effects of β-adrenergic receptor blockade on drug-related memory reconsolidation in abstinent heroin addicts. |
Q71566627 | Effects on the endocrine system of drugs used in treating the ethanol withdrawal syndrome: a survey |
Q91072394 | Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials |
Q104691627 | Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis |
Q35865410 | Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study |
Q36071603 | Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. |
Q48188499 | Efficacy of brief motivational intervention in reducing binge drinking in young men: A randomized controlled trial |
Q36771943 | Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats |
Q42669785 | Efficacy of clonidine in opiate withdrawal: a study of thirty patients |
Q47431078 | Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. |
Q113185708 | Efficacy of computer and therapist brief interventions for drug users |
Q73434136 | Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet |
Q36287820 | Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial |
Q46588026 | Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients |
Q34665529 | Efficacy of dual focus mutual aid for persons with mental illness and substance misuse |
Q37204912 | Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial |
Q44836269 | Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology |
Q51093828 | Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine. |
Q71141873 | Efficacy of psychotherapeutic counselling during 21-day ambulatory heroin detoxification |
Q39798314 | Efficacy of the Community Reinforcement and Family Training for concerned significant others of treatment-refusing individuals with alcohol dependence: A randomized controlled trial. |
Q58633743 | Efforts to diversity research populations can pay dividends |
Q51126901 | Electroencephalographic correlates of marihuana-induced euphoria. |
Q91624743 | Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment |
Q37139833 | Electronic cigarette use by college students |
Q93371612 | Electronic decision support for treatment of hospitalized smokers: A qualitative analysis of physicians' knowledge, attitudes, and practices |
Q48468722 | Elementary particles for models of drug dependence 10th Okey Memorial Lecture presented at the Institute of Psychiatry, London on 19th March 1997. |
Q48500578 | Elementary particles for models of drug dependence, 10th Okey Memorial Lecture presented at the Institute of Psychiatry, London on 19th March 1997. |
Q39229712 | Elementary schoolchildren's use of alcohol, cigarettes and marijuana and classmates' attribution of socialization |
Q36365069 | Elevated alcohol and sexual risk behaviors among young Thai lesbian/bisexual women |
Q36157218 | Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY) |
Q88087019 | Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure |
Q99624483 | Elevated prevalence of antisocial behavior in adolescent children whose mothers misuse opioids |
Q37634976 | Emergence of cocaine and methamphetamine injection among HIV-positive injection drug users in northern and western India |
Q39674161 | Emergency department based intervention with adolescent substance users: 10year economic and health outcomes. |
Q104286951 | Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment |
Q91311697 | Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland |
Q46651938 | Emergency department-based intervention with adolescent substance users: 12-month outcomes. |
Q36592521 | Emerging adults' treatment outcomes in relation to 12-step mutual-help attendance and active involvement |
Q38112852 | Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption |
Q39668901 | Emerging psychoactive substance use among regular ecstasy users in Australia |
Q51801454 | Emotion differentiation predicts likelihood of initial lapse following substance use treatment. |
Q36689502 | Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users |
Q47318186 | Emotion dysregulation and peer drinking norms uniquely predict alcohol-related problems via motives |
Q87676987 | Emotion regulation and drug abuse: Implications for prevention and treatment |
Q89804003 | Emotional memory bias in binge drinking women |
Q37014837 | Emotional self-control and dysregulation: A dual-process analysis of pathways to externalizing/internalizing symptomatology and positive well-being in younger adolescents |
Q43753625 | Empirical subtypes of DSM-III-R alcohol dependence: United States, 1988. |
Q33653584 | Empirically defined subtypes of alcohol dependence in an Irish family sample |
Q40335928 | Employment experience in relation to alcohol, tobacco, and betel nut use among youth in Taiwan. |
Q90908391 | Employment recovery capital in the treatment of substance use disorders: Six-month follow-up observations |
Q68046828 | Employment, stressful life events and the development of alcohol dependence |
Q35633106 | Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial |
Q58572311 | End-of-day reports of daily hassles and stress in men and women with opioid-use disorder: Relationship to momentary reports of opioid and cocaine use and stress |
Q43813093 | Endemic asthma inhaler abuse among antisocial adolescents |
Q43070748 | Endogenous opioids: overview and current issues |
Q77504433 | Endorsement of DSM-IV dependence criteria among caffeine users |
Q39733641 | Endothelial dysfunction during acute alcohol withdrawal syndrome |
Q38677785 | Enduring changes in brain metabolites and executive functioning in abstinent cocaine users. |
Q37342710 | Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT. |
Q61443762 | Energy drink consumption among young Australian adults: Associations with alcohol and illicit drug use |
Q57177973 | Energy drink consumption and the perceived risk and disapproval of drugs: Monitoring the Future, 2010-2016 |
Q38742777 | Energy drink use frequency among an international sample of people who use drugs: Associations with other substance use and well-being. |
Q52662093 | Energy drinks, alcohol and cardiovascular functioning. |
Q39930793 | Engagement in a National Naloxone Programme among people who inject drugs |
Q30500168 | Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders |
Q42416589 | Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys |
Q48665344 | Enhanced striatal responses during expectancy coding in alcohol dependence |
Q28377971 | Enhanced treatment outcomes for cocaine-using methadone patients |
Q51671813 | Enhancement of cocaine-induced hepatotoxicity by ethanol. |
Q46402347 | Enhancing access and retention in substance abuse treatment: the role of Medicaid payment acceptance and cultural competence |
Q36662466 | Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users |
Q41693069 | Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy |
Q89470153 | Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial |
Q34618868 | Enhancing response inhibition by incentive: comparison of adolescents with and without substance use disorder |
Q39812889 | Enjoyment of smoking and urges to smoke as predictors of attempts and success of attempts to stop smoking: a longitudinal study |
Q33625208 | Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992-2002 |
Q36689254 | Environmental cues and attempts to change in daily cannabis users: An intensive longitudinal study |
Q50517115 | Environmental enrichment as a potential intervention for heroin seeking |
Q91272638 | Environmental enrichment reverses increased addiction risk caused by prenatal ethanol exposure |
Q36345401 | Environmental risk, social cognition, and drug use among young men who have sex with men: longitudinal effects of minority status on health processes and outcomes |
Q47910634 | Environmental risks outweigh dopaminergic genetic risks for alcohol use and abuse from adolescence through early adulthood |
Q28194876 | Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet |
Q69885710 | Epidemiologic issues pertinent to international regulation of 28 stimulant-hallucinogen drugs |
Q34984833 | Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. |
Q37337921 | Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003. |
Q53418462 | Epidemiological survey of the use and abuse of agonist-antagonist analgesics in the Western Pacific region. |
Q44677600 | Epidemiology of adolescent Salvia divinorum use in Canada |
Q93596355 | Epidemiology of liver cirrhosis morbidity and mortality in Western Australia, 1971-82: some preliminary findings |
Q36536405 | Epidemiology of pain among outpatients in methadone maintenance treatment programs |
Q40347473 | Epidemiology of road accidents involving young adults: alcohol, drugs and other factors |
Q92176315 | Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers |
Q33700792 | Epidemiology of substance use in adolescence: prevalence, trends and policy implications |
Q112646027 | Epigenome-wide study of brain DNA methylation following acute opioid intoxication |
Q41586923 | Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM). |
Q98956276 | Episodic future thinking reduces chronic pain severity: A proof of concept study |
Q38199856 | Equity impact of population-level interventions and policies to reduce smoking in adults: a systematic review |
Q46847773 | Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment |
Q61507580 | Erratum |
Q45068918 | Erratum to "A reexamination of medical marijuana policies in relation to suicide risk" [Drug Alcohol Depend. 152 (2015) 68-72]. |
Q92731455 | Erratum to "Distinct effects of cocaine and cocaine + cannabis on neurocognitive functioning and abstinence: A six-month follow-up study" [Drug Alcohol Depend. 205 (2019) 107642] |
Q92262468 | Erratum to "Economic demand analysis of within-session dose-reduction during nicotine self-administration" [Drug Alcohol Depend. 201 (2019) 188-196] |
Q88109042 | Erratum to "Emergency department based intervention with adolescent substance users: 10year economic and health outcomes" [Drug Alcohol Depend. 165 (2016) 168-174] |
Q42349862 | Erratum to "Intra-individual changes in Stroop-related activations linked to cigarette abstinence in adolescent tobacco smokers: Preliminary findings" [Drug Alcohol Depend. 167 (2016) 182-189]. |
Q92575293 | Erratum to "Methamphetamine use and cognitive function: A systematic review of neuroimaging research" [Drug Alcohol Depend. 194 (2019) 75-87] |
Q88423411 | Erratum to "Prevalence and socio-demographic correlates of alcohol consumption: Survey findings from five states in India" [Drug Alcohol Depend. 185C (2018) 381-390] |
Q89223517 | Erratum to "Prevalence of driving under the influence of psychoactive substances and road traffic crashes among Brazilian crack-using drivers" [Drug Alcohol Depend. 168 (2016) 255-262] |
Q44449331 | Erratum to "Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties". |
Q45054409 | Erratum to "Short communication: Genetic association between schizophrenia and cannabis use" [Drug Alcohol Depend. 171 (2017) 117-121]. |
Q90507292 | Erratum to "When DAWN went dark: Can the Nationwide Emergency Department Sample (NEDS) fill the surveillance gap left by the discontinued Drug Abuse Warning Network (DAWN)?" [Drug Alcohol Depend. (2018) 201-207] |
Q73128980 | Erratum to 'Inter-rater reliability of the SCID alcohol and substance use disorders section among adolescents' |
Q59138856 | Erratum to “Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian treatment outcome study (ATOS): prevalence and risk factors” |
Q87974538 | Erratum to “Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system” [Drug Alcohol Depend. 157 (2015) 158–165] |
Q52664218 | Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release [Drug and Alcohol Dependence 184 (2018) 57-63]. |
Q38778506 | Error detection and behavioural inhibition in young heavy drinkers. |
Q34116529 | Errors in reported degrees and respondent driven sampling: implications for bias |
Q43463237 | Erythrocyte and plasma lipid peroxides in chronic alcoholic patients |
Q72568882 | Erythrocyte membrane properties of the chronic alcoholic rat |
Q44668414 | Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers |
Q40048764 | Escalating patterns of emergency health care prior to first admission with amphetamine psychosis: A window of opportunity? |
Q35181578 | Escalation of cocaine consumption in short and long access self-administration procedures |
Q91166868 | Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors |
Q37156355 | Escalation of methamphetamine self-administration in adolescent and adult rats |
Q44093285 | Essential ("precursor") chemical control for heroin: impact of acetic anhydride regulation on US heroin availability |
Q48742780 | Establishing preference for oral cocaine without an associative history with a reinforcer |
Q70664581 | Establishment and maintenance of oral ethanol self-administration in the baboon |
Q113442652 | Estimated effect of state syringe policy on source of last-used injection equipment |
Q46624760 | Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France |
Q100530745 | Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis |
Q104456571 | Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method |
Q52278005 | Estimates of total alcohol consumption in Russia, 1980-1994. |
Q101451262 | Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital-Denver, Colorado, 2017 |
Q45284812 | Estimating drug treatment needs among state prison inmates |
Q69720023 | Estimating illicit drug use through telephone interviews and the randomized response technique |
Q48757086 | Estimating measurement error in alcohol dependence symptomatology: findings from a multisite study. |
Q45796776 | Estimating older hazardous and binge drinking prevalence using AUDIT-C and AUDIT-3 thresholds specific to older adults. |
Q30493558 | Estimating risk of alcohol dependence using alcohol screening scores |
Q37672648 | Estimating the causal effects of cumulative treatment episodes for adolescents using marginal structural models and inverse probability of treatment weighting |
Q44555344 | Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). |
Q115217231 | Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school children |
Q96830352 | Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis |
Q38920597 | Estimating the harms and costs of cannabis-attributable collisions in the Canadian provinces |
Q89680309 | Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails |
Q91893482 | Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016 |
Q104456462 | Estimating the prevalence of and characteristics associated with prescription opioid diversion among a clinic population living with HIV: Indirect and direct questioning techniques |
Q103024471 | Estimating the price elasticity of demand for JUUL E-cigarettes among teens |
Q45002650 | Estimating the size of the population of persons who inject drugs in the island of Montréal, Canada, using a six-source capture-recapture model |
Q41685879 | Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan |
Q33872297 | Estimation of the number of injection drug users in St. Petersburg, Russia |
Q30678053 | Estimation of usual occasion-based individual drinking patterns using diary survey data |
Q42547171 | Ethanol alters hemodynamic responses to cocaine in rats |
Q51766364 | Ethanol and Ro 15-4513: behaviour maintained by operant procedures (DRL-72s and PTZ-drug discrimination) in rats. |
Q67694352 | Ethanol and acetaldehyde metabolism in the pregnant mouse |
Q45000252 | Ethanol does not alter the binding of the gamma-hydroxybutyric acid (GHB) receptor ligand [3H]NCS-382 in the rat brain |
Q69444351 | Ethanol exposure as inducer of stable voluntary ethanol drinking in the male rat |
Q34090159 | Ethanol increases plasma Delta(9)-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers |
Q36958946 | Ethanol intake patterns in female mice: influence of allopregnanolone and the inhibition of its synthesis |
Q42500123 | Ethanol stimulates basal and serotonin-induced formation of [32P]phosphatidic acid in human platelets |
Q52014403 | Ethanol vapor self-administration in adult C57BL/6J male mice. |
Q69416632 | Ethanol's effects on auditory thresholds and reaction times during the acquisition of chronic ethanol self-administration in baboons |
Q44349001 | Ethanol-induced FOS immunoreactivity in the brain of mu-opioid receptor knockout mice |
Q39168470 | Ethanol-induced changes in activities of adenylate cyclase, guanylate cyclase and cyclic adenosine 3′,5′-monophosphate dependent protein kinase in the brain and liver |
Q69664940 | Ethanol-induced changes in lipid peroxidation and glutathione content in rat brain |
Q68999021 | Ethanol-induced hypothermia and biogenic amine metabolites |
Q67672157 | Ethanol-induced smooth and skeletal muscle myopathy: use of animal studies |
Q67013573 | Ethanol: A gonadal toxin in the female |
Q37129274 | Ethical concerns about non-active conditions in smoking cessation trials and methods to decrease such concerns |
Q34626158 | Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study |
Q37039976 | Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders |
Q33727048 | Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment |
Q36336526 | Ethnic differences in the effect of drug use and drug dependence on brief motivational interventions targeting alcohol use. |
Q39435378 | Ethnic differences in the psychosocial antecedents of needle/syringe disinfection |
Q67290335 | Ethnic variation in use and effects of alcohol |
Q37954476 | Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians |
Q37216852 | Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists. |
Q46197662 | Evaluating network-level predictors of behavior change among injection networks enrolled in the HPTN 037 randomized controlled trial |
Q93342474 | Evaluating opioid overdose using the National Violent Death Reporting System, 2016 |
Q92527070 | Evaluating peer-influence processes in a prison-based therapeutic community: a dynamic network approach |
Q113185710 | Evaluating potential moderators of efficacy for a single-session computer-delivered 5As intervention for smoking in pregnancy |
Q44351149 | Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries |
Q33522825 | Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys |
Q47662911 | Evaluating the effect of smoking cessation treatment on a complex dynamical system |
Q99200978 | Evaluating the impact of COVID-19: A cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A. |
Q51147333 | Evaluating the influence of at-risk alcohol use on factors associated with smoking cessation: Combining laboratory and ecological momentary assessment. |
Q48794602 | Evaluating the reinforcement value of clinic-based privileges through a multiple choice procedure |
Q98509864 | Evaluating the resource allocation index as a potential fMRI-based biomarker for substance use disorder |
Q91679360 | Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine content |
Q34778962 | Evaluating the validity and utility of scaling alcohol consumption indices alongside AUD symptoms in treatment-seeking adolescents |
Q36050631 | Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis |
Q48420378 | Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal |
Q48616131 | Evaluation of Wistar rats' individual sensitivity to the development of physical dependence on morphine |
Q30683666 | Evaluation of a brief intervention to reduce the negative consequences of drug misuse among adult emergency department patients |
Q58044422 | Evaluation of a brief smoking cessation intervention for inpatient substance users with elevated depressive symptoms |
Q46011244 | Evaluation of a depression-related model of alcohol problems in 430 probands from the San Diego prospective study. |
Q44934098 | Evaluation of a modified contingency management intervention for consistent attendance in therapeutic workplace participants. |
Q99371353 | Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids |
Q51589377 | Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable. |
Q41640336 | Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use |
Q71141869 | Evaluation of a structured alcohol education course in a secondary school system in north Italy |
Q46870066 | Evaluation of a telephone-based stepped care intervention for alcohol-related disorders: a randomized controlled trial |
Q43925634 | Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry |
Q36328262 | Evaluation of an implementation of methadone maintenance treatment in China |
Q71035555 | Evaluation of an inpatient alcohol rehabilitation programme |
Q44620673 | Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. |
Q91227786 | Evaluation of dynorphin and kappa-opioid receptor level in the human blood lymphocytes and plasma: Possible role as a biomarker in severe opioid use disorder |
Q45068072 | Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis |
Q68046838 | Evaluation of marrow cellularity in alcoholism and hepatic cirrhosis, by aspiration, biopsy and histomorphometric |
Q40376509 | Evaluation of medication-assisted treatment of opioid dependence-The physicians' perspective |
Q44976540 | Evaluation of metabolite/drug ratios in blood and urine as a tool for confirmation of a reduced tolerance in methadone-related deaths in Denmark |
Q51211467 | Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects. |
Q33625390 | Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. |
Q44929605 | Evaluation of nefazodone self-administration in rhesus monkeys |
Q90733052 | Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial |
Q67504244 | Evaluation of outpatient prescribing for substance misusers in Kuwait: the need for a rational approach |
Q37394887 | Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception |
Q60632687 | Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample |
Q30415208 | Evaluation of sex differences in cannabinoid dependence. |
Q47626035 | Evaluation of the AC-OK mental health and substance abuse screening measure in an international sample of Latino immigrants |
Q37362258 | Evaluation of the Alcohol Craving Questionnaire-Now factor structures: application of a cue reactivity paradigm |
Q51618204 | Evaluation of the abuse liability of aminorex. |
Q34121013 | Evaluation of the abuse potential of the novel analgesic flupirtine maleate. |
Q45106095 | Evaluation of the acute behavioral effects and abuse potential of a C8-C9 isoparaffin solvent |
Q92225561 | Evaluation of the cholinesterase activity of a potential therapeutic cocaine esterase for cocaine overdose |
Q45107694 | Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine |
Q44076432 | Evaluation of the effectiveness of a school-based cannabis prevention program. |
Q35552288 | Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs |
Q52178679 | Evaluation of the intravenous reinforcing effects of clonidine in baboons. |
Q48765847 | Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys |
Q28274805 | Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine |
Q45086414 | Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats |
Q98956273 | Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats |
Q39766738 | Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department. |
Q51206077 | Evaluation of tilidine for morphine-like subjective effects and euphoria. |
Q92568996 | Evaluation of tobacco dependence measures in South Asian smokeless tobacco users |
Q49943667 | Even in early childhood offspring alcohol expectancies correspond to parental drinking |
Q40444442 | Event-level analysis of alcohol consumption and condom use in partnership contexts among men who have sex with men and transgender women in Lima, Peru |
Q34219147 | Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses |
Q92413237 | Everyday discrimination indirectly influences smoking cessation through post-quit self-efficacy |
Q40255776 | Everyday functional ability in HIV and methamphetamine dependence |
Q35186905 | Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population |
Q35005248 | Evidence for a deficit in the salience attribution to errors in smokers. |
Q36493558 | Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies. |
Q41552443 | Evidence for an endorphin dysfunction in methadone addicts: Lack of ACTH response to naloxone |
Q92042765 | Evidence for essential unidimensionality of AUDIT and measurement invariance across gender, age and education. Results from the WIRUS study |
Q48360718 | Evidence for overshadowing by components of the heterogeneous discriminative stimulus effects of ethanol |
Q80304149 | Evidence for specificity of transmission of alcohol and nicotine dependence in an offspring of twins design |
Q90485670 | Evidence for state, community and systems-level prevention strategies to address the opioid crisis |
Q40727448 | Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection. |
Q39378251 | Evidence of deficits in behavioural inhibition and performance monitoring in young female heavy drinkers. |
Q35534549 | Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE study |
Q35661152 | Evidence of injection drug use in Kisumu, Kenya: Implications for HIV prevention |
Q39793599 | Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey |
Q47563773 | Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment |
Q44345993 | Evidence that anhedonia is a symptom of opioid dependence associated with recent use. |
Q39940604 | Examination of a possible J-shaped relationship between alcohol consumption and internalizing disorders in a longitudinal birth cohort. |
Q36577836 | Examination of a recommended algorithm for eliminating nonsystematic delay discounting response sets |
Q129660161 | Examination of reward processing dysfunctions in the left dorsal striatum and other brain regions among psychiatric inpatients with substance use |
Q34614145 | Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women |
Q33624310 | Examining differential effects of psychosocial treatments for cocaine dependence: an application of latent trajectory analyses |
Q52374677 | Examining effects of medical cannabis narratives on beliefs, attitudes, and intentions related to recreational cannabis: A web-based randomized experiment. |
Q34524893 | Examining maternal weight gain during contingency-management treatment for smoking cessation among pregnant women |
Q40546031 | Examining mechanisms of action in 12-Step community outpatient treatment |
Q93167551 | Examining motivational interviewing's effect on confidence and commitment using daily data |
Q40101237 | Examining non-response bias in substance use research--are late respondents proxies for non-respondents? |
Q91124485 | Examining opioid-involved overdose mortality trends prior to fentanyl: New York City, 2000-2015 |
Q52317446 | Examining racial/ethnic differences in patterns of benzodiazepine prescription and misuse. |
Q89744533 | Examining sleep over time in a randomized control trial comparing two integrated PTSD and alcohol use disorder treatments |
Q94500691 | Examining the Utility of a General Substance Use Spectrum Using Latent Trait Modeling |
Q37320844 | Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls |
Q38664128 | Examining the effects of illicit drug use on tobacco cessation outcomes in the Helping HAND 2 randomized controlled trial |
Q40757867 | Examining the efficacy of a computer facilitated HIV prevention tool in drug court |
Q30938843 | Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003 |
Q38727664 | Examining the influence of adolescent marijuana use on adult intelligence: Further evidence in the causation versus spuriousness debate |
Q46651925 | Examining the influence of drop-outs in a follow-up of maintained opiate users |
Q38834487 | Examining the interaction between cognitive control and reward sensitivity in substance use dependence |
Q50780340 | Examining the link between collision involvement and cocaine use. |
Q90451707 | Examining the link between reward and response inhibition in individuals with substance abuse tendencies |
Q34167709 | Examining the relationship between the physical availability of medical marijuana and marijuana use across fifty California cities |
Q34472770 | Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology |
Q39066938 | Excess mortality among people who report lifetime use of illegal drugs in the United States: A 20-year follow-up of a nationally representative survey |
Q47298073 | Excess mortality in children born to opioid-addicted parents: A national register study in Taiwan |
Q98882479 | Excessive alcohol use and drug overdose deaths, New Mexico, 2015-2016 |
Q52174880 | Excessive discounting of delayed rewards in substance abusers with gambling problems. |
Q47176669 | Excessive drinking situations in German alcoholics: replication of a three-factor model used for North Americans |
Q37436630 | Excessive state switching underlies reversal learning deficits in cocaine users |
Q48162559 | Excessive suicide mortality and risk factors for suicide among patients with heroin dependence. |
Q40480630 | Excitatory amino acids and drugs of abuse: a role for N-methyl-d-aspartate receptors in drug tolerance, sensitization and physical dependence |
Q48291663 | Executive dysfunction in chronic cocaine users: an exploratory study |
Q50675414 | Executive function and appetitive processes in the self-control of alcohol use: the moderational role of drinking restraint |
Q38811920 | Executive function fails to predict smoking outcomes in a clinical trial to motivate smokers to quit. |
Q46591246 | Executive functions and risky decision-making in patients with opiate dependence |
Q50617026 | Executive functions in alcohol-dependence: A theoretically grounded and integrative exploration |
Q36418253 | Exempt preparations: Historical perspectives |
Q39318901 | Exencephaly and axial skeletal dysmorphogenesis induced by acute doses of ethanol in mouse fetuses |
Q43781002 | Exercise increases plasma THC concentrations in regular cannabis users. |
Q33689401 | Exercise reinforcement, stress, and β-endorphins: an initial examination of exercise in anabolic-androgenic steroid dependence |
Q38664894 | Exercise training - A beneficial intervention in the treatment of alcohol use disorders? |
Q112273704 | Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis |
Q101241554 | Expanding accessibility: Outpatient intensive treatment for substance use disorder during covid-19 pandemic |
Q34543220 | Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers |
Q46948794 | Expanding the role for scientists from low and middle income countries in the journal publication process |
Q38667952 | Expectancy of impairment attenuates marijuana-induced risk taking |
Q39196812 | Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. |
Q46449723 | Experience of emotions in substance abusers exposed to images containing neutral, positive, and negative affective stimuli. |
Q68249663 | Experiences of a methadone detoxification programme for opium addicts |
Q50579477 | Experiences related to drinking as a function of annual alcohol intake and by sex and age. |
Q38657525 | Experiences with SCRAMx alcohol monitoring technology in 100 alcohol treatment outpatients |
Q54240153 | Experiences with skin and soft tissue infections among people who inject drugs in Philadelphia: A qualitative study. |
Q44192930 | Experimental approaches to the evaluation of alcohol abuse and dependence development |
Q90800175 | Explaining continuity in substance use: The role of criminal justice system involvement over the life course of an urban African American prospective cohort |
Q47686783 | Explaining the effects of electronic cigarettes on craving for tobacco in recent quitters |
Q97895990 | Explication of CB1 receptor contributions to the hypothermic effects of Δ9-tetrahydrocannabinol (THC) when delivered by vapor inhalation or parenteral injection in rats |
Q114190333 | Exploration of dose tapering strategies for methadone maintenance treatment based on relapse risks: A subpopulation treatment effect pattern plot (STEPP) analysis |
Q48706460 | Exploration of the relationship between frequency of illness, attrition from alcohol treatment, neuropsychological status and field dependence |
Q41180567 | Exploration of the telescoping effect among not-in-treatment, intensive heroin-using research volunteers |
Q35510576 | Exploring age of onset as a causal link between major depression and nonmedical use of prescription medications. |
Q57177970 | Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family |
Q128244771 | Exploring patterns of alcohol use and alcohol use disorder among Asian Americans with a finer lens |
Q34071550 | Exploring psychological benefits associated with moderate alcohol use: a necessary corrective to assessments of drinking outcomes? |
Q91707966 | Exploring recovery capital among adolescents in an alternative peer group |
Q40319269 | Exploring the e-cigarette e-commerce marketplace: Identifying Internet e-cigarette marketing characteristics and regulatory gaps |
Q34161014 | Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch |
Q47635833 | Exploring the perils of cross-national comparisons of drug prevalence: The effect of survey modality |
Q43284656 | Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment |
Q39893947 | Exploring the role of consumer participation in drug treatment. |
Q57333490 | Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use |
Q52281997 | Exploring the use and non-use of marijuana as reasoned actions: an application of Fishbein and Ajzen's methodology. |
Q96614314 | Exposure and engagement with tobacco-related social media and associations with subsequent tobacco use among young adults: A longitudinal analysis |
Q43925612 | Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use. |
Q91416007 | Exposure to alcohol outlets, alcohol access, and alcohol consumption among adolescents |
Q45299439 | Exposure to alcohol, drugs and tobacco and the risk of subsequent suicidality: findings from the Mexican Adolescent Mental Health Survey |
Q90343748 | Exposure to car smoking among youth in seven cities across the European Union |
Q34644002 | Exposure to childhood neglect and physical abuse and developmental trajectories of heavy episodic drinking from early adolescence into young adulthood |
Q96648915 | Exposure to e-cigarette information and advertising in social media and e-cigarette use in Australia: A mixed methods study |
Q37448346 | Exposure to the Lebanon War of 2006 and effects on alcohol use disorders: the moderating role of childhood maltreatment |
Q34258957 | Exposure to trauma: a comparison of cocaine-dependent cases and a community-matched sample. |
Q46688805 | Expression of N-methyl-d-aspartate (NMDA) receptor subunits and splice variants in an animal model of long-term voluntary alcohol self-administration |
Q34133170 | Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: A proton MRS study |
Q91384329 | Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users |
Q33595868 | Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial |
Q37389692 | Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure |
Q38882435 | Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. |
Q33653888 | External pressure, motivation, and treatment outcome among pregnant substance-using women |
Q58605675 | Externalizing and self-medicating: Heterogeneity among repeat DUI offenders |
Q46091928 | Extinction learning of stimulus reward contingencies: The acute effects of alcohol |
Q35635681 | Extinguished cocaine cues increase drug seeking when presented simultaneously with a non-extinguished cocaine cue. |
Q35082566 | Extra-medical stimulant dependence among recent initiates |
Q93346627 | Eye movement data reveal increased attention to combined health warnings on cigarette packs |
Q97522804 | Eye tracking of smoking-related stimuli in tobacco use disorder: A proof-of-concept study combining attention bias modification with alpha-transcranial alternating current stimulation |
Q43774564 | Facial electromyographic (EMG) responses to emotionally significant visual images: differences between light and heavy drinkers |
Q36376967 | Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial |
Q50691078 | Facilitators and barriers in treatment seeking for cannabis dependence. |
Q46841024 | Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users. |
Q37164982 | Factor structure of PTSD symptoms in opioid-dependent patients rating their overall trauma history |
Q71099439 | Factor structure of common drug usage |
Q37282367 | Factorial structure of the Brief Symptom Inventory (BSI)-18 among Chinese drug users |
Q91301544 | Factorial validity of a substance-use stigma scale in methamphetamine-using adults in China |
Q37908427 | Factors affecting cognitive function of opiate-dependent patients |
Q35729981 | Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort |
Q39768758 | Factors affecting the drinking driver |
Q47909138 | Factors associated with alcohol drinking behavior of cancer survivors: The Korean National Health and Nutrition Examination Survey. |
Q38960083 | Factors associated with alcohol use prior to and during pregnancy among HIV-infected pregnant women in Cape Town, South Africa |
Q47957049 | Factors associated with an evidence-based measure of implementation for the Adolescent Community Reinforcement Approach. |
Q36702722 | Factors associated with attendance in 12-step groups (Alcoholics Anonymous/Narcotics Anonymous) among adults with alcohol problems living with HIV/AIDS |
Q37308020 | Factors associated with being asked to initiate someone into injection drug use |
Q41618672 | Factors associated with coercion in entering treatment for alcohol problems |
Q46140996 | Factors associated with cognitive impairment in a cohort of older homeless adults: Results from the HOPE HOME study |
Q51124387 | Factors associated with coping in persons undergoing alcohol and drug detoxification. |
Q54244417 | Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada. |
Q46242657 | Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users |
Q37362299 | Factors associated with event-level stimulant use during sex in a sample of older, low-income men who have sex with men in Los Angeles |
Q36164730 | Factors associated with experiences of stigma in a sample of HIV-positive, methamphetamine-using men who have sex with men. |
Q42680551 | Factors associated with exposure to hepatitis B virus in injection drug users |
Q104269818 | Factors associated with health-related cannabis use intentions among a community sample of people who inject drugs in Los Angeles and San Francisco, CA 2016 to 2018 |
Q90130731 | Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts |
Q43032578 | Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs |
Q44337235 | Factors associated with history of non-fatal overdose among opioid users in the Swedish criminal justice system |
Q34287159 | Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs |
Q34773972 | Factors associated with initiating someone into illicit drug injection. |
Q33624610 | Factors associated with initiation of ecstasy use among US adolescents: findings from a national survey |
Q40665677 | Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia |
Q46439826 | Factors associated with lapses to heroin use during methadone maintenance |
Q42660057 | Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver |
Q44852805 | Factors associated with methadone maintenance treatment retention among street-recruited injection drug users |
Q33746189 | Factors associated with missing data in an experience sampling investigation of substance use determinants |
Q39858703 | Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients |
Q61602144 | Factors associated with perceived loss of libido in people who inject opioids: Results from a community-based survey in France |
Q43570044 | Factors associated with readiness to change drug use among needle-exchange users |
Q50138552 | Factors associated with sedative use and misuse among heroin users. |
Q96293821 | Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: A comparative examination of data from two surveys |
Q36767289 | Factors associated with smoking frequency among current waterpipe smokers in the United States: Findings from the National College Health Assessment II |
Q46380993 | Factors associated with substance use during pregnancy: results from a national sample |
Q40696351 | Factors associated with substance use treatment completion in residential facilities |
Q34536352 | Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability. |
Q27491349 | Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study |
Q38548175 | Factors associated with variability and stability of cannabis use in young adulthood |
Q41503208 | Factors contributing to self-reported drug use among London undergraduates 1971-72. |
Q47753266 | Factors contributing to the rise of buprenorphine misuse: 2008-2013. |
Q59604529 | Factors influencing alcohol and illicit drug use amongst medical students |
Q37171585 | Factors mediating and moderating the relationship between gender and utilization of health care among Puerto Rican drug users in New York |
Q33716509 | Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals |
Q46747753 | Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel |
Q47236189 | Factors predictive of alcohol consumption in a representative sample of French male teenagers: a five-year prospective study |
Q88245704 | Factors related to cigarette smoking and intent to quit among adolescent inpatients with psychiatric and substance use disorders |
Q37415184 | Factors related to correctional facility incarceration among active injection drug users in Baltimore, MD |
Q34551070 | Factors related to frequency of narghile (waterpipe) use: the first insights on tobacco dependence in narghile users. |
Q44410438 | Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat. |
Q51559252 | Failure of ritanserin to block cocaine cue reactivity in humans. |
Q66990159 | Failure to diagnose alcoholism and drug abuse |
Q30466085 | Failure to sustain prepulse inhibition in adolescent marijuana users |
Q34046830 | Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction? |
Q59408355 | Falling rates of marijuana dependence among heavy users |
Q37180125 | Familial and non-familial smoking: effects on smoking and nicotine dependence |
Q36507447 | Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders |
Q34349579 | Familiality of addiction and its developmental mechanisms in girls |
Q68671008 | Family alcohol problems among pregnant women: links with maternal substance use and birth abnormalities |
Q93198435 | Family and school social capitals in late childhood predict youthful drinking behaviors and problems |
Q34980334 | Family history density predicts long term substance use outcomes in an adolescent treatment sample |
Q31870827 | Family history influence on drug abuse severity and treatment outcome |
Q93683336 | Family history of problem drinking among young male social drinkers: reliability of the Family Tree Questionnaire |
Q44565081 | Family interventions and their effect on adolescent alcohol use in general populations; a meta-analysis of randomized controlled trials |
Q50983709 | Family members affected by a relative's substance misuse looking for social support: who are they? |
Q50952325 | Family structure, personality, drinking, smoking and illicit drug use: a study of UK teenagers. |
Q34051077 | Family ties: maternal-offspring attachment and young adult nonmedical prescription opioid use. |
Q42103529 | Faster entry into HIV care among HIV-infected drug users who had been in drug-use treatment programs |
Q79616208 | Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers--a competing risk approach |
Q114190370 | Fathers’ alcohol consumption and risk of substance-related disorders in offspring |
Q50514682 | Favorable associations with alcohol and impaired self-regulation: A behavioral economic analysis. |
Q46705226 | Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients |
Q33448168 | Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials |
Q46436173 | Feasibility and validity of computerized ambulatory monitoring in drug-dependent women |
Q58324030 | Feasibility of ecological momentary assessment to study mood and risk behavior among young people who inject drugs |
Q51983341 | Feasibility of multidimensional substance abuse treatment matching: automating the ASAM Patient Placement Criteria. American Society of Addiction Medicine. |
Q44030054 | Features of cocaine dependence with concurrent alcohol abuse |
Q37222716 | Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers |
Q50061813 | Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings |
Q57499581 | Federal parity does not lead to large increases in spending on substance use disorder treatment: Results from year 1 |
Q70578336 | Female referral to employees assistance programs: the impact of specialized intervention |
Q47670261 | Female smokers have the highest alcohol craving in a residential alcoholism treatment cohort |
Q90097535 | Female-male differences in prescription pain reliever dependence levels: Evidence on newly incident adolescent and young adult users in the United States, 2002-2014 |
Q41472268 | Fenetylline: new results on pharmacology, metabolism and kinetics |
Q28303904 | Fenetylline: therapeutic use, misuse and/or abuse |
Q100295817 | Fentanyl analog positivity among near-real-time urine drug test results in patients seeking health care |
Q104076587 | Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011-2016 |
Q91112659 | Fentanyl and fentanyl-analog involvement in drug-related deaths |
Q51746933 | Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis. |
Q90125159 | Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder |
Q69661600 | Fetal addiction to methadone: postnatal abstinence syndrome and development of visual evoked potentials |
Q60031014 | Field evidence for stress-induced drug use |
Q37444001 | Filling service gaps: Providing intensive treatment services for offenders |
Q47559586 | Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients |
Q94548437 | Financial incentives promote engagement in employment services for unemployed adults in treatment for opioid use disorder |
Q46559129 | Financial strain indirectly influences smoking cessation through withdrawal symptom severity |
Q44668416 | Finding order in the DSM-IV nicotine dependence syndrome: a Rasch analysis |
Q44466693 | Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis |
Q39997285 | First cigarette on waking and time of day as predictors of puffing behaviour in UK adult smokers |
Q45092722 | First effects of warning labels on alcoholic beverage containers |
Q24683265 | First injection of ketamine among young injection drug users (IDUs) in three U.S. cities |
Q33781291 | First-year college students' interest in trying dissolvable tobacco products. |
Q46131266 | Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample |
Q94472465 | Flavor-specific enhancement of electronic cigarette liquid consumption and preference in mice |
Q91504253 | Flavored cigar smoking among African American young adult dual users: An ecological momentary assessment |
Q44312041 | Flow cytometric analysis of oxidative product formation in phytohemagglutinin-stimulated ethanol-treated immune mononuclear cells |
Q77367051 | Fluctuations in heroin purity and the incidence of fatal heroin overdose |
Q69416637 | Fluid balance, vasopressin and withdrawal symptoms during detoxification from alcohol |
Q51600472 | Flunitrazepam and nordiazepam slowly released from silastic capsules induce physical dependence in rat |
Q51975078 | Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability. |
Q47262972 | Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification |
Q43647878 | Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. |
Q44349217 | Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts |
Q49504022 | Folate deficiency in patients seeking treatment of alcohol use disorder |
Q70824886 | Folic acid in serum and cerebrospinal fluid of chronic alcoholics and methamphetamine addicts |
Q52874498 | Follow-up attrition in alcohol treatment studies: is 'no news' bad news, good news or no news? |
Q44942076 | Follow-up of Vietman veterans. I. Relapse to drug use after Vietnam service |
Q45337636 | Follow-up of Vietnam veterans II. Social adjustment |
Q46172324 | Follow-up study of subjects on methadyl acetate and methadone |
Q52304349 | Food, water and ethanol consumption by rats under a fixed-interval schedule of food presentation. |
Q51488270 | Forced opiate withdrawal under anaesthesia augments and prolongs the occurrence of withdrawal signs in rats. |
Q44434935 | Foreword to: buprenorphine and buprenorphine/naloxone: a guide for clinicians |
Q36900386 | Formal and informal substance use treatment utilization and alcohol abstinence over seven years: is the relationship different for blacks and whites? |
Q36024507 | Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls |
Q46940363 | Formulation considerations for the development of medications with abuse potential |
Q104270712 | Forty-eight years of research on psychosocial interventions in the treatment of opioid use disorder: A scoping review |
Q35752014 | Four-year outcomes from the Early Re-Intervention (ERI) experiment using Recovery Management Checkups (RMCs). |
Q63363835 | Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia |
Q73662639 | Frequency and intensity of crack use as predictors of women's involvement in HIV-related sexual risk behaviors |
Q38768785 | Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre. |
Q24169894 | Frequent binge drinking five to six years after exposure to 9/11: findings from the World Trade Center Health Registry |
Q79258113 | Frequent cannabis use among 14/15 years old in Northern Ireland |
Q57841705 | Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing |
Q33897988 | Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers |
Q33653383 | Friendship networks of inner-city adults: a latent class analysis and multi-level regression of supporter types and the association of supporter latent class membership with supporter and recipient drug use. |
Q31020845 | From data to evidence, to action: findings from a systematic review of hospital screening studies for high risk alcohol consumption |
Q38933587 | From initiating injecting drug use to regular injecting: Retrospective survival analysis of injecting progression within a sample of people who inject drugs regularly |
Q35124183 | From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States |
Q40907065 | Frontal P300 decrements, childhood conduct disorder, family history, and the prediction of relapse among abstinent cocaine abusers |
Q36315756 | Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response |
Q44350864 | Frustration stress (unexpected loss of alternative reinforcement) increases opioid self-administration in a model of recovery |
Q44555339 | Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat. |
Q118732537 | Functional evaluation of NK antagonism on cue reactivity in opiate dependence; An fMRI study |
Q52316728 | Functional inactivation of the orbitofrontal cortex disrupts context-induced reinstatement of alcohol seeking in rats. |
Q37682570 | Functional interaction between HIV-gp120 and opioid system in the preoptic anterior hypothalamus |
Q48526346 | Functional magnetic resonance imaging of the acute effect of intravenous heroin administration on visual activation in long-term heroin addicts: results from a feasibility study |
Q52027232 | Functional relationships, previous history and the discrimination of a drug mixture in rats. |
Q37960735 | Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology |
Q51529952 | Further analysis of choice between cocaine and food using the unit price model of behavioral economics. |
Q36627210 | Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study |
Q37276885 | Further evidence of differences in substance use and dependence between Australia and the United States |
Q52290298 | Further investigation of psychological and environmental correlates of substance use in adolescence in six European countries. |
Q70754034 | Further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism |
Q35690381 | Further validation of a marijuana purchase task |
Q41093291 | Future time perspective in current and previous injecting drug users. |
Q43070751 | G protein-coupled receptor (GPCR) trafficking in the central nervous system: relevance for drugs of abuse |
Q34528008 | GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings |
Q96031642 | GABAA Receptor Subtypes and the Reinforcing Effects of Benzodiazepines in Remifentanil-Experienced Rhesus Monkeys |
Q35670267 | GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor |
Q35803722 | GABRA2 and KIBRA genotypes predict early relapse to substance use. |
Q51669447 | GBR 12909 fails to antagonize cocaine-induced elevation of dopamine in striatal slices. |
Q36857686 | GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles |
Q44026548 | GHB use among Australians: characteristics, use patterns and associated harm |
Q34215767 | GHB: a new and novel drug of abuse |
Q61628938 | GSK3B silencing in the NAc produces addiction- and depression-like phenotypes opposite of environmental enrichment and alters neuronal excitability |
Q91301541 | Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system |
Q33872764 | Gabapentin improves cold-pressor pain responses in methadone-maintained patients |
Q40523176 | Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans |
Q92673253 | Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder |
Q45234132 | Gamma hydroxybutyrric acid (GHB) withdrawal does not occur at therapeutic dosage |
Q42631336 | Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients |
Q44394321 | Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study |
Q36952331 | Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanism |
Q40748902 | Gastrointestinal protein turnover and alcohol misuse |
Q93076106 | Gaze entropy measures detect alcohol-induced driver impairment |
Q37767509 | Gender and NAS: does sex matter? |
Q36248819 | Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III. |
Q50116660 | Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 study |
Q38889399 | Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. |
Q33836185 | Gender and race/ethnicity differences for initiation of alcohol-related service use among persons with alcohol dependence |
Q37605155 | Gender and racial differences in smoking of long/ultra-long and king size cigarettes among U.S. adult smokers, NHANES 1999-2012. |
Q51908868 | Gender and the assessment of at-risk drinking: evidence from the GENACIS Canada (2004-2005) telephone survey version of the AUDIT. |
Q40546016 | Gender comparisons of drug abuse treatment outcomes and predictors |
Q44344909 | Gender differences among opioid abusers: pathways to disorder and profiles of psychopathology |
Q37727990 | Gender differences between predictors of HIV status among PWID in Ukraine. |
Q47667205 | Gender differences in acculturation and aggression as predictors of drug use in minorities |
Q36652144 | Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions |
Q37417649 | Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States. |
Q34717570 | Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram |
Q36925170 | Gender differences in cocaine dependence |
Q50974059 | Gender differences in cocaine dependent patients: a 6 month follow-up study. |
Q39434193 | Gender differences in crack users who are research volunteers |
Q96126825 | Gender differences in driving control of young alcohol-impaired drivers |
Q37586442 | Gender differences in factors associated with alcohol drinking: delay discounting and perception of others' drinking |
Q44480306 | Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q44330205 | Gender differences in hostility of opioid-dependent outpatients: role in early treatment termination |
Q39785005 | Gender differences in injection risk behaviors at the first injection episode. |
Q44110890 | Gender differences in manifestations of antisocial personality disorder among residential drug abuse treatment clients |
Q36090298 | Gender differences in mortality among treated opioid dependent patients |
Q35184385 | Gender differences in pharmacokinetics of maintenance dosed buprenorphine |
Q58633917 | Gender differences in risk factors for nonmedical use of prescription stimulants among youth 10 to 18 years in the US |
Q39650097 | Gender differences in self-reported withdrawal symptoms and reducing or quitting smoking three years later: A prospective, longitudinal examination of U.S. adults |
Q39407586 | Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers |
Q45255734 | Gender differences in socio-demographic and clinical characteristics of methamphetamine inpatients in a Chinese population |
Q39066425 | Gender differences in substance abuse, PTSD and intentional self-harm among veterans health administration patients |
Q36468281 | Gender differences in the comorbidity of smoking behavior and major depression |
Q45136331 | Gender differences in the correlates of hazardous drinking among Iraq and Afghanistan veterans |
Q59540403 | Gender differences in the development of emotion circuitry in youth at risk for substance abuse: A longitudinal FMRI study |
Q45234113 | Gender differences in the distribution of cocaine and heroin in Central Harlem |
Q35992206 | Gender differences in the factor structure of the Alcohol Use Disorders Identification Test in multinational general population surveys |
Q38675445 | Gender differences in the real-world effectiveness of smoking cessation medications: Findings from the 2010-2011 Tobacco Use Supplement to the Current Population Survey. |
Q50628992 | Gender differences in the relationship between alcohol use and anxiety symptoms among Nigerian college students |
Q37204799 | Gender differences in the relationship between gambling problems and the incidence of substance-use disorders in a nationally representative population sample |
Q36830658 | Gender differences in the relationship between white matter organization and adolescent substance use disorders. |
Q34192312 | Gender differences in the relationship of internalizing and externalizing psychopathology to alcohol dependence: likelihood, expression and course |
Q48009650 | Gender differences in trajectories of alcohol use from ages 13 to 33 across Latina/o ethnic groups |
Q37302725 | Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis |
Q44335869 | Gender effect on association between DRD2 polymorphism and substance dependence in a Spanish sample |
Q34604511 | Gender identity and substance use among students in two high schools in Monterrey, Mexico |
Q64943880 | Gender moderates the association between distress tolerance and alcohol use among individuals with opioid use disorder. |
Q43515108 | Gender stereotypes and drinking cognitions as indicators of moderate and high risk drinking among young women and men. |
Q44342781 | Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance |
Q47725338 | Gender, injury status and acculturation differences in performance of screening instruments for alcohol problems among US Hispanic emergency department patients |
Q35228310 | Gender, race, and group behavior in group drug treatment |
Q35075760 | Gender, violence and brief interventions for alcohol in the emergency department |
Q38929839 | Gender-based differences in injecting drug use by young adults who experienced maltreatment in childhood: Findings from an Australian birth cohort study |
Q37724793 | General and substance-specific predictors of young adult nicotine dependence, alcohol use disorder, and problem behavior: replication in two samples |
Q52272319 | General practice involvement in the management of alcohol misuse: dynamics and resistances. |
Q47907118 | Generalised inhibitory impairment to appetitive cues: From alcoholic to non-alcoholic visual stimuli. |
Q39293671 | Generalist health and welfare workers' response to alcohol related problems: role legitimacy and the need for role-support, an example from an Australian rural community |
Q37128195 | Generalizability of clinical trials for alcohol dependence to community samples |
Q35582292 | Generalizability of clinical trials for cannabis dependence to community samples |
Q52923634 | Generalizability of project MATCH: a comparison of clients enrolled to those not enrolled in the study at one aftercare site. |
Q52293380 | Generalization of drug-seeking behavior in dogs |
Q44771252 | Generational and other differences between males and females in problem drinking and its treatment |
Q34214061 | Genes in drug abuse |
Q130413720 | Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study |
Q48145001 | Genetic alcohol sensitivity regulated by ALDH2 and ADH1B polymorphisms is strongly associated with depression and anxiety in Japanese employees |
Q39274802 | Genetic analysis of AUTS2 as a susceptibility gene of heroin dependence |
Q36328311 | Genetic and environmental contributions to initiation of cigarette smoking in young African-American and European-American women |
Q52230345 | Genetic and environmental influences on drug use and abuse/dependence in male and female twins. |
Q73154630 | Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs |
Q44332675 | Genetic and environmental risk factors for the onset of drug use and problems in adoptees |
Q70150509 | Genetic and marital status in alcohol dependent women |
Q67019748 | Genetic aspects of tolerance and dependence. Moderator's comments |
Q67019747 | Genetic aspects of tolerance and dependence. Rapporteurs' report |
Q36613940 | Genetic correlates of morphine withdrawal in 14 inbred mouse strains |
Q53400295 | Genetic correlation of antisocial behaviour with alcohol, nicotine, and cannabis use. |
Q49022173 | Genetic effects on various measures of ethanol dependence in mice: a diallel analysis |
Q35928700 | Genetic etiology of the common liability to drug dependence: evidence of common and specific mechanisms for DSM-IV dependence symptoms. |
Q47563056 | Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse |
Q47563049 | Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse |
Q40860714 | Genetic influences in antisocial personality and drug use disorders. |
Q46449728 | Genetic influences on quantity of alcohol consumed by adolescents and young adults |
Q45070277 | Genetic influences on the rate of development of ethanol tolerance and the ethanol physical withdrawal syndrome in mice |
Q34873137 | Genetic moderators and psychiatric mediators of the link between sexual abuse and alcohol dependence |
Q35875400 | Genetic overlap between alcohol use disorder and bulimic behaviors in European American and African American women |
Q33966114 | Genetic studies of substance abuse |
Q35956179 | Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation |
Q42211009 | Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans |
Q59480187 | Genetic variation in alcohol metabolizing enzymes among Inuit and its relation to drinking patterns |
Q31159653 | Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses |
Q62274652 | Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence |
Q44612984 | Genetics and ethanol tolerance |
Q77147080 | Genetics of alcohol and other abused drugs |
Q99604399 | Genome-wide association analysis of opioid use disorder: A novel approach using clinical data |
Q37393114 | Genome-wide linkage analysis of heroin dependence in Han Chinese: results from Wave Two of a multi-stage study |
Q28943513 | Genome-wide survival analysis of age at onset of alcohol dependence in extended high-risk COGA families |
Q36482303 | Genomewide linkage survey of nicotine dependence phenotypes |
Q88515548 | Gentrification and binge drinking in California neighborhoods: It matters how long you've lived there |
Q33624530 | Geographic clustering of underage drinking and the influence of community characteristics |
Q91281889 | Geographic gender differences in traumatic unintentional injury hospitalization and youth drinking |
Q90866146 | Geographic patterns of prescription opioids and opioid overdose deaths in New York State, 2013-2015 |
Q96773482 | Geographic proximity to buprenorphine treatment providers in the U.S. |
Q88882746 | Geographic variation in postpartum prescription opioid use: Opportunities to improve maternal safety |
Q99202209 | Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis |
Q37251689 | Geographical clustering of cannabis use: results from the New Zealand Mental Health Survey 2003-2004 |
Q51017919 | German mental health legislation and alcoholism treatment: results of a retrospective long-term study in a Berlin state mental health hospital. |
Q91207280 | Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model |
Q30492423 | Getting patients the services they need using a computer-assisted system for patient assessment and referral--CASPAR. |
Q96680242 | Getting to the point: Methamphetamine injection is associated with biomarkers relevant to HIV pathogenesis |
Q48154382 | Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice |
Q63684291 | Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies |
Q43076075 | Glial and neuroinflammatory targets for treating substance use disorders |
Q38532911 | Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats |
Q36164790 | Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes |
Q70283733 | Glycoprotein sialyl- and galactosyl transferase activities in erythrocyte membranes in alcoholic patients and healthy controls |
Q71141890 | Glycosylated hemoglobin in chronic alcoholics |
Q47424125 | Goal Management Training and Mindfulness Meditation improve executive functions and transfer to ecological tasks of daily life in polysubstance users enrolled in therapeutic community treatment. |
Q90587141 | Goal-driven attentional capture by appetitive and aversive smoking-related cues in nicotine-dependent smokers |
Q39076639 | Going into the groin: Injection into the femoral vein among people who inject drugs in three urban areas of England. |
Q73128973 | Gonadal hormone levels in injection drug users |
Q47263012 | Gradient of association between parenting styles and patterns of drug use in adolescence: A latent class analysis. |
Q36189354 | Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. |
Q92323625 | Greater delay discounting and cannabis coping motives are associated with more frequent cannabis use in a large sample of adult cannabis users |
Q93189165 | Greater risk for frequent marijuana use and problems among young adult marijuana users with a medical marijuana card |
Q93175674 | Greater tolerance to losses in sensation seeking: Evidence from probability and delay discounting |
Q51175295 | Grief, alcohol dependence and women. |
Q97555341 | Grocery purchase data in the study of alcohol use - A validity study |
Q36249056 | Group 1 mGlu-family proteins promote neuroadaptation to ethanol and withdrawal-associated hippocampal damage |
Q34115023 | Group therapy for women with substance use disorders: results from the Women's Recovery Group Study |
Q57192148 | Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries |
Q48367137 | Growth hormone response to placebo, apomorphine and growth hormone releasing hormone in abstinent alcoholics and control subjects |
Q39961208 | Growth in alcohol use in at-risk adolescent boys: two-part random effects prediction models |
Q40093465 | Growth in spending on substance use disorder treatment services for the privately insured population |
Q69057056 | Growth, liver lipid and blood amino acids in rats fed ethanol with an adequate diet |
Q35132177 | Guidelines and methodological reviews concerning drug abuse liability assessment |
Q43955914 | Guillain-Barré syndrome in chronic alcoholism |
Q69953066 | Guillain-Barré's syndrome in alcoholics |
Q46157014 | Guns and blood alcohol levels among homicide victims |
Q49049304 | Gustatory avoidance in rats: effects of cocaine under a mild water deprivation schedule |
Q40168892 | HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens |
Q61646092 | HIV among Puerto Rican people who inject drugs: Health disparities continue |
Q38129627 | HIV among female sex workers in the Central Asian Republics, Afghanistan, and Mongolia: contexts and convergence with drug use. |
Q42279732 | HIV and HCV among people who inject drugs in Central Asia. |
Q33552332 | HIV and people who use drugs in central Asia: confronting the perfect storm |
Q64136858 | HIV infection among MSM who inject methamphetamine in 8 US cities |
Q46449713 | HIV infection among female drug users in Northern Thailand |
Q51624039 | HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. |
Q35659939 | HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors |
Q60944705 | HIV pre-exposure prophylaxis for people who inject drugs: Willingness to prescribe among general internists |
Q74667328 | HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old |
Q36826868 | HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions |
Q36488694 | HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse |
Q45161006 | HIV risk behaviors and alcohol intoxication among injection drug users in Puerto Rico |
Q42691283 | HIV risks, gender, and cocaine use among opiate users |
Q39446847 | HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study |
Q31044010 | HIV seroprevalence among drug users: an analysis of selected variables based on 10 years of data collection in Porto Alegre, Brazil |
Q40317001 | HIV sexual risk behaviors among injection drug users in Shanghai |
Q33963069 | HIV transmission from drug injectors to partners who do not inject, and beyond: modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia |
Q50049779 | HIV treatment optimism and crystal methamphetamine use and initiation among HIV-negative men who have sex with men in Vancouver, Canada: A longitudinal analysis |
Q30838130 | HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report |
Q36069676 | HIV-gp120 and physical dependence to buprenorphine |
Q46775961 | HIV-positive patients' discussion of alcohol use with their HIV primary care providers |
Q51642277 | HIV-transmission knowledge in drug users from outpatient facilities in Spain. A national survey. |
Q39758546 | HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania |
Q34949224 | HIV/AIDS services in private substance abuse treatment programs |
Q37174853 | HPA axis response to psychological stress and treatment retention in residential substance abuse treatment: a prospective study |
Q52239987 | Habituation of skin conductance response in a methadone population. |
Q39491866 | Hair analysis and its concordance with self-report for drug users presenting in emergency department |
Q33842156 | Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use. |
Q51134386 | Hair ethyl glucuronide as a biomarker of alcohol consumption in alcohol-dependent patients: role of gender differences. |
Q38163213 | Hair ethyl glucuronide levels as a marker for alcohol use and abuse: a review of the current state of the art. |
Q34180184 | Hallucinogen persisting perception disorder: what do we know after 50 years? |
Q37323629 | Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. |
Q52918835 | Hardcore drug users claim to be occasional users: drug use frequency underreporting. |
Q57298270 | Harm perceptions of electronic cigarettes and nicotine: A nationally representative cross-sectional survey of young people in Great Britain |
Q42997808 | Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention. |
Q90566473 | Harmful alcohol use among acutely ill hospitalized medical patients in Oslo and Moscow: A cross-sectional study |
Q99624616 | Harms associated with inhalant misuse in adolescent females - a review of the pre-clinical and clinical evidence |
Q35846764 | Have Halpern et al. (2004) detected 'residual neuropsychological effects' of MDMA? Not likely |
Q37145886 | Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. |
Q42022205 | Hazardous alcohol consumption and sense of coherence in emergency department patients with minor trauma |
Q48409679 | Hazardous alcohol users during pregnancy: psychiatric health and personality traits |
Q44692588 | Hazardous drinking and its association with homelessness among veterans in care |
Q98155447 | Health Literacy among Swedish Patients in Opioid Substitution Treatment: A Mixed-Methods Study |
Q41063883 | Health behaviors of young adult heroin injectors in the Seattle area. |
Q101358377 | Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study |
Q101358365 | Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study |
Q40814157 | Health insurance coverage and healthcare utilization among infants of mothers in the national methadone maintenance treatment program in Taiwan |
Q40648705 | Health insurance, alcohol and tobacco use among pregnant and non-pregnant women of reproductive age. |
Q41923534 | Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses |
Q51913337 | Health related quality of life among both current and former injection drug users who are HIV-infected. |
Q44350606 | Health related quality of life trajectories of patients in opioid substitution treatment |
Q40721057 | Health, perceived quality of life and health services use among homeless illicit drug users |
Q104691623 | Health, social and legal outcomes of individuals with diagnosed or at risk for fetal alcohol spectrum disorder: Canadian example |
Q98299677 | Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trial |
Q45386434 | Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection |
Q51983337 | Health-related service utilization and HIV risk behaviors among HIV infected injection drug users and crack smokers. |
Q50687369 | Healthcare professionals' regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services. |
Q45592892 | Heart rate correlates of utilitarian moral decision-making in alcoholism |
Q82354080 | Heart rate turbulence during acute alcohol withdrawal syndrome |
Q93171119 | Heart rate variability as a potential biomarker for alcohol use disorders: A systematic review and meta-analysis |
Q38810879 | Heart rate variability changes and emotion regulation abilities in short- and long-term abstinent alcoholic individuals |
Q69616640 | Heart rate variability in chronic alcoholics: a follow-up study |
Q53924243 | Heart rate variability in withdrawing alcoholic patients. |
Q50713242 | Heart rate variability predicts alcohol craving in alcohol dependent outpatients: further evidence for HRV as a psychophysiological marker of self-regulation. |
Q97522795 | Heated tobacco product use and associated factors among U.S. youth, 2019 |
Q90507490 | Heated tobacco products: Cigarette complements, not substitutes |
Q40641074 | Heavy alcohol consumption and physical health problems: a review of the epidemiological evidence |
Q35660921 | Heavy alcohol use and suicidal behavior among people who use illicit drugs: A cohort study |
Q48909049 | Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system |
Q34113852 | Heavy cannabis use among UK teenagers: an exploration |
Q46917185 | Heavy drinking during periods of high unemployment: 15-year trend study of the role of race/ethnicity |
Q70870022 | Heavy drug abuse in Sweden 1979 — A national case-finding study |
Q40614828 | Heavy episodic drinking among transgender persons: Disparities and predictors. |
Q45965502 | Heavy smokers show abnormal microstructural integrity in the anterior corpus callosum: a diffusion tensor imaging study with tract-based spatial statistics. |
Q48064953 | Heavy tobacco dependence in suicide attempters making recurrent and medically serious attempts |
Q43684867 | Help seeking for drug and alcohol problems among adults age 50 and older: a comparison of the NLAES and NESARC surveys |
Q43202740 | Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status |
Q35612492 | Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection |
Q43067540 | Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 1987-2006. |
Q46158321 | Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances |
Q90904453 | Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle |
Q31870680 | Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment |
Q39705792 | Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs |
Q115162875 | Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system |
Q59351256 | Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, China |
Q42985727 | Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience |
Q35875495 | Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. |
Q59352127 | Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use |
Q68046848 | Hepatocyte and nuclear areas and fatty infiltration of the liver in chronic alcoholic liver disease |
Q41459633 | Hepatocyte and nuclear areas in alcoholic liver cirrhosis: their relationship with the size of the nodules and the degree of fibrosis |
Q34022193 | Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand |
Q44533574 | Hepatotoxicity is not increased in alcoholics with positive urinary cocaine metabolites |
Q39845300 | Heritabilities of Alcohol Use Disorders Identification Test (AUDIT) scores and alcohol biomarkers in Koreans: the KoGES (Korean Genome Epi Study) and Healthy Twin Study. |
Q47686548 | Heritability of lifetime ecstasy use. |
Q49098023 | Heroin addict responses to six weeks of detoxification with LAAM. |
Q67233629 | Heroin addiction, renal failure, and methadone maintenance: a follow-up report |
Q46190462 | Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up |
Q91211488 | Heroin and nonmedical prescription opioid use among high school students in urban school districts |
Q38721421 | Heroin and pharmaceutical opioid overdose events: Emergency medical response characteristics |
Q52313358 | Heroin and saccharin demand and preference in rats. |
Q43553183 | Heroin dependence and HIV infection in Malaysia |
Q46121162 | Heroin overdose among young injection drug users in San Francisco. |
Q52278715 | Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. |
Q43469663 | Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. |
Q38643889 | Heroin use onset among nonmedical prescription opioid users in the club scene |
Q59138909 | Heroin-related deaths in New South Wales, Australia, 1992–1996 |
Q31798917 | Heroin-related deaths in Victoria: a review of cases for 1997 and 1998. |
Q24610416 | Heterogeneity in the composition of marijuana seized in California |
Q52650934 | Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001-2005 and 2011-2015. |
Q44994525 | Heterosexual relationships among heroin users in Italy |
Q46699011 | Hierarchical linear modeling (HLM) of longitudinal brain structural and cognitive changes in alcohol-dependent individuals during sobriety |
Q39431969 | High HIV incidence in a cohort of male injection drug users in Delhi, India |
Q44035189 | High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004. |
Q44751209 | High blood lead level in alcoholics: wine vs. beer |
Q44587557 | High cotinine levels are persistent during the first days of life in newborn second hand smokers. |
Q37124671 | High dead-space syringes and the risk of HIV and HCV infection among injecting drug users |
Q47237247 | High frequency of the DRD2/ANKK1 A1 allele in Mexican Native Amerindians and Mestizos and its association with alcohol consumption |
Q47349217 | High frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex for methamphetamine use disorders: A randomised clinical trial |
Q43119788 | High mortality among people suspected of drunk-driving. An 18-year register-based follow-up |
Q40832752 | High mortality rate of unintentional poisoning due to prescription opioids in adults enrolled in Medicaid compared to those not enrolled in Medicaid in Montana. |
Q33989662 | High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities |
Q60663072 | High prevalence of alexithymia in male patients with alcohol dependence |
Q83401766 | High prevalence of substance use among heterosexuals living in communities with high rates of AIDS and poverty in Washington, DC |
Q46380841 | High prevalence of substance use disorders among adolescents who use marijuana and inhalants |
Q39717529 | High prevalence of unhealthy alcohol use and comparison of self-reported alcohol consumption to phosphatidylethanol among women engaged in sex work and their male clients in Cambodia |
Q37204765 | High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes. |
Q34694391 | High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors) |
Q36728346 | High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants |
Q94951551 | High willingness to use overdose prevention sites among female sex workers in Baltimore, Maryland |
Q98384663 | High-dose adolescent nicotine exposure permits spontaneous nicotine self-administration in adult male rats |
Q38658094 | High-intensity drinking and nonmedical use of prescription drugs: Results from a national survey of 12th grade students |
Q34980145 | High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia |
Q38490034 | High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study |
Q42651511 | High-risk drug-use practices among a large sample of Australian prisoners |
Q44873847 | High-sensitivity γ-glutamyltransferase fraction pattern in alcohol addicts and abstainers |
Q90677928 | Higher average potency across the United States is associated with progression to first cannabis use disorder symptom |
Q95314509 | Higher impulsivity and lower grey matter volume in the bilateral prefrontal cortex in long-term abstinent individuals with severe methamphetamine use disorder |
Q60441560 | Higher levels of BDNF are associated with inpatient treatment adherence of crack-cocaine users |
Q72921018 | Higher levels of nicotine in arterial than in venous blood after cigarette smoking |
Q36778313 | Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion |
Q47851680 | Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin |
Q40347012 | Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease |
Q33912741 | Higher serum caffeine in smokers with schizophrenia compared to smoking controls |
Q36926250 | Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. |
Q34193693 | Hippocampal volume mediates the relationship between measures of pre-treatment cocaine use and within-treatment cocaine abstinence |
Q40319697 | Hispanic drug abuse in an evolving cultural context: an agenda for research |
Q79772811 | Hispanic drug abuse research: challenges and opportunities |
Q42486656 | Histological and histochemical changes of the placenta in fetal alcohol syndrome due to maternal administration of acute doses of ethanol in the mouse |
Q39820246 | Historical introduction and review of chemistry |
Q46818016 | Historical studies and strategies against alcohol and drug abuse |
Q58566034 | Historical trends in the grade of onset and sequence of cigarette, alcohol, and marijuana use among adolescents from 1976-2016: Implications for "Gateway" patterns in adolescence |
Q24670012 | Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections |
Q46948799 | History and current perspectives on the use of drug formulations to decrease the abuse of prescription drugs |
Q44070856 | History of abuse and drinking outcomes following inpatient alcohol treatment: a prospective study |
Q48217776 | History of cannabis use is associated with altered gait. |
Q33462295 | History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress |
Q99357874 | History of opioid use as a risk factor for current use and mental health consequences among retired National Football League athletes: A 9-year follow-up investigation |
Q89859373 | History of suicidality and alcohol craving trajectories during inpatient treatment for alcohol use disorder |
Q92878166 | History of withdrawal modulates drug- and food-cue reactivity in cocaine dependent participants |
Q44450812 | Hookah use among college students: prevalence, drug use, and mental health. |
Q41051609 | Hopelessness in i.v. drug users not in treatment and seeking HIV testing and counselling |
Q77989975 | Hormonal and behavioral homeostasis in boys at risk for substance abuse |
Q52270300 | Hormone levels in methadone-treated drug addicts. |
Q44425756 | Hospital admission rates for alcoholic intoxication after policy changes in the canton of Geneva, Switzerland |
Q101119537 | Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort study |
Q72536770 | Hospitalization and alcohol-related morbidity within three years after screening in middle-aged men |
Q47864964 | Hostility predicts alcohol consumption over a 21-year follow-up in the Gazel cohort |
Q43162015 | How NIDA became interested in precise nuances of injection behaviors |
Q34176823 | How adolescents with substance use disorder spend research payments |
Q47574940 | How alcohol use problem severity affects the outcome of brief intervention delivered in-person versus through computer-generated feedback letters |
Q37765394 | How can free radicals cause damage to hepatic cells. A multidisciplinary approach |
Q38861808 | How clients' during-treatment motivations relate to their perceptions and impressions of methadone maintenance treatment: A multilevel analysis of a cross-sectional survey in Guangdong Province, China |
Q36874662 | How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. |
Q35088325 | How do recovery definitions distinguish recovering individuals? Five typologies |
Q37592885 | How effective and cost-effective was the national mass media smoking cessation campaign 'Stoptober'? |
Q43570032 | How helpful are drug abuse helplines? |
Q47889940 | How many or how much? Testing the relative influence of the number of social network risks versus the amount of time exposed to social network risks on post-treatment substance use. |
Q103798466 | How much and how fast: Alcohol consumption patterns, drinking-episode affect, and next-day consequences in the daily life of underage heavy drinkers |
Q92749382 | How much are we exposed to alcohol in electronic media? Development of the Alcoholic Beverage Identification Deep Learning Algorithm (ABIDLA) |
Q45161008 | How much do Manhattan-arrestees spend on drugs? |
Q39773955 | How much for a dime bag? An exploration of youth drug markets |
Q41657308 | How much of the cocaine market are we missing? Insights from respondent-driven sampling in a mid-sized American city |
Q48033299 | How profitable is methamphetamine dealing in Australia? |
Q41221166 | How should opiate withdrawal be measured? |
Q113185717 | How substance use can affect HIV test rates following a computer-based video intervention |
Q50186412 | How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities |
Q88728498 | How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis |
Q34949512 | Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum |
Q67290317 | Human spinal fluid methadone levels |
Q40530381 | Human subject issues in drug abuse research. College on Problems of Drug Dependence |
Q33255155 | Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families |
Q37204926 | Hyperactivation of the cognitive control network in cocaine use disorders during a multisensory Stroop task |
Q35957993 | Hyperactivation to pleasant interoceptive stimuli characterizes the transition to stimulant addiction |
Q46861774 | Hyperactivity-inattention symptoms in childhood and substance use in adolescence: the youth gazel cohort |
Q58633748 | Hypertension medication use among past 30-day marijuana users in a community sample from northeast Florida |
Q35001625 | Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys |
Q88934843 | Hypocretin/orexin antagonists decrease cocaine self-administration by female rhesus monkeys |
Q48463385 | Hypothalamus-pituitary-adrenal axis of heroin addicts |
Q93198426 | I wake up and hit the JUUL: Analyzing Twitter for JUUL nicotine effects and dependence |
Q33918496 | IV prenatal nicotine exposure increases the reinforcing efficacy of methamphetamine in adult rat offspring. |
Q46449701 | Ian Stolerman service as editor for Drug and Alcohol Dependence |
Q38899759 | Ibogaine for treating drug dependence. What is a safe dose? |
Q91777395 | Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder |
Q37698675 | Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study |
Q53573894 | Ibudilast may improve attention during early abstinence from methamphetamine. |
Q48183460 | Ibudilast reverses the decrease in the synaptic signaling protein phosphatidylethanolamine-binding protein 1 (PEBP1) produced by chronic methamphetamine intake in rats. |
Q88737545 | Identification and medical utilization of incident cases of alcohol dependence: A population-based case-control study |
Q52221350 | Identification of alcohol by smell among young children: an objective measure of early learning in the home. |
Q43839707 | Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats |
Q41624934 | Identification of smokers, drinkers and risky drinkers by general practitioners |
Q91092279 | Identification of substance use disorders among pregnant women: A comparison of screeners |
Q37107170 | Identification of trajectories of social network composition change and the relationship to alcohol consumption and norms |
Q46478482 | Identifying attendance patterns in a smoking cessation treatment and their relationships with quit success |
Q101163438 | Identifying factors that conjointly influence nicotine vaping product relative harm perception among smokers and recent ex-smokers: Findings from the 2016 ITC Four Country Smoking and Vaping Survey |
Q99590256 | Identifying fetal alcohol spectrum disorder among South African children at aged 1 and 5 years |
Q52175874 | Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators. |
Q41441061 | Identifying misclassification in youth self-reported smoking status: testing different consent processes of biological sample collection to capture misclassification |
Q37002263 | Identifying mortality risks in patients with opioid use disorder using brief screening assessment: Secondary mental health clinical records analysis |
Q64127576 | Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis |
Q59780923 | Identifying predictive profiles of amphetamine, heroin, and polysubstance dependence using machine learning approaches |
Q35626993 | Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire |
Q91281892 | Identifying subtypes of cannabis users based on simultaneous polysubstance use |
Q52271008 | Identity disturbances in drug addicts. |
Q38558130 | Identity in recovery from problematic alcohol use: A qualitative study of online mutual aid. |
Q38798952 | If it works there, will it work here? The effect of a multi-component responsible beverage service (RBS) programme on violence in Oslo |
Q72612375 | Illegal drug taking and driving: patterns of drug taking among Spanish drivers |
Q51412440 | Illegal drug use and its correlates in San Juan, Puerto Rico. |
Q91247158 | Illegal drug use and prospective memory: A systematic review |
Q37281796 | Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals. |
Q51419183 | Illicit cocaine use patterns in intravenous-naive cocaine users following investigational intravenous cocaine administration. |
Q47327628 | Illicit drug consumption in school populations measured by wastewater analysis. |
Q30374944 | Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. |
Q36267395 | Illicit drug use and injuries: A review of emergency room studies |
Q92302296 | Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles |
Q96680909 | Illicit drug use and the genetic overlap with Cannabis use |
Q90888079 | Illicit drug use and work in a model therapeutic workplace |
Q35828550 | Illicit drug use in young adults and subsequent decline in general health: the Coronary Artery Risk Development in Young Adults (CARDIA) Study |
Q38677790 | Illicit drug use is increasing among non-medical users of prescription drugs-Results from population-based surveys 2002-2014. |
Q33246541 | Illicit drug use research in Latin America: epidemiology service use, and HIV. |
Q39732602 | Illicit drug use, alcohol use and problem drinking among infrequent and frequent road ragers |
Q33563439 | Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women |
Q41003759 | Illicit drug use, early age at first use and risk of premenstrual syndrome: A longitudinal study. |
Q59768924 | Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users |
Q43685925 | Illicit drugs and fitness to drive: assessment in Spanish Medical Driving Test Centres. |
Q37268694 | Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse |
Q35800468 | Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids |
Q44348924 | Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses |
Q44704918 | Illicit use of prescription pain medication among college students |
Q37164800 | Illicit use of prescription stimulants in a college student sample: a theory-guided analysis. |
Q48738092 | Imagery of craving in opiate addicts undergoing detoxification |
Q35990231 | Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. |
Q48794595 | Imipramine treatment of cocaine abuse: possible boundaries of efficacy |
Q79997803 | Imitation of cigarette smoking: an experimental study on smoking in a naturalistic setting |
Q91227788 | Immigrant enclaves and risk of drug involvement among asylum-seeking immigrants in Sweden: A quasi-experimental study |
Q92547073 | Immigration and the decline in adolescent binge drinking |
Q70213446 | Immunity and nutrition in heroin addicts |
Q51531146 | Immunization for prevention and treatment of cocaine abuse: legal and ethical implications. |
Q44836273 | Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users |
Q71473812 | Immunoglobulin levels in heroin addicts after treatment with methadone and methadyl acetate |
Q68046836 | Immunoheterogeneity of serum calcitonin in heroin addicts |
Q70998942 | Immunological imbalance in uncomplicated chronic alcoholism |
Q58293197 | Immunological status in heroin addicts: Effects of methadone maintenance treatment |
Q98498945 | Impact of 12 step mutual help groups on drug use disorder patients across six clinical trials |
Q37286873 | Impact of ADHD and cannabis use on executive functioning in young adults |
Q43287956 | Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions |
Q37028208 | Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence. |
Q38686179 | Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity |
Q92225564 | Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis |
Q93171123 | Impact of a community-based naloxone distribution program on opioid overdose death rates |
Q114190382 | Impact of a community-policing initiative promoting substance use disorder treatment over criminal charges on arrest recidivism |
Q40670880 | Impact of a computer-assisted Screening, Brief Intervention and Referral to Treatment on reducing alcohol consumption among patients with hazardous drinking disorder in hospital emergency departments. The randomized BREVALCO trial |
Q92176841 | Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder |
Q46220729 | Impact of a preventive intervention targeting childhood disruptive behavior problems on tobacco and alcohol initiation from age 10 to 13 years |
Q42611734 | Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia. |
Q34065030 | Impact of adaptive functioning on readmission to alcohol detoxification among Alaska Native People |
Q59540405 | Impact of adolescent marijuana use on emotion processing: An fMRI study |
Q44138257 | Impact of alcohol detoxification on anxiety and depressive symptoms |
Q47344296 | Impact of alcohol use motives and internalizing symptoms on mood changes in response to drinking: An ecological momentary assessment investigation |
Q50787381 | Impact of alcohol use on mortality in the elderly: results from the Korean Longitudinal Study on Health and Aging. |
Q36728603 | Impact of alcohol use on sexual behavior among men who have sex with men and transgender women in Lima, Peru |
Q36249047 | Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care |
Q99708417 | Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis |
Q38374844 | Impact of brief interventions and brief treatment on admissions to chemical dependency treatment |
Q89026959 | Impact of e-liquid flavors on e-cigarette vaping behavior |
Q46141765 | Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes |
Q92120692 | Impact of electronic nicotine delivery systems and other respondent characteristics on tobacco use transitions among a U.S. national sample of women of reproductive age |
Q83035736 | Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report |
Q98469979 | Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections |
Q99371671 | Impact of polysubstance use on high-sensitivity cardiac troponin I over time in homeless and unstably housed women |
Q37176971 | Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis |
Q91387383 | Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity |
Q68759612 | Impact of research on designing strategies for preventing and treating dependence on drugs and alcohol |
Q37917039 | Impact of research on designing strategies for preventing and treating dependence on drugs: the case for developing countries especially African countries |
Q39362815 | Impact of scheduling on the practice of medicine and biomedical research |
Q43197504 | Impact of severity of drug use on discrete emotions recognition in polysubstance abusers |
Q101216097 | Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017 |
Q37077036 | Impact of the Good Behavior Game, a universal classroom-based behavior intervention, on young adult service use for problems with emotions, behavior, or drugs or alcohol |
Q39965373 | Impact of the post-2008 economic crisis on harmful drinking in the Dutch working-age population |
Q34021803 | Impact of trauma symptomatology on personal networks among substance using women |
Q36663106 | Impacts of age of onset of substance use disorders on risk of adult incarceration among disadvantaged urban youth: a propensity score matching approach. |
Q50654689 | Impacts of drinking-age laws on mortality in Canada, 1980-2009. |
Q35661011 | Impaired Bayesian learning for cognitive control in cocaine dependence |
Q43067546 | Impaired cerebral autoregulation during acute alcohol withdrawal |
Q83965136 | Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users |
Q46847457 | Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies |
Q40294554 | Impaired decision-making in psychopathic heroin addicts |
Q44026073 | Impaired inhibitory control of behavior in chronic cocaine users |
Q27312057 | Impaired learning from errors in cannabis users: Dorsal anterior cingulate cortex and hippocampus hypoactivity |
Q44145500 | Impaired oculomotor response inhibition in children of alcoholics: The role of attention deficit hyperactivity disorder |
Q44701192 | Impaired performance in a test of decision-making by opiate-dependent tobacco smokers |
Q48182148 | Impaired performance of rats in the Morris swim-maize test late in abstinence following long-term sodium barbital treatment |
Q90097537 | Impaired subjective self-control in alcohol use: An ecological momentary assessment study |
Q24679730 | Impaired time perception and motor timing in stimulant-dependent subjects |
Q86128760 | Impairment due to amphetamines and benzodiazepines, alone and in combination |
Q44934095 | Impairment due to intake of carisoprodol |
Q47603536 | Impairment of manual but not saccadic response inhibition following acute alcohol intoxication. |
Q57069727 | Impairments in reversal learning following short access to cocaine self-administration |
Q59768362 | Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin |
Q96588207 | Implementation and enforcement of state opioid prescribing laws |
Q46359524 | Implementation of a discontinuation letter to reduce long-term benzodiazepine use--a cluster randomized trial |
Q45332361 | Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years. |
Q30151710 | Implementation of online opioid overdose prevention, recognition and response trainings for professional first responders: Year 1 survey results |
Q98283310 | Implementation science outcomes of a gender-focused HIV and alcohol risk-reduction intervention in usual-care settings in South Africa |
Q59654189 | Implementing routine emergency department naloxone rescue kits for patients at risk of opioid overdose |
Q71351967 | Implication of the placenta in acetaldehyde-induced intrauterine growth retardation |
Q92987474 | Implications of insular cortex laterality for treatment of nicotine addiction |
Q37876284 | Implications of the multiplicity of opioid receptors for the problem of addiction |
Q53564831 | Implicit and explicit drinking identity predict latent classes that differ on the basis of college students' drinking behaviors. |
Q48321073 | Implicit and explicit reward learning in chronic nicotine use. |
Q30470633 | Implicit attitudes to smoking are associated with craving and dependence |
Q98498946 | Imprecise action selection in substance use disorder: Evidence for active learning impairments when solving the explore-exploit dilemma |
Q90665180 | Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies |
Q52177661 | Improvement in naltrexone treatment compliance with contingency management. |
Q47995766 | Improving control over the impulse for reward: sensitivity of harmful alcohol drinkers to delayed reward but not immediate punishment |
Q36509486 | Improving drug treatment services for Hispanics: research gaps and scientific opportunities |
Q36532466 | Improving linkage with substance abuse treatment using brief case management and motivational interviewing |
Q38852630 | Improving substance use prevention efforts with executive function training |
Q38102806 | Improving the reliability and reporting of genetic association studies. |
Q45070905 | Improving tobacco dependence treatment outcomes for smokers of lower socioeconomic status: A randomized clinical trial |
Q35925986 | Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes |
Q34425175 | Impulsive suicide attempts predict post-treatment relapse in alcohol-dependent patients |
Q96113382 | Impulsiveness as a moderator of amphetamine treatment response for cocaine use disorder among ADHD patients |
Q115474167 | Impulsivity Scale-12 and its utilization in alcohol use disorder |
Q104691624 | Impulsivity and craving in subjects with opioid use disorder on methadone maintenance treatment |
Q52186363 | Impulsivity and history of drug dependence. |
Q38112851 | Impulsivity and substance-related attentional bias: a meta-analytic review |
Q39639785 | Impulsivity differences in recreational cannabis users and binge drinkers in a university population. |
Q46777662 | Impulsivity in Hong Kong-Chinese club-drug users |
Q50740921 | Impulsivity in adult ADHD patients with and without cocaine dependence. |
Q49915690 | Impulsivity related personality traits and cigarette smoking in adults: A meta-analysis using the UPPS-P model of impulsivity and reward sensitivity |
Q45068068 | Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. |
Q33856557 | In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. |
Q45001709 | In the heat of the moment: alcohol consumption and smoking lapse and relapse among adolescents who have quit smoking |
Q44487814 | In vitro effect of methanol on folate-deficient rat hepatocytes |
Q72843054 | In vivo and in vitro properties of ANTI-Δ9-Tetrahydrocannabinol antibody |
Q93198420 | In vivo characterization of toxicity of norcocaethylene and norcocaine identified as the most toxic cocaine metabolites in male mice |
Q92749386 | In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation |
Q40824869 | In vivo effects of methamphetamine on HIV-1 replication: A population-based study |
Q43010715 | In vivo evidence for long-term CNS toxicity, associated with chronic binge use of methamphetamine |
Q36014606 | In what sense are addicts irrational? |
Q52290196 | In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone. |
Q36253355 | Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine. |
Q39407573 | Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting |
Q37542937 | Inactivation of the paraventricular thalamus abolishes the expression of cocaine conditioned place preference in rats. |
Q37204816 | Inattention, impulsive action, and subjective response to D-amphetamine |
Q40322302 | Incidence and antecedents of nonmedical prescription opioid use in four US communities. The Coronary Artery Risk Development in Young Adults (CARDIA) prospective cohort study |
Q37114061 | Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors |
Q51189116 | Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. |
Q91384317 | Incidence and predictors of drug overdoses among a cohort of >10,000 patients treated for substance use disorder |
Q38992215 | Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia. |
Q35690302 | Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. |
Q95298642 | Incidence and treatment costs of severe bacterial infections among people who inject heroin: A cohort study in South London, England |
Q43890373 | Incidence of alcohol dependence among drunken drivers |
Q28300365 | Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies |
Q90310228 | Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual |
Q39896190 | Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France |
Q39365853 | Incidence of self-medication among Nigerian university students |
Q39648645 | Income distribution and risk of fatal drug overdose in New York City neighborhoods. |
Q37353621 | Income does not affect response to contingency management treatments among community substance abuse treatment-seekers |
Q36101111 | Income generating activities of people who inject drugs. |
Q37093180 | Income received during treatment does not affect response to contingency management treatments in cocaine-dependent outpatients |
Q48789168 | Incongruity between occupational interests and academic skills in drug abusing women |
Q44730097 | Inconsistent condom use among HIV-infected patients with alcohol problems |
Q52278436 | Incorporating the AUDIT into a general population telephone survey: a methodological experiment. |
Q35132185 | Incorporating the assessment of abuse liability into the drug discovery and development process |
Q40115550 | Increase in anger symptoms after smoking cessation predicts relapse |
Q60680221 | Increased QT interval variability index in acute alcohol withdrawal |
Q71364578 | Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate |
Q37346354 | Increased drinking in a trial of treatments for marijuana dependence: substance substitution? |
Q33872563 | Increased error-related thalamic activity during early compared to late cocaine abstinence |
Q56352879 | Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats |
Q44094326 | Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression |
Q48306477 | Increased intracellular calcium level in peripheral blood mononuclear cells of alcoholic patients under withdrawal |
Q46346352 | Increased levels of adiponectin and resistin in alcohol dependence--possible link to craving. |
Q40633509 | Increased mortality among previously apprehended drunken and drugged drivers |
Q70643977 | Increased mortality associated with dependence on legal drugs? |
Q91028768 | Increased neural activity in the right dorsolateral prefrontal cortex during a risky decision-making task is associated with cocaine use in methadone-maintained patients |
Q64115939 | Increased overdose mortality during the first week of the month: Revisiting the "check effect" through a spatial lens |
Q70724465 | Increased prolactin reserve in alcoholics |
Q43959363 | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs |
Q44959927 | Increased risk-taking decision-making but not altered response to punishment in stimulant-using young adults |
Q42251776 | Increased sensitivity to picrotoxin as an index of physical dependence on alcohol in the mouse |
Q52175876 | Increased specificity of ethanol's discriminative stimulus effects in an ethanol-pentobarbital-water discrimination in rats. |
Q46590888 | Increased white matter hyperintensities in male methamphetamine abusers |
Q44347338 | Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances |
Q38770880 | Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004-2013. |
Q38743071 | Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids |
Q36089748 | Increases in the availability of prescribed opioids in a Canadian setting |
Q67399588 | Increases in youthful admissions to alcoholism treatment in Ontario |
Q42271095 | Increasing availability of illicit drugs among people who inject drugs in Bangkok, Thailand |
Q44348679 | Increasing employment of opioid dependent outpatients: an intensive behavioral intervention |
Q70905529 | Increasing incidence of Pseudomonas endocarditis among parenteral drug abusers |
Q47413952 | Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. |
Q52201235 | Increasing opiate abstinence through voucher-based reinforcement therapy. |
Q39459624 | Increasing popularity of injection as the route of administration of amphetamine in Edinburgh |
Q88358600 | Increasing rates of quetiapine overdose, misuse, and mortality in Victoria, Australia |
Q91545786 | Increasing substance use disorder counselors' self-efficacy and skills in talking to patients about sex and HIV risk: A randomized training trial |
Q36130551 | Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies |
Q35902306 | Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting |
Q35124169 | Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study |
Q47639846 | Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. |
Q40696359 | Independent and combined associations of risky single-occasion drinking and drinking volume with alcohol use disorder: Evidence from a sample of young Swiss men. |
Q36421563 | Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit |
Q90000183 | Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain |
Q35181162 | Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States |
Q104571365 | Independent effects of entering recovery as a young versus older adult on long-term functioning and quality of life: Results from a U.S. national study of recovering persons |
Q92481048 | Independent or synergistic? Effects of varying size and using pictorial images in tobacco health warning labels |
Q35899209 | Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomes |
Q38662942 | Indicators of dependence for different types of tobacco product users: Descriptive findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) study |
Q71502548 | Indicators of genetic and environmental influences in drug abusing individuals |
Q39793351 | Indicators of use of methamphetamine and other substances among men who have sex with men, San Francisco, 2003-2006. |
Q59745676 | Indigence, marginalization and HIV infection among Brazilian cocaine users |
Q46473591 | Individual and community correlates of young people's high-risk drinking in Victoria, Australia |
Q35952168 | Individual and neighborhood predictors of mortality among HIV-positive Latinos with history of injection drug use, Florida, 2000-2011. |
Q34669368 | Individual and network factors associated with non-fatal overdose among rural Appalachian drug users |
Q99574418 | Individual and social network correlates of recent treatment for substance use disorders among persons who use drugs in Baltimore, MD (2014 - 2017) |
Q46904848 | Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics |
Q36936326 | Individual differences in brain responses to cigarette-related cues and pleasant stimuli in young smokers. |
Q91227791 | Individual differences in human opioid abuse potential as observed in a human laboratory study |
Q45024550 | Individual differences in the reinforcing and subjective effects of amphetamine and diazepam |
Q33700798 | Individual risk factors for adolescent substance use. |
Q33731082 | Individual traits and family contexts predict sons' externalizing behavior and preliminary relative risk ratios for conduct disorder and substance use disorder outcomes. |
Q36401894 | Individual variability in the locus of prefrontal craving for nicotine: implications for brain stimulation studies and treatments |
Q46139214 | Individual, peer, and family factor modification of neighborhood-level effects on adolescent alcohol, cigarette, e-cigarette, and marijuana use. |
Q36983061 | Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample |
Q42624249 | Individual-level syringe coverage among Needle and Syringe Program attendees in Australia. |
Q53131042 | Individualised but not general alcohol Stroop predicts alcohol use. |
Q35690322 | Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse |
Q89349728 | Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial |
Q90672379 | Individuals with spinal cord injury have greater odds of substance use disorders than non-sci comparisons |
Q48405801 | Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action |
Q52273623 | Induction of antibodies to morphine during chronic morphine treatment in rodents and opiate addicts. |
Q46259651 | Induction of brain CYP2E1 changes the effects of ethanol on dopamine release in nucleus accumbens shell. |
Q37067368 | Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention |
Q58633885 | Ineligible for most protocols: What differentiates drug users? |
Q33872350 | Infant autonomic functioning and neonatal abstinence syndrome |
Q30447697 | Infant pupillary response to methadone administration during treatment for neonatal abstinence syndrome: a feasibility study |
Q47655444 | Inflammatory chemokine eotaxin-1 is correlated with age in heroin dependent patients under methadone maintenance therapy |
Q48694665 | Influence of abstinence and conditions of cocaine access on the reinforcing strength of cocaine in nonhuman primates |
Q41826481 | Influence of age on effects induced by intermittent ethanol treatment on the ethanol drinking pattern and related neurochemical changes in the rat. |
Q43803496 | Influence of brain catalase on ethanol-induced loss of righting reflex in mice |
Q58022730 | Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: A general population-based study |
Q59350262 | Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV |
Q60687988 | Influence of dorsolateral prefrontal cortex and ventral striatum on risk avoidance in addiction: A mediation analysis |
Q35180751 | Influence of dorsolateral prefrontal cortex and ventral striatum on risk avoidance in addiction: a mediation analysis |
Q92547068 | Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers |
Q44070872 | Influence of estrous cycle and estradiol on behavioral sensitization to cocaine in female rats |
Q62066589 | Influence of ethanol on gastric absorption and metabolism of albendazole and mebendazole |
Q92391398 | Influence of experimental alcoholism on the repair process of bone defects filled with beta-tricalcium phosphate |
Q70988327 | Influence of morphine and naloxone on human peripheral blood T-lymphocytes |
Q30431946 | Influence of reinforcer magnitude and nicotine amount on smoking's acute reinforcement enhancing effects |
Q28143431 | Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding |
Q91311700 | Influences of victimization and comorbid conditions on latency to illicit drug use among adolescents and young adults |
Q50934525 | Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. |
Q44762086 | Influencing adolescent life style: the role of mass media |
Q58451929 | Informing drinkers: Can current UK alcohol labels be improved? |
Q46913875 | Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use. |
Q35069802 | Inhalant use and disorders among adults in the United States |
Q36024008 | Inhalant use and suicidality among incarcerated youth |
Q71358668 | Inhalants to heroin: a prospective analysis from adolescence to adulthood |
Q36409544 | Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice |
Q34330352 | Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms |
Q44394301 | Inhaled drugs of abuse enhance serotonin-3 receptor function |
Q35783002 | Inhibiting glycine transporter-1 facilitates cocaine-cue extinction and attenuates reacquisition of cocaine-seeking behavior |
Q67694347 | Inhibition of epinephrine-induced myocardial necrosis in rats by administration of single doses of ethanol |
Q40432255 | Inhibition of gap junction currents by the abused solvent toluene |
Q72921023 | Inhibition of non-enzymatic lipid peroxidation by 'Essentiale' a drug enriched in phosphatidylcholine in ethanol-induced liver injury |
Q52176393 | Inhibitors of cytochrome P450 differentially modify discriminative-stimulus and antinociceptive effects of hydrocodone and hydromorphone in rhesus monkeys. |
Q39152380 | Inhibitory control dysfunction in nicotine dependence and the influence of short-term abstinence |
Q92170998 | Inhibitory-control training for cocaine use disorder and contingency management for clinic attendance: A randomized pilot study of feasibility, acceptability and initial efficacy |
Q35785884 | Initial RCT of a distress tolerance treatment for individuals with substance use disorders |
Q92220748 | Initial e-cigarette flavoring and nicotine exposure and e-cigarette uptake among adolescents |
Q52290164 | Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. |
Q37154272 | Initial insight into why physical activity may help prevent adolescent smoking uptake |
Q40868930 | Initial opportunity to use marijuana and the transition to first use: United States, 1979-1994. |
Q36888373 | Initial reliability and validity studies of the revised Treatment Services Review (TSR-6). |
Q90665523 | Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting |
Q33895593 | Initial tobacco use episodes in children and adolescents: current knowledge, future directions |
Q38599959 | Initial validation of a proxy indicator of functioning as a potential tool for establishing a clinically meaningful cocaine use outcome. |
Q73815811 | Initiating abstinence in cocaine abusing dually diagnosed homeless persons |
Q88758591 | Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes |
Q91485328 | Initiation and engagement as mechanisms for change caused by collaborative care in opioid and alcohol use disorders |
Q33775166 | Initiation and engagement in chronic disease management care for substance dependence |
Q90631216 | Initiation into heroin use among street-involved youth in a Canadian setting: A longitudinal cohort study |
Q36012512 | Initiation into methamphetamine use for young gay and bisexual men |
Q39250810 | Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs |
Q36108262 | Initiation of alcohol, marijuana, and inhalant use by American-Indian and white youth living on or near reservations |
Q88951789 | Initiation of vaporizing cannabis: Individual and social network predictors in a longitudinal study of young adults |
Q44472655 | Initiation to drug injection among street youth: a gender-based analysis |
Q36248852 | Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior |
Q35937711 | Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. |
Q42597966 | Injecting behaviour and risky needle use amongst methadone maintenance clients. |
Q72921020 | Injecting drug users and HIV/AIDS: risk behaviours and risk perception |
Q39050418 | Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework. |
Q35671438 | Injecting transition risk and depression among Mexican American non-injecting heroin users. |
Q42610150 | Injecting-related injury and disease among clients of a supervised injecting facility. |
Q41502073 | Injection drug use cessation and use of North America's first medically supervised safer injecting facility |
Q88773628 | Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review |
Q92120682 | Injection drug use, unknown HIV positive status, and self-reported current PrEP use among Black men who have sex with men attending U.S. Black pride events, 2014-2017 |
Q43685953 | Injection drug users: hospital care and charges |
Q44430857 | Injection frequency mediates health service use among persons with a history of drug injection |
Q35230687 | Injection methamphetamine use is associated with an increased risk of attempted suicide: a prospective cohort study |
Q42660895 | Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia |
Q42981249 | Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users |
Q43925602 | Injection risk behaviors at the first and at the most recent injections among drug users |
Q35592728 | Injury risk associated with cannabis and cocaine use. |
Q34984561 | Injury, pain, and prescription opioid use among former National Football League (NFL) players |
Q43192249 | Inmate responses to prison-based drug treatment: a repeated measures analysis |
Q22252230 | Innovative alcohol use: Assessing the prevalence of alcohol without liquid and other non-oral routes of alcohol administration |
Q70910548 | Innovative perspectives on strategies to develop effective alcoholism treatment programs |
Q96113385 | Inpatient addiction consultation and post-discharge 30-day acute care utilization |
Q96591738 | Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders |
Q99201687 | Inpatient link to peer recovery coaching: Results from a pilot randomized control trial |
Q41632722 | Inpatient male alcoholics: predicting program completion time in days and characteristics of fast and slow completers |
Q52278003 | Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months. |
Q38609917 | Insights into the link between drug use and criminality: Lifetime offending of criminally-active opiate users |
Q49083523 | Insomnia among addicts during supervised withdrawal from opiates: a comparison of oral methadone and electrostimulation |
Q45326545 | Insomnia severity as a mediator of the association between mental health symptoms and alcohol use in young adult veterans |
Q47629758 | Insomnia treatment in the context of alcohol use disorder: A systematic review and meta-analysis |
Q36494912 | Insula reactivity to negative stimuli is associated with daily cigarette use: A preliminary investigation using the Human Connectome Database |
Q47572208 | Insulin resistant rats display enhanced rewarding effects of nicotine |
Q91624738 | Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial |
Q96225971 | Integrated dual diagnosis treatment among United States mental health treatment facilities: 2010 to 2018 |
Q44574573 | Integrated family and cognitive-behavioral therapy for adolescent substance abusers: a stage I efficacy study |
Q26745837 | Integrating affect and impulsivity: The role of positive and negative urgency in substance use risk |
Q36090491 | Integrating alcohol response feedback in a brief intervention for young adult heavy drinkers who smoke: A pilot study |
Q36906548 | Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes |
Q33949269 | Integrating field methodology and web-based data collection to assess the reliability of the Alcohol Use Disorders Identification Test (AUDIT). |
Q37397043 | Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine |
Q92850452 | Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites |
Q35784178 | Intensive intervention for alcohol-dependent smokers in early recovery: a randomized trial |
Q48882898 | Intensive referral to 12-step dual-focused mutual-help groups |
Q48431349 | Intention to utilize formal help in a sample with alcohol problems: a prospective study |
Q30724117 | Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data |
Q33625141 | Intentions to quit smoking among youth in substance abuse treatment |
Q38677793 | Intentions to quit tobacco smoking in 14 low- and middle-income countries based on the transtheoretical model. |
Q51745367 | Inter-informant agreement and prevalence estimates for substance use disorders: direct interview versus family history method. |
Q35875576 | Inter-observer reliability of DSM-5 substance use disorders |
Q52923627 | Inter-rater reliability of the SCID alcohol and substance use disorders section among adolescents. |
Q68486407 | Inter-relationship between serum potassium and plasma catecholamines and 3':5' cyclic monophosphate in alcohol withdrawal |
Q91251470 | Inter-trial variability in brain activity as an indicator of synergistic effects of HIV-1 and drug abuse |
Q42285584 | Interaction between alcohol deprivation and morphine withdrawal in mice |
Q35738878 | Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. |
Q48463394 | Interaction of ethanol with 111In-labelled membranes: evaluation by the perturbed angular correlation-sum peak ratio method |
Q46962332 | Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine |
Q91441400 | Interaction with the justice system and other factors associated with pregnant women's self-report and continuation of use of marijuana |
Q34167489 | Interactions among drinking identity, gender and decisional balance in predicting alcohol use and problems among college students |
Q41830722 | Interactions between alcohol and nicotine on intracranial self-stimulation and locomotor activity in rats |
Q40530386 | Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants |
Q36146591 | Interactions between implicit and explicit cognition and working memory capacity in the prediction of alcohol use in at-risk adolescents |
Q44994521 | Interactions between low concentrations of ethanol and nicotine on firing rate of ventral tegmental dopamine neurones |
Q96126530 | Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures |
Q50936880 | Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse. |
Q91327894 | Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry |
Q37409026 | Interactive effects of chronic cigarette smoking and age on hippocampal volumes. |
Q33586764 | Interest in quitting and lifetime quit attempts among smokers living with HIV infection |
Q99346824 | Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State |
Q37234887 | Interim methadone treatment: impact on arrests |
Q89804014 | Intermittent binge-like ethanol exposure during adolescence attenuates the febrile response by reducing brown adipose tissue thermogenesis in rats |
Q51852450 | Internal reliability of measures of substance-related cognitive bias. |
Q47626484 | Internal reliability of the alcohol-related visual probe task is increased by utilising personalised stimuli and eye-tracking |
Q34624495 | Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012 |
Q50224987 | Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support |
Q36971578 | Internalizing and externalizing disorders as predictors of alcohol use disorder onset during three developmental periods |
Q92231024 | Internalizing and externalizing factors on the pathway from adverse experiences in childhood to non-medical prescription opioid use in adulthood |
Q38799187 | Internalizing symptoms and conduct problems: Redundant, incremental, or interactive risk factors for adolescent substance use during the first year of high school? |
Q45094062 | International Cannabis Research Society meeting summary, Keystone, CO (June 19-20, 1992). |
Q38997872 | International approaches to driving under the influence of cannabis: A review of evidence on impact |
Q53431735 | International drug treaties: the connexion between ratification and social and economic conditions. |
Q32067888 | International traffic in coca through the early 20th century |
Q38112932 | Internet and computer based interventions for cannabis use: a meta-analysis |
Q57163339 | Internet searches for opioids predict future emergency department heroin admissions |
Q96830357 | Internet use and adolescent drinking: Does it matter what young people do online? |
Q35129693 | Internet-based group contingency management to promote abstinence from cigarette smoking: a feasibility study |
Q92408032 | Interoceptive accuracy and interoceptive sensibility in individuals with alcohol use disorder-Different phenomena with different clinical correlations? |
Q91306995 | Interpersonal trauma exposure and startle reactivity to uncertain threat in individuals with alcohol use disorder |
Q52304290 | Interpersonal violence against wives by substance dependent men. |
Q34167457 | Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction |
Q50230731 | Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice |
Q33271787 | Interpreting treatment effects when cases are institutionalized after treatment |
Q35869733 | Interrelationship of substance use and psychological distress over the life course among a cohort of urban African Americans. |
Q47956011 | Interrelationships between marijuana demand and discounting of delayed rewards: Convergence in behavioral economic methods |
Q39493981 | Interrupting the social processes linked with initiation of injection drug use: results from a pilot study. |
Q91852877 | Intersecting burdens: Homophobic victimization, unstable housing, and methamphetamine use in a cohort of men of color who have sex with men |
Q37014842 | Intersections between cardiac physiology, emotion regulation and interpersonal warmth in preschoolers: Implications for drug abuse prevention from translational neuroscience. |
Q34615401 | Interventions for reducing alcohol consumption among general hospital inpatient heavy alcohol users: a systematic review |
Q64135292 | Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review |
Q38140394 | Interventions to prevent the initiation of injection drug use: a systematic review |
Q48039249 | Interview with Dr Jerome H Jaffe |
Q48061830 | Interview with Eddy Award Winner Charles O'Brien, MD, PhD. |
Q48061826 | Interview with Eddy Award Winner Dr Robert Balster |
Q51642274 | Interviewer severity ratings and composite scores of the ASI: a further look. |
Q37283235 | Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users |
Q35952380 | Intimate partner violence and substance use risk among young men who have sex with men: The P18 cohort study. |
Q43685945 | Intimate relationship characteristics associated with condom use among drug users and their sex partners: a multilevel analysis |
Q57298094 | Intimate relationships and patterns of drug and sexual risk behaviors among people who inject drugs in Kazakhstan: A latent class analysis |
Q47651711 | Intoxication and substance use disorder to Areca catechu nut containing betel quid: A review of epidemiological evidence, pharmacological basis and social factors influencing quitting strategies |
Q42167701 | Intra-couple communication dynamics of HIV risk behavior among injecting drug users and their sexual partners in Northern Vietnam |
Q39446865 | Intra-individual changes in Stroop-related activations linked to cigarette abstinence in adolescent tobacco smokers: Preliminary findings |
Q48684503 | Intracranial self-stimulation in female and male rats: no sex differences using a rate-independent procedure |
Q50179718 | Intragastric drug self-administration by rats exposed successively to morphine and ethanol |
Q36803326 | Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers |
Q42551264 | Intrathecally administered flumazenil and PK 11195 precipitate abstinence syndrome in freely moving diazepam dependent rats |
Q39763239 | Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls |
Q38763518 | Intrauterine exposure to tobacco and executive functioning in high school |
Q34977212 | Intravenous and non-intravenous cocaine abusers admitted to inpatient detoxification treatment: a 3-year medical-chart review of patient characteristics and predictors of treatment re-admission. |
Q92569001 | Intravenous and oral caffeine self-administration in rats |
Q36874673 | Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans. |
Q43701374 | Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior |
Q30451390 | Intravenous gestational nicotine exposure results in increased motivation for sucrose reward in adult rat offspring |
Q40097031 | Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. |
Q44332689 | Intravenous opiate maintenance in a cohort of injecting drug addicts |
Q30429611 | Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats. |
Q50575637 | Intravenous self-administration of (-)-cathinone and 2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane in rhesus monkeys |
Q28262141 | Intravenous self-administration of 4-methylaminorex in primates |
Q50155322 | Intravenous self-administration of fencamfamine and cocaine by beagle dogs under fixed-ratio and progressive-ratio schedules of reinforcement |
Q34630587 | Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons |
Q43501032 | Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. |
Q99731883 | Introducing NIDA's New National Drug Early Warning System |
Q86482205 | Introduction |
Q88045898 | Introduction to CPDD abstracts |
Q54459569 | Introduction to CPDD abstracts from the 2016 conference. |
Q43270706 | Introduction to College on Problems of Drug Dependence special conference on risk management and post-marketing surveillance of CNS drugs |
Q50777583 | Introduction to DSM-5 criteria linked papers in drug and alcohol dependence. |
Q43540757 | Introduction to special issue on substance abuse and the immune system |
Q33888140 | Introduction to the College on Problems of Drug Dependence special issue: contemporary advances in opioid neuropharmacology |
Q50596986 | Introduction to the role of excitatory amino acids in the actions of abused drugs: a symposium presented at the 1993 annual meeting of the College on Problems of Drug Dependence |
Q100941659 | Introduction to the special issue on the HEALing Communities Study |
Q73315859 | Introduction to the special issue: treatment process in DATOS |
Q44152864 | Introduction to the supplemental issue on measurement and design issues in tobacco and drug use research |
Q73693976 | Introduction to tobacco, nicotine, and youth: the tobacco etiology research network |
Q36823122 | Investigating dimensionality and measurement bias of DSM-5 alcohol use disorder in a representative sample of the largest metropolitan area in South America |
Q92811428 | Investigating how perceived risk and availability of marijuana relate to marijuana use among adolescents in Argentina, Chile, and Uruguay over time |
Q57380107 | Investigating possible causal effects of externalizing behaviors on tobacco initiation: A Mendelian randomization analysis |
Q91384301 | Investigating the causal effect of cannabis use on cognitive function with a quasi-experimental co-twin design |
Q53409476 | Investigating the correlation between wastewater analysis and roadside drug testing in South Australia. |
Q50964394 | Investigating the drinking patterns of young people over the course of the evening at weekends. |
Q56889991 | Investigating the effect of Alcohol Brief Interventions within accident and emergency departments using a data informatics methodology |
Q41482088 | Investigating the factor structure of the Illness Perception Questionnaire-revised for substance dependence among injecting drug users in China |
Q91809411 | Investigating the genetic and causal relationship between initiation or use of alcohol, caffeine, cannabis and nicotine |
Q37216539 | Investigating the long-term influence of adolescent delinquency on drug use initiation. |
Q48318723 | Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers. |
Q31058903 | Investigation of agreement between wastewater-based epidemiology and survey data on alcohol and nicotine use in a community. |
Q30040318 | Investigation of hallucinogenic and related beta-carbolines |
Q35898817 | Investigation of sex-dependent effects of cannabis in daily cannabis smokers |
Q33895575 | Investing in substance abuse research: The Robert Wood Johnson Foundation story |
Q39168054 | Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice. |
Q57655237 | Involvement of families in group therapy of heroin addicts |
Q52302156 | Involvement of the NLRP3 inflammasome in the modulation of an LPS-induced inflammatory response during morphine tolerance. |
Q37854232 | Involvement of the endocannabinoid system in alcohol dependence: the biochemical, behavioral and genetic evidence. |
Q38690837 | Ionized magnesium in plasma and erythrocytes for the assessment of low magnesium status in alcohol dependent patients |
Q40625990 | Irritability, acute alcohol consumption and aggressive behavior in men and women |
Q92940422 | Is E-cigarette use a gateway to marijuana use? Longitudinal examinations of initiation, reinitiation, and persistence of e-cigarette and marijuana use |
Q42691292 | Is antisocial personality disorder associated with increased HIV risk behaviors in cocaine users? |
Q37053843 | Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers? |
Q34514047 | Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United States |
Q35875597 | Is cannabis use associated with less opioid use among people who inject drugs? |
Q91572550 | Is cannabis use associated with tobacco cessation outcome? An observational cohort study in primary care |
Q94941277 | Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review |
Q41149381 | Is drug use a response to stress? |
Q37616341 | Is ecstasy a drug of dependence? |
Q45234127 | Is ecstasy perceived to be safe? A critical survey |
Q88906661 | Is family history of alcohol dependence a risk factor for disturbed sleep in alcohol dependent subjects? |
Q42658825 | Is frequency of drinking an indicator of problem drinking? A psychometric analysis of a modified version of the alcohol use disorders identification test in Switzerland |
Q91608796 | Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes? |
Q43842930 | Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission |
Q92750122 | Is marijuana use associated with lower inflammation? Results from waves III and IV of the national longitudinal study of adolescent to adult health |
Q43562024 | Is opioid substitution treatment beneficial if injecting behaviour continues? |
Q44672967 | Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting? |
Q48413613 | Is parenting style a context for smoking-specific parenting practices? |
Q34620651 | Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder |
Q38874514 | Is social interaction associated with alcohol consumption in Uganda? |
Q46012116 | Is socioeconomic status associated with awareness of and receptivity to the truth campaign? |
Q50038093 | Is the Fagerström test for nicotine dependence invariant across secular trends in smoking? A question for cross-birth cohort analysis of nicotine dependence. |
Q39559399 | Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? |
Q37281959 | Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability? |
Q52236045 | Is the strength and the desirability of alcohol-related expectancies positively related? A test with an adult Swedish sample. |
Q43833061 | Is there a misplaced focus on AmED? Associations between caffeine mixers and bar patron intoxication |
Q92749403 | Is time elapsed between cannabis use and sleep start time associated with sleep continuity? An experience sampling method |
Q31043967 | Is treatment for alcohol use disorder associated with reductions in criminal offending? A national data linkage cohort study in England. |
Q63313854 | Is voluntary household smoking ban differentially effective for men's and women's smokeless tobacco use and addiction? Findings from the global adult tobacco survey in India |
Q47817967 | Israeli college student alcohol use: the association of background characteristics and regular drinking patterns |
Q41745368 | It is not just memory: propositional thinking influences performance on the autobiographical IAT. |
Q95943565 | Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special? |
Q36681184 | Item banks for alcohol use from the Patient-Reported Outcomes Measurement Information System (PROMIS): use, consequences, and expectancies. |
Q30672255 | Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)): Severity of use and positive appeal of use. |
Q44668426 | Item functioning of the alcohol dependence scale in a high-risk sample |
Q37561266 | Item response theory analyses of DSM-IV and DSM-5 stimulant use disorder criteria in an American Indian community sample |
Q43981665 | Ito cells and fibrogenesis in chronic alcoholic liver disease |
Q47961586 | J-shaped relationship between supervised methadone consumption and retention in methadone maintenance treatment (MMT) in primary care: National cohort study |
Q92595407 | JUUL electronic cigarettes: Nicotine exposure and the user experience |
Q33912508 | Job loss discrimination and former substance use disorders |
Q51983340 | Job strain and non-medical drug use. |
Q38572693 | Journey through the K-hole: phenomenological aspects of ketamine use. |
Q61646098 | Junkie habitus: Beyond disease and moral defect |
Q30421694 | Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice |
Q59505383 | KCNH2 polymorphism and methadone dosage interact to enhance QT duration |
Q57817819 | Keeping smoking affordable in higher tax environments via smoking thinner roll-your-own cigarettes: Findings from the International Tobacco Control Four Country Survey 2006-15 |
Q44448734 | Keeping the lid on: a century of drug regulation and control |
Q36447398 | Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains |
Q42124923 | Ketamine impairs multiple cognitive domains in rhesus monkeys. |
Q44563864 | Ketamine is associated with lower urinary tract signs and symptoms |
Q43925629 | Ketoconazole increases cocaine and opioid use in methadone maintained patients |
Q31424140 | Ketoconazole reduces low dose cocaine self-administration in rats |
Q46277438 | Khat chewing spread to the Somali community in Rome |
Q38265856 | Khat consumption: a pharmacological review |
Q92880761 | Klotho levels and ethanol consumption |
Q51102511 | Knowledge and experience of drug use amongst church affiliated young people. |
Q46539717 | Knowledge and views on drug abuse of primary health care workers in Nigeria |
Q36211982 | Knowledge of HIV seropositivity is a predictor for initiation of illicit drug use: incidence of drug use initiation among female sex workers in a high HIV-prevalence area of China |
Q71510717 | Knowledge of drug names determines associations to drug names more than habits for the drugs |
Q99569623 | Knowledge, preparedness, and compassion fatigue among law enforcement officers who respond to opioid overdose |
Q40211773 | Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users |
Q89580792 | Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic |
Q91712125 | Kratom as a substitute for opioids: Results from an online survey |
Q47563684 | Kratom use and mental health: A systematic review |
Q37637054 | L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors |
Q106189599 | LGBTQ state policies: A lever for reducing SGM youth substance use and bullying |
Q90924168 | Laboratory analysis of driving behavior and self-perceived physiological impairment at 0.03%, 0.05% and 0.08% blood alcohol concentrations |
Q50657538 | Laboratory analysis of risky driving at 0.05% and 0.08% blood alcohol concentration |
Q48711887 | Laboratory measurement of adaptive behavior change in humans with a history of substance dependence |
Q72843046 | Laboratory verification of “heavy” and “light” users of cannabis |
Q36090484 | Laboratory-induced stress and craving among individuals with prescription opioid dependence |
Q52274697 | Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users. |
Q69748686 | Lack of agreement between two questionnaires that evaluate the severity of the alcohol dependence syndrome |
Q70678387 | Lack of association between preference for and dependence on ethanol |
Q48273422 | Lack of association of DRD4 exon 3 VNTR genotype with reactivity to dynamic smoking cues in movies |
Q37126999 | Lack of attentional retraining effects in cigarette smokers attempting cessation: a proof of concept double-blind randomised controlled trial |
Q93370766 | Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial |
Q42953481 | Lack of inhibitory control predicts cigarette smoking dependence: evidence from a non-deprived sample of light to moderate smokers |
Q48822410 | Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons |
Q34380741 | Lack of sex differences to the subjective effects of nitrous oxide in healthy volunteers |
Q93371574 | Lamotrigine attenuates the motivation to self-administer ketamine and prevents cue- and prime-induced reinstatement of ketamine-seeking behavior in rats |
Q33716625 | Late-life and life history predictors of older adults' high-risk alcohol consumption and drinking problems |
Q102053188 | Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women |
Q36733815 | Latent class analysis of current e-cigarette and other substance use in high school students |
Q37397052 | Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio |
Q34314707 | Latent class analysis of polysubstance use, sexual risk behaviors, and infectious disease among South African drug users |
Q41085120 | Latent class analysis of substance use among men who have sex with men in Malaysia: Findings from the Asian Internet MSM Sex Survey. |
Q35842949 | Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors |
Q38705792 | Latent classes of polysubstance use among adolescents-a systematic review. |
Q37626630 | Law enforcement attitudes toward overdose prevention and response |
Q93175678 | Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review |
Q28257743 | Lefetamine: new abuse of an old drug--clinical evaluation of opioid activity |
Q114196974 | Left frontal pole repetitive transcranial magnetic stimulation reduces cigarette cue-reactivity in correlation with verbal memory performance |
Q38689166 | Left frontal pole theta burst stimulation decreases orbitofrontal and insula activity in cocaine users and alcohol users. |
Q33931864 | Left middle frontal gyrus response to inhibitory errors in children prospectively predicts early problem substance use. |
Q38617582 | Legal changes to increase access to naloxone for opioid overdose reversal in the United States |
Q89714517 | Legal requirements and recommendations to prescribe naloxone |
Q114190326 | Legal review of state emergency medical services policies and protocols for naloxone administration |
Q71473803 | Legal sanctions and information about drugs as influences upon the decision by adolescents whether to use illicit drugs |
Q50587148 | Legalizing marijuana for medical purposes will increase risk of long-term, deleterious consequences for adolescents |
Q93072101 | Leisure activities and alcohol consumption among adolescents from Peru and El Salvador |
Q94595351 | Length of hospitalization and hospital readmissions among patients with substance use disorders in New York City, NY USA |
Q71008146 | Lessons from a methadone treatment program in Laos, 1972-75 |
Q35659644 | Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats |
Q69416635 | Level of agreement between questionnaire measures of alcohol dependence, alcoholism and problem drinking in a sample presenting at a specialist alcohol treatment service |
Q40806289 | Level of education and injecting drug use among African Americans |
Q70888107 | Levels and correlates of polydrug use among heroin users and regular amphetamine users |
Q69811542 | Levels of arsenic in Indian opium eaters |
Q69020537 | Levels of arsenic in alcohol-related liver disease |
Q77462310 | Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison |
Q44336295 | Levels of opioid physical dependence in heroin addicts |
Q97539608 | Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity |
Q94595346 | Leveraging health information exchange for clinical research: Extreme underreporting of hospital service utilization among patients with substance use disorders |
Q97553030 | Leveraging immersive technology to expand access to opioid overdose reversal training in community settings: Results from a randomized controlled equivalence trial |
Q66990154 | Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts I. Dosage schedule for induction and stabilization |
Q36540636 | Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform |
Q33863689 | Liberty caps: recreational hallucinogenic mushrooms |
Q47326937 | Licit and illicit drug initiations and alcohol-related problems amongst illicit drug users in Edinburgh |
Q67399585 | Life change, disease, perception and heroin addiction |
Q58633754 | Life chaos among drug users and non-drug users |
Q45304105 | Life events and alcohol use disorder clinical course: Modeling the dynamic association |
Q46703033 | Lifecourse socioeconomic predictors of midlife drinking patterns, problems and abstention: findings from the 1958 British Birth Cohort Study |
Q36270703 | Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia |
Q44189346 | Lifetime correlates associated with amphetamine use among northern Thai men attending STD and HIV anonymous test sites |
Q72118561 | Lifetime drinking patterns of elders from a general population survey |
Q46925162 | Lifetime psychiatric comorbidity of alcohol dependence and bulimia nervosa in women |
Q35878044 | Lifetime victimization and past year alcohol use in a U.S. population sample of men and women drinkers |
Q36417293 | Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age |
Q41471940 | Limitations of scalogram analysis as a method for investigating drug use behavior |
Q40833689 | Limits of habituation and extinction: implications for relapse prevention programs in addictions. |
Q43685949 | Limits to buprenorphine dosing: a comparison between quintuple and sextuple the maintenance dose every 5 days |
Q36493705 | Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample |
Q34434374 | Linkage scan of alcohol dependence in the UCSF Family Alcoholism Study |
Q37128227 | Linking measures of adolescent nicotine dependence to a common latent continuum |
Q36520167 | Linking measures of adult nicotine dependence to a common latent continuum and a comparison with adolescent patterns |
Q47787688 | Linking patients with buprenorphine treatment in primary care: Predictors of engagement |
Q96018545 | Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose |
Q48291110 | Lipids and fatty acids in membranes from astroglial cells cultured in ethanol-containing media |
Q96680912 | Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket |
Q57816512 | Literature review of substance abuse “treatment as usual” for psychosocial interventions |
Q69748694 | Liver cirrhosis mortality in Argentina: its relationship to alcohol intake |
Q51726054 | Liver function tests in non-parenteral cocaine users. |
Q103798471 | Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature |
Q60142491 | Loaded: Gun involvement among opioid users |
Q28293572 | Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists |
Q36593564 | Location and longing: the nicotine craving experience in virtual reality |
Q87851535 | Location, location, location: Assessing the spatial patterning between marijuana licenses, alcohol outlets and neighborhood characteristics within Washington state |
Q93101167 | Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats |
Q28206079 | Locomotor stimulant effects of novel phenyltropanes in the mouse |
Q68046845 | Locus of control in couples with different patterns of alcohol consumption |
Q71141879 | Loitering by patients on methadone maintenance: a perception or a problem |
Q47302874 | Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration |
Q47807783 | Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. |
Q94548431 | Long-term changes in delay discounting following a smoking cessation treatment for patients with depression |
Q33624119 | Long-term effect of community-based treatment: evidence from the Adolescent Outcomes Project |
Q33791640 | Long-term effects of exposure to methamphetamine in adolescent rats |
Q45000247 | Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users |
Q27312340 | Long-term effects of minimum legal drinking age laws on marijuana and other illicit drug use in adulthood |
Q47771452 | Long-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial |
Q45068087 | Long-term heavy marijuana users make costly decisions on a gambling task |
Q39192052 | Long-term heroin use was associated with the downregulation of systemic platelets, BDNF, and TGF-β1, and it contributed to the disruption of executive function in Taiwanese Han Chinese |
Q48405246 | Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys |
Q91246777 | Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder |
Q88299019 | Long-term opioid use after inpatient surgery - A retrospective cohort study |
Q40587311 | Long-term outcome after benzodiazepine withdrawal treatment in subjects with complicated dependence |
Q50224381 | Long-term outcomes after adolescent in-patient treatment due to alcohol intoxication: A control group study |
Q35532106 | Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study |
Q44077896 | Long-term outcomes of adolescents treated for substance misuse |
Q35687716 | Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. |
Q24649521 | Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? |
Q38672774 | Long-term recall of social relationships related to addiction and HIV risk behaviors |
Q91211473 | Long-term use of hydrocodone vs. oxycodone in primary care |
Q90709695 | Long-term users of benzodiazepines in Colombia: Patterns of use and cessation of treatment |
Q44701188 | Long-term voluntary D-amphetamine consumption and behavioral predictors for subsequent D-amphetamine addiction in rats |
Q37081970 | Longitudinal ECG changes in cocaine users during extended abstinence |
Q96616393 | Longitudinal analysis of alcohol use and intimate partner violence perpetration among men with HIV in northern Vietnam |
Q36360618 | Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia |
Q35336367 | Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance |
Q36936208 | Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain |
Q33653589 | Longitudinal associations between depression and substance dependence from adolescence through early adulthood |
Q91599800 | Longitudinal associations between marijuana and cigar use in young adults |
Q93106966 | Longitudinal associations between minority stressors and substance use among sexual and gender minority individuals |
Q96769554 | Longitudinal associations between the disruption of incarceration and community re-entry on substance use risk escalation among Black men who have sex with men; A causal analysis |
Q92634388 | Longitudinal associations between use and co-use of cigars and cigarettes: A pooled analysis of three adolescent cohorts |
Q61707506 | Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study |
Q48600206 | Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students |
Q40509384 | Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia. |
Q41911418 | Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes |
Q91994141 | Longitudinal changes of amygdala functional connectivity in adolescents prenatally exposed to cocaine |
Q92720121 | Longitudinal effects of interoceptive awareness training through mindful awareness in body-oriented therapy (MABT) as an adjunct to women's substance use disorder treatment: A randomized controlled trial |
Q62895876 | Longitudinal patterns of amphetamine use from adolescence to adulthood: A latent class analysis of a 20-year prospective study of Australians |
Q38450725 | Longitudinal patterns of binge drinking among first year college students with a history of tobacco use. |
Q103834908 | Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach |
Q38778006 | Longitudinal patterns of marijuana use across ages 18-50 in a US national sample: A descriptive examination of predictors and health correlates of repeated measures latent class membership. |
Q34424567 | Longitudinal predictors of addictions treatment utilization in treatment-naïve adults with alcohol use disorders |
Q46858949 | Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. |
Q37631251 | Looking for the uninsured in Massachusetts? Check opioid dependent persons seeking detoxification |
Q92941616 | Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys |
Q104800265 | Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial |
Q33797662 | Losing faith and finding religion: religiosity over the life course and substance use and abuse |
Q35071095 | Loss of functional specificity in the dorsal striatum of chronic cocaine users. |
Q96113377 | Loss of naive T lymphocytes is associated with advanced liver fibrosis in alcohol use disorder |
Q37466864 | Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012. |
Q33251399 | Low bone density in patients receiving methadone maintenance treatment |
Q51888746 | Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats. |
Q34337044 | Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study |
Q37145902 | Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness |
Q38651439 | Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15. |
Q92850456 | Low overdose responding self-efficacy among adults who report lifetime opioid use |
Q42595697 | Low power? Use two-dimensional confidence regions as a graphical method for depicting uncertainty |
Q37171134 | Low prefrontal perfusion linked to depression symptoms in methadone-maintained opiate-dependent patients |
Q37167372 | Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial |
Q43198677 | Low-to-moderate alcohol consumption and smoking cessation rates: retrospective analysis of 4576 elderly ever-smokers |
Q92008106 | Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study |
Q44340044 | Lower rates of consistent urine drug tests for prescribed psychotropic medications among patients on opioid replacement therapy |
Q92721899 | Lower smoking rates and increased perceived harm of cigarettes among French adults one year after comprehensive tobacco control measures |
Q42615685 | Lower syringe sharing and re-use after syringe legalization in Rhode Island |
Q100446762 | Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence |
Q113185715 | MAPIT: Development of a computer-based intervention targeting substance abuse treatment in the criminal justice system |
Q51990374 | MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. |
Q43925609 | MDMA ('ecstasy') use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City |
Q35575169 | MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity. |
Q34216989 | MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans |
Q71389899 | MMPI subtypes and antisocial behaviors in adolescent alcohol and drug abusers |
Q37114207 | Machine-learning identifies substance-specific behavioral markers for opiate and stimulant dependence |
Q46775183 | Mad, bad and dangerous to know: dimensions and measurement of attitudes toward injecting drug users |
Q90366736 | Made from concentrate? A national web survey assessing dab use in the United States |
Q42366796 | Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder |
Q44346718 | Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up |
Q45070304 | Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys |
Q35633131 | Major depression and treatment response in adolescents with ADHD and substance use disorder |
Q30241262 | Major increases in opioid analgesic abuse in the United States: concerns and strategies |
Q91144805 | Making a bridge between general hospital and specialised community-based treatment for alcohol use disorder-A pragmatic randomised controlled trial |
Q89714507 | Making pharmacotherapy trials for substance use disorder more efficient: Leveraging real-world data capture to maximize power and expedite the medication development pipeline |
Q36499418 | Male alcohol use and unprotected sex with non-regular partners: evidence from wine shops in Chennai, India |
Q71039627 | Male and female differences in severity of problems with alcohol at the workplace |
Q44848669 | Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes |
Q35632996 | Male injection drug users try new drugs following U.S. deportation to Tijuana, Mexico. |
Q39219854 | Male solitary drinking and hazardous alcohol use in nine countries of the former Soviet Union |
Q57163343 | Male-female differences in the onset of heavy drinking episode soon after first full drink in contemporary United States: From early adolescence to young adulthood |
Q48654160 | Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol |
Q35089730 | Malnutrition in a population of HIV-positive and HIV-negative drug users living in Chennai, South India |
Q38553005 | Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol |
Q44332154 | Management of neonatal abstinence syndrome in neonates born to opioid maintained women |
Q34128519 | Management of relapse in naltrexone maintenance for heroin dependence |
Q88737522 | Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing |
Q39988739 | Manufactured and hand-rolled cigarettes and smokeless tobacco consumption in Mozambique: regional differences at early stages of the tobacco epidemic |
Q72911730 | Marihuana and sex: A critical survey |
Q69661613 | Marihuana use across the menstrual cycle |
Q71510720 | Marihuana use by pregnant women: neurobehavioral effects in neonates |
Q40457963 | Marijuana advertising exposure among current marijuana users in the U.S. |
Q90485675 | Marijuana and alcohol use among injured drivers evaluated at level I trauma centers in Arizona, 2008-2014 |
Q44994514 | Marijuana and cocaine use among female African-American welfare recipients |
Q38733864 | Marijuana and tobacco co-use among a nationally representative sample of US pregnant and non-pregnant women: 2005-2014 National Survey on Drug Use and Health findings |
Q47336955 | Marijuana buyers in the United States, 2010-2014. |
Q36938853 | Marijuana dependence moderates the effect of posttraumatic stress disorder on trauma cue reactivity in substance dependent patients |
Q57163353 | Marijuana eCHECKUPTO GO: Effects of a personalized feedback plus protective behavioral strategies intervention for heavy marijuana-using college students |
Q37589006 | Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults |
Q37233147 | Marijuana expectancies and relationships with adolescent and adult marijuana use |
Q40809346 | Marijuana initiates and their impact on future drug abuse treatment need |
Q45940507 | Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. |
Q53436195 | Marijuana use among US tobacco users: Findings from wave 1 of the population assessment of tobacco health (PATH) study. |
Q89065026 | Marijuana use among adolescent multiple tobacco product users and unique risks of dual tobacco and marijuana use |
Q47576969 | Marijuana use among adults: Initiation, return to use, and continued use versus quitting over a one-year follow-up period |
Q34021975 | Marijuana use and achievement of abstinence from alcohol and other drugs among people with substance dependence: a prospective cohort study. |
Q44070862 | Marijuana use and cessation of tobacco smoking in adults from a community sample |
Q38897343 | Marijuana use and physical dating violence among adolescents and emerging adults: A systematic review and meta-analysis. |
Q43110062 | Marijuana use and service utilization among adolescents 7 years post substance use treatment |
Q35417708 | Marijuana use and tobacco smoking cessation among heavy alcohol drinkers |
Q91345233 | Marijuana use by middle-aged and older adults in the United States, 2015-2016 |
Q64138017 | Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study |
Q47579914 | Marijuana use during pregnancy: A comparison of trends and correlates among married and unmarried pregnant women |
Q49677645 | Marijuana use is associated with hypersensitivity to multiple allergens in US adults |
Q36016493 | Marijuana use patterns among African-American middle-school students: a longitudinal latent class regression analysis |
Q61707508 | Marijuana use predicts onset of current little cigar use in a national sample of US young adults |
Q40445322 | Marijuana use trajectories among drug-using youth presenting to an urban emergency department: Violence and social influences |
Q36808312 | Marijuana use trajectories and academic outcomes among college students |
Q36495034 | Marijuana use trajectories during college predict health outcomes nine years post-matriculation |
Q36078325 | Marijuana use trajectories during the post-college transition: health outcomes in young adulthood |
Q58633953 | Marijuana users’ perceptions of health research |
Q36997018 | Marijuana withdrawal and aggression among a representative sample of U.S. marijuana users. |
Q103722813 | Marijuana, but not alcohol, use frequency associated with greater loneliness, psychological distress, and less flourishing among young adults |
Q99708416 | Marital status, partner acknowledgment of paternity, and neighborhood influences on smoking during first pregnancy: findings across race/ethnicity in linked administrative and census data |
Q47874316 | Marked ethnic differences in HIV prevalence and risk behaviors among injection drug users in Dushanbe, Tajikistan, 2004. |
Q52289476 | Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. |
Q39621028 | Matching adolescents with a cannabis use disorder to multidimensional family therapy or cognitive behavioral therapy: treatment effect moderators in a randomized controlled trial |
Q71493252 | Matching substance abuse patients to appropriate treatments: a conceptual and methodological approach |
Q44994507 | Mate similarity for substance dependence and antisocial personality disorder symptoms among parents of patients and controls |
Q36249018 | Maternal age and trajectories of cannabis use. |
Q37311494 | Maternal alcohol consumption producing fetal alcohol spectrum disorders (FASD): quantity, frequency, and timing of drinking. |
Q41670350 | Maternal alcohol use during pregnancy and offspring trajectories of height and weight: A prospective cohort study |
Q44348921 | Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine |
Q50421124 | Maternal and partner prenatal alcohol use and infant cognitive development |
Q50983411 | Maternal and paternal indoor or outdoor smoking and the risk of asthma in their children: a nationwide prospective birth cohort study. |
Q47712360 | Maternal buprenorphine treatment and infant outcome |
Q92606194 | Maternal buprenorphine treatment during pregnancy and maternal physiology |
Q36531416 | Maternal risk factors for fetal alcohol spectrum disorders in a province in Italy. |
Q35291858 | Maternal risk factors predicting child physical characteristics and dysmorphology in fetal alcohol syndrome and partial fetal alcohol syndrome |
Q35685699 | Maternal smoking cessation and reduced academic and behavioral problems in offspring |
Q69677284 | Maternal smoking during pregnancy affects children's vigilance performance |
Q40604932 | Maternal smoking during pregnancy and offspring's tobacco dependence. A study of exposure-discordant sibling pairs |
Q92297333 | Maternal use of illicit drugs, tobacco or alcohol and the risk of childhood cancer before 6 years of age |
Q42971507 | Maternal welfare, morbidity and mortality 6-15 years after a pregnancy complicated by alcohol and substance abuse: a register-based case-control follow-up study of 524 women |
Q41186770 | Mating assortment and the liability to substance abuse |
Q51593037 | Mazindol treatment for cocaine dependence. |
Q44152857 | Measurement and design issues in tobacco and drug use research |
Q100486688 | Measurement invariance and psychometric properties of Perceived Stigma toward People who use Substances (PSPS) among three types of substance use disorders: Heroin, amphetamine, and alcohol |
Q60441547 | Measurement invariance of the alcohol use disorders identification test: Establishing its factor structure in different settings and across gender |
Q35871731 | Measurement of gender-sensitive treatment for women in mixed-gender substance abuse treatment programs |
Q27312224 | Measurement of multiple nicotine dependence domains among cigarette, non-cigarette and poly-tobacco users: Insights from item response theory |
Q37276438 | Measurement of opioid problems among chronic pain patients in a general medical population |
Q37475271 | Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice |
Q51603063 | Measures of cocaine-seeking behavior using a multiple schedule of food and drug self-administration in rats. |
Q93167564 | Measures of nicotine dependence enhance interpretation of number of cigarettes smoked in youth smoking surveillance |
Q36421307 | Measures of outcome for stimulant trials: ACTTION recommendations and research agenda |
Q34091899 | Measuring addiction propensity and severity: the need for a new instrument |
Q43188947 | Measuring collaboration and integration activities in criminal justice and substance abuse treatment agencies |
Q37824767 | Measuring costs of alcohol harm to others: a review of the literature. |
Q37261023 | Measuring historical trauma in an American Indian community sample: contributions of substance dependence, affective disorder, conduct disorder and PTSD |
Q74610609 | Measuring interstate variations in drug problems |
Q33895586 | Measuring nicotine dependence among youth: a review of available approaches and instruments |
Q34634366 | Measuring pain medication expectancies in adults treated for substance use disorders |
Q34709097 | Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment |
Q90566517 | Measuring the effects on quality of life and alcohol consumption of a program to reduce binge drinking in Spanish adolescents |
Q44240599 | Measuring the learning potential of abstinent alcoholics |
Q50184358 | Measuring the stability of illicit drug markets: why does it matter? |
Q95651834 | Mechanisms for the reduction of caffeine consumption: What, how and why |
Q46321213 | Mechanisms of adolescent smoking cessation: roles of readiness to quit, nicotine dependence, and smoking of parents and peers |
Q35283662 | Mechanisms of change associated with technology-based interventions for substance use. |
Q34277682 | Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence |
Q44073051 | Mechanisms of ethanol tolerance at a cholinergic nerve terminal |
Q33716519 | Mechanisms underlying the lifetime co-occurrence of tobacco and cannabis use in adolescent and young adult twins |
Q38733862 | Media alcohol advertising with drinking behaviors among young adolescents in Taiwan |
Q90696046 | Media coverage of harm reduction, 2000-2016: A content analysis of tone, topics, and interventions in Canadian print news |
Q88360781 | Media portrayal of prenatal and postpartum marijuana use in an era of scientific uncertainty |
Q44049031 | Mediating mechanisms for the impact of bupropion in smoking cessation treatment |
Q40018550 | Mediating mechanisms of a military Web-based alcohol intervention. |
Q33650143 | Mediation designs for tobacco prevention research. |
Q47669486 | Mediation of effects of the level of response to alcohol and impulsivity 15 years later in 36-year-old men: Implications for prevention efforts |
Q115217260 | Mediational pathways among trait impulsivity, use consequences, and quit attempts in cocaine users |
Q44346681 | Mediational relations of substance use risk profiles, alcohol-related outcomes, and drinking motives among young adolescents in the Netherlands |
Q52280126 | Mediator mechanisms of cathinone effects on animal behaviour. |
Q35704357 | Mediators of a smoking cessation intervention for persons living with HIV/AIDS. |
Q104289456 | Medicaid prescription limits and their implications for naloxone accessibility |
Q92070228 | Medicaid trends in prescription opioid and non-opioid use by HIV status |
Q35616765 | Medical and nonmedical use of prescription pain medication by youth in a Detroit-area public school district |
Q35228118 | Medical marijuana diversion and associated problems in adolescent substance treatment |
Q46638742 | Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs |
Q35651468 | Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence |
Q39557460 | Medical marijuana legalization and cigarette and marijuana co-use in adolescents and adults |
Q38750804 | Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. |
Q38834312 | Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration |
Q34535192 | Medical service use and financial charges among opioid users at a public hospital |
Q90378753 | Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: Differences by insurance status |
Q44336081 | Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA. |
Q38367241 | Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder |
Q97590278 | Medications for opioid use disorder in pregnancy in a state women's prison facility |
Q43944867 | Medico-legal aspects of treatment and prophylactic care of narcotic drug addicts |
Q69589529 | Mefenorex (Rondimen) |
Q94683484 | Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review |
Q36297525 | Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults |
Q34510484 | Memory functioning in polysubstance dependent women |
Q46489637 | Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. |
Q90130172 | Men's age at first birth and alcohol-related morbidity and mortality among siblings |
Q36368385 | Menstrual cycle phase and responses to drugs of abuse in humans |
Q34468802 | Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion |
Q92556851 | Menstrual cycle phase modulates responses to smoking cues in the putamen: Preliminary evidence for a novel target |
Q57389801 | Menstrual disturbances and fertility in chronic alcoholic women |
Q104492855 | Mental and physical health in family members of substance users: A scoping review |
Q46790551 | Mental disorders and smoking trajectories: a 10-year prospective study among adolescents and young adults in the community |
Q33961393 | Mental disorders in ecstasy users: a prospective-longitudinal investigation |
Q90001571 | Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain |
Q52104782 | Mental health in first grade and teenage drug, alcohol, and cigarette use. |
Q46166414 | Mental health of heroin users with differing injection drug use histories: A non-treatment sample of Mexican American young adult men. |
Q40743200 | Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers. |
Q52077692 | Mental rehearsal of a task before or after ethanol: tolerance facilitating effects. |
Q42409901 | Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation |
Q37706820 | Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats |
Q34012500 | Meta-analysis of depression and substance use and impairment among cocaine users |
Q39042239 | Meta-analysis of six genes (BDNF, DRD1, DRD3, DRD4, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence |
Q39096742 | Meta-analysis of the relationship between impulsivity and substance-related cognitive biases |
Q68249647 | Metabolic disposition of 2-phenylethylamine and the role of depression in methadone-dependent and detoxified patients |
Q47332501 | Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse. |
Q39243193 | Metabolic phenotyping of urine for discriminating alcohol-dependent from social drinkers and alcohol-naive subjects |
Q67019749 | Metabolic tolerance to ethanol. Moderator's comments |
Q66972159 | Metabolic tolerance to ethanol. Rapporteurs' report |
Q37346293 | Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey |
Q37282456 | Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial |
Q70905538 | Methadone disposition following oral versus parenteral dose administration in rats during chronic treatment |
Q72048563 | Methadone dosages and therapeutic compliance during a methadone maintenance program |
Q72658670 | Methadone dose and treatment outcome |
Q37033936 | Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia |
Q45352727 | Methadone maintenance and cancer risk: an Israeli case registry study |
Q34176572 | Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan |
Q37700353 | Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response |
Q46839236 | Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico |
Q50634641 | Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence |
Q39324890 | Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use. |
Q100957520 | Methadone maintenance therapy service components linked to improvements in HIV care cascade outcomes: A systematic review of trials and observational studies |
Q91647640 | Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months |
Q42998327 | Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users |
Q36637864 | Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity |
Q37023241 | Methadone patients in the therapeutic community: a test of equivalency |
Q43620007 | Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials. |
Q43470765 | Methadone treatment in Spain, 1994. |
Q42677719 | Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian |
Q91384334 | Methadone treatment of arrestees: A randomized clinical trial |
Q52653848 | Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. |
Q72125547 | Methadone use in patients with chronic renal disease |
Q36619638 | Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis |
Q73434132 | Methadone, methadone treatment and non-fatal overdose |
Q39235901 | Methadone-assisted rehabilitation of Swedish heroin addicts |
Q49071737 | Methadone-maintained males' reactions to success and failure: causal attributions, self-efficacy, and attitudes toward heroin |
Q39490487 | Methadone-maintenance outcomes for Hispanic and African-American men and women |
Q90133150 | Methamphetamine and Opioid Cue Database (MOCD): Development and Validation |
Q37463557 | Methamphetamine and other substance use trends among street-recruited men who have sex with men, from 2008 to 2011. |
Q37141557 | Methamphetamine dependent individuals show attenuated brain response to pleasant interoceptive stimuli |
Q35703205 | Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada |
Q39961491 | Methamphetamine injection and syringe sharing among a community-recruited sample of injection drug users in Bangkok, Thailand |
Q58566025 | Methamphetamine use and cognitive function: A systematic review of neuroimaging research |
Q52582675 | Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications. |
Q92575289 | Methamphetamine use and violence: Findings from a longitudinal birth cohort |
Q92225566 | Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial |
Q36301137 | Methamphetamine use is associated with childhood sexual abuse and HIV sexual risk behaviors among patrons of alcohol-serving venues in Cape Town, South Africa |
Q33624189 | Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults |
Q37200552 | Methamphetamine use, aggressive behavior and other mental health issues among high-school students in Cape Town, South Africa |
Q38070239 | Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. |
Q46125789 | Methamphetamine-alcohol interactions in murine models of sequential and simultaneous oral drug-taking. |
Q30435613 | Methamphetamine-induced behavioral sensitization in a rodent model of posttraumatic stress disorder |
Q46890344 | Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs |
Q34973698 | Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment |
Q34181746 | Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature |
Q57380518 | Methodological considerations in cognitive bias research: The next steps |
Q43515111 | Methods for enhancing transition of substance dependent patients from inpatient to outpatient treatment |
Q36920488 | Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time |
Q50154380 | Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). |
Q33541921 | Methods used to detect drug abuse in pregnancy: a brief review |
Q37552221 | Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology |
Q47683932 | Methylphenidate disintegration from oral formulations for intravenous use by experienced substance users. |
Q36213502 | Mexican immigration to the US and alcohol and drug use opportunities: does it make a difference in alcohol and/or drug use? |
Q48118194 | Mexico's precursor chemical controls: emergence of less potent types of methamphetamine in the United States |
Q52061621 | Michigan Alcoholism Screening Test (MAST)--its possibilities and shortcomings as a screening device in a pre-selected non-clinical population. |
Q90696051 | MicroNIR/Chemometrics: A new analytical platform for fast and accurate detection of Δ9-Tetrahydrocannabinol (THC) in oral fluids |
Q51827815 | Midazolam oral self-administration. |
Q36813560 | Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge |
Q37164723 | Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature. |
Q26745840 | Mindfulness meditation improves emotion regulation and reduces drug abuse |
Q39310012 | Mindfulness practice moderates the relationship between craving and substance use in a clinical sample. |
Q36746540 | Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. |
Q35317350 | Mindfulness training for smoking cessation: results from a randomized controlled trial |
Q92568992 | Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial |
Q48575968 | Minor orthopaedic disease: registration for alcoholism and serum gamma-glutamyltransferase in men. |
Q34863447 | Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference |
Q58131549 | Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders |
Q30877467 | Missing data in substance abuse research? Researchers' reporting practices of sexual orientation and gender identity |
Q36116697 | Misuse of methamphetamine and prescription stimulants among youths and young adults in the community. |
Q90130182 | Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism |
Q53577484 | Mixed-amphetamine salts expectancies among college students: Is stimulant induced cognitive enhancement a placebo effect? |
Q33442209 | Mobile phone ownership, usage and readiness to use by patients in drug treatment |
Q44394305 | Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study |
Q36619373 | Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence |
Q33744007 | Modafinil does not serve as a reinforcer in cocaine abusers |
Q24652419 | Modafinil for the treatment of cocaine dependence |
Q35583271 | Modafinil for the treatment of methamphetamine dependence |
Q37418649 | Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression. |
Q100758554 | Model and approach for assessing implementation context and fidelity in the HEALing Communities Study |
Q30613414 | Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study |
Q37366155 | Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory. |
Q34625711 | Modeling substance use in emerging adult gay, bisexual, and other YMSM across time: the P18 cohort study. |
Q34001086 | Modeling the impact of age and sex on a dimension of poly-substance use in adolescence: a longitudinal study from 11- to 17-years-old |
Q45401392 | Modelling the hepatitis C virus epidemic in Australia |
Q42288989 | Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing |
Q38667949 | Moderate and vigorous physical activity patterns among marijuana users: Results from the 2007-2014 National Health and Nutrition Examination Surveys |
Q37164840 | Moderate/heavy alcohol use and HCV infection among injection drug users in two Russian cities |
Q36409501 | Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults. |
Q36495150 | Moderators and mediators of the relationship between receiving versus being denied a pregnancy termination and subsequent binge drinking |
Q71736716 | Modern treatment of substance abuse |
Q38095245 | Modernizing methodology for the WHO assessment of substances for the international drug control conventions |
Q89729210 | Modes of marijuana use - smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States |
Q40105590 | Modification of glycoprotein residues as Ca2+ receptor sites after chronic ethanol exposure |
Q70564087 | Modification of the drug talking behavior in rats by interference in the metabolism of 5-hydroxytryptamine and catecholamines |
Q43774552 | Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males |
Q35947830 | Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: a longitudinal perfusion fMRI study |
Q42930209 | Modulation of risk-taking in marijuana users by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC). |
Q34565591 | Modulation of smoking and decision-making behaviors with transcranial direct current stimulation in tobacco smokers: a preliminary study |
Q36737704 | Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women |
Q91195640 | Momentary fluctuations in impulsivity domains: Associations with a history of childhood ADHD, heavy alcohol use, and alcohol problems |
Q99547723 | Momentary patterns of impulsivity and alcohol use: A cause or consequence? |
Q58633800 | Monetary payment for research participation: What do marijuana users think? |
Q68822647 | Monitoring changing patterns of drug dependence in accident and emergency departments |
Q91092274 | Monitoring consumption of methadone and heroin in major Chinese cities by wastewater-based epidemiology |
Q114261733 | Monitoring marijuana use and risk perceptions with Google Trends data |
Q30881909 | Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre |
Q91854728 | Monitoring opioid addiction and treatment: Do you know if your population is engaged? |
Q43277526 | Monitoring risk: post marketing surveillance and signal detection |
Q30407764 | Monoamine polygenic liability in health and cocaine dependence: imaging genetics study of aversive processing and associations with depression symptomatology |
Q44070858 | Mood and anxiety symptoms among 140 children from alcoholic and control families |
Q51105034 | Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. |
Q51082351 | Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. |
Q48421801 | Moral decision-making in polysubstance dependent individuals. |
Q43408051 | Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study |
Q91992886 | More drugs, more problems? Simultaneous use of alcohol and marijuana at parties among youth and young adults |
Q36248999 | More than just someone to inject drugs with: Injecting within primary injection partnerships |
Q38661249 | Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant users |
Q44715345 | Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat. |
Q40714142 | Morphine responses in humans: a retrospective analysis of sex differences |
Q45105118 | Morphine tolerance-induced modulation of [3H]glyburide binding to mouse brain and spinal cord |
Q24646270 | Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6 |
Q68801967 | Morphologic changes of small intestine epithelium in the course of post-alcoholic liver cirrhosis |
Q33904304 | Morphometric abnormalities of the lateral ventricles in methamphetamine-dependent subjects |
Q48429084 | Morphometric changes in alcoholic mice of neurons of areas 6 and 17 and ependyma of the subcommissural organ |
Q37561850 | Mortality among amphetamine users: a systematic review of cohort studies |
Q38449652 | Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved |
Q43583622 | Mortality among clients seeking treatment for buprenorphine abuse in Finland. |
Q33688746 | Mortality among cocaine users: a systematic review of cohort studies |
Q43214981 | Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study |
Q36676321 | Mortality among heroin users and users of other internationally regulated drugs: A 27-year follow-up of users in the Epidemiologic Catchment Area Program household samples. |
Q44348152 | Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment |
Q38390784 | Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS). |
Q35027505 | Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011 |
Q46651948 | Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs. |
Q39077677 | Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012. |
Q88870247 | Mortality and causes of death among people who inject amphetamine: A long-term follow-up cohort study from a needle exchange program in Sweden |
Q46920511 | Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999-2008. |
Q40405818 | Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study. |
Q41131441 | Mortality from alcohol consumption and alcohol use disorder: Findings from the Vietnam Experience Study |
Q43663455 | Mortality in alcohol use disorder in the Lundby Community Cohort--a 50 year follow-up |
Q46588020 | Mortality in heroin-assisted treatment in Switzerland 1994-2000. |
Q43567416 | Mortality in patients with dependence on prescription drugs |
Q43774542 | Mortality of opiate users in Vienna, Austria |
Q44337311 | Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study |
Q30313973 | Motivating smokers to quit using computer-generated letters that target either reduction or cessation: A population-based randomized controlled trial among smokers who do not intend to quit. |
Q37473987 | Motivation Enhancement Therapy with pregnant substance-abusing women: does baseline motivation moderate efficacy? |
Q43765709 | Motivation for alcohol in rats: position and bottle preferences do not cause drinking |
Q35836541 | Motivational assessment of non-treatment buprenorphine research participation in heroin dependent individuals |
Q45330844 | Motivational interview improves treatment entry in homeless veterans |
Q44477920 | Motivational interviewing combined with chess accelerates improvement in executive functions in cocaine dependent patients: a one-month prospective study |
Q36662456 | Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study |
Q35156728 | Motivational interviewing to reduce substance-related consequences: effects for incarcerated adolescents with depressed mood |
Q35211237 | Motivational profiles of clients seeking methadone maintenance therapy in China |
Q39729659 | Motivationally enhanced group counseling for substance users in a soup kitchen: a randomized clinical trial |
Q98299673 | Motivations for opioid and stimulant use among drug using black sexual minority men: A life course perspective |
Q39688624 | Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs. |
Q35783081 | Motives for smoking in movies affect future smoking risk in middle school students: an experimental investigation |
Q34607261 | Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals |
Q46830775 | Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres |
Q92634395 | Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia |
Q31014426 | Multi-level analysis of causal attribution of injury to alcohol and modifying effects: Data from two international emergency room projects |
Q39450592 | Multi-level covariance structure analysis of intra-familial substance use. |
Q47308179 | Multi-phasic Questionnaire profile of alcoholics and related factors |
Q103722825 | Multi-session electrical neuromodulation effects on craving, relapse and cognitive functions in cocaine use disorder: A randomized, sham-controlled tDCS study |
Q47321386 | Multi-site exploration of sex differences in brain reactivity to smoking cues: Consensus across sites and methodologies. |
Q57484977 | Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data |
Q60144145 | Multidimensional assessment of cue-elicited increases in incentive salience for marijuana |
Q45284800 | Multidimensional assessment of nicotine dependence in adolescents |
Q46631918 | Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: a randomised controlled trial in Western European outpatient settings |
Q39957020 | Multilevel influences of school and family on alcohol-purchasing behaviors in school-aged children |
Q91804550 | Multimodal assessment of sleep in men and women during treatment for opioid use disorder |
Q35174502 | Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors |
Q96762366 | Multiple drug use disorder diagnoses among drug-involved hospitalizations in the United States: Results from the 2016 National Inpatient Sample |
Q41467902 | Multiple family therapy and naltrexone in the treatment of opiate dependence |
Q83332457 | Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China |
Q40670128 | Multiple substance use patterns in adolescents-A multilevel latent class analysis |
Q48874394 | Multivariate analysis of behaviour related to alcohol abuse in rats |
Q70643973 | Multivariate analysis of familial and non-familial influences for commonality in drug use |
Q45714785 | Multivariate family factors in lifetime and current marijuana use among American Indian and white adolescents residing on or near reservations |
Q80272951 | Multivariate framework of the Brief Questionnaire of Smoking Urges |
Q43570049 | Multiwave analysis of retest artifact in the National Longitudinal Survey of Youth drug use. |
Q36381393 | Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine. |
Q44267073 | Mutagenic activity of aldehydes |
Q36095762 | Mutual influence in therapist competence and adherence to motivational enhancement therapy |
Q47825865 | N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order. |
Q39900665 | NIDA 35-year anniversary: Past lessons, present accomplishments and future challenges (2001-2003). |
Q46592670 | NIDA drug supply and analytical services program: providing research resources and tools to the scientific community |
Q43162017 | NIDA in the 90s: (1994-2001). |
Q43162025 | NIDA, this is your life |
Q36773254 | NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent |
Q51866518 | NR2B subunit of NMDA receptor at nucleus accumbens is involved in morphine rewarding effect by siRNA study. |
Q34564244 | Nalbuphine |
Q46975517 | Nalbuphine is effective in decreasing the rewarding effect induced by morphine in rats |
Q44331738 | Nalmefene: blockade of intravenous morphine challenge effects in opioid abusing humans |
Q57177971 | Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States |
Q42008314 | Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study. |
Q38782369 | Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal |
Q51850898 | Naloxone-induced taste aversions in opiate-naïve Lewis and Fischer 344 rat strains. |
Q33653182 | Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. |
Q59768935 | Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification |
Q51080825 | Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans. |
Q35000244 | Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study |
Q39020096 | Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures |
Q28374621 | Naltrexone shortened opioid detoxification with buprenorphine |
Q37638805 | Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? |
Q41616332 | Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison |
Q49014499 | Naltrexone treatment of heroin addiction: one-year follow-up |
Q67594492 | Naltrexone treatment of opiate-dependent persons |
Q37677214 | Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia |
Q30492342 | Narcotic addiction in two Asian cultures: a comparison and analysis |
Q39136305 | Narcotic and narcotic antagonist pKa's and partition coefficients and their significance in clinical practice |
Q52299272 | Narcotic-reinforced responding: a rapid evaluation procedure. |
Q95825123 | National Institute on Drug Abuse at its first 35 years |
Q36090205 | National multi-cohort time trends in adolescent risk preference and the relation with substance use and problem behavior from 1976 to 2011 |
Q34959778 | National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009. |
Q39618340 | National trends in alcohol pharmacotherapy: Findings from an Australian claims database |
Q37604339 | National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. |
Q50881884 | National-level drug policy and young people's illicit drug use: a multilevel analysis of the European Union. |
Q36011523 | Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions. |
Q46105253 | Naturalistic changes in the readiness of postpartum women to quit smoking |
Q89714513 | Naturalistic measurement of dual cue attentional bias in moderate to heavy-drinking smokers: A preliminary investigation |
Q47764356 | Nature versus intensity of intoxication: Co-ingestion of alcohol and energy drinks and the effect on objective and subjective intoxication |
Q35875443 | Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin users |
Q42609607 | Needle exchange program participation by anabolic steroid injectors, United States 1998. |
Q42636455 | Needle sharing in opioid-dependent outpatients: psychological processes underlying risk |
Q42640971 | Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting. |
Q36502743 | Needs and scientific opportunities for research on substance abuse treatment among Hispanic adults |
Q90343739 | Negative and positive life events and their relation to substance and behavioral addictions |
Q129750375 | Negative consequences associated with daily alcohol use as a nonlinear function of number of drinks in a daily diary study |
Q50894508 | Negative emotion-driven impulsivity predicts substance dependence problems. |
Q90587133 | Negative experiences of pain and withdrawal create barriers to abscess care for people who inject heroin. A mixed methods analysis |
Q35798687 | Negative reinforcement learning is affected in substance dependence |
Q30459500 | Negative reinforcement smoking outcome expectancies are associated with affective response to acute nicotine administration and abstinence |
Q93106984 | Negative urgency and ad-libitum smoking topography |
Q43531901 | Negative urgency, disinhibition and reduced temporal pole gray matter characterize the comorbidity of cocaine dependence and personality disorders. |
Q37302896 | Negative urgency, mood induction, and alcohol seeking behaviors |
Q36463342 | Neighborhood characteristics and the initiation of marijuana use and binge drinking |
Q36368367 | Neighborhood context and substance use disorders: a comparative analysis of racial and ethnic groups in the United States |
Q40482366 | Neighborhood disorder, peer network health, and substance use among young urban adolescents. |
Q34259031 | Neighborhood education inequality and drinking behavior. |
Q39439976 | Neighborhood environment and opportunity to use cocaine and other drugs in late childhood and early adolescence |
Q37590558 | Neighborhood of residence and risk of initiation into injection drug use among street-involved youth in a Canadian setting |
Q37147630 | Neighborhood smoking norms modify the relation between collective efficacy and smoking behavior. |
Q39424131 | Neighborhood socioeconomic characteristics, the retail environment, and alcohol consumption: a multilevel analysis. |
Q37204939 | Neighborhood socioeconomic status and substance use by U.S. adults |
Q37574417 | Neighborhood-level LGBT hate crimes and current illicit drug use among sexual minority youth |
Q35661027 | Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS |
Q41735755 | Neighbourhood crime and adolescent cannabis use in Canadian adolescents |
Q45000235 | Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure |
Q33982854 | Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy |
Q44335330 | Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. |
Q42415953 | Network Support II: Randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder |
Q36885269 | Network analysis of substance abuse and dependence symptoms |
Q52300164 | Networks of verbal habits for drugs. |
Q103722818 | Neural activation during anticipation of monetary gain or loss does not associate with positive subjective response to alcohol in binge drinkers |
Q35522915 | Neural activation during inhibition predicts initiation of substance use in adolescence. |
Q59540394 | Neural activity in childhood predicts adolescent substance use initiation |
Q34751439 | Neural basis of inhalant abuse |
Q27312041 | Neural correlates of cigarette health warning avoidance among smokers. |
Q90016533 | Neural correlates of visual attention in alcohol use disorder |
Q30547526 | Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder |
Q47563051 | Neural response to errors is associated with problematic alcohol use over time in combat-exposed returning veterans: An event-related potential study |
Q52166063 | Neural responses associated with cue evoked emotional states and heroin in opiate addicts. |
Q34808522 | Neural reward and punishment sensitivity in cigarette smokers |
Q92850955 | Neural reward response to substance-free activity images in opiate use disorder patients with depressive symptoms |
Q48405820 | Neuroadaptations involved in amphetamine and cocaine addiction |
Q45157510 | Neurobehavior disinhibition in childhood predicts suicide potential and substance use disorder by young adulthood |
Q34290144 | Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood: direct and mediated etiologic pathways |
Q37380642 | Neurobehavior disinhibition, parental substance use disorder, neighborhood quality and development of cannabis use disorder in boys |
Q36227513 | Neurobehavioral disinhibition predicts initiation of substance use in children with prenatal cocaine exposure |
Q31021713 | Neurobiological phenotypes associated with a family history of alcoholism |
Q44340290 | Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. |
Q47651598 | Neurochemical and behavioural correlates of the interaction between amphetamine and Δ9-tetrahydrocannabinol in the rat |
Q67020053 | Neurochemical aspects in pathogenesis of alcohol and drug dependence |
Q48913202 | Neurochemical similarities between d,l-cathinone and d-amphetamine |
Q36009932 | Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. |
Q37075300 | Neurocognitive deficits are associated with unemployment in chronic methamphetamine users |
Q99242650 | Neurocognitive performance in alcohol use disorder using the NIH toolbox: Role of severity and sex differences |
Q44071037 | Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure |
Q39729497 | Neurocognitive skills moderate urban male adolescents' responses to preventive intervention materials. |
Q43685941 | Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans |
Q34208002 | Neuroendocrine responses to experimentally-induced emotions among abstinent opioid-dependent subjects. |
Q92499402 | Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent |
Q44730103 | Neurological and cognitive impairment associated with leaded gasoline encephalopathy |
Q68249650 | Neurological assessment of patients on prolonged methadone maintenance |
Q48383436 | Neuronal depletion in the globus pallidus of heroin addicts |
Q66972160 | Neuronal membranes, calcium and tolerance and dependence. Rapporteurs' report |
Q48230823 | Neurophysiological capacity in a working memory task differentiates dependent from nondependent heavy drinkers and controls |
Q47587781 | Neurophysiological, psychological and behavioural correlates of rTMS treatment in alcohol dependence |
Q45161014 | Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study |
Q90039466 | Neuropsychiatric characterization of individuals with inhalant use disorder and polysubstance use according to latent profiles of executive functioning |
Q39144289 | Neuropsychological deficit in polydrug users. A preliminary report of the findings of the collaborative neuropsychological study of polydrug users |
Q44026557 | Neuropsychological deficits and opiate abuse |
Q35624088 | Neuropsychological deficits associated with cannabis use in young adults |
Q51665297 | Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. |
Q42542421 | Neuropsychological functioning in drug abusers |
Q46489623 | Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers |
Q24681779 | Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment |
Q52128078 | Neuropsychological performance in opiate addicts after rapid detoxification. |
Q35685490 | Neuropsychological performance of South African treatment-naïve adolescents with alcohol dependence |
Q33801746 | Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence |
Q42279864 | Neuropsychological performance of recently abstinent alcoholics and cocaine abusers |
Q46863214 | Neuropsychological predictors of clinical outcome in opiate addiction |
Q46222154 | Neuroscience education for health profession undergraduates in a call-center for drug abuse prevention |
Q48715281 | Neurotransmitter transporters as molecular targets for addictive drugs. |
Q72843050 | Neutralization of the effect of delta 9-tetrahydrocannabinol on barbiturate sleeping time by specific active immunization |
Q92176847 | New approach for the measurement of long-term alcohol consumption trends: Application of wastewater-based epidemiology in an Australian regional city |
Q30573588 | New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users |
Q57449398 | New generation tamoxifen analogs as potential treatments for amphetamine abuse |
Q80163465 | New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure |
Q71210066 | New patients versus revolving door patients |
Q47720149 | New product trial, use of edibles, and unexpected highs among marijuana and hashish users in Colorado |
Q39994404 | New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015. |
Q43235490 | Newborns' cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers |
Q104470999 | News and social media coverage is associated with more downloads and citations of manuscripts that focus on substance use |
Q38611345 | Next generation of novel psychoactive substances on the horizon - A complex problem to face |
Q51091427 | Nicodermal patch adherence and its correlates. |
Q120360539 | Nicotine acutely alters temporal properties of resting brain states |
Q46744251 | Nicotine addiction: past, present and future. Marian Fischman lecture given at the 2007 meeting of CPDD. |
Q36649143 | Nicotine and methamphetamine share discriminative stimulus effects |
Q49597796 | Nicotine as a discriminative stimulus for ethanol use. |
Q35184463 | Nicotine behavioral pharmacology: clues from planarians |
Q38661924 | Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency |
Q41640343 | Nicotine concentration of e-cigarettes used by adolescents |
Q47837765 | Nicotine dependence among clients receiving publicly funded substance abuse treatment |
Q36037208 | Nicotine dependence and comorbid psychiatric disorders: examination of specific genetic variants in the CHRNA5-A3-B4 nicotinic receptor genes |
Q37357248 | Nicotine dependence and genetic variation in the nicotinic receptors |
Q33374945 | Nicotine dependence and psychiatric and substance use comorbidities in a sample of American Indian male veterans |
Q45972755 | Nicotine dependence and psychiatric and substance use disorder comorbidities among American Indians/Alaska Natives: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. |
Q34605163 | Nicotine dependence as a moderator of a quitline-based message framing intervention |
Q33893086 | Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome |
Q52572220 | Nicotine dependence predicts cannabis use disorder symptoms among adolescents and young adults. |
Q33624822 | Nicotine dependence symptoms among recent onset adolescent smokers. |
Q34074843 | Nicotine dependence, "background" and cue-induced craving and smoking in the laboratory |
Q33625959 | Nicotine elicits methamphetamine-seeking in rats previously administered nicotine |
Q34022102 | Nicotine exposure beginning in adolescence enhances the acquisition of methamphetamine self-administration, but not methamphetamine-primed reinstatement in male rats |
Q46627190 | Nicotine increases alcohol self-administration in non-dependent male smokers |
Q33451603 | Nicotine levels, withdrawal symptoms, and smoking reduction success in real world use: A comparison of cigarette smokers and dual users of both cigarettes and E-cigarettes |
Q45284824 | Nicotine lozenge efficacy in light smokers |
Q93015893 | Nicotine matters in predicting subsequent smoking after e-cigarette experimentation: A longitudinal study among Finnish adolescents |
Q51909058 | Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking. |
Q89499851 | Nicotine metabolite ratio predicts smoking topography: The Pennsylvania Adult Smoking Study |
Q112295423 | Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies |
Q59417105 | Nicotine mydriasis |
Q33709630 | Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program |
Q37186254 | Nicotine percentage replacement among smokeless tobacco users with nicotine patch |
Q93346633 | Nicotine pre-treatment reduces sensitivity to the interoceptive stimulus effects of commonly abused drugs as assessed with taste conditioning paradigms |
Q94500693 | Nicotine reduction does not alter essential value of nicotine or reduce cue-induced reinstatement of nicotine seeking |
Q36640128 | Nicotine related brain activity: the influence of smoking history and blood nicotine levels, an exploratory study |
Q35673450 | Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats |
Q33716576 | Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders |
Q52275176 | Nicotine, caffeine and alcohol use in high- and low-dose benzodiazepine users. |
Q78245997 | Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice |
Q57403491 | No association between the c2 allele at the cytochrome P450IIE1 gene and alcohol induced liver disease, alcohol Korsakoff's syndrome or alcohol dependence syndrome |
Q35083939 | No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample |
Q48942336 | No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. |
Q96634957 | No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users |
Q30547529 | No untoward effects of smoking cues in anti-smoking public service announcements |
Q88503818 | Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice |
Q64091246 | Non drug-related and opioid-specific causes of 3262 deaths in Scotland's methadone-prescription clients, 2009-2015 |
Q30743487 | Non-cigarette tobacco and poly-tobacco use among persons living with HIV drawn from a nationally representative sample |
Q35100126 | Non-daily smoking predicts hazardous drinking and alcohol use disorders in young adults in a longitudinal U.S. sample |
Q91402435 | Non-fatal drug overdose after release from prison: A prospective data linkage study |
Q39432778 | Non-fatal injuries and the use of psychoactive drugs among young adults in Spain |
Q58555044 | Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014 |
Q43496113 | Non-fatal overdose among adult prisoners with a history of injecting drug use in two Australian states |
Q34470475 | Non-fatal overdose and subsequent drug treatment among injection drug users |
Q36803528 | Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs |
Q33636934 | Non-fatal overdose in the 12 months following treatment for substance use disorders |
Q35844048 | Non-injection drug use and Hepatitis C Virus: a systematic review |
Q57213280 | Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico |
Q30233730 | Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. |
Q103722828 | Non-invasive brain stimulation as a tool to decrease chronic pain in current opiate users: A parametric evaluation of two promising cortical targets |
Q39365846 | Non-medical drug use amongst non-student youth in India |
Q38912664 | Non-medical opioid use and sources of opioids among pregnant and non-pregnant reproductive-aged women |
Q34167572 | Non-medical use of non-opioid psychotherapeutic medications in a community-based cohort of HIV-infected indigent adults |
Q57299912 | Non-medical use of prescription drugs and cultural orientation among college students in China |
Q34334023 | Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults |
Q36328495 | Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey |
Q50627256 | Non-medical use of prescription stimulants for academic purposes among college students: a test of social learning theory. |
Q46863217 | Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates |
Q37098953 | Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates |
Q92568988 | Non-nicotine constituents in e-cigarette aerosol extract attenuate nicotine's aversive effects in adolescent rats |
Q42438136 | Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin |
Q95644069 | Non-pharmacological interventions for methamphetamine use disorder: a systematic review |
Q50203933 | Non-physiological mechanisms influencing disulfiram treatment of alcohol use disorder: A grounded theory study |
Q34585668 | Non-prescribed use of pain relievers among adolescents in the United States |
Q40910579 | Non-prescribed use of psychoactive prescription drugs among drug-impaired drivers in Sweden |
Q46135292 | Non-response bias in a community survey of drinking, alcohol-related experiences and public opinion on alcohol policy |
Q36562437 | Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects |
Q89346235 | Non-suicidal self-injury in Chinese heroin-dependent patients receiving methadone maintenance treatment: Prevalence and associated factors |
Q33872247 | Non-treatment laboratory stress- and cue-reactivity studies are associated with decreased substance use among drug-dependent individuals |
Q36744409 | Non-treatment-seeking heavy drinkers: effects of chronic cigarette smoking on brain structure |
Q91608782 | Nonhuman animal models of substance use disorders: Translational value and utility to basic science |
Q52609885 | Nonmedical opioid use among electronic dance music party attendees in New York City. |
Q36421383 | Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors |
Q46963073 | Nonmedical prescription opioids and pathways of drug involvement in the US: Generational differences |
Q36540000 | Nonmedical prescription pain reliever and alcohol consumption among cannabis users |
Q63313855 | Nonmedical use of oxycodone and other opiate analgesics in the US, 2004–2011: Are military veterans at increased risk? |
Q46664441 | Nonmedical use of prescription drugs among a longitudinal sample of dependent and problem drinkers |
Q46946485 | Nonmedical use of prescription stimulants in the United States |
Q44878982 | Nonprescription syringe sales: Resistant pharmacists' attitudes and practices |
Q34167558 | Nonresponse bias in a longitudinal measurement design examining substance use across the transition out of high school |
Q51105028 | Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis. |
Q34650511 | Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups |
Q70361772 | Normal electroretinogram and no toxicity signs after chronic and acute administration of the alcohol dehydrogenase inhibitor 4-methylpyrazole to the cynomolgus monkey (Macaca fascicularis) — A possible new treatment of methanol poisoning |
Q57163350 | Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine |
Q60619459 | Normal testosterone plasma levels in non-abstinent alcoholics |
Q47778104 | Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study |
Q57177967 | Not just heroin: Extensive polysubstance use among US high school seniors who currently use heroin |
Q54296062 | Notes on prediction of behavioural change in evaluation of drug education |
Q90714882 | Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice |
Q104571671 | Novel circuit biomarker of impulsivity and craving in male heroin-dependent individuals |
Q52316805 | Novel prodrug PRX-P4-003, selectively activated by gut enzymes, may reduce the risk of iatrogenic addiction and abuse. |
Q58439956 | Novel psychoactive substance use in the European Union |
Q31870887 | Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users |
Q48505152 | Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats |
Q73795242 | Nutritional assessment in alcoholic patients. Its relationship with alcoholic intake, feeding habits, organic complications and social problems |
Q51607590 | Nutritional assessment of drug addicts. |
Q33921223 | OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models |
Q34033147 | OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences |
Q48436575 | Obituary. Stephen G. Holtzman |
Q30362582 | Obituary:Nancy K.Mello,Ph.D.(March 20,1935–November 25,2013). |
Q37528673 | Objective and perceived neighborhood characteristics and tobacco use among young adults |
Q36971104 | Objective and specific tracking of anhedonia via event-related potentials in individuals with cocaine use disorders. |
Q52270469 | Objectives perceived by administrators within the 'decision to divert network': conflict and resolution. |
Q71736692 | Observations on a decade of alcohol and drug dependence research |
Q44348517 | Observed transition from opioid analgesic deaths toward heroin |
Q33811199 | Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints |
Q45090500 | Occupation and alcohol-related causes of death |
Q39981935 | Occupational and demographic factors associated with drug use among female sex workers at the China-Myanmar border. |
Q52267320 | Occurrence and patterns of driving behavior for alcoholics in treatment. |
Q39254252 | Older marijuana users: Life stressors and perceived social support |
Q39695906 | Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders |
Q33522859 | On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data |
Q90594472 | On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine |
Q36092293 | On the development of nicotine dependence in adolescence |
Q94587323 | On the discounting of cannabis and money: Sensitivity to magnitude vs. delay |
Q37585526 | On the importance of the psychotropic effects of alcohol |
Q91171202 | On the limitations of the Alcohol Use Disorders Identification Test (AUDIT) |
Q44677803 | On the predictive validity of automatically activated approach/avoidance tendencies in abstaining alcohol-dependent patients |
Q57575110 | On the relative importance of D-1 vs. D-2 dopaminergic receptors in the control of audiogenic seizures in ethanol withdrawn rats |
Q47217585 | Ondansetron does not prevent physical dependence in patients taking opioid medications chronically for pain control |
Q35661177 | One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone |
Q48421994 | One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving |
Q73795244 | One year follow-up of cannabis dependence among long-term users in Sydney, Australia |
Q46847452 | One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). |
Q77634928 | One-year mortality rates following methadone treatment discharge |
Q40757707 | One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence |
Q36557039 | Online survey characterizing vaporizer use among cannabis users |
Q34400345 | Onset and course of alcoholism over 25 years in middle class men |
Q43685947 | Onset and pattern of substance use in intravenous drug users of an opiate maintenance program |
Q37348090 | Onset and persistence of daily smoking: the interplay of socioeconomic status, gender, and psychiatric disorders |
Q37097002 | Onset of opportunity to use cannabis and progression from opportunity to dependence: Are influences consistent across transitions? |
Q91166488 | Onset of regular cannabis use and adult sleep duration: Genetic variation and the implications of a predictive relationship |
Q72843043 | Ontogenetic determinants of behavioral responses to morphine in rats |
Q34607076 | Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence |
Q39386472 | Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification |
Q100941663 | Operationalizing and selecting outcome measures for the HEALing Communities Study |
Q51243236 | Opiate addiction and depression--cause or effect? |
Q28306990 | Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine |
Q71096966 | Opiate detoxification with lofexidine |
Q44072604 | Opiate maintenance and abstinence--attitudes, treatment modalities and outcome |
Q44672975 | Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users |
Q44348704 | Opioid abuse and cognitive performance |
Q40932429 | Opioid abuse and depression in adolescents: Results from the National Survey on Drug Use and Health |
Q37547886 | Opioid abusers' ability to differentiate an opioid from placebo in laboratory challenge testing |
Q92682557 | Opioid agonist treatment and the process of injection drug use initiation |
Q93078144 | Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data |
Q57069724 | Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests |
Q44339104 | Opioid antagonist challenges in buprenorphine maintained patients |
Q44349723 | Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial |
Q40226801 | Opioid antagonists block acetaldehyde-induced increments in dopamine neurons activity |
Q34614499 | Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients |
Q37433452 | Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course |
Q44340791 | Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection |
Q44340798 | Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine |
Q99569624 | Opioid initiation and injection transition in rural northern New England: A mixed-methods approach |
Q42940382 | Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor |
Q44347491 | Opioid medication misuse among unhealthy drinkers |
Q44340601 | Opioid miosis: effects of lighting intensity and monocular and binocular exposure |
Q96352453 | Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest risk |
Q34773536 | Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions |
Q95314468 | Opioid prescribing history prior to heroin overdose among commercially insured adults |
Q91195602 | Opioid prescribing rates from the emergency department: Down but not out |
Q91166864 | Opioid prescription rates and risk for substantiated child abuse and neglect: A Bayesian spatiotemporal analysis |
Q36004099 | Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR |
Q44352978 | Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance |
Q38416854 | Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study |
Q35911267 | Opioid substitution therapy: Lowering the treatment thresholds. |
Q35619851 | Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone |
Q92208516 | Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study |
Q52676810 | Opioid use and stigma: The role of gender, language and precipitating events. |
Q37276433 | Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients. |
Q44337635 | Opioid use disorder in the United States: insurance status and treatment access |
Q112162175 | Opioid use following an outpatient detoxification and induction onto XR-NTX: Testing the blockade as a predictor of retention in treatment |
Q90220869 | Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment |
Q41810036 | Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans |
Q90565445 | Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs |
Q44345738 | Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment |
Q91511798 | Opioid-related deaths and previous care for drug use and pain relief in Sweden |
Q92225572 | Opioid-related hospitalizations in Pennsylvania: A latent class analysis |
Q100422775 | Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time |
Q44350713 | Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects |
Q52317450 | Opioids in oral fluid of Spanish drivers. |
Q34179298 | Opioids, opioid receptors, and the immune response |
Q63501701 | Opportunities in Hispanic Drug Abuse Research |
Q37042758 | Opportunities to use drugs and stages of drug involvement outside the United States: Evidence from the Republic of Chile |
Q42996717 | Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs |
Q43859925 | Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: follow-up of a randomised trial |
Q38822680 | Optimizing follow-up and study retention in the 21st century: Advances from the front line in alcohol and tobacco research |
Q51739779 | Optimizing heroin-assisted treatment (HAT): assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use. |
Q36303094 | Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats |
Q57550404 | Oral and intravenous methadone use: some clinical and pharmacokinetic aspects |
Q39020765 | Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers |
Q83976073 | Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms |
Q67399589 | Oral drug dependence: Intellectual characteristics of patients receiving treatment at a london drug dependence unit |
Q35844154 | Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients |
Q39813212 | Oral ketamine as a positive control in human abuse potential studies |
Q45109747 | Oral methylphenidate challenge selectively decreases putaminal T2 in healthy subjects |
Q52230604 | Oral self-administration of pentobarbital by rhesus monkeys: relative reinforcing effects under concurrent signalled differential-reinforcement-of-low-rates schedules |
Q35189459 | Oral tobacco products: preference and effects among smokers. |
Q44352334 | Orally delivered methadone as a reinforcer: Effects of the opioid antagonist naloxone |
Q48808275 | Orally self-administered cocaine in rhesus monkeys: transition from negative or neutral behavioral effects to positive reinforcing effects |
Q100944511 | Ordering in alcohol and cannabis co-use: Impact on daily consumption and consequences |
Q44220978 | Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system |
Q43825523 | Organizational factors and collaboration and integration activities in criminal justice and drug abuse treatment agencies |
Q37443969 | Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions |
Q50531777 | Other drug use does not impact cognitive impairments in chronic ketamine users |
Q92478758 | Out-of-state cannabis purchases in the United States |
Q52269998 | Out-patient detoxification of patients addicted to sedative-hypnotics and anxiolytics. |
Q52272321 | Outcome after methadone treatment: influence of prior treatment factors and current treatment status. |
Q93072095 | Outcome evaluation of a "common factors" approach to develop culturally tailored HIV prevention interventions for people who inject drugs |
Q73045439 | Outcome of a second episode of methadone maintenance |
Q72961693 | Outcome of contingency contracting for illicit drug use in a methadone maintenance program |
Q41640311 | Outcome of the California Civil Addict commitments:1961-1972. |
Q41819104 | Outcome of treatment in alcoholic women |
Q37360818 | Outcome specificity in deepened extinction may limit treatment feasibility: co-presentation of a food cue interferes with extinction of cue-elicited cocaine seeking. |
Q43570051 | Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study |
Q36352347 | Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use. |
Q46477033 | Outpatient alcoholism treatment: predictors of outcome after 3 years |
Q36502257 | Outpatient drug abuse treatment for Hispanic adolescents |
Q104286950 | Outpatient prescribing of opioids to adults diagnosed with mental disorders in the United States |
Q91511709 | Outpatient psychosocial substance use treatments for young people: An overview of reviews |
Q52576731 | Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. |
Q91691326 | Over the influence: The HIV care continuum among methamphetamine-using men who have sex with men |
Q50280598 | Over-expression of CD8(+) T-cell activation is associated with decreased CD4(+) cells in patients seeking treatment of Alcohol Use Disorder |
Q70398655 | Over-reports of recent alcohol consumption in a clinical population: a validity study |
Q39395111 | Overcoming professionals' challenging experiences to promote a trustful therapeutic alliance in addiction treatment: A qualitative study |
Q39785201 | Overdose after detoxification: a prospective study |
Q95647548 | Overdose and risk factors for coronavirus disease 2019 |
Q119013143 | Overdose and substance-related mortality after release from prison in Washington State: 2014-2019 |
Q101409230 | Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-llevel differences and the role of opioids |
Q91976884 | Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort |
Q44295286 | Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts |
Q63375727 | Overexpression of miR-495 in nucleus accumbens attenuates cocaine intake on a progressive ratio schedule of reinforcement |
Q50986228 | Overexpression of α3/α5/β4 nicotinic receptor subunits modifies impulsive-like behavior. |
Q91375687 | Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: "Holy Trinity" prescribing in the state of Florida |
Q37146219 | Overview and historical perspective of four papers presented on research related to the endogenous opioid system |
Q46744256 | Overview of conference on preclinical abuse liability testing: current methods and future challenges |
Q45157506 | Overview of workshop on drug abuse and suicidal behavior |
Q78067929 | Overview-tackling troubled teenagers together |
Q48490028 | Oxidative capacity and ethanol. An in vivo study on hepatocytes and some brain regions of the female rat. |
Q57297865 | Oxytocin receptor gene methylation and substance use problems among young African American men |
Q41317022 | P-hydroxy-norephedrine as a possible mediator causing the reduction of oral intake of D-amphetamine in rats |
Q77504439 | PROP taster status and parental history of alcohol dependence |
Q101241555 | PTSD improvement and substance use disorder treatment utilization in veterans: Evidence from medical record data |
Q50963127 | Pain acceptance and opiate use disorders in addiction treatment patients with comorbid pain. |
Q101216098 | Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity |
Q88088916 | Pain interference and alcohol, nicotine, and cannabis use disorder in a national sample of substance users |
Q28190901 | Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent |
Q34614139 | Pain is associated with risky drinking over time among HIV-infected persons in St. Petersburg, Russia |
Q34022107 | Pain management perceptions among prescription opioid dependent individuals |
Q93057753 | Pain severity and prescription opioid misuse among individuals with chronic pain: The moderating role of alcohol use severity |
Q40815646 | Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy. |
Q38864335 | Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients |
Q91231041 | Pain, psychological flexibility, and continued substance use in a predominantly hispanic adult sample receiving methadone treatment for opioid use disorder |
Q97561763 | Pain-related anxiety, sex, and co-use of alcohol and prescription opioids among adults with chronic low back pain |
Q39052819 | Panic attack history and smoking topography |
Q43619988 | Panic disorder in a Spanish sample of 89 patients with pure alcohol dependence |
Q69885707 | Papers presented at the Committee on Problems of Drug Dependence Symposium on Stimulants and Hallucinogens. June/September, 1984 |
Q93596351 | Paradigm shift or change in ownership? The conceptual significance of D.L. Davies's classic paper |
Q90067313 | Parallel modeling of pain and depression in prediction of relapse during buprenorphine and naloxone treatment: A finite mixture model |
Q31926136 | Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activity |
Q35182052 | Parent training plus contingency management for substance abusing families: a Complier Average Causal Effects (CACE) analysis |
Q33924868 | Parent training skills and methadone maintenance: clinical opportunities and challenges |
Q36446130 | Parent, sibling and peer associations with subtypes of psychiatric and substance use disorder comorbidity in offspring |
Q90873816 | Parent-based interventions on adolescent alcohol use outcomes: A systematic review and meta-analysis |
Q98776075 | Parental alcohol-specific rules effectively reduce adolescents' tobacco and cannabis use: A longitudinal study |
Q33924505 | Parental psychopathology moderates the influence of parental divorce on lifetime alcohol use disorders among Israeli adults |
Q37538117 | Parental separation and early substance involvement: results from children of alcoholic and cannabis dependent twins |
Q44026069 | Parental substance use disorder and the risk of adolescent drug abuse: an event history analysis |
Q93171134 | Parental supply of alcohol as a predictor of adolescent alcohol consumption patterns: A prospective cohort |
Q98882474 | Parental supply of sips and whole drinks of alcohol to adolescents and associations with binge drinking and alcohol-related harms: A prospective cohort study |
Q93180234 | Parental views on state cannabis laws and marijuana use for their medically vulnerable children |
Q44465869 | Parental, peer and school experiences as predictors of alcohol drinking among first and second generation immigrant adolescents in Israel |
Q51846586 | Parenteral abuse of diazepam: a case report. |
Q52259914 | Pargyline and naltrexone fail to antagonize the gustatory avoidance response induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. |
Q100408326 | Parsing impulsivity in individuals with anxiety and depression who use Cannabis |
Q43540763 | Partial characterization and tissue distribution of the feline mu opiate receptor |
Q37167147 | Partner aggression among men and women in substance use disorder treatment: correlates of psychological and physical aggression and injury |
Q33634779 | Partner smoking and maternal cotinine during pregnancy: implications for negative control methods |
Q38761236 | Partner-level substance use associated with increased sexual risk behaviors among men who have sex with men in San Francisco, CA. |
Q37166739 | Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q34493702 | Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex. |
Q47195101 | Past 15-year trends in lifetime cocaine use among US high school students |
Q44574564 | Past alcohol problems do not predict worse smoking cessation outcomes |
Q38649044 | Past year cannabis use and problematic cannabis use among adults by ethnicity in Ontario |
Q58121499 | Past-month cannabis use among U.S. individuals from 2002-2015: An age-period-cohort analysis |
Q93171150 | Past-year use of prescription opioids and/or benzodiazepines among adults in the United States: Estimating medical and nonmedical use in 2015-2016 |
Q45157515 | Paternal alcohol dependence and offspring suicidal behaviors in a children-of-twins study |
Q36335931 | Pathogenesis of alcoholic myopathy: roles of ethanol and malnutrition |
Q40976431 | Pathological gambling among methadone patients |
Q37235468 | Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q46507620 | Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability |
Q36689824 | Pathways to adolescent sexual risk behaviors: Effects of prenatal cocaine exposure. |
Q43429596 | Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance? |
Q35291225 | Pathways to treatment retention for individuals legally coerced to substance use treatment: the interaction of hope and treatment motivation |
Q51083809 | Patient and program attributes related to treatment process indicators in DATOS. |
Q36800122 | Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study |
Q41711444 | Patient histories, retention, and outcome models for younger and older adults in DATOS. |
Q71141867 | Patient perspectives of opiate withdrawal |
Q90200242 | Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital |
Q46470950 | Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment |
Q40083753 | Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine. |
Q39434197 | Patient retention in mobile and fixed-site methadone maintenance treatment |
Q50780337 | Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning. |
Q45942201 | Patients' abstinence status affects the benefits of 12-step self-help group participation on substance use disorder outcomes. |
Q39156410 | Pattern and risk of developing alcohol use disorders, illegal substance use and psychiatric disorders after early onset of alcohol use: Results of the Thai National Mental Health Survey 2013. |
Q43842086 | Pattern of use and subjective effects of Salvia divinorum among recreational users. |
Q49073830 | Pattern shift visual evoked potentials in abstinent cocaine-dependent, alcohol-dependent, and cross-dependent patients |
Q45125656 | Patterns and correlates of attempted suicide by heroin users over a 3-year period: findings from the Australian treatment outcome study |
Q50619580 | Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: findings from the Australian Treatment Outcome Study |
Q91647635 | Patterns and correlates of purchasing cigarettes on Indian reservations among daily smokers in the United States |
Q102209697 | Patterns and correlates of workplace and non-workplace cannabis use among Canadian workers before the legalization of non-medical cannabis |
Q47213209 | Patterns and covariates of alcohol drinking among high school students in 10 towns in Italy: a cross-sectional study |
Q64135917 | Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016 |
Q35552402 | Patterns and levels of illicit drug use among men who have sex with men in Asia |
Q73662644 | Patterns of HIV risk and alcohol use among African-American crack abusers |
Q47719207 | Patterns of Kratom use and health impact in the US-Results from an online survey |
Q51915515 | Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment. |
Q40126237 | Patterns of alcohol consumption and health-related quality of life in older adults. |
Q43455438 | Patterns of alcohol consumption, smoking and illicit drug use in British university students: interfaculty comparisons |
Q44441824 | Patterns of alcohol expectancies and alcohol use across age and gender |
Q91566378 | Patterns of alcohol use and associated characteristics and HIV-related outcomes among a sample of African-American women living with HIV |
Q37085032 | Patterns of alternative tobacco use among adolescent cigarette smokers |
Q41285054 | Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis |
Q40475255 | Patterns of cigarette smoking among students from 19 colleges and universities in Jiangsu Province, China: a latent class analysis. |
Q44070875 | Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure |
Q34023006 | Patterns of concurrent substance use among nonmedical ADHD stimulant users: results from the National Survey on Drug Use and Health. |
Q72114179 | Patterns of drug use among secondary school children in post-revolutionary Iran |
Q43774562 | Patterns of drug use among young men in Piedmont (Italy). |
Q47617660 | Patterns of drug use amongst Malaysian secondary schoolchildren |
Q34920487 | Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort |
Q35928541 | Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users |
Q33624129 | Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health |
Q52279036 | Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. |
Q42625788 | Patterns of injecting and sharing in a Scottish prison |
Q37146737 | Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting |
Q67594496 | Patterns of long-term heavy cannabis use in north India and its effects on cognitive functions: a preliminary report |
Q35875378 | Patterns of major depression and nonmedical use of prescription opioids in the United States |
Q45233392 | Patterns of marihuana smoking among Brazilian students |
Q37218242 | Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand |
Q92453159 | Patterns of nicotine concentrations in electronic cigarettes sold in the United States, 2013-2018 |
Q34239996 | Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats |
Q90378740 | Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis |
Q57586014 | Patterns of performance and image enhancing drug use among men accessing needle and syringe programs in Sydney, Australia |
Q38653536 | Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. |
Q49030831 | Patterns of polydrug use in Great Britain: findings from a national household population survey |
Q92721902 | Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis |
Q91207256 | Patterns of polysubstance use and simultaneous co-use in high risk young adults |
Q59256255 | Patterns of recent alcohol consumption by race among a sample of urban men who have sex with men |
Q33637963 | Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence |
Q99708451 | Patterns of substance use among adolescents: A systematic review |
Q46754802 | Patterns of use and harm reduction practices of ecstasy users in Australia |
Q44283696 | Patterns of use and harms associated with non-medical ketamine use. |
Q34904385 | Pavlovian conditioning of multiple opioid-like responses in mice |
Q35690420 | Peak ages of risk for starting nonmedical use of prescription stimulants |
Q115162791 | Pediatric surgery and future risk of cocaine, opioid, cannabis, and other substance use in women: longitudinal cohort study |
Q43195429 | Peer influence and selection effects on adolescent smoking |
Q36243565 | Peer substance use as a mediator between early pubertal timing and adolescent substance use: longitudinal associations and moderating effect of maltreatment |
Q35609368 | Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives |
Q38994174 | Peers and social network on alcohol drinking through early adolescence in Taiwan |
Q39820262 | Pentazocine. |
Q42266150 | Pentazocine/tripelennamine (T's and blues) abuse: a five year survey of St. Louis, Missouri |
Q30717997 | People and places: Relocating to neighborhoods with better economic and social conditions is associated with less risky drug/alcohol network characteristics among African American adults in Atlanta, GA. |
Q129290353 | People with a tobacco use disorder exhibit misaligned Bayesian belief updating by falsely attributing non-drug cues as worse predictors of positive outcomes compared to drug cues |
Q52233362 | Peptide-neurotransmitter interactions influencing ethanol tolerance |
Q38995928 | Perceived cessation treatment effectiveness, medication preferences, and barriers to quitting among light and moderate/heavy homeless smokers. |
Q51789323 | Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia. |
Q91522762 | Perceived discrimination in addiction recovery: Assessing the prevalence, nature, and correlates using a novel measure in a U.S. National sample |
Q68801963 | Perceived family relationships in drug abusing adolescents |
Q47651438 | Perceived harm as a mediator of the relationship between social norms and marijuana use and related consequences among American Indian youth |
Q92391380 | Perceived harmfulness of various alcohol- and cannabis use modes: Secular trends, differences, and associations with actual substance use behaviors among Norwegian adolescents, 2007-2015 |
Q85535040 | Perceived interpersonal pressure and drinking behavior in South China |
Q37184377 | Perceived need for substance abuse treatment among illicit stimulant drug users in rural areas of Ohio, Arkansas, and Kentucky |
Q37144710 | Perceived peer delinquency and the genetic predisposition for substance dependence vulnerability |
Q36390166 | Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups |
Q39528212 | Perceived risk of cocaine use and experience with cocaine: do they cluster within US neighborhoods and cities? |
Q36911651 | Perceived risk of harm and intentions of future inhalant use among adolescent inhalant users |
Q27312319 | Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity |
Q104060870 | Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic |
Q42617143 | Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities |
Q98182397 | Perceived social capital and binge drinking in older adults: The Health and Retirement Study, US data from 2006-2014 |
Q58566066 | Perceived social status and unhealthy habits in Korea |
Q37307436 | Perceived stress and substance use in methadone-maintained smokers |
Q36368537 | Perceived unmet need for alcohol and drug use treatments and future use of services: results from a longitudinal study |
Q89804007 | Perception of treatment need among adults with substance use disorders: Longitudinal data from a representative sample of adults in the United States |
Q52316798 | Perceptions and practices addressing diversion among US buprenorphine prescribers. |
Q99708413 | Perceptions of U.S. and Canadian Cannabis Package Warnings Among U.S. Adults |
Q41230233 | Perceptions of research risk and undue influence: Implications for ethics of research conducted with cocaine users |
Q48932925 | Performance monitoring and stop signal inhibition in abstinent patients with cocaine dependence |
Q46015751 | Performance of cigarette susceptibility index among e-cigarette and hookah users. |
Q30919504 | Performance of the RAPS4/RAPS4-QF for DSM-5 compared to DSM-IV alcohol use disorders in the general population: Data from the 2000-2010 National Alcohol Surveys |
Q114671048 | Performance ramifications of abnormal functional connectivity of ventral posterior lateral thalamus with cerebellum in abstinent individuals with Alcohol Use Disorder |
Q72400730 | Performance, subjective, and physiological effects of nicotine in non-smokers |
Q48881103 | Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs |
Q45099342 | Perinatal exposure to methadone affects central cholinergic activity in the weanling rat. |
Q35287442 | Perinatal substance use: a prospective evaluation of abstinence and relapse |
Q48552425 | Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see page |
Q47718372 | Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory |
Q42246164 | Peripheral neuropathy after disulfiram administration: Reversibility despite continued therapy |
Q90200239 | Peripheral proinflammatory markers are upregulated in abstinent alcohol-dependent patients but are not affected by cognitive bias modification: Preliminary findings |
Q39707926 | Persistence of a “subacute withdrawal syndrome” following chronic ethanol intake |
Q53081116 | Persistence of attentional bias toward alcohol-related stimuli in intoxicated social drinkers. |
Q52221349 | Persistence of ethanol self-administration as a function of interreinforcer interval and concentration. |
Q39053755 | Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. |
Q40105608 | Persistent abnormalities in central nervous system function (long-term tolerance) after brief ethanol administration |
Q33912348 | Person-environment interaction in the prediction of alcohol abuse and alcohol dependence in adulthood |
Q40509656 | Personal and perceived peer use and attitudes towards the use of nonmedical prescription stimulants to improve academic performance among university students in seven European countries |
Q36931404 | Personal network correlates of alcohol, cigarette, and marijuana use among homeless youth |
Q71736688 | Personal reflections |
Q35661096 | Personality and alcohol consumption: Pooled analysis of 72,949 adults from eight cohort studies |
Q93659091 | Personality and attitude correlates of psychosedative drug use |
Q68134260 | Personality and religion among female drug misusers |
Q44348462 | Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence |
Q52270566 | Personality core dynamics and drug preference. |
Q66980040 | Personality dependence in drug dependence |
Q60681340 | Personality disorders and alcoholism treatment outcome. |
Q36082601 | Personality disorders in early adolescence and the development of later substance use disorders in the general population |
Q40537738 | Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population group |
Q47423614 | Personality profile of binge drinking in university students is modulated by sex. A study using the Alternative Five Factor Model |
Q36724376 | Personality traits and illicit substances: the moderating role of poverty |
Q43884113 | Personality, drug of choice, and comorbid psychopathology among substance abusers. |
Q44487808 | Personality, substance of choice, and polysubstance involvement among substance dependent patients |
Q38832124 | Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review |
Q36368709 | Pharmaco-economics of community maintenance for opiate dependence: a review of evidence and methodology |
Q91991426 | Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis |
Q39822307 | Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration |
Q91567404 | Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users |
Q44335728 | Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients |
Q66972151 | Pharmacogenetic aspects of alcohol use and abuse |
Q78170779 | Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet |
Q37425629 | Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone |
Q33389907 | Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naı̈ve healthy male volunteers under a naltrexone block |
Q35124194 | Pharmacokinetics of the combination tablet of buprenorphine and naloxone |
Q34650967 | Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine |
Q34500342 | Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans |
Q52260103 | Pharmacologic and reinforcing properties of phencyclidine and the enantiomers of N-allylnormetazocine in the dog. |
Q51895171 | Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats. |
Q39466518 | Pharmacological characteristics of agonist-antagonist analgesics |
Q28287674 | Pharmacological content of tablets sold as "ecstasy": results from an online testing service |
Q44857251 | Pharmacological effects of methamphetamine and other stimulants via inhalation exposure |
Q45084478 | Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction |
Q34125281 | Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol |
Q40553862 | Pharmacological mechanisms in cocaine's cardiovascular effects |
Q45101897 | Pharmacological potency and biodisposition of phencyclidine via inhalation exposure in mice |
Q45098382 | Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys |
Q34256300 | Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy |
Q40948730 | Pharmacotherapy and psychotherapy for the treatment of alcoholism in Germany |
Q91260665 | Pharmacotherapy for amphetamine dependence: A systematic review |
Q41739068 | Pharmacotherapy of cerebral ischemia in cocaine dependence |
Q91731197 | Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study |
Q41135933 | Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City. |
Q87383479 | Phenobarbital compared to benzodiazepines in alcohol withdrawal treatment: A register-based cohort study of subsequent benzodiazepine use, alcohol recidivism and mortality |
Q38639259 | Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women |
Q48765761 | Phosphatidylethanol inhibits phosphatidylinositol-phospholipase C activity in a competitive manner with phosphatidylinositol-4,5-bisphosphate |
Q44283704 | Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes |
Q35875420 | Physical dating violence among adolescents and young adults with alcohol misuse |
Q34183294 | Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur |
Q28323146 | Physical dependence on benzodiazepines: differences within the class |
Q39287005 | Physical dependence on ethanol: Conceptual considerations |
Q41030986 | Physical dependence on ethanol: Its relation to tolerance |
Q37033882 | Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons. |
Q31926130 | Physical injecting sites among injecting drug users in Sydney, Australia. |
Q37109399 | Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States |
Q36943313 | Physical violence among a prospective cohort of injection drug users: a gender-focused approach |
Q42110342 | Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements. |
Q47273079 | Physicians-in-training are not prepared to prescribe medical marijuana |
Q44070866 | Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler |
Q35257856 | Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. |
Q46287509 | Physiological basis of opiate dependence |
Q33588446 | Physiological response to reward and extinction predicts alcohol, marijuana, and cigarette use two years later |
Q46637418 | Picenadol |
Q33795316 | Pilot randomized controlled trial of an internet-based smoking cessation intervention for pregnant smokers ('MumsQuit') |
Q35875805 | Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial |
Q34231186 | Piperazine compounds as drugs of abuse. |
Q43123297 | Pituitary gland volume among heroin users stabilised on substitution pharmacotherapy |
Q47410780 | Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence |
Q91976878 | Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV |
Q39925271 | Planning deficits in polysubstance dependent users: Differential associations with severity of drug use and intelligence |
Q88740839 | Planting the seed for marijuana use: Changes in exposure to medical marijuana advertising and subsequent adolescent marijuana use, cognitions, and consequences over seven years |
Q67868391 | Plasma cholesterol and triglycerides in heroin addicts |
Q51451508 | Plasma concentrations of buprenorphine 24 to 72 hours after dosing. |
Q57550393 | Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment |
Q70148381 | Plasma concentrations of δ-9-tetrahydrocannabinol and impaired motor function |
Q60619454 | Plasma cyclic AMP in non-abstinent chronic alcoholics. Relation to clinical parameters |
Q44350732 | Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program |
Q72876498 | Plasma methadone monitoring with methadone maintenance treatment |
Q36176728 | Plasma progesterone levels and cocaine-seeking in freely cycling female rats across the estrous cycle |
Q70398720 | Plasma urea and creatinine status in chronic alcoholics |
Q71141885 | Plasma vitamin E status in chronic alcoholic patients |
Q68641076 | Platelet monoamine oxidase activity and personality traits in alcoholics and methamphetamine dependents |
Q71099431 | Platelet monoamine oxidase and erythrocyte catechol-o-methyltransferase activity in alcoholism and controlled abstinence |
Q60619461 | Platelet monoamine oxidase and plasma dopamine-β-hydroxylase activities in non-abstinent chronic alcoholics. Relation to clinical parameters |
Q35088335 | Police bribery and access to methadone maintenance therapy within the context of drug policy reform in Tijuana, Mexico |
Q46379004 | Police custody following drink-driving: a prospective study |
Q37302930 | Police education as a component of national HIV response: lessons from Kyrgyzstan |
Q39084936 | Police officer attitudes towards intranasal naloxone training |
Q91211485 | Police officer attitudes towards syringe services programming |
Q34432434 | Policing and risk of overdose mortality in urban neighborhoods |
Q46882241 | Policy drives harm reduction for drug abuse and HIV/AIDS prevention in some developing countries |
Q68759615 | Political implications of scientific research in the field of drug abuse: the case of cannabis |
Q41897583 | Politicians and scientists in the combat against drug abuse |
Q35933827 | Poly-club-drug use among gay and bisexual men: a longitudinal analysis |
Q43837396 | Poly-tobacco use among adults in 44 countries during 2008-2012: evidence for an integrative and comprehensive approach in tobacco control. |
Q53435388 | Poly-victimization and trajectories of binge drinking from adolescence to young adulthood among serious juvenile offenders. |
Q36266246 | Polydrug abuse: a review of opioid and benzodiazepine combination use |
Q53357261 | Polydrug dependence and psychiatric comorbidity among heroin injectors. |
Q57167964 | Polydrug use among heroin users in Cleveland, OH |
Q36593640 | Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users |
Q92408021 | Polydrug use disorders in individuals with opioid use disorder |
Q47567584 | Polygenic risk for alcohol consumption and its association with alcohol-related phenotypes: Do stress and life satisfaction moderate these relationships? |
Q41640368 | Polygenic risk scores for cigarettes smoked per day do not generalize to a Native American population. |
Q44730349 | Polymorphism in glutathione-S-transferases: a risk factor in alcoholic liver cirrhosis |
Q59780360 | Polymorphisms of alcohol-metabolizing enzymes and the risk for alcoholism and alcoholic liver disease in Caucasian Spanish women |
Q49161921 | Polysomnographic study of terminal sleep following delirium tremens |
Q36759409 | Polysubstance and alcohol dependence: unique abnormalities of magnetic resonance-derived brain metabolite levels |
Q48034246 | Polysubstance dependent patients display a more utilitarian profile in moral decision-making than alcohol-dependent patients, depressive patients and controls |
Q98721643 | Polysubstance use among youth experiencing homelessness: The role of trauma, mental health, and social network composition |
Q47319180 | Polysubstance use by psychiatry inpatients with co-occurring mental health and substance use disorders. |
Q44574577 | Polyunsaturated fatty acid status and aggression in cocaine addicts |
Q48443919 | Poor educational attainment and sexually transmitted infections associated with positive HIV serostatus among female in-patient substance abusers in Trinidad and Tobago |
Q35235473 | Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine |
Q36936156 | Poor, persecuted, young, and alone: Toward explaining the elevated risk of alcohol problems among Black and Latino men who drink |
Q114190386 | Poorer pre-potent response inhibition in cocaine-dependent patients vs. healthy controls during an affect-congruent Go-NoGo task |
Q37659226 | Poppers use and risky sexual behaviors among men who have sex with men in Beijing, China. |
Q43469301 | Population screening of risky alcohol and drug use via Internet and Interactive Voice Response (IVR): a feasibility and psychometric study in a random sample |
Q39998064 | Population surveys compared with wastewater analysis for monitoring illicit drug consumption in Italy in 2010-2014. |
Q41837901 | Positive affect and processes of recovery among treatment-seeking methamphetamine users |
Q52574196 | Positive alcohol use expectancies moderate the association between anxiety sensitivity and alcohol use across adolescence. |
Q50543743 | Positive and negative metacognitions about alcohol use among university students: Psychometric properties of the PAMS and NAMS French versions. |
Q44108382 | Positive smoker identity as a barrier to quitting smoking: findings from a national survey of smokers in England |
Q90347539 | Positive urgency worsens the impact of normative feedback on 21st birthday drinking |
Q58557841 | Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS |
Q48150095 | Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride |
Q33555438 | Possible effects of normetabolites on the subjective and reinforcing characteristics of opioids in animals and man |
Q40283145 | Possible influence of opioid normetabolites on the onset, magnitude and quality of the opioid abstinence syndrome |
Q44832756 | Possible involvement of acetaldehyde, norepinephrine and their tetrahydroisoquinoline derivatives in the regulation of ethanol seld-administration |
Q52600950 | Post-9/11 drug- and alcohol- related hospitalizations among World Trade Center Health Registry enrollees, 2003-2010. |
Q91569670 | Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci |
Q34749074 | Post-exposure prophylaxis use and recurrent exposure to HIV among men who have sex with men who use crystal methamphetamine |
Q59537846 | Post-incarceration factors and relapse to opioid injection in St. Petersburg, Russia |
Q45338870 | Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing |
Q47262072 | Post-mortem review of fentanyl-related overdose deaths among identified drug users in Southern Bavaria, Germany, 2005-2014. |
Q33448273 | Post-quit stress mediates the relation between social support and smoking cessation among socioeconomically disadvantaged adults |
Q36056071 | Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates |
Q90659042 | Post-traumatic stress disorder and risk of prescription opioid use, over-use, and misuse among World Trade Center Health Registry enrollees, 2015-2016 |
Q44683835 | Post-traumatic stress disorder, drug dependence, and suicidality among male Vietnam veterans with a history of heavy drug use. |
Q72106084 | Post-treatment depressive symptoms and relapse to drug use in different age groups of an alcohol and other drug abuse population |
Q37271975 | Post-treatment drinking among HIV patients: Relationship to pre-treatment marijuana and cocaine use. |
Q35132192 | Postmarketing surveillance for drug abuse |
Q44332680 | Postmarketing surveillance of abuse liability of sibutramine |
Q88501724 | Postmortem blood alcohol content among late-middle aged and older suicide decedents: Associations with suicide precipitating/risk factors, means, and other drug toxicology |
Q45010556 | Postnatal or in utero ethanol exposure reduction of the volume of the sexually dimorphic nucleus of the preoptic area in male rats |
Q45876350 | Postoperative risks associated with alcohol screening depend on documented drinking at the time of surgery |
Q69616646 | Postpartum acute renal failure in a drug addict |
Q49806719 | Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder |
Q88728491 | Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey |
Q34743241 | Posttraumatic stress disorder and other psychopathology in substance abusing patients |
Q36090404 | Posttraumatic stress disorder symptoms and risky behaviors among trauma-exposed inpatients with substance dependence: The influence of negative and positive urgency |
Q28255604 | Potent substituted-3β-phenyltropane analogs of cocaine have cocaine-like discriminative stimulus effects |
Q33899158 | Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine |
Q52298567 | Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States. |
Q92561030 | Potential undercounting of overdose deaths caused by specific drugs in vital statistics data: An analysis of Florida |
Q30209241 | Potentially modifiable deployment characteristics and new-onset alcohol abuse or dependence in the US National Guard |
Q35945004 | Powder cocaine and crack use in the United States: an examination of risk for arrest and socioeconomic disparities in use |
Q91031784 | PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland |
Q90105932 | Practicing prospection promotes patience: Repeated episodic future thinking cumulatively reduces delay discounting |
Q91568685 | Pragmatic randomized controlled trial of a web-based intervention for alcohol use among Brazilian college students: Motivation as a moderating effect |
Q40238042 | Pragmatic trial of a Study Navigator Model (NAU) vs. Ambassador Model (N+) to increase enrollment to health research among community members who use illicit drugs |
Q50049534 | Pre- and postnatal tobacco and cannabis exposure and child behavior problems: Bidirectional associations, joint effects, and sex differences. |
Q42249303 | Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896. |
Q52264329 | Precursors to heroin: a pilot study of young heroin addicts and their nonaddicted friends |
Q43263919 | Predicting DUI recidivism of male drunken driving: a prospective study of the impact of alcohol markers and previous drunken driving |
Q46693253 | Predicting DUI recidivism: Personality, attitudinal, and behavioral risk factors |
Q37367850 | Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables |
Q60030998 | Predicting craving and mood 90min into the future using GPS data |
Q33653366 | Predicting drinking onset with discrete-time survival analysis in offspring from the San Diego prospective study |
Q47764825 | Predicting dyscontrolled drinking with implicit and explicit measures of alcohol attitude |
Q39822292 | Predicting later problematic cannabis use from psychopathological symptoms during childhood and adolescence: Results of a 25-year longitudinal study |
Q88737532 | Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016 |
Q52322157 | Predicting premorbid functioning in crack-cocaine abusers. |
Q78170781 | Predicting proximal factors in cocaine relapse and near miss episodes: clinical and theoretical implications |
Q84272370 | Predicting rapid DUI recidivism using the Driver Risk Inventory on a state-wide sample of Floridian DUI offenders |
Q89476525 | Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes |
Q72066750 | Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI |
Q43696120 | Predicting smoking relapse with a multidimensional versus a single-item tobacco craving measure |
Q100944512 | Predicting the first smoking lapse during a quit attempt: A machine learning approach |
Q44596499 | Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. |
Q44094307 | Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals |
Q35731021 | Predicting use of assistance when quitting: a longitudinal study of the role of quitting beliefs |
Q34066432 | Prediction of 7 months methadone maintenance treatment response by four measures of antisociality |
Q46234189 | Prediction of alcohol-related casualties: a comparison of two emergency room populations |
Q46749218 | Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. |
Q38657359 | Prediction of incidence and stability of alcohol use disorders by latent internalizing psychopathology risk profiles in adolescence and young adulthood |
Q36462579 | Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment |
Q41453775 | Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance program |
Q46588041 | Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users |
Q48249212 | Prediction of treatment outcome in cocaine dependent males using quantitative EEG. |
Q36288383 | Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC |
Q52259778 | Predictive validity of four factors derived from an 'hyperactivity/MBD' questionnaire. |
Q57448672 | Predictive validity of four nicotine dependence measures in a college sample |
Q104694796 | Predictive validity of genome-wide polygenic scores for alcohol use from adolescence to young adulthood |
Q39309155 | Predictive validity of the AUDIT for hazardous alcohol consumption in recently released prisoners |
Q45348125 | Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking |
Q97094323 | Predictive validity of the adult tobacco dependence index: Findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study |
Q36268844 | Predictors and consequences of prescription drug misuse during middle school |
Q43728926 | Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients |
Q97895986 | Predictors of Opioid Misuse During Emerging Adulthood: An Examination of Adolescent Individual, Family and Peer Factors |
Q47190571 | Predictors of a favourable socio-economic situation in middle age for Swedish conscripts with self-reported drug use. |
Q91211467 | Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use |
Q35875773 | Predictors of adherence to pharmacological and behavioral treatment in a cessation trial among smokers in Aleppo, Syria |
Q44668407 | Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling |
Q90591484 | Predictors of availability of long-acting medication for opioid use disorder |
Q34749223 | Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers |
Q33653252 | Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study |
Q28369776 | Predictors of cardiovascular response to smoked cocaine in humans |
Q30989000 | Predictors of cessation in smokers suspected of TB: Secondary analysis of data from a cluster randomized controlled trial. |
Q48718824 | Predictors of cessation of marijuana use: an event history analysis |
Q39077416 | Predictors of changes in daily alcohol consumption in the aftermath of military deployment |
Q36555703 | Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence |
Q39890305 | Predictors of crack cocaine initiation among Montréal street youth: a first look at the phenomenon |
Q78170764 | Predictors of discharges against medical advice from a short-term hospital detoxification unit |
Q50738661 | Predictors of drinking patterns in adolescence: a latent class analysis. |
Q36496900 | Predictors of dropout from group therapy among patients with bipolar and substance use disorders |
Q77462288 | Predictors of dropout from psychosocial treatment of cocaine dependence |
Q44138235 | Predictors of drug abuse treatment entry among crack-cocaine smokers |
Q46523492 | Predictors of engagement in continuing care following residential substance use disorder treatment |
Q104456461 | Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study |
Q73434112 | Predictors of expressed partner and non-partner violence among patients in substance abuse treatment |
Q49039546 | Predictors of favorable outcome following naltrexone treatment |
Q40600680 | Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). |
Q37234994 | Predictors of frequent use of amphetamine type stimulants among HIV-negative gay men in Sydney, Australia |
Q45966417 | Predictors of health functioning in two high-risk groups of smokers. |
Q74667324 | Predictors of increased condom use following HIV intervention with heterosexually active drug users |
Q51747535 | Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico. |
Q37218318 | Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). |
Q40651521 | Predictors of internalizing and externalizing problems among children of cocaine and opiate dependent parents |
Q33912719 | Predictors of longitudinal substance use and mental health outcomes for patients in two integrated service delivery systems |
Q36248633 | Predictors of marijuana use among married couples: the influence of one's spouse |
Q100515967 | Predictors of marijuana vaping onset and escalation among young adults |
Q35141390 | Predictors of methadone treatment retention from a multi-site study: a survival analysis |
Q100733763 | Predictors of nicotine dependence among adolescent waterpipe and cigarette smokers: A 6-year longitudinal analysis |
Q33563671 | Predictors of nicotine dependence symptoms among never-smoking adolescents: a longitudinal analysis from the Nicotine Dependence in Teens Study |
Q48664716 | Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. |
Q44342159 | Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). |
Q37405260 | Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence |
Q36328406 | Predictors of outcome from computer-based treatment for substance use disorders: Results from a randomized clinical trial. |
Q31926069 | Predictors of outpatient treatment retention: patient versus substance use characteristics |
Q35915739 | Predictors of persistent nicotine dependence among adults in the United States |
Q57177972 | Predictors of positive drinking outcomes among youth receiving an alcohol brief intervention in the emergency department |
Q33523647 | Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials |
Q36026302 | Predictors of postpartum relapse to smoking |
Q47757230 | Predictors of quit attempts and successful quit attempts among individuals with alcohol use disorders in a nationally representative sample |
Q57298269 | Predictors of resistant alcohol withdrawal (RAW): A retrospective case-control study |
Q46733509 | Predictors of retention in methadone programs: a signal detection analysis |
Q42688149 | Predictors of risky needle use following interventions with injection drug users in Ukraine |
Q36739199 | Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients |
Q59745543 | Predictors of substance abuse treatment entry for crime-involved, cocaine-dependent women |
Q39705777 | Predictors of substance use frequency and reductions in seriousness of use among persons living with HIV. |
Q38450245 | Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study |
Q27312260 | Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy |
Q46590637 | Predictors of therapeutic engagement in prison-based drug treatment |
Q92413244 | Predictors of timely opioid agonist treatment initiation among veterans with and without HIV |
Q36619410 | Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study |
Q90942478 | Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence |
Q90777824 | Predictors of treatment initiation for alcohol use disorders in primary care |
Q50136741 | Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. |
Q35770563 | Predictors of utilization of an IVR self-monitoring program by problem drinkers with recent natural resolutions |
Q37130877 | Predictors of violence following Emergency Department visit for cocaine-related chest pain |
Q35876131 | Predictors of waterpipe smoking progression among youth in Irbid, Jordan: A longitudinal study (2008-2011). |
Q90180010 | Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities |
Q40896462 | Preference weights for the spectrum of alcohol use in the U.S. Population |
Q115162890 | Preferences for research design and treatment of comorbid depression among patients with an opioid use disorder: A cross-sectional discrete choice experiment |
Q47656345 | Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. |
Q36074911 | Prefrontal and limbic resting state brain network functional connectivity differs between nicotine-dependent smokers and non-smoking controls. |
Q37268687 | Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia |
Q48100432 | Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study |
Q33802542 | Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. |
Q88951843 | Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors |
Q35783426 | Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes |
Q62656766 | Pregnancy incidence and contraceptive use among young women who inject drugs in Sydney, Australia |
Q91200996 | Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016 |
Q45161030 | Preliminary evidence of an association between childhood abuse and cannabis dependence among African American first-episode schizophrenia-spectrum disorder patients |
Q74507741 | Preliminary evidence of good treatment response in antisocial drug abusers |
Q92318497 | Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users |
Q49922957 | Preliminary evidence that reactivity to uncertain threat is an endophenotype for alcohol use disorder |
Q72231605 | Preliminary finding: consumption of benzodiazepines in Brazil during the years 1988 and 1989 |
Q28645840 | Preliminary findings on the association between clients' perceived helpfulness of substance abuse treatment and outcomes: does race matter? |
Q40903492 | Preliminary note: dangerous use of anticholinergic drugs in Brazil |
Q40590115 | Preliminary study on reducing oral moist snuff use. |
Q53632915 | Preliminary test of cigarette nicotine discrimination threshold in non-dependent versus dependent smokers. |
Q44399441 | Premature mortality among prominent American authors noted for alcohol abuse |
Q48687817 | Premorbid and current neuropsychological function in opiate abusers receiving treatment. |
Q104063003 | Prenatal Substance Exposure and Developmental Trajectories of Internalizing Symptoms: Toddlerhood to Preadolescence |
Q52213950 | Prenatal alcohol and offspring development: the first fourteen years. |
Q63352603 | Prenatal alcohol exposure and facial morphology in a UK cohort |
Q64091237 | Prenatal alcohol exposure and offspring mental health: A systematic review |
Q64984217 | Prenatal and concurrent cocaine, alcohol, marijuana, and tobacco effects on adolescent cognition and attention. |
Q39410224 | Prenatal care and drug use in pregnant women |
Q34626723 | Prenatal cocaine exposure and age of sexual initiation: direct and indirect effects |
Q39470221 | Prenatal cocaine exposure and school-age intelligence |
Q36421464 | Prenatal cocaine exposure, illicit-substance use and stress and craving processes during adolescence |
Q90948577 | Prenatal cocaine exposure: Direct and indirect associations with 21-year-old offspring substance use and behavior problems |
Q92413227 | Prenatal drug exposure from infancy through emerging adulthood: Results from neuroimaging |
Q92182764 | Prenatal drug exposure: Lead by language limitations |
Q40189604 | Prenatal effects of alcohol |
Q48405830 | Prenatal effects of drugs of abuse on brain development |
Q94663395 | Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats |
Q50056433 | Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes |
Q48271726 | Prenatal exposure to morphine enhances cocaine and heroin self-administration in drug-naive rats |
Q88737541 | Prenatal exposures to tobacco and cannabis: Associations with adult electronic cigarette use |
Q91441421 | Prescriber responses to a pain clinic law: Cease or modify? |
Q91306505 | Prescribing diamorphine in the United States: Insights from a nationally representative survey |
Q93646485 | Prescribing methadone for the opiate addict: a problem of dosage conversion |
Q38699889 | Prescribing of benzodiazepines and opioids to individuals with substance use disorders |
Q46063612 | Prescribing patterns of buprenorphine waivered physicians |
Q33644065 | Prescription drug misuse among homeless youth |
Q40371189 | Prescription drug misuse and suicidal ideation: Findings from the National Survey on Drug Use and Health |
Q42694929 | Prescription drug monitoring program design and function: A qualitative analysis |
Q58857080 | Prescription drug use, misuse and related substance use disorder symptoms vary by educational status and attainment in U.S. adolescents and young adults |
Q36457495 | Prescription drugs purchased through the internet: who are the end users? |
Q36438049 | Prescription medication exchange patterns among methadone maintenance patients. |
Q37015810 | Prescription monitoring programs and emergency department visits involving opioids, 2004-2011. |
Q37833338 | Prescription of analgesics to patients in opioid maintenance therapy: a pharmacoepidemiological study |
Q36248982 | Prescription of opioid analgesics for nontraumatic dental conditions in emergency departments |
Q90110128 | Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018 |
Q40230061 | Prescription opioid abuse among enrollees into methadone maintenance treatment. |
Q35630313 | Prescription opioid abuse in patients presenting for methadone maintenance treatment |
Q39021790 | Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses |
Q44344556 | Prescription opioid addiction and chronic pain: More than a feeling |
Q92194304 | Prescription opioid misuse among African-American adults: A rural-urban comparison of prevalence and risk |
Q92170990 | Prescription opioid misuse among heterosexual versus lesbian, gay, and bisexual military veterans: Evidence from the 2015-2017 national survey of drug use and health |
Q60697171 | Prescription opioid misuse among youth in primary care: A comparison of risk factors |
Q100430480 | Prescription opioid misuse and its correlates among veterans and military in the United States: A systematic literature review |
Q52601305 | Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the cue-primed reactivity task. |
Q37107292 | Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. |
Q109315763 | Prescription opioid use and employment: A nationwide Finnish register study |
Q36565007 | Prescription opioid use, misuse, and diversion among street drug users in New York City |
Q52312534 | Prescription opioids: New perspectives and research on their role in chronic pain management and addiction. |
Q96762370 | Presence of a social peer enhances acquisition of remifentanil self-administration in male rats |
Q70578328 | Presence of arsenic and copper in alcoholic cirrhosis |
Q73417019 | Presence of illegal drugs in drivers involved in fatal road traffic accidents in Spain |
Q46525735 | Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. |
Q43162022 | Present at the creation--NIDA's first five years |
Q33756396 | Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment |
Q44958391 | Pretreatment with transdermal nicotine enhances some of ethanol's acute effects in men. |
Q52271103 | Pretrial release performance of addict defendants: examination of court non-appearance and rearrest rates. |
Q40625985 | Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology |
Q41438379 | Prevalence and associated factors of inhaled nitrites use among men who have sex with men in Beijing, China |
Q36090432 | Prevalence and characteristics of fetal alcohol syndrome and partial fetal alcohol syndrome in a Rocky Mountain Region City. |
Q44348646 | Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada |
Q40050494 | Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents |
Q47655800 | Prevalence and correlates of "Vaping" as a route of cannabis administration in medical cannabis patients |
Q35141597 | Prevalence and correlates of 'agua celeste' use among female sex workers who inject drugs in Ciudad Juarez, Mexico |
Q88680419 | Prevalence and correlates of adolescents' e-cigarette use frequency and dependence |
Q37658318 | Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health |
Q84503887 | Prevalence and correlates of alcohol use disorders during antiretroviral treatment in injection-driven HIV epidemics in Vietnam |
Q44360035 | Prevalence and correlates of areca nut use among psychiatric patients in India |
Q47564334 | Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically |
Q52600952 | Prevalence and correlates of binge drinking among older adults with multimorbidity. |
Q90378733 | Prevalence and correlates of cannabis poisoning diagnosis in a national emergency department sample |
Q44349299 | Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication. |
Q31150012 | Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. |
Q48259090 | Prevalence and correlates of depressive symptoms during early methamphetamine withdrawal in Han Chinese population |
Q36626237 | Prevalence and correlates of dual diagnoses in U.S. Latinos |
Q97588915 | Prevalence and correlates of ever having a substance use problem and substance use recovery status among adults in the United States, 2018 |
Q33283100 | Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities |
Q38721417 | Prevalence and correlates of light and non-daily smoking in Brazil: Results from a nationwide representative survey. |
Q92318504 | Prevalence and correlates of nonmedical use of prescription drugs (NMUPD) among Young adults experiencing homelessness in seven cities across the United States |
Q97539634 | Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California |
Q35946118 | Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city |
Q39616464 | Prevalence and correlates of prescription opioid residue injection |
Q47634651 | Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain |
Q38603642 | Prevalence and correlates of smoking and e-cigarette use among young men who have sex with men and transgender women |
Q34259013 | Prevalence and correlates of specialty substance use disorder treatment for Department of Veterans Affairs Healthcare System patients with high alcohol consumption |
Q34980327 | Prevalence and correlates of substance use among trans female youth ages 16-24 years in the San Francisco Bay Area |
Q37478571 | Prevalence and correlates of substance use among youth living with HIV in clinical settings. |
Q43647882 | Prevalence and correlates of substance use disorders among older adolescents in Puerto Rico and the United States: a cross-cultural comparison |
Q59138948 | Prevalence and correlates of the injection of methadone syrup in Sydney, Australia |
Q53593654 | Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. |
Q34949658 | Prevalence and correlates of waterpipe tobacco smoking by college students in North Carolina |
Q45115352 | Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population |
Q35181285 | Prevalence and determinants of resistance to use drugs among adolescents who had an opportunity to use drugs |
Q40489066 | Prevalence and distribution patterns of amphetamine and methamphetamine consumption in a federal state in southwestern Germany using wastewater analysis |
Q35660924 | Prevalence and experience of chronic pain in suburban drug injectors |
Q40914411 | Prevalence and factors associated with sex trading in the year prior to entering treatment for drug misuse in England. |
Q104571670 | Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey |
Q47318726 | Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program |
Q47651722 | Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study |
Q50064297 | Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy |
Q45074972 | Prevalence and pattern of substance use among undergraduates in a Nigerian University |
Q30395687 | Prevalence and patterns of cigarette smoking among patients co-infected with human immunodeficiency virus and tuberculosis in Tanzania |
Q36845692 | Prevalence and patterns of commonly abused psychoactive prescription drugs in a sample of university students from Lebanon: an opportunity for cross-cultural comparisons |
Q90250825 | Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco |
Q34154036 | Prevalence and patterns of smoking, alcohol use, and illicit drug use in young men who have sex with men. |
Q34920358 | Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies |
Q92160242 | Prevalence and recognition of highly significant medication-smoking cessation interactions in a smoke-free hospital |
Q88069507 | Prevalence and socio-demographic correlates of alcohol consumption: Survey findings from five states in India |
Q51200618 | Prevalence and temporal trends of crack injection among injection drug users in eastern central Canada. |
Q91960738 | Prevalence and treatment of opioid use disorders among primary care patients in six health systems |
Q34559445 | Prevalence and trends of alcohol use and misuse among adolescents and young adults in the Netherlands from 1993 to 2000. |
Q34252044 | Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010. |
Q44332638 | Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada. |
Q37055258 | Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample |
Q28240573 | Prevalence of DSM/ICD-defined nicotine dependence |
Q91030427 | Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012-2017) |
Q46520063 | Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy |
Q77462295 | Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment |
Q45646075 | Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department |
Q64977901 | Prevalence of alcohol use in pregnant women with substance use disorder. |
Q39523825 | Prevalence of at-risk drinking among Brazilian truck drivers and its interference on the performance of executive cognitive tasks |
Q28256352 | Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis |
Q91238549 | Prevalence of binge drinking and relationships between masculine role discrepancy and binge drinking via discrepancy stress among Chinese men |
Q104748076 | Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis |
Q38173126 | Prevalence of clinically recognized alcohol and other substance use disorders among VA outpatients with unhealthy alcohol use identified by routine alcohol screening. |
Q59202609 | Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis |
Q38527184 | Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis. |
Q39276629 | Prevalence of depressive symptoms and associated factors among people who inject drugs in China. |
Q48760682 | Prevalence of driving under the influence of psychoactive substances and road traffic crashes among Brazilian crack-using drivers. |
Q88236523 | Prevalence of drug use among students in mainland China: A systematic review and meta-analysis for 2003-2013 |
Q101119539 | Prevalence of e-cigarette use (2016 to 2018) and cigarette smoking (2012 to 2019) among U.S. adults by state: An interactive data visualization dashboard |
Q88098687 | Prevalence of gabapentin in drug overdose postmortem toxicology testing results |
Q39739134 | Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia |
Q46387039 | Prevalence of long QTc interval in methadone maintenance patients. |
Q43516289 | Prevalence of mental illnesses in adult offspring of alcoholic mothers |
Q36476423 | Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment |
Q100295811 | Prevalence of obesity among U.S. population with substance dependence |
Q90756740 | Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials |
Q39768011 | Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users |
Q46380849 | Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes |
Q44345227 | Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. |
Q30514051 | Prevalence of psychiatric disorders among young injection drug users |
Q90631190 | Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use |
Q46230853 | Prevalence of substance abuse in a psychiatric evaluation unit |
Q39109204 | Prevalence of unhealthy alcohol use in hospital outpatients |
Q40886800 | Prevalence of youth substance use: the impact of methodological differences between two national surveys |
Q30404240 | Prevalence, characteristics, and predictors of police training initiatives by US SEPs: building an evidence base for structural interventions |
Q38689168 | Prevalence, correlates, comorbidity and treatment of electronic nicotine delivery system use in the United States |
Q38928825 | Prevalence, correlates, comorbidity, and age of onset of alcohol use disorders in adult males from five provinces in China |
Q58566042 | Prevalence, incidence, recovery, and recurrence of alcohol use disorders from childhood to age 30 |
Q37714350 | Prevalence, patterns and predictors of substance use among Latino migrant men in a new receiving community |
Q88318918 | Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients |
Q41062896 | Prevalence, prescribed quantities, and trajectory of multiple prescriber episodes for benzodiazepines: A 2-year cohort study |
Q39155104 | Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. |
Q38791170 | Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States |
Q72066755 | Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients |
Q44507429 | Prevalence, timing, and predictors of transitions from inhalant use to inhalant use disorders |
Q46242661 | Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. |
Q45072455 | Preventing relapse to smoking with transcranial magnetic stimulation: Feasibility and potential efficacy |
Q42155985 | Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats |
Q69444349 | Prevention of alcohol-related problems. Introduction to a symposium |
Q48957461 | Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251. |
Q31060951 | Price and purity analysis for illicit drug: data and conceptual issues |
Q39784409 | Price elasticity of on- and off-premises demand for alcoholic drinks: A Tobit analysis |
Q67963101 | Primary and secondary depression in alcoholism--clinical features and family history |
Q42105248 | Primary care physicians' perspectives on the prescription opioid epidemic |
Q72106087 | Primary drug abuse among women: a national study |
Q44283691 | Primary health care professionals' activity in intervening in patients' alcohol drinking during a 3-year brief intervention implementation project |
Q43890388 | Primary health care professionals' activity in intervening in patients' alcohol drinking: a patient perspective |
Q40315442 | Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine |
Q35291735 | Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders. |
Q35132182 | Principles of drug abuse liability assessment in laboratory animals |
Q35132181 | Principles of initial experimental drug abuse liability assessment in humans |
Q34981070 | Principles of laboratory assessment of drug abuse liability and implications for clinical development |
Q47750575 | Prior binge-drinking history promotes the positive affective valence of methamphetamine in mice |
Q36537895 | Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations |
Q41711441 | Prior treatment experience related to process and outcomes in DATOS. |
Q44049012 | Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone |
Q42622098 | Prison experience of injecting drug users in Glasgow |
Q37251168 | Prize contingency management for smoking cessation: a randomized trial |
Q46867632 | Prize-based contingency management does not increase gambling |
Q39655216 | Proactive telephone counseling for adolescent smokers: Comparing regular smokers with infrequent and occasional smokers on treatment receptivity, engagement, and outcomes |
Q35113687 | Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) |
Q37046041 | Probability and predictors of relapse to smoking: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). |
Q34749978 | Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) |
Q36794523 | Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. |
Q36682087 | Probability and predictors of treatment-seeking for substance use disorders in the U.S. |
Q38677297 | Problem alcohol use and healthcare utilization among persons with cannabis use disorder in the United States. |
Q37598745 | Problem drinking is associated with increased prevalence of sexual risk behaviors among men who have sex with men (MSM) in Lima, Peru |
Q36402037 | Problem-free drinking over 16 years among individuals with alcohol use disorders |
Q34268063 | Problematic substance use in urban adolescents: role of intrauterine exposures to cocaine and marijuana and post-natal environment |
Q44958394 | Problems assessment for substance using psychiatric patients: development and initial psychometric evaluation |
Q102334775 | Problems experienced by children from families with histories of substance misuse: An ABCD study® |
Q37384505 | Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population |
Q48742444 | Processes of change assessment in heroin addicts following the Prochaska and DiClemente transtheoretical model |
Q42841691 | Processing dynamic facial affect in frequent cannabis-users: evidence of deficits in the speed of identifying emotional expressions |
Q45950412 | Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice. |
Q99358054 | Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia |
Q36407292 | Profile of lifetime methamphetamine use among homeless adults in Los Angeles |
Q104506539 | Profiles of patients with cocaine and alcohol use disorder based on cognitive domains and their relationship with relapse |
Q36173346 | Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China |
Q41435321 | Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics. |
Q37766669 | Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics |
Q46489611 | Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users |
Q46590891 | Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users |
Q50188719 | Program versus time: Length of stay patterns in alcoholism |
Q39287018 | Progress toward a voluntary oral consumption model of alcoholism |
Q43833873 | Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents |
Q46208504 | Progression to established patterns of cigarette smoking among young adults. |
Q48943735 | Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys |
Q52909477 | Prohibition of take-home dosages: negative consequences on methadone maintenance treatment. |
Q70376970 | Prolactin and thyrotropin pituitary response to thyrotropin releasing hormone in young female heroin addicts |
Q91246768 | Prolonged ethanol administration prevents the development of tolerance to morphine-induced respiratory depression |
Q37304946 | Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. |
Q44351393 | Prolonged use of benzodiazepines is associated with childhood trauma in opioid-maintained patients |
Q35318730 | Promethazine use among chronic pain patients |
Q34147422 | Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. |
Q47305906 | Prone to feel guilty: Self-evaluative emotions in alcohol-dependence. |
Q39500316 | Property damage and public disorder: their relationship with sales of alcohol in New South Wales, Australia. |
Q72503781 | Propoxyphene napsylate maintenance treatment for narcotic dependence: A non-methadone model |
Q58121250 | Propylene glycol, a major electronic cigarette constituent, attenuates the adverse effects of high-dose nicotine as measured by intracranial self-stimulation in rats |
Q34558978 | Propylhexdrine |
Q36989489 | Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse |
Q93072103 | Prospective associations between insomnia symptoms and alcohol use problems among former and current military service personnel |
Q94495672 | Prospective associations between parental substance use and youth highly processed food intake in the Fragile Families and Child Wellbeing Study |
Q100312100 | Prospective associations of e-cigarette use with cigarette, alcohol, marijuana, and nonmedical prescription drug use among US adolescents |
Q71364573 | Prospective evaluation of a model of risk for HIV infection among injecting drug users |
Q44809245 | Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse |
Q46780570 | Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution |
Q36004509 | Prospective patterns and correlates of quality of life among women in substance abuse treatment. |
Q91233430 | Prospective predictors of flavored e-cigarette use: A one-year longitudinal study of young adults in the U.S. |
Q37727156 | Prospective risk factors for traumatic event reexposure in community syringe exchange participants. |
Q69953063 | Prospective study of alcoholism treatment in Kuwait: a 5-year follow-up report |
Q31047181 | Prospective validation of substance abuse severity measures from administrative data |
Q40157867 | Prostaglandins in alcohol intolerance and hangover |
Q37147598 | Protecting against intergenerational problem behavior: mediational effects of prevented marijuana use on second-generation parent-child relationships and child impulsivity |
Q91124477 | Protective behavioral strategies predict alcohol-related problems among injured patients following a brief intervention |
Q46712102 | Protective effect against alcohol dependence of the thermolabile variant of MTHFR. |
Q73316264 | Protective effect of N-acetylcysteine on reduced glutathione, reduced glutathione-related enzymes and lipid peroxidation in methanol intoxication |
Q66972163 | Protective factors in alcoholism |
Q46512479 | Protective resources and long-term recovery from alcohol use disorders |
Q97518134 | Protracted renal clearance of fentanyl in persons with opioid use disorder |
Q38737065 | Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma. |
Q45361692 | Providing services for women with difficulties with alcohol or other drugs: the current U.K. situation as seen by women practitioners researchers and policy makers in the field |
Q103798454 | Province-specific alcohol-attributable cancer deaths and years of potential life lost in China |
Q35073306 | Proximal and distal social influence on alcohol consumption and marijuana use among middle school adolescents. |
Q37004591 | Proximity of off-premise alcohol outlets and heavy alcohol consumption: a cohort study |
Q48442511 | Pseudo-Cushing's syndrome: an example of alcohol-induced central disorder in corticotropin-releasing factor-ACTH release? |
Q41511291 | Pseudoepidemics of heroin addiction |
Q35936959 | Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers |
Q60618519 | Psychiatric comorbidities associated with a positive screening using the Montreal Cognitive Assessment (MoCA) test in subjects with severe alcohol use disorder |
Q92170978 | Psychiatric comorbidities in a comparative effectiveness smoking cessation trial: Relations with cessation success, treatment response, and relapse risk factors |
Q49066094 | Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders |
Q46876203 | Psychiatric comorbidity in young heroin users. |
Q33700806 | Psychiatric comorbidity with substance misuse in children and teenagers |
Q36666864 | Psychiatric diagnoses among quitters versus continuing smokers 3 years after their quit day |
Q34949206 | Psychiatric disorder symptoms, substance use, and sexual risk behavior among African-American out of school youth |
Q44701195 | Psychiatric disorders and attempted suicide among adolescents with substance use disorders |
Q35915954 | Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions. |
Q72048560 | Psychiatric distress in antisocial drug abusers: relation to other personality disorders |
Q51907131 | Psychiatric predictors of adolescent and young adult drug use and abuse. |
Q51907301 | Psychiatric predictors of adolescent and young adult drug use and abuse: what have we learned? |
Q52275542 | Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. |
Q51994399 | Psychiatric symptom severity in cocaine-dependent outpatients: demographics, drug use characteristics and treatment outcome. |
Q67575079 | Psychiatric symptoms in drug abusing adolescents |
Q40355130 | Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia |
Q37398130 | Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence |
Q36198525 | Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. |
Q50659997 | Psychoactive substance abuse among inmates of a Nigerian prison population |
Q34520354 | Psychoactive substance use and related behaviours of 135 regular illicit drug users in Scotland |
Q39329780 | Psychoactive substances--some new, some old: a scan of the situation in the U.S. |
Q48721606 | Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users |
Q51160867 | Psychological change during residence in a rehabilitation centre for female drug misusers. Part I. Drug misusers. |
Q48874389 | Psychological change during residence in a rehabilitation centre for female drug misusers. Part II. Children of drug misusers |
Q40109545 | Psychological characteristics and development of narcotic-addicted infants |
Q68046850 | Psychological defence, phase of dependence and further prerequisites for the intention of alcoholics to abstain |
Q36389704 | Psychological processes and stimulant use among men who have sex with men. |
Q52271045 | Psychological severity and response to alcoholism rehabilitation |
Q43570042 | Psychometric assessment of the Hallucinogen Rating Scale. |
Q71538283 | Psychometric evaluation of diagnostic criteria: application to a two-dimensional model of alcohol abuse and dependence |
Q35211165 | Psychometric modeling of cannabis initiation and use and the symptoms of cannabis abuse, dependence and withdrawal in a sample of male and female twins |
Q40272833 | Psychometric properties of brief indexes designed to measure social-cognitive predictors of smoking initiation |
Q51837008 | Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents. |
Q47627522 | Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study |
Q33872287 | Psychometric properties of the contingency management competence scale |
Q103722831 | Psychometric properties of the polish version of the Alcohol Use Disorders Identification Test (AUDIT) |
Q44335669 | Psychometric properties, validity, and reliability of the Temporal Experience of Pleasure Scale state version in an opioid-dependent sample. |
Q42142516 | Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity |
Q43569964 | Psychopathology and HIV risk behaviors among injection drug users in and out of treatment |
Q38675536 | Psychopathology and tobacco demand |
Q45234117 | Psychopathology associated with drinking and alcohol use disorders in the college and general adult populations |
Q36536847 | Psychopathy and the prediction of alcohol-related physical aggression: the roles of impulsive antisociality and fearless dominance |
Q33653525 | Psychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sex |
Q72118564 | Psychopharmacology and abuse potential of transnasal butorphanol |
Q48599170 | Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers |
Q38282011 | Psychophysiology of pain and opioid use: implications for managing pain in patients with an opioid use disorder |
Q33980564 | Psychosocial and contextual determinants of alcohol and drug use disorders in the National Latino and Asian American Study |
Q123600452 | Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults |
Q49806734 | Psychosocial and neural indicators of resilience among youth with a family history of substance use disorder |
Q39710825 | Psychosocial and substance-use risk factors for intimate partner violence. |
Q46304653 | Psychosocial correlates of alcohol, tobacco and cannabis use: findings from a Nigerian university |
Q41503219 | Psychosocial correlates of chronic cannabis use. |
Q79890928 | Psychosocial correlates of substance use in adolescence: a cross-national study in six European countries |
Q44963791 | Psychosocial effects of longterm cannabis use in India A study of fifty heavy users and controls |
Q49123601 | Psychosocial factors influencing alcohol problems in West German survey samples |
Q36149670 | Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method |
Q44934076 | Psychosocial profiles of older adolescent MDMA users. |
Q49806754 | Psychosocial stress increases craving for alcohol in social drinkers: Effects of risk-taking |
Q34567589 | Psychosocial treatments for cocaine dependence: The role of depressive symptoms |
Q35017227 | Psychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms |
Q72687665 | Psychotropic drug consumption and other factors associated with heroin overdose |
Q55043041 | Pubertal maturation and the development of alcohol use and abuse. |
Q38104454 | Public health strategies for prevention and control of HSV-2 in persons who use drugs in the United States |
Q34001228 | Public injecting and HIV risk behaviour among street-involved youth. |
Q68916203 | Publication trends in fetal alcohol, tobacco and narcotic effects |
Q94953646 | Puffing topography and physiological responses in men and women with low versus high waterpipe dependence during smoking: The WiHi Irbid project |
Q43884133 | Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia |
Q53977871 | Punishing pregnant drug users: enhancing the flight from care. |
Q43745879 | Pupillography response to methadone challenge: Aid to diagnosis of opioid dependence |
Q58089959 | Purchases of prescription drugs before an alcohol-related death: A ten-year follow-up study using linked routine data |
Q41614495 | Pyrazole-insensitive alcohol dehydrogenase activity in human serum |
Q85847474 | QT interval prolongation associated with low magnesium in chronic alcoholics |
Q39375394 | Qualitative process study of community pharmacist brief alcohol intervention effectiveness trial: Can research participation effects explain a null finding? |
Q38039745 | Quality of life among alcohol-dependent patients: how satisfactory are the available instruments? A systematic review |
Q43947590 | Quality of life and personality disorders in heroin abusers |
Q47850710 | Quality of life in a cohort of high-dose benzodiazepine dependent patients |
Q39845397 | Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence |
Q34511268 | Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes |
Q46524896 | Quantification of EtG in hair, EtG and EtS in urine and PEth species in capillary dried blood spots to assess the alcohol consumption in driver's licence regranting cases. |
Q45249961 | Quantifying cannabis use with the timeline followback approach: a psychometric evaluation |
Q36621079 | Quantifying crime associated with drug use among a large cohort of sanctioned offenders in England and Wales |
Q71181993 | Quantitation and comparison of phenobarbital levels in the plasma, saliva, and cerebrospinal fluid of the rat, and the demonstration of an alteration of drug passage by ethanol |
Q84518496 | Quantitative assessment of time dependent drug-use trends by the analysis of drugs and related metabolites in raw sewage |
Q90631211 | Quantitative biochemical screening for marijuana use and concordance with tobacco use in urban adolescents |
Q66972156 | Quantitative correlation of ethanol elimination rates in vivo with liver alcohol dehydrogenase activities in fed, fasted and food-restricted rats |
Q48684491 | Quantitative electroencephalographic differences associated with alcohol, cocaine, heroin and dual-substance dependence |
Q31926100 | Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: a preliminary report |
Q115031484 | Quantitative review of psychosocial and ethical contents of home drug testing for parents on the Internet |
Q99723813 | Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems |
Q92478763 | Quasi-experimentally examining the impact of introducing tobacco pictorial health warnings: Findings from the International Tobacco Control (ITC) 4C and Netherlands surveys in the Netherlands, Australia, Canada, United Kingdom, and the United States |
Q41435315 | Quetiapine for the treatment of cocaine use disorder |
Q101378056 | Quetiapine treatment for cannabis use disorder |
Q30531050 | Quick screen to detect current substance use disorder in adolescents and the likelihood of future disorder |
Q97539586 | Quit ratios for cigarette smoking among individuals with opioid misuse and opioid use disorder in the United States |
Q33912528 | Quitting smoking and change in alcohol consumption in the International Tobacco Control (ITC) Four Country Survey |
Q38605561 | Race/ethnicity and marijuana use in the United States: Diminishing differences in the prevalence of use, 2006-2015. |
Q34190594 | Race/ethnicity and sex differences in progression from drinking initiation to the development of alcohol dependence |
Q37320860 | Race/ethnicity, socioeconomic factors, and smoking among early adolescent girls in the United States |
Q36499522 | Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic |
Q38673634 | Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample |
Q100446759 | Racial and gender inequities in the implementation of a cannabis criminal justice diversion program in a large and diverse metropolitan county of the USA |
Q37172383 | Racial differences in heritability of cigarette smoking in adolescents and young adults |
Q44396014 | Racial differences in marijuana-users' risk of arrest in the United States |
Q91306985 | Racial differences in overdose events and polydrug detection in Indianapolis, Indiana |
Q93130561 | Racial differences in the relationship between alcohol/pregnancy policies and birth outcomes and prenatal care utilization: A legal epidemiology study |
Q33923466 | Racial differences in the validity of self-reported drug use among men who have sex with men in Atlanta, GA |
Q45161002 | Racial differences in trajectories of cigarette use. |
Q35672881 | Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males. |
Q91024575 | Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients |
Q41911006 | Racial factors influencing college students' ratings of alcohol's usefulness |
Q39151704 | Racial/ethnic differences in 30-year trajectories of heavy drinking in a nationally representative U.S. sample |
Q44215401 | Racial/ethnic differences in correlates of prescription drug misuse among young adults |
Q95647554 | Racial/ethnic differences in opioid-involved overdose deaths across metropolitan and non-metropolitan areas in the United States, 1999-2017 |
Q27312280 | Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users. |
Q98563545 | Racial/ethnic discrimination and alcohol use disorder severity among United States adults |
Q68249658 | Radioimmunoassay of amphetamines in rat parotid saliva |
Q67599531 | Radioimmunoassay of methadone in rat parotid saliva |
Q46239777 | Random responses inflate statistical estimates in heavily skewed addictions data. |
Q74741334 | Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal |
Q59769137 | Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal |
Q89577132 | Randomized Trial of Screening and Brief Intervention to Reduce Injury and Substance Abuse in an urban Level I Trauma Center |
Q37164750 | Randomized clinical trial examining duration of voucher-based reinforcement therapy for cocaine abstinence |
Q54226260 | Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment. |
Q44348336 | Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone |
Q44344528 | Randomized controlled trial of a computerized opioid overdose education intervention |
Q91339370 | Randomized controlled trial of a positive affect intervention for methamphetamine users |
Q93351006 | Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders |
Q36630235 | Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders |
Q43278930 | Randomized response estimates for doping and illicit drug use in elite athletes. |
Q102058333 | Randomized trial of methadone treatment of arrestees: 24-month post-release outcomes |
Q33441401 | Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy |
Q34424620 | Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. |
Q33873511 | Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence |
Q40320100 | Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence |
Q36839403 | Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence |
Q44679867 | Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence |
Q38034585 | Rapid adaptation to neuronal membrane effects of ethanol and low temperature: Some speculations on mechanism |
Q42644267 | Rapid assessment of drug-related HIV risk among men who have sex with men in three South African cities |
Q73316256 | Rapid cortical hemoglobin deoxygenation after heroin and methadone injection in humans: a preliminary report |
Q42767360 | Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats |
Q40509840 | Rapid transition from drinking to alcohol dependence among adolescent and young-adult newly incident drinkers in the United States, 2002-2013. |
Q47803823 | Rapid widespread distribution of intranasal naloxone for overdose prevention. |
Q59138815 | Rates and correlates of mortality amongst heroin users: Findings from the Australian Treatment Outcome Study (ATOS), 2001–2009 |
Q39542428 | Rates of past-year alcohol treatment across two time metrics and differences by alcohol use disorder severity and mental health comorbidities |
Q94548449 | Rates, characteristics and manner of cannabis-related deaths in Australia 2000-2018 |
Q46491044 | Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP). |
Q90444540 | Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features |
Q60485528 | Reaching and enrolling drug users for HIV prevention: a multi-site analysis |
Q103822117 | Reactions to targeted tobacco control messaging: Transgender and gender diverse young adult perspectives |
Q52252648 | Reactivity to alcohol stimuli in alcoholics: is there a role for temptation? |
Q24655024 | Reactivity to laboratory stress provocation predicts relapse to cocaine |
Q39943824 | Readiness-to-change as a moderator of a web-based brief intervention for marijuana among students identified by health center screening. |
Q57166657 | Real-time predictors of smoking among sexual minority and heterosexual young adults: An ecological momentary assessment study |
Q37402666 | Real-time tracking of neighborhood surroundings and mood in urban drug misusers: application of a new method to study behavior in its geographical context |
Q58450681 | Real-time, continuous electrochemical monitoring of drugs in vivo |
Q41640417 | Rearing environment differentially modulates cocaine self-administration after opioid pretreatment: A behavioral economic analysis. |
Q43890406 | Rearrest rates among Norwegian drugged drivers compared with drunken drivers |
Q49092895 | Reasons adduced by high school students for not using drugs |
Q89714503 | Reasons for assisting with injection initiation: Results from a large survey of people who inject drugs in Los Angeles and San Francisco, California |
Q47204719 | Reasons for non-drinking among Israeli adolescents of four religions |
Q58633804 | Reasons for prescription opioid misuse while playing in the NFL associated with current use and misuse among retired players |
Q42359197 | Reasons for using flavored liquids among electronic cigarette users: A concept mapping study |
Q40832748 | Reasons to use e-cigarettes and associations with other substances among adolescents in Switzerland |
Q68249644 | Reassessing the goal of drug education: diversity of preference among teachers and students |
Q47741373 | Recalled first reactions to inhaling nicotine predict the level of physical dependence |
Q44448276 | Recanting of substance use reports in a longitudinal prevention study |
Q54213589 | Receipt of alcohol-related care among patients with HCV and unhealthy alcohol use. |
Q91231032 | Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs |
Q44331742 | Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors |
Q36619578 | Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients |
Q45719859 | Receiving versus being denied an abortion and subsequent drug use. |
Q44154872 | Recent cannabis use among adolescent and young adult immigrants in the Netherlands--the roles of acculturation strategy and linguistic acculturation |
Q31870862 | Recent evolution in opiate dependence in France during generalisation of maintenance treatments |
Q94540262 | Recent incarceration and risk of first-time injection initiation assistance: A prospective cohort study of persons who inject drugs |
Q52650502 | Recent rapid decrease in adolescents' perception that marijuana is harmful, but no concurrent increase in use. |
Q100501573 | Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments |
Q40728562 | Recent trends in cannabis use in Canada |
Q90672405 | Recent trends in cooperativeness among participants in the national survey of drug use and health 2002-2015 |
Q48114861 | Receptor selectivity of icv morphine in the rat cold water tail-flick test |
Q67353189 | Recidivism among clients of alcoholism halfway houses |
Q67353191 | Recidivism and indices of drug abuse treatment effectiveness |
Q67353187 | Recidivism as a measure of the persistency of deviant behavior |
Q67353183 | Recidivism in alcoholism and substance abuse programs. An introduction to the symposium |
Q103825512 | Reciprocal influences of tobacco use on illicit opioid and alcohol use during the first six-months of specialist addiction treatment |
Q35605861 | Reciprocal inhibitory effects of intravenous d-methamphetamine self-administration and wheel activity in rats |
Q37694825 | Recognition and management of alcohol misuse in OEF/OIF and other veterans in the VA: a cross-sectional study |
Q38832784 | Recognition and response to opioid overdose deaths-New Mexico, 2012. |
Q45161029 | Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study |
Q37674006 | Recovery benefits of the "therapeutic alliance" among 12-step mutual-help organization attendees and their sponsors |
Q47651636 | Recovery capital pathways: Modelling the components of recovery wellbeing. |
Q35952024 | Recovery definitions: Do they change? |
Q92892386 | Recreational ART use among individuals living with HIV/AIDS in South Africa: Examining longitudinal ART initiation and viral suppression |
Q92736311 | Recreational cannabis use impairs driving performance in the absence of acute intoxication |
Q24650832 | Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men |
Q48573782 | Recreational drug use and risk of HIV infection among men who have sex with men: A cross-sectional study in Shenzhen, China |
Q58555059 | Recreational marijuana legalization and prescription opioids received by Medicaid enrollees |
Q40702802 | Recreational phenethylamine poisonings reported to a French poison control center |
Q37467733 | Redressing the epidemics of opioid overdose and HIV among people who inject drugs in Central Asia: the need for a syndemic approach |
Q34093206 | Reduced anterior prefrontal cortex activation in young binge drinkers during a visual working memory task. |
Q60680227 | Reduced baroreflex sensitivity in acute alcohol withdrawal syndrome and in abstained alcoholics |
Q44161274 | Reduced cardio-respiratory coupling in acute alcohol withdrawal |
Q44668411 | Reduced cardiovascular effects of methamphetamine following treatment with selegiline |
Q44672960 | Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. |
Q35206732 | Reduced cortical gray matter volume in male adolescents with substance and conduct problems. |
Q48233797 | Reduced frontal cortical thickness and increased caudate volume within fronto-striatal circuits in young adult smokers |
Q48025502 | Reduced interhemispheric executive control network coupling in men during early cocaine abstinence: A pilot study |
Q47233701 | Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior |
Q36575460 | Reduced posterior mesofrontal cortex activation by risky rewards in substance-dependent patients |
Q59540399 | Reduced precuneus activation in adolescents at risk for food addiction |
Q43905204 | Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence |
Q44084042 | Reduced ventral medial prefrontal cortex (vmPFC) volume and impaired vmPFC-default mode network integration in codeine-containing cough syrups users |
Q71721803 | Reducing alcohol-use disorders via decreased consumption: a comparison of population and high-risk strategies |
Q71035551 | Reducing attrition from conjoint therapy with alcoholic couples |
Q35146787 | Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants |
Q44338821 | Reducing opioid. analgesic abuse: models for successful collaboration among government, industry and other key stakeholders |
Q33642268 | Reducing readmissions to detoxification: an interorganizational network perspective |
Q60031018 | Reducing the cost of free time: Treatment success in a randomized trial of clonidine as adjunct to buprenorphine maintenance is associated with more leisure activities in the clonidine condition |
Q43570022 | Reducing the harms caused by cannabis use: the policy debate in Australia |
Q46930879 | Reducing the time and dose of morphine application used in Marshall and Grahame-Smith method for induction of morphine tolerance and dependence in mice |
Q93371619 | Reduction in methamphetamine consumption trends from 2015 to 2018 detected by wastewater-based epidemiology in Dalian, China |
Q92246555 | Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population |
Q92587979 | Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population |
Q48900155 | Reduction of the sialic acid and galactose concentrations in erythrocyte membranes in alcoholics |
Q73434142 | Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes |
Q44333159 | Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study |
Q46651921 | Reductions in criminal convictions after addiction treatment: 5-year follow-up |
Q59138830 | Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study |
Q36421232 | Reductions in physical pain predict lower risk of relapse following alcohol treatment |
Q90166721 | Redundant visual signals reduce the intensity of alcohol impairment |
Q50574950 | Referral for chronic hepatitis C treatment from a drug dependency treatment setting |
Q35781994 | Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes |
Q48437291 | Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse |
Q44574561 | Regional cerebral blood flow in female cocaine-addicted subjects following limbic activation |
Q50083696 | Regional cerebral blood flow predictors of relapse and resilience in substance use recovery: A coordinate-based meta-analysis of human neuroimaging studies |
Q36205006 | Regional differences in drug use rates among American Indian youth |
Q66985010 | Regional differences in high-affinity choline uptake in brain after acute and chronic treatment with ethanol |
Q39758554 | Regional differences in injecting practices and other substance use-related behaviour among entrants into opioid maintenance pharmacotherapy treatment in New South Wales, Australia |
Q92601168 | Regional differences in white matter integrity in stimulant use disorders: A meta-analysis of diffusion tensor imaging studies |
Q34480610 | Regional gray matter deficits in alcohol dependence: A meta-analysis of voxel-based morphometry studies |
Q92160664 | Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States |
Q78246018 | Regional variations in alcohol use among young people in France. Epidemiological approach to alcohol use and abuse by adolescents and conscripts |
Q70578340 | Regional variations in the consumption of alcohol in the U.S.A. |
Q37725081 | Regionally-specific alterations in myelin proteins in nonhuman primate white matter following prolonged cocaine self-administration |
Q42403475 | Registered reports: a new submission format at Drug and Alcohol Dependence |
Q37592882 | Regression to the mean and alcohol consumption: a cohort study exploring implications for the interpretation of change in control groups in brief intervention trials |
Q91665835 | Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs |
Q47914548 | Regular cannabis and alcohol use is associated with resting-state time course power spectra in incarcerated adolescents |
Q90309181 | Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease |
Q37238635 | Regular drinking may strengthen the beneficial influence of social support on depression: findings from a representative Israeli sample during a period of war and terrorism |
Q39708844 | Regular use of alcohol and tobacco in India and its association with age, gender, and poverty. |
Q33949643 | Regularly drinking alcohol before sex in the United States: effects of relationship status and alcohol use disorders |
Q33624263 | Regulation of craving by cognitive strategies in cigarette smokers |
Q37719125 | Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications |
Q82981849 | Regulatory challenges for new formulations of controlled substances in today's environment |
Q71736709 | Rehabilitation of drug-dependent persons: where are we going wrong? |
Q52316316 | Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service. |
Q30375616 | Reinforcement enhancing effects of acute nicotine via electronic cigarettes. |
Q39528221 | Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation |
Q46588014 | Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers |
Q51854924 | Reinforcements from the first drug experience can predict later drug habits and/or addiction: Results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine |
Q88109047 | Reinforcer pathologies: Predicting alcohol related problems in college drinking men and women |
Q34387041 | Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys |
Q43803503 | Reinforcing and discriminative-stimulus effects of ephedrine isomers in rhesus monkeys |
Q45109753 | Reinforcing and subjective effects of the volatile anesthetic, sevoflurane |
Q48858301 | Reinforcing breath carbon monoxide reductions in chronic obstructive pulmonary disease |
Q43728938 | Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys |
Q34362487 | Reinforcing effects of extended inhalation of nitrous oxide in humans |
Q37204887 | Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial |
Q51848710 | Reinforcing properties of lorazepam in normal volunteers. |
Q40567512 | Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis |
Q28210514 | Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP |
Q35541827 | Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone |
Q71099424 | Relapse rates for former clients of alcoholism rehabilitation units who are drinking without symptoms |
Q48405844 | Relapse to drug-seeking: neural and molecular mechanisms |
Q70664585 | Relapse to morphine self-administration in morphine, methadone, and levo-alpha-acetylmethadol (LAAM) post-addict rats |
Q46326723 | Relapse to opiate use provokes biphasic changes of blood pressure in heroin-withdrawn addicts treated with clonidine |
Q52585390 | Relapse to smoking following release from smoke-free correctional facilities in Queensland, Australia. |
Q37667076 | Relation among HPA and HPG neuroendocrine systems, transmissible risk and neighborhood quality on development of substance use disorder: results of a 10-year prospective study |
Q45109730 | Relation between cognitive distortions and neurobehavior disinhibition on the development of substance use during adolescence and substance use disorder by young adulthood: a prospective study |
Q44958387 | Relation of attachment style to family history of alcoholism and alcohol use disorders in early adulthood |
Q115217234 | Relations between impulsive personality traits, alcohol and cannabis co-use, and negative alcohol consequences: A test of cognitive and behavioral mediators |
Q47760890 | Relations between mental health diagnoses, mental health treatment, and substance use in homeless youth. |
Q51915976 | Relations between parent and adolescent problems among adolescents presenting for family-based marijuana abuse treatment. |
Q44337911 | Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT). |
Q70709841 | Relationship between HBV markers and heroin as a cause of liver injury in drug addicts |
Q44026080 | Relationship between LAAM-methadone preference and treatment outcomes |
Q48378696 | Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study |
Q69677298 | Relationship between alcohol consumption and breast cancer morbidity rates in Western Australia, 1971--1984 |
Q44324902 | Relationship between betel quid chewing and risks of cardiovascular disease in older adults: a cross-sectional study in Taiwan |
Q46588054 | Relationship between blood alcohol concentration and carbohydrate-deficient transferrin among drivers |
Q40105598 | Relationship between brain levels of cyclic nucleotides and γ-aminobutyric acid during ethanol withdrawal in rats |
Q92774315 | Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012-2017 |
Q43647888 | Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram |
Q58591005 | Relationship between childhood abuse and substance misuse problems is mediated by substance use coping motives, in school attending South African adolescents |
Q38913566 | Relationship between early symptoms of alcohol craving and binge drinking 2.5 years later |
Q44094315 | Relationship between extent of cocaine use and dependence among adolescents and adults in the United States |
Q88650775 | Relationship between fMRI response during a nonverbal memory task and marijuana use in college students |
Q68035113 | Relationship between hepatic histology and conventional biochemical liver function test in chronic alcoholic patients |
Q51666814 | Relationship between intravenous use and achieving initial cocaine abstinence. |
Q47337756 | Relationship between masculinity and feminity in drinking in alcohol-related behavior in a general population sample |
Q69337760 | Relationship between plasma adrenocorticotrophic hormone and cortisol concentrations in chronic alcoholic patients with depression |
Q48631036 | Relationship between plasma cortisol concentrations and depression in chronic alcoholic patients |
Q36797296 | Relationship between sex hormones and cognitive performance in men with substance use. |
Q90110141 | Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers |
Q51136571 | Relationship between subjective effects and drug preferences: ethanol and diazepam. |
Q88532741 | Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study |
Q48499377 | Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls |
Q68641078 | Relationship between waiting time and retention in treatment amongst substance abusers |
Q92773796 | Relationship functioning and substance use in same-sex male couples |
Q77893762 | Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents |
Q34612772 | Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders. |
Q43199063 | Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war. |
Q71389895 | Relationship of family history of alcoholism to patterns of drinking and physical dependence in male alcoholics |
Q91019991 | Relationship of media exposure to substance use among adolescents in Saudi Arabia: Results from a national study |
Q40091587 | Relationship of opioid prescription sales and overdoses, North Carolina. |
Q72629337 | Relationship of specialty and access to substance use among registered nurses: an exploratory analysis |
Q78170784 | Relationships between characteristics of drinking occasions and negative and positive experiences related to drinking |
Q93122295 | Relationships between drinking quantity and frequency and behavioral and hippocampal BOLD responses during working memory performance involving allocentric spatial navigation in college students |
Q50943092 | Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. |
Q38846267 | Relationships between needle and syringe programs and police: An exploratory analysis of the potential role of in-service training |
Q72180017 | Relationships of personality disorders with problem severity in methadone patients |
Q34170690 | Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users |
Q49019338 | Relative abuse of diazepam and oxazepam: prescription forgeries and theft/loss reports in Sweden |
Q34649494 | Relative bioavailability of different buprenorphine formulations under chronic dosing conditions |
Q90202469 | Relative importance of caregiver characteristics for future alcohol consumption in youth involved with child welfare system |
Q44189352 | Relative reinforcing effects of different benzodiazepine doses for rhesus monkeys |
Q51611678 | Relative reinforcing effects of different doses of orally delivered cocaine. |
Q68090742 | Relative risk factors in detecting adolescent drug abuse |
Q38307013 | Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats |
Q99209500 | Relevance of routine activities for understanding the impact of the dual systems model on binge drinking among college students |
Q43571808 | Reliability and discriminant validity of the Type I/II and Type A/B alcoholic subtype classifications in untreated problem drinkers: a test of the Apollonian--Dionysian hypothesis |
Q37222587 | Reliability and validity of a short form of the Marijuana Craving Questionnaire. |
Q77462282 | Reliability and validity of self-report: on the importance of considering context |
Q50669509 | Reliability and validity of the Westminster Substance Use Questionnaire among Lancashire adolescents |
Q36087857 | Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). |
Q93596358 | Reliability of a family tree questionnaire for assessing family history of alcohol problems |
Q74447010 | Reliability of drug dependents' self-reports |
Q39446741 | Reliability of drug dependents' self-reports. |
Q74507731 | Reliability of self-reported antisocial personality disorder symptoms among substance abusers |
Q70478117 | Reliability of self-reports of low ethanol consumption by problem drinkers over 18 months of follow-up |
Q47686705 | Reliability of substance use disorder diagnoses among African-Americans and Caucasians |
Q51914207 | Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia. |
Q40879940 | Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule--Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison |
Q36089480 | Reliability of use, abuse, and dependence of four types of inhalants in adolescents and young adults. |
Q54724081 | Religion and alcohol in the U.S. National Alcohol Survey: how important is religion for abstention and drinking? |
Q54791081 | Religion and attitudes towards alcohol use in the Western Isles. |
Q36672654 | Religiosity and substance use among Asian American college students: moderated effects of race and acculturation |
Q36689460 | Religiosity as a protective factor for hazardous drinking and drug use among sexual minority and heterosexual women: Findings from the National Alcohol Survey |
Q37574561 | Religious factors associated with alcohol involvement: results from the Mauritian Joint Child Health Project |
Q91195636 | Religious involvement and racial disparities in opioid use disorder between 2004-2005 and 2012-2013: Results from the National Epidemiologic Survey on Alcohol and Related Conditions |
Q101241556 | Remifentanil-food choice follows predictions of relative subjective value |
Q35903423 | Remission from alcohol and other drug problem use in public and private treatment samples over seven years |
Q37204853 | Remission from substance dependence: differences between individuals in a general population longitudinal survey who do and do not seek help |
Q38950931 | Remission from substance use disorders: A systematic review and meta-analysis |
Q52278405 | Remissions from drug dependence: is treatment a prerequisite? |
Q43062360 | Removal notice to "Sustained-release naltrexone for opioid dependence: A cochrane review and meta-analysis" [Drug Alcohol Depend. 146 (2015) e165-e166]. |
Q51809769 | Repeated administration of diazepam and triazolam to subjects with histories of drug abuse. |
Q51763333 | Repeated intranasal cocaine administration: lack of tolerance to pressor effects. |
Q39674168 | Repeated measures latent class analysis of daily smoking in three smoking cessation studies |
Q112585825 | Repeated morphine exposure activates synaptogenesis and other neuroplasticity-related gene networks in the dorsomedial prefrontal cortex of male and female rats |
Q47411978 | Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway. |
Q48456524 | Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. |
Q70793304 | Repeated withdrawal from barbital as a drive for 'drug taking behavior' in rats |
Q38893356 | Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers |
Q37023967 | Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment |
Q39767800 | Reported alcohol drinking and mental health problems in Hong Kong Chinese adolescents |
Q42595690 | Reporting of HIV risk behaviors by injection drug using heterosexual couples in methadone maintenance |
Q31028892 | Reproducibility and differential item functioning of the alcohol dependence syndrome construct across four alcohol treatment studies: An integrative data analysis |
Q58330025 | Republic of Georgia estimates for prevalence of drug use: Randomized response techniques suggest under-estimation |
Q68759607 | Research and policy |
Q59488289 | Research design strategies to evaluate the impact of formulations on abuse liability |
Q37917032 | Research is badly needed to improve programmes for the prevention and treatment of drug abuse and drug dependence in Brazil |
Q41447847 | Research issues concerning alcohol consumption among aging populations |
Q37811591 | Research issues in assessing addiction treatment efficacy: how cost effective are Alcoholics Anonymous and private treatment centers? |
Q37917020 | Research on drug use: a review of problems, needs and future perspectives |
Q37917008 | Research on psychopathology and addiction: treatment implications |
Q92076017 | Research on women with substance use disorders: Reviewing progress and developing a research and implementation roadmap |
Q36975144 | Researching the intoxicated: informed consent implications for alcohol and drug research |
Q36496674 | Residual effects of intranasal methamphetamine on sleep, mood, and performance. |
Q48739520 | Residual effects of repeated cocaine smoking in humans |
Q44994499 | Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs |
Q93072104 | Resiliency factors that protect against post-deployment drug use among male US Army Reserve and National Guard soldiers |
Q34162203 | Resisting temptation: decreasing alcohol-related affect and drinking behavior by training response inhibition |
Q96762364 | Respiratory and emotional reactivity to ethanol odor in human neonates is dependent upon maternal drinking patterns during pregnancy |
Q48097663 | Respiratory effects of diazepam/methadone combination in rats: a study based on concentration/effect relationships. |
Q47567218 | Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK. |
Q34167609 | Respondent driven sampling is an effective method for engaging methamphetamine users in HIV prevention research in South Africa |
Q50160157 | Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand |
Q46449718 | Respondent-driven sampling to recruit MDMA users: a methodological assessment |
Q35667147 | Respondent-driven sampling to recruit young adult non-medical users of pharmaceutical opioids: problems and solutions |
Q51876576 | Responding maintained by cocaine or d-amphetamine under fixed-interval schedules in baboons. |
Q37462396 | Response disinhibition evoked by the administration of nicotine and nicotine-associated contextual cues |
Q56678970 | Response inhibition and fronto-striatal-thalamic circuit dysfunction in cocaine addiction |
Q36164768 | Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation |
Q91780583 | Response letter to Qiu et al |
Q52277303 | Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants, and opioids. |
Q92520630 | Response to Kwon et al. "Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016" |
Q91569661 | Response to Manthey, Carr, and Rehm |
Q45198803 | Response to alcohol cues as a function of consumption level |
Q34474280 | Response to alcohol in women: Role of the menstrual cycle and a family history of alcoholism |
Q46742376 | Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. |
Q46112128 | Response to methadone maintenance treatment of opiate dependent patients with and without significant pain |
Q46987212 | Responsiveness of EQ-5D utility indices in alcohol-dependent patients |
Q130081933 | Resting state functional connectivity in dependent cannabis users: The moderating role of cannabis attitudes |
Q49895331 | Resting state functional connectivity of the amygdala and problem drinking in non-dependent alcohol drinkers |
Q37138543 | Resting state synchrony in long-term abstinent alcoholics with versus without comorbid drug dependence |
Q36746203 | Resting-state activity in the left executive control network is associated with behavioral approach and is increased in substance dependence |
Q35181313 | Resting-state regional cerebral blood flow during adolescence: associations with initiation of substance use and prediction of future use disorders. |
Q47567346 | Restricting the availability of alcohol and rates of personal violence (suicide and homicide). |
Q37400844 | Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence |
Q31926065 | Results of a baseline urine test predict levels of cocaine use during treatment |
Q30423352 | Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system |
Q35685676 | Results of an initial clinical trial of varenicline for the treatment of cocaine dependence |
Q44980776 | Results of prevention programs with adolescents |
Q51614416 | Results of the NIDA treatment demonstration grants' cocaine workgroup: characteristics of cocaine users and HIV risk behaviors. |
Q51745704 | Resumption of injecting drug use following release from prison in Australia. |
Q24678345 | Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram |
Q45960603 | Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study. |
Q52083391 | Retention and patient engagement models for different treatment modalities in DATOS. |
Q42637737 | Retention in a low-threshold methadone maintenance program |
Q43009162 | Retention in naltrexone implant treatment for opioid dependence |
Q57209689 | Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage |
Q71099435 | Retention of driving-under-the-influence offenders in alcoholism treatment |
Q104571669 | Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes |
Q43884128 | Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis |
Q93107816 | Retraction notice to Confirmed Marijuana Use and Lymphocyte Count in Black People Living with HIV [DAD 180 (2017) 22 - 25] |
Q43540768 | Reversal of acute effects of high dose morphine on lymphocyte activity by chlorisondamine |
Q44024561 | Reversibility of morphine effects on phagocytosis by murine macrophages |
Q52049498 | Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat. |
Q46133428 | Reversing the sequence: reducing alcohol consumption by overcoming alcohol attentional bias |
Q39820251 | Review of self-administration |
Q100941584 | Review of sexualized drug use associated with sexually transmitted and blood-borne infections in gay, bisexual and other men who have sex with men |
Q89116297 | Review: Adjunctive pharmacologic approaches for benzodiazepine tapers |
Q47330073 | Revisiting the role of the insula and smoking cue-reactivity in relapse: A replication and extension of neuroimaging findings |
Q93341138 | Reward activation in childhood predicts adolescent substance use initiation in a high-risk sample |
Q58566049 | Reward and executive control network resting-state functional connectivity is associated with impulsivity during reward-based decision making for cocaine users |
Q35624288 | Reward expectations lead to smoking uptake among depressed adolescents |
Q36803318 | Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users |
Q47683914 | Reward-related frontostriatal activity and smoking behavior among adolescents in treatment for smoking cessation |
Q35738885 | Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients |
Q42602102 | Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. |
Q57482317 | Rising incidence of ageing opioid users within the EU wide treatment demand indicator; The Irish opioid epidemic from 1996 to 2014 |
Q90347532 | Risk and protective factors for heroin use in a nationally representative sample of Ecuadorian youth |
Q91441409 | Risk and protective factors for opioid misuse in American Indian adolescents |
Q89714510 | Risk and protective factors for repeated overdose after opioid overdose survival |
Q33489194 | Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco |
Q42688141 | Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia |
Q45828609 | Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms. |
Q39263170 | Risk characteristics associated with chronic unemployment in methadone clients |
Q30636591 | Risk estimates for starting tobacco, alcohol, and other drug use in the United States: male-female differences and the possibility that 'limiting time with friends' is protective |
Q38021096 | Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis |
Q91804544 | Risk factors associated with subsequent initiation of cigarettes and e-cigarettes in adolescence: A structural equation modeling approach |
Q44574557 | Risk factors for HIV infection among drug injectors in southern Thailand |
Q36024480 | Risk factors for adolescent smoking: parental smoking and the mediating role of nicotine dependence |
Q69908894 | Risk factors for alcohol hepatotoxicity among male alcoholics |
Q44440408 | Risk factors for alcoholism in the Oklahoma Family Health Patterns project: impact of early life adversity and family history on affect regulation and personality |
Q48917789 | Risk factors for all-cause, overdose and early deaths after release from prison in Washington state |
Q44487811 | Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study |
Q42167719 | Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs |
Q50885003 | Risk factors for concurrent use of benzodiazepines and opioids among individuals under community corrections supervision. |
Q58633922 | Risk factors for consumption of energy drinks, alcohol and both among a sample of youth from 10 U.S. metropolitan areas |
Q47642420 | Risk factors for gambling and substance use among recent college students. |
Q44338085 | Risk factors for high levels of prescription drug misuse and illicit drug use among substance-using young men who have sex with men (YMSM). |
Q33613641 | Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample |
Q58633810 | Risk factors for prescription opioid misuse by duration of misuse |
Q37282087 | Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting |
Q48132282 | Risk factors for relapse to problem drinking among current and former US military personnel: a prospective study of the Millennium Cohort |
Q35876117 | Risk factors for stimulant use among homeless and unstably housed adult women |
Q47322257 | Risk factors for substances use and misuse among young people in France: What can we learn from the Substance Use Risk Profile Scale? |
Q39884718 | Risk factors for unnatural death: Fatal accidental intoxication, undetermined intent and suicide: Register follow-up in a criminal justice population with substance use problems. |
Q36357013 | Risk for prescription opioid misuse among patients with a history of substance use disorder |
Q59522594 | Risk identification, risk assessment, and risk management of abusable drug formulations |
Q33748353 | Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report |
Q43274021 | Risk management and post-marketing surveillance of CNS drugs |
Q43278393 | Risk management and post-marketing surveillance of CNS drugs: an introduction |
Q37420971 | Risk management of drug products and the U.S. Food and Drug Administration: evolution and context |
Q70578320 | Risk of alcohol-related hospital admissions by marital status and social class among females |
Q101120078 | Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysis |
Q49833345 | Risk of fentanyl-involved overdose among those with past year incarceration: Findings from a recent outbreak in 2014 and 2015. |
Q38742100 | Risk of injury from alcohol, marijuana and other drug use among emergency department patients |
Q36689488 | Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. |
Q91387380 | Risk of polysubstance use among sexual minority and heterosexual youth |
Q58633889 | Risk of sexual abuse among ecstasy users differs by gender and other drug use |
Q50532572 | Risk of substance use disorders following prenatal or postnatal exposure to bereavement |
Q89515971 | Risk perception, changing social context, and norms prevent transition to regular injection among people who smoke heroin |
Q89652000 | Risk perceptions regarding cigarette smoking in the United States continue to decline |
Q46693259 | Risk profile of individuals who provide assistance with illicit drug injections |
Q37304594 | Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013 |
Q41586930 | Risk-taking and drug-use behaviour: an examination |
Q43004655 | Risk-taking but not response inhibition or delay discounting predict alcohol consumption in social drinkers |
Q57394305 | Risk-taking propensity and (un)healthy behavior in Germany |
Q35591763 | Risks associated with crack cocaine smoking among exotic dancers in Baltimore, MD |
Q33577658 | Risks for early substance involvement associated with parental alcoholism and parental separation in an adolescent female cohort |
Q34258923 | Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study |
Q90039480 | Risks of fatal opioid overdose during the first year following nonfatal overdose |
Q50043507 | Risky alcohol use in Danish physicians: Associated with alexithymia and burnout? |
Q42199479 | Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan |
Q39041535 | Risky behaviors, e-cigarette use and susceptibility of use among college students. |
Q51808595 | Risky decision-making predicts short-term outcome of community but not residential treatment for opiate addiction. Implications for case management. |
Q39281142 | Risky driving and sexual behaviors as developmental outcomes of co-occurring substance use and antisocial behavior |
Q44668432 | Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners |
Q40509748 | Risky substance use and peer pressure in Swiss young men: Test of moderation effects |
Q44915814 | Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study |
Q36440977 | Robust and stable drinking behavior following long-term oral alcohol intake in rhesus macaques |
Q53428759 | Role of agonist-antagonist analgesics in medicine. |
Q39287014 | Role of calcium in ethanol-membrane interactions: A model for tolerance and dependence |
Q44394319 | Role of catalase in ethanol-induced conditioned taste aversion: a study with 3-amino-1,2,4-triazole |
Q27015058 | Role of cigarette sensory cues in modifying puffing topography |
Q47791795 | Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants |
Q58633894 | Role of gender in age of initiation of nonmedical use of prescription drugs among youth 10 to 18 years |
Q36952379 | Role of individual, peer and family factors in the use of cannabis and other illicit drugs: a longitudinal analysis among Finnish adolescent twins |
Q71502555 | Role of noradrenergic hyperactivity in neonatal opiate abstinence |
Q122896543 | Role of parental divorce and discord in the intergenerational transmission of alcohol use disorder |
Q36739205 | Role of phenmetrazine as an active metabolite of phendimetrazine: evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys |
Q52423273 | Role of self-efficacy in predicting outcomes from a programme for controlled drinking. |
Q39906878 | Role of serotonin in tolerance to ethanol and barbiturates: Evidence for a specific vs. non-specific concept of tolerance |
Q37366254 | Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders |
Q63313857 | Role of substance abuse in physical and mental health trajectories throughout the deployment cycle: A national guard study |
Q28276141 | Role of the increased noradrenergic neurotransmission in drug self-administration |
Q92749395 | Role of the treatment environment in the effects of aripiprazole on ethanol-induced behavioral sensitization and conditioned place preference in female mice |
Q91072381 | Roll-your-own cigarette smoking among youth experiencing homelessness |
Q47728417 | Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy-results from a double-blind, randomized, placebo-controlled clinical trial |
Q93057762 | Route of administration effects on nicotine discrimination in female and male mice |
Q36068409 | Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle |
Q44836271 | Routine screening for risky alcohol consumption at an emergency department using the AUDIT-C questionnaire. |
Q92568984 | Rumination and problematic substance use among individuals with a long-term history of illicit drug use |
Q42698813 | Rural and urban comparisons of polysubstance use profiles and associated injection behaviors among people who inject drugs in Puerto Rico |
Q33855987 | SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individuals |
Q51639842 | Saccadic distractibility in cocaine dependent patients: a preliminary laboratory exploration of the cocaine-OCD hypothesis. |
Q35124206 | Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence |
Q44277328 | Safety and side-effects of buprenorphine in the clinical management of heroin addiction |
Q36328458 | Safety of oral dronabinol during opioid withdrawal in humans |
Q39315866 | Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder |
Q37218859 | Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials |
Q36404102 | Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance |
Q49632622 | Salience network coupling is linked to both tobacco smoking and symptoms of attention deficit hyperactivity disorder (ADHD). |
Q60633118 | Salivary hexosaminidase in smoking alcoholics with bad periodontal and dental states |
Q47312876 | Salivary immune proteins monitoring can help detection of binge and chronic alcohol drinkers: Preliminary findings |
Q100722995 | Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity |
Q93171128 | Salivary proteome characterization of alcohol and tobacco dependents |
Q33520598 | Salvia divinorum: effects and use among YouTube users |
Q47979827 | Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study |
Q72486648 | Saving face ? Survey respondents who claim their last week's drinking was atypical |
Q38150525 | Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward |
Q52264850 | Schedule-induced drinking in humans: a potential factor in excessive alcohol use. |
Q51739845 | Schedule-induced oral self-administration of cocaine and ethanol solutions: lack of effect of chronic desipramine. |
Q48592670 | Schedule-induced polydipsia alters cocaine- but not ethanol-induced suppression of saccharin consumption |
Q38782539 | School collective occupation movements and substance use among adolescents: A school-level panel design |
Q42167672 | School-level contextual influences on smoking and drinking among Asian and Pacific Islander adolescents |
Q68759609 | Science aid to policy dilemmas: implications of alcohol research to policy formulation in U.S.A. |
Q34487271 | Scientific overview: 2013 BBC plenary symposium on tobacco addiction |
Q43654140 | Scottish cocaine users: wealthy snorters or delinquent smokers? |
Q92850944 | Screen of drug use: Diagnostic accuracy for opioid use disorder |
Q96614316 | Screening and brief intervention for lower-risk drug use in primary care: A pilot randomized trial |
Q90740550 | Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales |
Q51017921 | Screening for alcohol problems in the emergency room: a rapid alcohol problems screen. |
Q46493174 | Screening for alcohol problems in two emergency service samples in Poland: comparison of the RAPS4, CAGE and AUDIT. |
Q39659073 | Screening for alcohol problems: comparison of the audit, RAPS4 and RAPS4-QF among African American and Hispanic patients in an inner city emergency department |
Q43277525 | Screening for atypical suicide risk with person fit statistics among people presenting to alcohol and other drug treatment |
Q83461518 | Screening for bipolar disorders in patients with alcohol or substance use disorders: performance of the mood disorder questionnaire |
Q44430863 | Screening for cannabis use disorders in an adolescent emergency department sample. |
Q52267490 | Screening for current drug use disorders in alcoholics: an application of receiver operating characteristic analysis. |
Q44852801 | Screening for drug use disorders in the emergency department: performance of the rapid drug problems screen (RDPS). |
Q41237409 | Screening for major depression among alcoholics: an application of receiver operating characteristic analysis |
Q113032038 | Screening for oral cancer in tobacco and/or alcohol addicts: A comparison of different organizations |
Q70578357 | Screening for problem drinkers among medical inpatients |
Q34497011 | Screening for sexually transmitted infections at a DeAddictions service in south India |
Q36862587 | Screening for sexually transmitted infections in substance abuse treatment programs. |
Q98234067 | Screening illicit substance use in college students: The Chinese version of the Drug Abuse Screening Test |
Q39478042 | Screening mammography: a missed opportunity |
Q34859268 | Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later |
Q70598656 | Seasonality of alcohol-related hospital admissions has implications for prevention |
Q90722336 | Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15 |
Q34981295 | Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry. |
Q43271125 | Seeing the forest through the trees: a comparison of different IAT variants measuring implicit alcohol associations |
Q43611635 | Seeking truth in heroin indicators: the case of New York City |
Q41108973 | Segmental hair analysis to assess effectiveness of single-session motivational intervention to stop ethanol use during pregnancy. |
Q39013297 | Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline. |
Q95651844 | Selective alterations in endogenous opioid system genes expression in rats selected for high ethanol intake during adolescence |
Q47393974 | Selective attention moderates the relationship between attentional capture by signals of nondrug reward and illicit drug use. |
Q43442536 | Selective processing of cannabis cues in regular cannabis users. |
Q96588205 | Selective visual and crossmodal impairement in the discrimination of anger and fear expressions in severe alcohol use disorder |
Q71035574 | Self assessment of social competence in situations with and without alcohol by female alcoholics in treatment |
Q42543507 | Self detoxication by amphetamine dependent patients: a pilot study |
Q43728947 | Self-administered ethanol as a discriminative stimulus in rats |
Q34510925 | Self-administration of bretazenil under progressive-ratio schedules: Behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines |
Q37127157 | Self-administration of cocaine-pentobarbital mixtures by rhesus monkeys |
Q91568671 | Self-administration of edible Δ9-tetrahydrocannabinol and associated behavioral effects in mice |
Q71241959 | Self-administration of ethanol by genetically heterogeneous mice (RU:NCS): relationship to sensitivity and tolerance |
Q44026061 | Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase |
Q42167690 | Self-administration of heroin, cocaine and their combination under a discrete trial schedule of reinforcement in rats |
Q51803175 | Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. |
Q51793804 | Self-administration of minaprine in rhesus monkeys. |
Q41884732 | Self-administration of progesterone and synthetic neuroactive steroids by male rhesus monkeys |
Q90130165 | Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry |
Q39853977 | Self-control and its relation to joint developmental trajectories of cannabis use and depressive mood symptoms |
Q47747973 | Self-efficacy and acceptance of cravings to smoke underlie the effectiveness of quitline counseling for smoking cessation |
Q93198417 | Self-efficacy as a pathway to long-term smoking cessation among low-income parents in the multilevel Kids Safe and Smokefree intervention |
Q69748702 | Self-estimates of blood alcohol concentration in drinking-driving context |
Q48775248 | Self-help activities in cocaine dependent patients entering treatment: results from NIDA collaborative cocaine treatment study |
Q74163410 | Self-help group attendance and participation among cocaine dependent patients |
Q46449705 | Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons |
Q46474845 | Self-injurious behaviour, traumatic life events and alexithymia among treatment-seeking opiate addicts: prevalence, pattern and correlates |
Q52662505 | Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws. |
Q46698604 | Self-mutilation in substance-dependent patients and relationship with childhood abuse and neglect, alexithymia and temperament and character dimensions of personality |
Q45029236 | Self-rated everyday and prospective memory abilities of cigarette smokers and non-smokers: a web-based study |
Q39204289 | Self-regulation and treatment retention in cocaine dependent individuals: a longitudinal study |
Q77462275 | Self-report among injecting drug users: a review |
Q36909696 | Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome |
Q36811945 | Self-report stability for substance use over 10 years: data from the St. Louis Epidemiologic Catchment Study |
Q46327945 | Self-report stability of adolescent substance use: are there differences for gender, ethnicity and age? |
Q51169745 | Self-report vs. laboratory measures of aggression as predictors of substance abuse. |
Q37451223 | Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda |
Q52267982 | Self-reported alcohol consumption among high school students in France. Epidemiological approach of the alcoholisation process and its evolution. |
Q68097389 | Self-reported alcohol consumption among population sub-groups in three areas of Britain |
Q41347734 | Self-reported cocaine reactions among social-recreational users: a factor analytic study |
Q84336407 | Self-reported drug use and mortality among a nationwide sample of Swedish conscripts - a 35-year follow-up |
Q44780511 | Self-reported lifetime marijuana use and interleukin-6 levels in middle-aged African Americans |
Q47357617 | Self-reported precedence of depression in alcoholism |
Q38855058 | Self-reported reasons for vaping among 8th, 10th, and 12th graders in the US: Nationally-representative results. |
Q28607852 | Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting |
Q49013701 | Self-stigma in alcohol dependence: consequences for drinking-refusal self-efficacy |
Q91572556 | Self-treatment of skin infections by people who inject drugs |
Q38706696 | Seller's reputation and capacity on the illicit drug markets: 11-month study on the Finnish version of the Silk Road |
Q44332660 | Sensation seeking as a common factor in opioid dependent subjects and high risk sport practicing subjects. A cross sectional study |
Q53421437 | Sensation seeking moderates television's cultivation of alcohol and tobacco beliefs: Evidence from a national study of French adolescents. |
Q43570035 | Sensation seeking needs among 8th and 11th graders: characteristics associated with cigarette and marijuana use. |
Q104456460 | Sensation seeking versus alcohol use: Evaluating temporal precedence using cross-lagged panel models |
Q52275175 | Sensitivity and specificity to amphetamine of a French version of the 49-item form of the addiction research center inventory. |
Q41465701 | Sensitivity of human lymphocytes to acetaldehyde: comparison between alcoholic and control subjects |
Q52230429 | Sensitivity of some human cognitive functions to effects of methamphetamine and secobarbital. |
Q37315276 | Sensitivity to reinforcer delay predicts ethanol's suppressant effects, but itself is unaffected by ethanol. |
Q42672615 | Sensitization of hypervigilance effects of cocaine can be induced by NK3 receptor activation in marmoset monkeys |
Q36986325 | Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats |
Q91886348 | Sensitized brain response to acute pain in patients using prescription opiates for chronic pain: A pilot study |
Q35840095 | Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC. |
Q36339147 | Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC. |
Q34205968 | Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC. |
Q34950909 | Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC |
Q36599609 | Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers |
Q44406627 | Separating intentional inhibition of prepotent responses and resistance to proactive interference in alcohol-dependent individuals |
Q47897406 | Separation of the locomotor stimulant and discriminative stimulus effects of cocaine by its C-2 phenyl ester analog, RTI-15. |
Q43926226 | Sequence of drug use among serious drug users: typical vs atypical progression |
Q34419757 | Sequential combination of self-report, breath carbon monoxide, and saliva cotinine to assess smoking status |
Q92070222 | Serious psychological distress and daily cannabis use, 2008 to 2016: Potential implications for mental health? |
Q47738225 | Serious suicide attempts in outpatients with multiple substance use disorders |
Q42632401 | Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users |
Q48438066 | Serotonergic responsiveness in human cocaine users |
Q34605239 | Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat |
Q42939215 | Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population |
Q30413322 | Serotonin transporter and receptor genes significantly impact nicotine dependence through genetic interactions in both European American and African American smokers |
Q46690681 | Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity |
Q73563353 | Serum and intracellular magnesium concentrations in intoxicated chronic alcoholic and control subjects |
Q36956267 | Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers |
Q69020539 | Serum desialotransferrin in the detection of alcohol abuse. Definition of a Tf index |
Q60710731 | Serum dopamine-β-Hydroxylase activity and alcohol withdrawal symptoms |
Q72503773 | Serum ferritin, gammaglutamyl-transferase and alcohol consumption in healthy middle-aged men |
Q71762439 | Serum folic acid levels and antipyrine clearance rates in smokers and non-smokers |
Q36956283 | Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers |
Q90266589 | Serum lipids, leptin, and soluble leptin receptor in alcohol dependence: A cross-sectional and longitudinal study |
Q72658681 | Serum neopterin levels in alcoholic liver disease |
Q52078330 | Serum prolactin correlates with depressed mood during alcohol withdrawal. |
Q97539618 | Serum proteomic profiling of patients with amphetamine use disorder |
Q58896377 | Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts |
Q51655219 | Serum tryptophan levels in alcoholics. |
Q71196818 | Serum zinc, magnesium and calcium status in the Wernicke-Korsakoff syndrome |
Q41996800 | Seven attitude scales used in assessing cannabis use amongst students |
Q70398688 | Seven year follow-up of heroin addicts: life histories summarised |
Q115217229 | Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway |
Q36444626 | Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. |
Q42655505 | Severity of drug dependence, economic pressure and HIV-related risk behaviors among non-institutionalized female injecting drug users who are also sex workers in China |
Q59780935 | Sex and HIV serostatus effects on high-risk decision making |
Q38587012 | Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations |
Q88388446 | Sex and orientation identity matter in the substance use behaviors of sexual minority adolescents in the United States |
Q46028074 | Sex differences and hormonal modulation of ethanol-enhanced risk taking in rats. |
Q54139585 | Sex differences in acetaldehyde on body temperature and open-field performance in the rat. |
Q34167852 | Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat |
Q36875735 | Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. |
Q59780937 | Sex differences in cognitive and motor impulsivity among users of different classes of drugs in protracted abstinence |
Q49113265 | Sex differences in correlates of problem drinking among employed males and females |
Q36586302 | Sex differences in disinhibition and its relationship to physical abuse in a sample of stimulant-dependent patients |
Q34492657 | Sex differences in dopamine binding and modafinil conditioned place preference in mice |
Q34625720 | Sex differences in drug use among polysubstance users. |
Q59780926 | Sex differences in effects of trait impulsivity on vulnerability to substance dependence |
Q44026550 | Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties |
Q53103896 | Sex differences in guanfacine effects on stress-induced stroop performance in cocaine dependence. |
Q92323620 | Sex differences in incidence and psychiatric comorbidity for alcohol dependence in patients with panic disorder |
Q51146947 | Sex differences in methamphetamine pharmacokinetics in adult rats and its transfer to pups through the placental membrane and breast milk. |
Q90672401 | Sex differences in nonmedical prescription tranquilizer and stimulant use trends among secondary school students in Argentina, Chile, and Uruguay |
Q43647880 | Sex differences in opioid antinociception: kappa and 'mixed action' agonists |
Q90378726 | Sex differences in prescription opioid use patterns assessed through a community engagement program in Florida |
Q92299379 | Sex differences in substance use from adolescence to young adulthood: Tests of increases in emergent adulthood and maturing out in later young adulthood |
Q61821986 | Sex differences in the cardiometabolic health of cannabis users with a psychotic illness |
Q33653490 | Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats |
Q43890396 | Sex differences in the effects of baclofen on the acquisition of intravenous cocaine self-administration in rats |
Q37625945 | Sex differences in the effects of estradiol in the nucleus accumbens and striatum on the response to cocaine: neurochemistry and behavior |
Q52234874 | Sex differences in the interaction of drinking, positive expectancies and symptoms of dependence in young adults |
Q69953054 | Sex differences in the marital functioning of treated alcoholics |
Q114190384 | Sex differences in the relationship between prescription opioid misuse and gun and other weapon-carrying behaviors |
Q90793399 | Sex differences in tobacco smokers: Executive control network and frontostriatal connectivity |
Q47855474 | Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies. |
Q33605769 | Sex heterogeneity in pharmacogenetic smoking cessation clinical trials |
Q104691628 | Sex moderates the effects of experimentally induced musculoskeletal pain on alcohol demand in healthy drinkers |
Q37204916 | Sex modulates approach systems and impulsivity in substance dependence |
Q52271161 | Sex ratio among opium addicts in Asia: influences of drug availability and sampling method. |
Q73662637 | Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack |
Q51747537 | Sex work, injection drug use, and abscesses: Associations in women, but not men. |
Q58555051 | Sex, THC, and hormones: Effects on density and sensitivity of CB cannabinoid receptors in rats |
Q91549225 | Sex, drugs, and sexually transmitted infections: A latent class analysis among men who have sex with men in Amsterdam and surrounding urban regions, the Netherlands |
Q58633898 | Sex, drugs, and violence: An analysis of women in drug court |
Q39168708 | Sex-dependent effects of cannabis-induced analgesia |
Q89952617 | Sex-related differences in subjective, but not neural, cue-elicited craving response in heavy cannabis users |
Q40289065 | Sex-related substance use and the externalizing spectrum |
Q91125477 | Sex-specific association of depressive disorder and transient emotional states with alcohol consumption in male and female alcoholics |
Q47559590 | Sexual HIV risk behavior outcomes of brief interventions for drug use in an inner-city emergency department: Secondary outcomes from a randomized controlled trial |
Q46737558 | Sexual and drug use behaviors among female crack users: a multi-site sample |
Q47187337 | Sexual attraction and the nonmedical use of opioids and sedative drugs among Chinese adolescents |
Q92754456 | Sexual minority disparities in opioid misuse, perceived heroin risk and heroin access among a national sample of US adults |
Q91760135 | Sexual minority substance use disparities: Bisexual women at elevated risk relative to other sexual minority groups |
Q100722993 | Sexual minority tobacco use disparities across adolescence and the transition to young adulthood |
Q50061806 | Sexual minority youth continue to smoke cigarettes earlier and more often than heterosexuals: Findings from population-based data |
Q91072386 | Sexual orientation and gender identity disparities in substance use disorders during young adulthood in a United States longitudinal cohort |
Q80257429 | Sexual orientation, gender, and alcohol use in a cohort study of U.S. adolescent girls and boys |
Q46256692 | Sexual orientation, minority stress, social norms, and substance use among racially diverse adolescents |
Q39952526 | Sexual orientation, treatment utilization, and barriers for alcohol related problems: Findings from a nationally representative sample |
Q59654175 | Sexual risk and substance use behaviors among partnered and non-partnered HIV-infected adults with substance dependence |
Q36283066 | Sexual risk behaviors and steroid use among sexual minority adolescent boys |
Q36619355 | Sexual-orientation differences in drinking patterns and use of drinking contexts among college students. |
Q45161011 | Shaping smoking cessation using percentile schedules |
Q93106972 | Shared and specific associations of substance use disorders on adverse outcomes: A national prospective study |
Q50064387 | Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014. |
Q90557874 | Shifting characteristics of nonmedical prescription tranquilizer users in the United States, 2005-2014 |
Q92677448 | Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders |
Q49415229 | Short communication: Genetic association between schizophrenia and cannabis use. |
Q97640861 | Short term effects of the REAL media e-learning media literacy substance prevention curriculum: An RCT of adolescents disseminated through a community organization |
Q36652120 | Short term health-related quality of life improvement during opioid agonist treatment |
Q61914297 | Short term impact of same intensity but different duration interventions for cannabis users |
Q95298650 | Short- and long-term changes in substance-related coping as mediators of in-person and computerized CBT for alcohol and drug use disorders |
Q92190361 | Short- and long-term effects of digital prevention and treatment interventions for cannabis use reduction: A systematic review and meta-analysis |
Q44574568 | Short-term alcohol and drug treatment outcomes predict long-term outcome |
Q44994519 | Short-term distribution of nicotine in the rat lung |
Q91041256 | Short-term stability of different drinking patterns over the course of four weeks among adults. A latent transition analysis |
Q92009753 | Short-term withdrawal from repeated exposure to cocaine during adolescence modulates dynorphin mRNA levels and BDNF signaling in the rat nucleus accumbens |
Q36848924 | Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia |
Q35082578 | Should anyone be riding to glory on the now-descending limb of the crack-cocaine epidemic curve in the United States? |
Q35286907 | Should pathological gambling and obesity be considered addictive disorders? A factor analytic study in a nationally representative sample |
Q48795078 | Should tolerance and withdrawal be required for substance dependence disorders? |
Q70479515 | Sialidase and beta-galactosidase activities in serum of alcoholic patients |
Q40048318 | Sigma effects of nalorphine in the chronic spinal dog |
Q98460925 | Sigma-1 antagonism inhibits binge ethanol drinking at adolescence |
Q37555639 | Signal detection in post-marketing surveillance for controlled substances. |
Q97895993 | Signal of increased opioid overdose during COVID-19 from emergency medical services data |
Q44352694 | Significance of biogenic amines for opioid-induced locomotor activity in rats |
Q93189176 | Significance of reduced number of cigarettes smoked after release from smoke-free prisons |
Q71035584 | Significance of tattooes in narcotic abusers |
Q91306991 | Significant decrease in the rate of fatal alcohol poisonings in Finland validated by blood alcohol concentration statistics |
Q33145592 | Significant interaction between clozapine and cocaine in cocaine addicts |
Q38467880 | Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. |
Q71035534 | Signs and symptoms of hangover: prevalence and relationship to alcohol use in a general adult population |
Q42615227 | Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task |
Q50059995 | Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center |
Q35952158 | Simulated driving performance under alcohol: Effects on driver-risk versus driver-skill |
Q44351204 | Simulated opioid withdrawal engenders risk-prone choice: a comparison of intravenous and intranasal-using populations |
Q37204836 | Simultaneous alcohol and marijuana use among U.S. high school seniors from 1976 to 2011: trends, reasons, and situations |
Q34495930 | Simultaneous cannabis and tobacco use and cannabis-related outcomes in young women |
Q36816923 | Simultaneous use of non-medical ADHD prescription stimulants and alcohol among undergraduate students |
Q44331299 | Single case study: panic disorder associated with opioid dependency and methadone maintenance treatment |
Q35122006 | Single versus multiple drug focus in substance abuse clinical trials research |
Q35122012 | Single versus multiple drug focus in substance abuse clinical trials research: the devil is in the details |
Q33932327 | Single versus recurrent depression history: differentiating risk factors among current US smokers |
Q91512013 | Single- and cross-commodity delay discounting of money and e-cigarette liquid in experienced e-cigarette users |
Q33451557 | Single-arm trial of the second version of an acceptance & commitment therapy smartphone application for smoking cessation |
Q48313014 | Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: investigations by the ED50 value and CNS content of naloxone |
Q54028812 | Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake. |
Q46537313 | Sixteen-year changes and stable remission among treated and untreated individuals with alcohol use disorders |
Q41364783 | Sleep and use of alcohol and drug in adolescence. A large population-based study of Norwegian adolescents aged 16 to 19 years |
Q35058880 | Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal |
Q91343126 | Sleep disturbances in early alcohol recovery: Prevalence and associations with clinical characteristics and severity of alcohol consumption |
Q48960473 | Sleep in babies born to chronically heroin addicted mothers. A follow up study |
Q43685921 | Sleep problems and substance use in adolescence |
Q46783606 | Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia |
Q51465672 | Small area associations between social context and alcohol-attributable mortality in a middle income country. |
Q34687574 | Smaller feedback ERN amplitudes during the BART are associated with a greater family history density of alcohol problems in treatment-naïve alcoholics |
Q90904436 | Smartphone application for unhealthy alcohol use: Pilot randomized controlled trial in the general population |
Q92628544 | Smile judgment in substance use disorders and its relationship to interpersonal and emotional functioning: An eye-tracking investigation |
Q36865668 | Smoke-free bar policies and smokers' alcohol consumption: findings from the International Tobacco Control Four Country Survey |
Q33738719 | Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample |
Q46698614 | Smoked cocaine discrimination in humans: effects of gabapentin |
Q48676112 | Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses |
Q38669813 | Smoked marijuana attenuates performance and mood disruptions during simulated night shift work |
Q41735263 | Smokeless tobacco brand switching: a means to reduce toxicant exposure? |
Q58575486 | Smokers with bipolar disorder, other affective disorders, and no mental health conditions: Comparison of baseline characteristics and success at quitting in a large 12-month behavioral intervention randomized trial |
Q91195598 | Smokers' behavioral intentions in response to a low-nicotine cigarette policy |
Q90874756 | Smoking abstinence effects on emotion dysregulation in adult cigarette smokers with and without attention-deficit/hyperactivity disorder |
Q96830348 | Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system |
Q37598453 | Smoking and drinking among college students: "it's a package deal". |
Q39843337 | Smoking and everyday prospective memory: a comparison of self-report and objective methodologies |
Q44975596 | Smoking and nicotine dependence in young adults: differences between blacks and whites |
Q41227361 | Smoking and potentially preventable hospitalisation: the benefit of smoking cessation in older ages |
Q39863429 | Smoking and psychiatric disorders in the rural and urban regions of Beijing, China: a community-based survey |
Q37282181 | Smoking and psychopathology increasingly associated in recent birth cohorts |
Q37482354 | Smoking and smoking cessation in disadvantaged women: assessing genetic contributions |
Q44430867 | Smoking and substance abuse in outpatients with schizophrenia: a 2-year follow-up study in Turkey. |
Q24655785 | Smoking and suicide: a brief overview |
Q44482480 | Smoking cessation behaviors among persons with psychiatric diagnoses: results from a population-level state survey |
Q44730113 | Smoking cessation efforts among substance abusing adolescents |
Q47320865 | Smoking cessation for substance misusers: A systematic review of qualitative studies on participant and provider beliefs and perceptions. |
Q90587183 | Smoking cessation in the context of recovery from drug and alcohol problems: Prevalence, predictors, and cohort effects in a national U.S. sample |
Q35669664 | Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis |
Q52265266 | Smoking cessation--gradual or sudden stopping? |
Q40092173 | Smoking during pregnancy in the United States, 2005-2014: The role of depression |
Q48762335 | Smoking habits and attitudes in a methadone maintenance treatment population |
Q38381998 | Smoking in male patients with schizophrenia in China: A meta-analysis |
Q36486761 | Smoking is associated with neurocognitive deficits in alcoholism |
Q37673401 | Smoking motives of daily and non-daily smokers: a profile analysis |
Q35017150 | Smoking outcome expectancies in young adult female smokers: individual differences and associations with nicotine dependence in a genetically informative sample |
Q37381028 | Smoking predicts posttraumatic stress symptoms among rescue workers: a prospective study of ambulance personnel involved in the Enschede Fireworks Disaster |
Q52199319 | Smoking produces a smaller increase in heart rate in the natural smoking environment than in the laboratory. |
Q92042773 | Smoking relapse risk is increased among individuals in recovery |
Q91456743 | Smoking related outcomes before and after implementation of tobacco-free grounds in residential substance use disorder treatment programs |
Q91673309 | Smoking status and quit behaviors among health center patients with substance use disorders: A national study |
Q40546023 | Smoking status and substance abuse severity in a residential treatment sample. |
Q48446021 | Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant women |
Q24650310 | Smoking tobacco along with marijuana increases symptoms of cannabis dependence |
Q50786767 | Smoking, MATRICS consensus cognitive battery and P50 sensory gating in a Han Chinese population. |
Q45161021 | Smoking, nicotine dependence and psychiatric comorbidity--a population-based study including smoking cessation after three years |
Q36249013 | Smoking, posttraumatic stress disorder, and alcohol use disorders in a nationally representative sample of Australian men and women |
Q45150453 | Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016. |
Q39732566 | Smoking-related prospective memory deficits in a real-world task. |
Q40752431 | Sniping and other high-risk smoking practices among homeless youth |
Q37002241 | Snus use and risk of schizophrenia and non-affective psychosis |
Q48469500 | Sobriety as an admission criterion for transitional housing: a multi-site comparison of programs with a sobriety requirement to programs with no sobriety requirement |
Q37109438 | Social anxiety disorder as a risk factor for alcohol use disorders: a prospective examination of parental and peer influences |
Q39365839 | Social attitudes, self-description and perceived reasons for using drugs: a survey of the secondary school population in Malaysia |
Q39365833 | Social background and attitudes towards drugs as predictors of drug use among Malaysian students |
Q66972165 | Social background, attitudes and personality in a three-year follow-up study of alcohol consumers |
Q47611831 | Social background, personal relationships, and self-descriptions as predictors of drug-user status: a study of adolescents in post-revolutionary Iran |
Q45109728 | Social behavioural profile of cocaine in isolated and grouped male mice |
Q48394596 | Social class and morbidity in clinically treated alcoholics |
Q39163587 | Social cognitive predictors of treatment outcome in cannabis dependence |
Q47302085 | Social contextual risk factors for stimulant use among adolescent American Indians |
Q47654818 | Social determinants of drug-related mortality in a general population |
Q48021063 | Social distance and homophily in adolescent smoking initiation |
Q70709844 | Social drinking in a simulated tavern: an experimental analysis |
Q39845390 | Social exclusion, personal control, self-regulation, and stress among substance abuse treatment clients |
Q50647201 | Social housing conditions influence morphine dependence and the extinction of morphine place preference in adolescent mice. |
Q34157204 | Social influences on morphine sensitization in adolescent females. |
Q91125481 | Social integration and alcohol consumption among older people: A four-year follow-up of a Swedish national sample |
Q93171146 | Social isolation proxy variables and prescription opioid and benzodiazepine misuse among older adults in the U.S.: A cross-sectional analysis of data from the National Survey on Drug Use and Health, 2015-2017 |
Q92046366 | Social marginalization, gender-based violence, and binge drinking among transgender women in Cambodia |
Q39453045 | Social network characteristics and injecting HIV-risk behaviors among street injection drug users |
Q39672115 | Social network correlates of self-reported non-fatal overdose |
Q33819260 | Social network drinking and family history contribute equally to first-onset alcohol dependence in high risk adults |
Q44349718 | Social networking online to recover from opioid use disorder: A study of community interactions |
Q90818165 | Social networks and substance use after transitioning into permanentsupportive housing |
Q46621021 | Social neuroscience: applications to addiction |
Q91441934 | Social norms towards smoking and vaping and associations with product use among youth in England, Canada, and the US |
Q41372376 | Social policy and drug dependence: an historical case study |
Q37596519 | Social preference and drug self-administration: a preclinical model of social choice within peer groups |
Q36989658 | Social rank and inhalant drug use: the case of lança perfume use in São Paulo, Brazil. |
Q43685935 | Social relationships and intravenous drug use among methadone maintenance patients |
Q36796429 | Social reward-conditioned place preference: a model revealing an interaction between cocaine and social context rewards in rats. |
Q52304034 | Social skills training and cognitive restructuring with alcoholics. |
Q36003731 | Social smoking among intermittent smokers |
Q67583574 | Social stability on admission and success of in-patient treatment for alcoholism |
Q43446377 | Social support and abstinence from opiates and cocaine during opioid maintenance treatment |
Q45094481 | Social support and anxiety in pregnant drug abusers and nonusers: unexpected findings of few differences |
Q98882472 | Social support modifies the association between hazardous drinking and depression symptoms among ART clients in Vietnam |
Q46812236 | Socialization to binge drinking: a population-based, longitudinal study with emphasis on parental influences |
Q35456868 | Socializing in an open drug scene: the relationship between access to private space and drug-related street disorder |
Q39872910 | Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago |
Q57163344 | Socio-cognitive functioning in stimulant polysubstance users |
Q47343055 | Socio-cultural factors affecting drug addiction treatment in Italy (fear of treatment). |
Q37046890 | Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China |
Q83068672 | Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: associations of risk with genetic complexity |
Q89837221 | Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review |
Q47201829 | Socio-demographic correlates and pattern of drug abuse in eastern Saudi Arabia |
Q104106004 | Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City |
Q41594223 | Socio-ecological factors associated with depression, suicidal ideation and suicidal attempt among female injection drug users who are sex workers in China |
Q44283693 | Socio-economic status and binge drinking in Israel |
Q53956075 | Socio-familial characteristics of black male heroin addicts and their nonaddicted friends. |
Q44836282 | Sociocultural diversity and substance use pattern in Arunachal Pradesh, India |
Q43487768 | Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity |
Q48428999 | Sociodemographic characteristics associated with binge drinking among Brazilians |
Q92116885 | Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths |
Q89454979 | Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data |
Q46866275 | Sociodemographic representation in published studies of cocaine abuse pharmacotherapy |
Q89937859 | Socioeconomic characteristics of women with substance use disorder during pregnancy and neonatal outcomes in their newborns: A national registry study from the Czech Republic |
Q38966057 | Socioeconomic inequalities in alcohol consumption in Chile and Finland |
Q97518127 | Socioeconomic marginalization and opioid-related overdose: A systematic review |
Q94491367 | Socioeconomic sequelae of drug abuse in a Swedish national cohort |
Q34404149 | Socioeconomic status and smokers' number of smoking friends: findings from the International Tobacco Control (ITC) Four Country Survey. |
Q89714497 | Socioeconomic status, mindfulness, and momentary associations between stress and smoking lapse during a quit attempt |
Q52279067 | Sociopathy, gender, and treatment outcome among outpatient substance abusers. |
Q71008144 | Soft drug use prior to and during pregnancy: a comparison of samples over a four-year period |
Q114190339 | Solitary alcohol use in adolescence predicts alcohol problems in adulthood: A 17-year longitudinal study in a large national sample of US high school students |
Q36248851 | Solitary cannabis use in adolescence as a correlate and predictor of cannabis problems |
Q48380490 | Solvay Award address. Drug abuse as an adjunctive behavior |
Q38689171 | Somatic health care utilization by patients treated for substance use disorders. |
Q50708037 | Some aspects of drug use among students in Benin City, Nigeria. |
Q67020052 | Some aspects of the changes induced by chronic barbital treatments in the male rat |
Q47600913 | Some career aspects of alcoholics not motivated to take part in therapy 6 months after detoxification |
Q37917013 | Some implications of animal alcohol self-administration studies for human alcohol problems |
Q71473794 | Some parameters of the use of alcohol by Israeli youth and its relationship to their involvement with cannabis and tobacco |
Q71736700 | Some personal reflections on drug abuse research, chiefly epidemiology and prevention |
Q52270563 | Some personality characteristics of imprisoned heroin addicts. |
Q43410556 | Some social consequences of partial prohibition in Auckland, New Zealand |
Q47598877 | Some sociocultural aspects of the problem of drug abuse in Nigeria |
Q67293936 | Some thoughts about endogenous opioids and addiction |
Q53926385 | Some thoughts about opiopeptins, peptides with opiate-like activity |
Q44836263 | Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users |
Q27312440 | Sources of nonmedically used prescription stimulants: differences in onset, recency and severity of misuse in a population-based study |
Q47230160 | Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI). |
Q90673086 | Spatial analysis of drug poisoning deaths in the American west: A comparison study using profile regression to adjust for collinearity and spatial correlation |
Q40954571 | Spatial and temporal trends in alcohol consumption in Belgian cities: A wastewater-based approach |
Q52002804 | Spatial cognition in alcoholics: influence of concurrent abuse of other drugs. |
Q36803554 | Spatial relationships between alcohol-related road crashes and retail alcohol availability. |
Q40803420 | Specialist services: the need for multi-agency partnership |
Q69875523 | Speech processing ability in alcoholics: a transient impairment and its relation to field dependence |
Q59351023 | Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment |
Q44715545 | Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001-2009. |
Q92269766 | Spirits purchasing and marijuana use behaviors of risky drinkers in the state of Washington from 2014 to 2016 |
Q34602952 | Spirituality/religiosity promotes acceptance-based responding and 12-step involvement |
Q46522634 | Spirituality/religiosity, substance use, and HIV testing among young black men who have sex with men. |
Q34982155 | Sponsorship and service as mediators of the effects of Making Alcoholics Anonymous Easier (MAAEZ), a 12-step facilitation intervention |
Q40641078 | Spontaneous recovery in alcoholics: a review and analysis of the available research |
Q38556156 | Sports and clean living: a useful myth? |
Q39066942 | Spousal concordance in the use of alternative tobacco products: A multi-country investigation |
Q40861725 | Spousal resemblance for smoking: Underlying mechanisms and effects of cohort and age. |
Q40402277 | Stability and instability in alcohol diagnosis from ages 18 to 21 and ages 21 to 25 years |
Q97522787 | Stability in effects of different smoking-related polygenic risk scores over age and smoking phenotypes |
Q49156883 | Stability of a factor-analytic description of smoking behavior |
Q94587328 | Stability of acute responses to drugs in humans across repeated testing: Findings with alcohol and amphetamine |
Q44343510 | Stability of opioid craving over time as measured by visual analog scales |
Q39552468 | Stability of scores and correlations with drinking behaviors over 15 years for the Self-Report of the Effects of Alcohol Questionnaire |
Q51094002 | Staff attitudes and retention of patients in methadone maintenance programs. |
Q40981140 | Stages and processes of change among polydrug users in methadone maintenance treatment |
Q33895599 | Stages in the development of adolescent smoking |
Q90507304 | Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study |
Q51818191 | Standardized measures for substance use stigma. |
Q48872133 | Starting, switching, stopping: users' explanations of illicit drug use. |
Q30431764 | Startle response to unpredictable threat in comorbid panic disorder and alcohol dependence |
Q68749028 | Stasis pigmentation and chronic alcoholism |
Q91311693 | State criminal justice policy context and opioid agonist treatment delivery among opioid treatment admissions, 2015 |
Q98182373 | State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress |
Q88959957 | State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies |
Q98776077 | State pain management clinic policies and county opioid prescribing: A fixed effects analysis |
Q93167558 | State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter |
Q39275722 | State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population |
Q73652643 | Statement on national drug policy. College on problems of drug dependence |
Q36328320 | States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence |
Q43563963 | Static and dynamic predictors of criminal involvement among people with heroin dependence: findings from a 3-year longitudinal study |
Q50159757 | Statistical considerations in the choice of endpoint for drug use disorder trials |
Q44138234 | Status hearings in drug court: when more is less and less is more |
Q100514241 | Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance |
Q36989649 | Steppingstone and gateway ideas: a discussion of origins, research challenges, and promising lines of research for the future |
Q51350403 | Stereotypic information about drinkers and students' observed alcohol intake: an experimental study on prototype-behavior relations in males and females in a naturalistic drinking context. |
Q89229049 | Steven G Holtzman: The blending of professional and personal lives |
Q38089390 | Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. |
Q47585949 | Stigma, discrimination and the health of illicit drug users |
Q43911752 | Stigmatization of people with drug dependence in China: a community-based study in Hunan province |
Q33722876 | Stimulant use and HIV disease management among men in same-sex relationships |
Q42690063 | Stimulant use and symptoms of abuse/dependence: epidemiology and associations with cannabis use--a twin study |
Q46339635 | Stimulant-associated cognitive abnormalities: mechanisms and impact on reward-related behavior and addiction |
Q93341142 | Stimulus effects of propylene glycol and vegetable glycerin in electronic cigarette liquids |
Q36468351 | Stimulus-response learning in long-term cocaine users: acquired equivalence and probabilistic category learning |
Q34708943 | Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. |
Q48283972 | Strain Interview (11/17/15)—Diann Gaalema |
Q48484575 | Strategic self-regulation, decision-making and emotion processing in poly-substance abusers in their first year of abstinence. |
Q35230724 | Strategies for characterizing complex phenotypes and environments: general and specific family environmental predictors of young adult tobacco dependence, alcohol use disorder, and co-occurring problems |
Q37933734 | Strategies for evaluating the economic value of drugs in alcohol dependence treatment |
Q95651849 | Strategies to improve treatment utilization for substance use disorders: A systematic review of intervention studies |
Q99547725 | Strategies to maintain persistence of opioid agonist therapy during the novel coronavirus pandemic in Taiwan |
Q92448862 | Strategies used by people who inject drugs to avoid stigma in healthcare settings |
Q58022756 | Stratifying delays for assessment by type of substance to improve the probability of attendance in outpatient services |
Q39553963 | Street pharmacology: uses of cocaine and heroin in the treatment of addiction |
Q39408628 | Street sale of heroin--a profitable way of making a living? |
Q51609340 | Strength of drug habits: for heroin, morphine, methadone, alcohol, barbiturates, pentobarbital, benzedrine, cocaine, and marijuana. |
Q36100799 | Stress and alcohol use in rural Chinese residents: A moderated mediation model examining the roles of resilience and negative emotions |
Q46225928 | Stress burden, drug dependence and the nativity paradox among U.S. Hispanics |
Q70793307 | Stress induced alteration of opiate withdrawal |
Q73434115 | Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress |
Q50138548 | Stress responding in cannabis smokers as a function of trauma exposure, sex, and relapse in the human laboratory |
Q92255139 | Stress, craving and mood as predictors of early dropout from opioid agonist therapy |
Q35828308 | Stress- and cue-induced cigarette craving: effects of a family history of smoking |
Q33872643 | Stress-induced changes in mood and cortisol release predict mood effects of amphetamine |
Q35606670 | Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type |
Q36496045 | Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. |
Q96126818 | Striatal and white matter volumes in chronic ketamine users with or without recent regular stimulant use |
Q35205029 | Striatal hyposensitivity to delayed rewards among cigarette smokers |
Q37004153 | Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors |
Q34793657 | Structural brain differences in alcohol-dependent individuals with and without comorbid substance dependence |
Q52313730 | Structural deficits in salience network regions are associated with increased impulsivity and compulsivity in alcohol dependence. |
Q40099379 | Structural equation modeling of the effects of racism, LGBTQ discrimination, and internalized oppression on illicit drug use in LGBTQ people of color. |
Q129417193 | Structural indices of brain aging in methamphetamine use disorder |
Q52266861 | Student cannabis use and enforcement activity in Canada: 1977-1987. |
Q39426588 | Students worry about the impact of alcohol on quality of life: Roles of frequency of binge drinking and drinker self-concept |
Q103722855 | Students' stimulant use for cognitive enhancement: A deliberate choice rather than an emotional response to a given situation |
Q48127563 | Studies of selected phenyltropanes at monoamine transporters |
Q66972152 | Studies on metabolic tolerance to alcohol, hepatomegaly and alcoholic liver disease |
Q70380932 | Studies on the effect of 4-methylpyrazole on methanol poisoning using the monkey as an animal model: with particular reference to the ocular toxicity |
Q57163337 | Study characteristics influence the efficacy of substance abuse treatments: A meta-analysis of medications for alcohol use disorder |
Q46152777 | Studying addiction in the age of neuroimaging. Marian W. Fischman Lecture given at the 2008 meeting of CPDD. |
Q39582272 | Studying psychoactive substance use in injured patients: does exclusion of late arriving patients bias the results? |
Q50067339 | Studying the interactive effects of menthol and nicotine among youth: An examination using e-cigarettes. |
Q35819406 | Sub-diagnostic psychiatric comorbidity in alcoholics |
Q48346770 | Subchronic treatment of rats with nicotine: effects on tolerance and on [3H]acetylcholine and [3H]nicotine binding in the brain |
Q71364563 | Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome |
Q39129920 | Subjective alcohol responses in a cross-sectional, field-based study of adolescents and young adults: Effects of age, drinking level, and dependence/consequences |
Q47748942 | Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration |
Q35618981 | Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers |
Q37059561 | Subjective effects for alcohol, tobacco, and marijuana association with cross-drug outcomes |
Q91258285 | Subjective effects of combustible, vaporized, and edible cannabis: Results from a survey of adolescent cannabis users |
Q51209057 | Subjective effects of khat chewing in humans. |
Q51099157 | Subjective effects of oral caffeine in formerly cocaine-dependent humans. |
Q36787655 | Subjective effects to cannabis are associated with use, abuse and dependence after adjusting for genetic and environmental influences |
Q34399503 | Subjective effects to marijuana associated with marijuana use in community and clinical subjects |
Q38969369 | Subjective experiences at first use of cigarette, e-cigarettes, hookah, and cigar products among Texas adolescents |
Q43890398 | Subjective quality of life and depressive symptoms in women with alcoholism during detoxification treatment |
Q36777907 | Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study. |
Q51657100 | Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV. |
Q34213701 | Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans. |
Q30482392 | Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers |
Q73789354 | Subjective sleep-wake parameters in treatment-seeking opiate addicts |
Q40811653 | Subjective well-being and hookah use among adults in the United States: A nationally-representative sample |
Q45882572 | Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers |
Q48746450 | Subjects with a history of drug dependence are more aggressive than subjects with no drug use history |
Q36170053 | Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone |
Q59633326 | Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence |
Q54255884 | Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. |
Q47741861 | Substance abuse and associated psychosocial problems among Argentina adolescents: sex heterogeneity and familial transmission |
Q40700822 | Substance abuse and post-traumatic stress disorder comorbidity |
Q43540759 | Substance abuse and the immune system |
Q44070885 | Substance abuse and the need for money management assistance among psychiatric inpatients |
Q92391384 | Substance abuse and white matter: Findings, limitations, and future of diffusion tensor imaging research |
Q33636042 | Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment |
Q36513431 | Substance abuse prevention intervention research with Hispanic populations |
Q33575538 | Substance abuse risk in emerging adults associated with smaller frontal gray matter volumes and higher externalizing behaviors |
Q50421832 | Substance abuse treatment engagement, completion and short-term outcomes in the Western Cape province, South Africa: Findings from the Service Quality Measures Initiative |
Q71721796 | Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users |
Q36495737 | Substance abuse treatment entry, retention, and outcome in women: a review of the literature |
Q40603130 | Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort |
Q48448713 | Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination |
Q40714133 | Substance abuse, pathological gambling, and impulsiveness |
Q42086155 | Substance abusers seeking emergency psychiatric care: motivation to treatment |
Q43059762 | Substance abusers' motives for using anabolic androgenic steroids |
Q58121257 | Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence |
Q43613918 | Substance risk, prevention treatments and the role of the environmental and cultural context in addressing Latinos and other ethnic/racial populations |
Q91740595 | Substance type moderates the longitudinal association between depression and substance use from pre-treatment through a 1-year follow-up |
Q35587222 | Substance use after participation in laboratory studies involving smoked cocaine self-administration |
Q39395715 | Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire |
Q47243955 | Substance use among Venezuelan medical and pharmacy students |
Q77989968 | Substance use among a regional sample of female nurses |
Q44026537 | Substance use among adolescents in Taiwan: associated personality traits, incompetence, and behavioral/emotional problems |
Q73434149 | Substance use among high school students in Greece: outburst of illicit drug use in a society under change |
Q34546957 | Substance use among high-school students in Southern Thailand: trends over 3 years (2002-2004). |
Q69720041 | Substance use among medical students in Barcelona (Spain). A comparison with previous surveys |
Q43292940 | Substance use among non-fatally injured patients attended at emergency departments in Spain |
Q70754025 | Substance use among resident doctors in Venezuela |
Q47206006 | Substance use among schoolchildren in the north of England |
Q40454752 | Substance use and STI acquisition: Secondary analysis from the AWARE study. |
Q27312536 | Substance use and drinking outcomes in Personalized Cognitive Counseling randomized trial for episodic substance-using men who have sex with men |
Q88934849 | Substance use and homelessness among emergency department patients |
Q30995447 | Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data |
Q41115463 | Substance use and mental health disorders are linked to different forms of intimate partner violence victimisation. |
Q96680913 | Substance use and mental health predictors of patterns of non-partner youth violence among high-risk urban youth |
Q51803455 | Substance use and predictors of substance dependence in homeless women. |
Q52195719 | Substance use and risky sexual behavior in female adolescents. |
Q30524748 | Substance use and sexual behavior among recent Hispanic immigrant adolescents: effects of parent-adolescent differential acculturation and communication |
Q46246690 | Substance use and substance use disorders in recently deployed and never deployed soldiers |
Q35690402 | Substance use and treatment of substance use disorders in a community sample of transgender adults |
Q60031001 | Substance use disorder and home neighborhood disorder do not predict posttraumatic stress symptoms |
Q34539480 | Substance use disorder treatment programs in Switzerland and the USA: Program characteristics and 1-year outcomes |
Q118186692 | Substance use disorders among adults who are deaf or hard of hearing in the United States |
Q123600443 | Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records |
Q52350385 | Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes. |
Q98731008 | Substance use disorders and risk of severe maternal morbidity in the United States |
Q89952612 | Substance use disorders before, at and after first episode psychosis hospitalizations in a young national Swedish cohort |
Q45083086 | Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment |
Q48443262 | Substance use disorders increase the odds of subsequent mood disorders |
Q58294150 | Substance use during pregnancy among young women with symptoms of psychological stress and depression |
Q35920033 | Substance use histories in patients seeking treatment for controlled-release oxycodone dependence |
Q96123725 | Substance use improvement depends on Race/Ethnicity: Outpatient treatment disparities observed in a large US national sample |
Q44668403 | Substance use in a sample of Turkish medical students |
Q36328334 | Substance use network characteristics and drug and alcohol use behaviors among young men who have sex with men (YMSM) |
Q33765325 | Substance use outcomes 51/2 years past baseline for partnership-based, family-school preventive interventions |
Q90818172 | Substance use patterns among women living with HIV compared with the general female population of Canada |
Q33924466 | Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States. |
Q97539644 | Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018 |
Q47342835 | Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study |
Q91384308 | Substance use prevention research funded by the NIH |
Q37626326 | Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations. |
Q36127902 | Substance use treatment outcomes for youth: integrating personal and environmental predictors |
Q44189356 | Substance use, abuse and dependence in adolescence: prevalence, symptom profiles and correlates |
Q40402624 | Substance use, dependence and treatment seeking in the United States and Australia: a cross-national comparison |
Q89138681 | Substance use, recovery, and linguistics: The impact of word choice on explicit and implicit bias |
Q90166726 | Substance use: Interplay between polygenic risk and neighborhood environment |
Q46554029 | Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences. A study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway |
Q74507735 | Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome |
Q35179458 | Substance-related traffic-risk behaviors among college students |
Q90130161 | Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type |
Q50085555 | Substitutability of nicotine alone and an electronic cigarette liquid using a concurrent choice assay in rats: A behavioral economic analysis |
Q44934080 | Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes |
Q52268127 | Substitution and primary dependence studies in animals. |
Q51729841 | Substitution of psychoactive drugs in pentobarbital-dependent rats. |
Q36169430 | Subtypes of alcohol dependence in a nationally representative sample |
Q34258698 | Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions |
Q24613527 | Subtypes of nonmedical prescription drug misuse |
Q99200896 | Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma |
Q42994848 | Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance |
Q69661603 | Successfully adjusted alcoholics lost to long-term follow-up. A prospective study |
Q92587984 | Sudden cardiac death associated to substances of abuse and psychotropic drugs consumed by young people: A population study based on forensic autopsies |
Q71865388 | Sufficient conditions for effective treatment of substance abusing homeless persons |
Q34369777 | Suicidal behavior, drug use and depressive symptoms after detoxification: a 2-year prospective study |
Q45157523 | Suicidal behaviors and drug abuse: impulsivity and its assessment |
Q34031665 | Suicidal ideation and substance use among adolescents and young adults: a bidirectional relation? |
Q90800199 | Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder |
Q37622005 | Suicide and substance use among female veterans: a need for research |
Q39798300 | Suicide attempts among alcohol-dependent pain patients before and after an inpatient hospitalization |
Q99708415 | Suicide attempts and death among heroin-involved women seeking methadone treatment in Taiwan |
Q48836719 | Suicide attempts and overdoses among adults entering addictions treatment: comparing correlates in a U.S. National Study |
Q42646679 | Suicide attempts prior to starting methadone maintenance treatment in Taiwan |
Q44555335 | Suicides and alcohol consumption in Russia, 1965-1999. |
Q36976706 | Suitability of the PROMIS alcohol use short form for screening in a HIV clinical care setting |
Q46744253 | Summary of NIDA medications workshop: new opportunities for chemists and pharmacologists |
Q48717700 | Superoxide dismutase activity in brains from chronic alcoholics |
Q52265325 | Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects. |
Q35471492 | Supervised injection services: what has been demonstrated? A systematic literature review |
Q39899186 | Supplementing the liquid alcohol diet with chow enhances alcohol intake in C57 BL/6 mice |
Q38816803 | Support for marijuana legalization in the US state of Washington has continued to increase through 2016. |
Q39578671 | Supporting the habit: income generation activities of frequent crack users compared with frequent users of other hard drugs |
Q44394325 | Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats |
Q48266872 | Suppression of ethanol tolerance and dependence in rats treated with DSP-4, a noradrenergic neurotoxin |
Q48369504 | Suppression of morphine abstinence syndrome by body electroacupuncture of different frequencies in rats |
Q70648680 | Suppression of withdrawal jumping: comparison of narcotic tolerance and dependence |
Q44341476 | Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment |
Q43728918 | Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis |
Q39385965 | Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users |
Q30494650 | Sustainability of intervention effects of an evidence-based HIV prevention intervention for African American women who smoke crack cocaine |
Q43808743 | Sustained administration of cyclazocine for antagonism of morphine |
Q98882476 | Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence |
Q34992657 | Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results |
Q95823474 | Sustained heavy drinking over 25 years is associated with increased N-terminal-pro-B-type natriuretic peptides in early old age: Population-based cohort study |
Q39312220 | Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. |
Q43218428 | Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study |
Q41586937 | Symmetry and complementarity in the alcoholic marriage: a pilot study |
Q40553878 | Sympathetic nervous system mediated cardiovascular effects of cocaine are primarily due to a peripheral site of action of the drug. |
Q52270911 | Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers. |
Q70578324 | Symptom profiles of 'driving under the influence' offenders referred for alcoholism treatment |
Q53768944 | Symptoms discriminating between heroin addicts seeking ambulatory detoxification or methadone maintenance. |
Q35186495 | Symptoms of alcohol dependence and smoking initiation and persistence: a longitudinal study among US adults |
Q37177691 | Symptoms of depression and PTSD are associated with elevated alcohol demand |
Q33912643 | Symptoms of substance dependence and risky sexual behavior in a probability sample of HIV-negative men who have sex with men in Chicago |
Q42095385 | Syndemic factors associated with adult sexual HIV risk behaviors in a sample of Latino men who have sex with men in New York City |
Q97539574 | Syndemic latent transition analysis in the HPTN 061 cohort: Prospective interactions between trauma, mental health, social support, and substance use |
Q49895336 | Syndemics among individuals enrolled in the PrEP Brasil Study |
Q43416009 | Synergism of ethanol and clofibrate in the lauric acid hydroxylation |
Q40366091 | Synthetic cannabimimetics in Bulgaria 2010-2013. |
Q34164162 | Synthetic cannabinoid JWH-018 and psychosis: an explorative study. |
Q34167511 | Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates |
Q35181572 | Synthetic cannabinoid use in a nationally representative sample of US high school seniors. |
Q53094148 | Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats. |
Q34617484 | Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications |
Q43637419 | Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample |
Q91504248 | Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens |
Q38710913 | Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats |
Q91678174 | Syringe disposal among people who inject drugs before and after the implementation of a syringe services program |
Q90362321 | Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder |
Q89044133 | Systemic barriers in substance use disorder treatment: A prospective qualitative study of professionals in the field |
Q41609663 | Systems of reinforcement and drug dependence |
Q57832953 | T1 and T2 relaxation time estimates and brain measures during withdrawal in alcoholic men |
Q96769556 | THC and CBD blood and brain concentrations following daily administration to adolescent primates |
Q88882751 | TV-1380 attenuates cocaine-induced changes in cardiodynamic parameters in monkeys and reduces the formation of cocaethylene |
Q90416090 | Take-home naloxone possession among people who inject drugs in rural West Virginia |
Q34021875 | Taking a life course approach to studying substance use treatment among a community cohort of African American substance users |
Q64123974 | Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program |
Q39211498 | Targeting practitioners: A review of guidelines, training, and policy in pain management |
Q61635359 | Targeting problematic users of illicit drugs with Internet-based screening and brief intervention: A randomized controlled trial |
Q44094329 | Taste function in methadone-maintained opioid-dependent men. |
Q37275074 | Taxometric analysis of DSM-IV and DSM-5 alcohol use disorders |
Q37048767 | Taxonomy of Caribbean tourism alcohol venues: implications for HIV transmission. |
Q43620003 | Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors' behavior. |
Q58400532 | Technology-based intervention preferences to enhance self-management of substance use disorders, HIV, and hepatitis c among patients in inpatient detoxification |
Q47314651 | Teenagers and alcohol: results of a Scottish national survey |
Q36700229 | Teenagers do not always lie: characteristics and correspondence of telephone and in-person reports of adolescent drug use. |
Q46588046 | Telephone self-monitoring among alcohol use disorder patients in early recovery: a randomized study of feasibility and measurement reactivity |
Q44672955 | Telephone versus in-person interviews for alcohol use: results of the 2000 National Alcohol Survey |
Q36553470 | Telephone-based continuing care counseling in substance abuse treatment: Economic analysis of a randomized trial |
Q39874271 | Television viewing and alcohol advertising with alcohol expectancies among school-aged children in Taiwan |
Q46719258 | Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients |
Q72629333 | Temperament: a salient correlate of risk factors for alcohol and drug abuse |
Q47753375 | Temporal and dose-dependent differences in simultaneously-induced cocaine hypervigilance and conditioned-place-preference in marmoset monkeys |
Q73140894 | Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Spanish Group for the Study of the Purity of Seized Drugs |
Q51643172 | Temporal changes in plasma levels and metabolism of ketone bodies by liver and brain after ethanol and/or starvation in C57BL/6J mice. |
Q46489616 | Temporal dynamics and determinants of whole brain tissue volume changes during recovery from alcohol dependence. |
Q37320909 | Temporal horizon: modulation by smoking status and gender |
Q33697808 | Temporal profile of fronto-striatal-limbic activity during implicit decisions in drug dependence. |
Q103722823 | Temporal relationship between a sudden disruption of a local illicit drug market in a deprived neighborhood of the Barcelona Metropolitan Area and the number of discarded syringes collected from public space |
Q45000255 | Temporal relationship between the age of onset of phobic disorders and development of substance dependence in adolescent psychiatric patients |
Q48684260 | Temporal studies of the inhibition of voluntary ethanol intake in the rat induced by intermittent ethanol treatment and some long term neurochemical consequences |
Q34166546 | Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11. |
Q44884491 | Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain |
Q36817075 | Ten-year stability of remission in private alcohol and drug outpatient treatment: non-problem users versus abstainers |
Q34056992 | Teratogenic effects of acetaldehyde in the rat. |
Q71502561 | Teratogenic effects of ethanol in the Quackenbush special mouse |
Q49132712 | Terminal sleep following delirium tremens in chronic alcoholics--polysomnographic and behavioral study |
Q33736641 | Test of association between GABRA2 (SNP rs279871) and adolescent conduct/alcohol use disorders utilizing a sample of clinic referred youth with serious substance and conduct problems, controls and available first degree relatives |
Q51910864 | Test of association between TaqIA A1 allele and alcohol use disorder phenotypes in a sample of adolescent patients with serious substance and behavioral problems. |
Q46861779 | Test of measurement invariance of the FTND across demographic groups: assessment, effect size, and prediction of cessation |
Q67377144 | Test-retest reliability and validity information for a high school drug use questionnaire |
Q100422780 | Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview |
Q129496870 | Test-retest reliability of DSM-5 substance use symptom checklists used in primary care and mental health care settings |
Q34714395 | Test-retest reliability of eye tracking during the visual probe task in cocaine-using adults |
Q47778146 | Test-retest reliability of the alcohol and drug use disorder sections of the schedules for clinical assessment in neuropsychiatry (SCAN). |
Q45926745 | Testing different thresholds for risky episodic drinking--what's so special about five drinks? |
Q44487800 | Testing hypotheses about the relationship between cannabis use and psychosis |
Q34541119 | Testing the abuse liability of anxiolytic and hypnotic drugs in humans |
Q62671051 | Testing the biosocial cognitive model of substance use in cannabis users referred to treatment |
Q100457952 | Testing the drug use and condomless anal sex link among sexual minority men: The predictive utility of marijuana and interactions with relationship status |
Q45264658 | Testing the dual pathway hypothesis to substance use in adolescence and young adulthood |
Q92116891 | Testing the reciprocal association between smoking and depressive symptoms from adolescence to adulthood: A longitudinal twin study |
Q38363648 | Testosterone suppression in opioid users: a systematic review and meta-analysis |
Q41877150 | Tetrahydroisoquinolines and the serotonergic system |
Q37876286 | The 'point of no return' as a target of experimental research on drug dependence |
Q44934071 | The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. |
Q36572535 | The 14-year course of alcoholism in a community sample: do men and women differ? |
Q45109743 | The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity |
Q39991084 | The Adolescent Substance Abuse Prevention Study: A randomized field trial of a universal substance abuse prevention program |
Q72795798 | The Alcohol Problems Questionnaire: reliability and validity |
Q35088286 | The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample |
Q41375342 | The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample |
Q44487795 | The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample |
Q46021419 | The Alcohol Use Disorders Identification Test (AUDIT) as a screening instrument for adolescents. |
Q46233348 | The Alcohol Use Disorders Identification Test revisited: establishing its structure using nonlinear factor analysis and identifying subgroups of respondents using latent class factor analysis |
Q99413408 | The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study |
Q92225556 | The Auckland alcohol detoxification outcome study: Measuring changes in quality of life in individuals completing a medicated withdrawal from alcohol in a detoxification unit |
Q33568364 | The Betel Quid Dependence Scale: replication and extension in a Guamanian sample |
Q37392290 | The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse |
Q46510091 | The Cannabis Problems Questionnaire: factor structure, reliability, and validity |
Q39732890 | The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress |
Q50689890 | The ClockΔ19 mutation in mice fails to alter the primary and secondary reinforcing properties of nicotine. |
Q34504902 | The Committee on Problems of Drug Dependence: a legacy of the National Academy of Sciences. A historical account |
Q34350035 | The Controlled Substances Act: how a "big tent" reform became a punitive drug law. |
Q46345484 | The DOP system: a manifestation of social exclusion. A personal commentary on 'Alcohol consumption amongst South African farm workers: a post-apartheid challenge, by L. London 1999'. |
Q71993968 | The DSM-IV field trial for substance use disorders: major results |
Q60941476 | The DSM-IV field trial for substance use disorders: major results. brief commentaries on this article by Cottler et al. pp. 59–69 Commebtary no. 2: The road to DSM-IV: confessions of an erstwhile nosologist |
Q37086029 | The Dynamic Assessment and Referral System for Substance Abuse (DARSSA): development, functionality, and end-user satisfaction |
Q51913342 | The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning. |
Q96110961 | The Efficacy of Lidocaine in Disrupting Cocaine Cue-Induced Memory Reconsolidation |
Q44781080 | The Emergency Department as a prevention site: a demographic analysis of substance use among ED patients |
Q47298208 | The European Community of twelve and the drug demand. Excerpt of a comparative study of legislations and judicial practice |
Q45063872 | The Experimental Tobacco Marketplace II: Substitutability and sex effects in dual electronic cigarette and conventional cigarette users |
Q92231019 | The Experimental Tobacco Marketplace: Narratives engage cognitive biases to increase electronic cigarette substitution |
Q44487790 | The Fagerström test for nicotine dependence in two adult population samples-potential influence of lifetime amount of tobacco smoked on the degree of dependence |
Q46502454 | The Fagerström test for nicotine dependence: a comparison of standard scoring and latent class analysis approaches |
Q91813555 | The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats |
Q33757216 | The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. |
Q50198765 | The Galician Beverage Picture Set (GBPS): A standardized database of alcohol and non-alcohol images. |
Q42632926 | The H2O2 scavenger ebselen decreases ethanol-induced locomotor stimulation in mice |
Q103038500 | The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices |
Q37385095 | The Hispanic Americans Baseline Alcohol Survey (HABLAS): the association between birthplace, acculturation and alcohol abuse and dependence across Hispanic national groups |
Q44852808 | The Italian version of the Obsessive-Compulsive Drinking Scale: validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics. |
Q44332668 | The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications |
Q46889105 | The MAO-A gene, platelet MAO-B activity and psychosocial environment in adolescent female alcohol-related problem behaviour |
Q37367811 | The Marijuana Ladder: measuring motivation to change marijuana use in incarcerated adolescents |
Q90386147 | The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans? |
Q35850617 | The Network for the Improvement of Addiction Treatment (NIATx): enhancing access and retention |
Q35944503 | The Nicotine Dependence Syndrome Scale in Finnish smokers |
Q35633126 | The Obsessive Compulsive Cocaine Use Scale: development and initial validation of a self-rated instrument for the quantification of thoughts about cocaine use. |
Q100941656 | The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study |
Q35785458 | The Physicians' Competence in Substance Abuse Test (P-CSAT): a multidimensional educational measurement tool for substance abuse training programs |
Q38737060 | The Prescription Opioid Addiction Treatment Study: What have we learned. |
Q92601767 | The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime Labs |
Q51775154 | The Role of GABA in morphine abstinence in rats |
Q46889101 | The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day. |
Q52317188 | The Self-Report Habit Index: Assessing habitual marijuana, alcohol, e-cigarette, and cigarette use. |
Q46822992 | The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. |
Q35791037 | The Sexual Discounting Task: HIV risk behavior and the discounting of delayed sexual rewards in cocaine dependence |
Q43852992 | The Society for the Study of Addiction: temperance, treatment or tolerance? (1930-1961). |
Q38770885 | The Standard Joint Unit |
Q39240670 | The Swedish methadone maintenance program: A controlled study |
Q98185771 | The Syrian Center for Tobacco Studies-13 (SCTS-13): Psychometric evaluation of a waterpipe-specific nicotine dependence instrument |
Q36942804 | The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors |
Q30353340 | The Twelve Promises of Alcoholics Anonymous: psychometric measure validation and mediational testing as a 12-step specific mechanism of behavior change. |
Q37277610 | The Washington circle engagement performance measures' association with adolescent treatment outcomes |
Q36920520 | The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. |
Q27312095 | The Yale Craving Scale: Development and psychometric properties |
Q35901006 | The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. |
Q45161025 | The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings |
Q46812069 | The acute effects of gabapentin in combination with alcohol in heavy drinkers. |
Q66972154 | The adaptive increase in ethanol metabolism due to pretreatment with ethanol: A rapid phenomenon |
Q52092635 | The addiction hospital: current status and an assessment. |
Q70150504 | The administration of transcranial electric treatment for affective disturbances therapy in alcoholic patients |
Q35792939 | The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters |
Q37443980 | The adoption of wraparound services among substance abuse treatment organizations serving criminal offenders: The role of a women-specific program |
Q37204862 | The aftermath of public housing relocation: relationship to substance misuse |
Q47701102 | The alcohol purchase task in young men from the general population |
Q35017102 | The alcohol relapse situation appraisal questionnaire: development and validation. |
Q44907459 | The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample |
Q40981146 | The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample |
Q36465741 | The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample |
Q48808225 | The alcohol-deprivation effect in hybrid mice |
Q52298974 | The aldehyde dehydrogenase 2 gene is associated with heroin dependence. |
Q36847296 | The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study |
Q47314666 | The amount of alcohol intake and some associated factors in a representative sample of 691 French boys aged 13-18. |
Q37165438 | The anabolic steroids testosterone propionate and nandrolone, but not 17alpha-methyltestosterone, induce conditioned place preference in adult mice |
Q69748679 | The appearance of 2,3-butanediol in the chronic ethanol treated pregnant rat |
Q73861218 | The applicability of the dependence syndrome to amphetamine |
Q70578317 | The appropriateness of laboratory tests in tracing young heavy drinkers |
Q39245380 | The arrest of drivers under the influence as a predictor of subsequent social disadvantage and death |
Q47613045 | The association between Act-Belong-Commit indicators and problem drinking among older Irish adults: Findings from a prospective analysis of the Irish Longitudinal Study on Ageing (TILDA). |
Q60169653 | The association between alcohol use and hepatitis C status among injecting drug users in Glasgow |
Q33624618 | The association between alcohol-related arrests and college football game days |
Q37403694 | The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults |
Q45131558 | The association between change in social network characteristics and non-fatal overdose: results from the SHIELD study in Baltimore, MD, USA. |
Q33648645 | The association between changes in alternative reinforcers and short-term smoking cessation |
Q51121140 | The association between childhood irritability and liability to substance use in early adolescence: a 2-year follow-up study of boys at risk for substance abuse. |
Q52235864 | The association between chronic cannabis use and cognitive functions |
Q51914926 | The association between cigarette smoking and DSM-IV nicotine dependence among first year college students. |
Q30587123 | The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol |
Q58633926 | The association between exposure to guns and gambling among community-recruited substance using women |
Q102140501 | The association between frequency of e-cigarette use and long-term smoking cessation outcomes among treatment-seeking smokers receiving a behavioral intervention |
Q91740576 | The association between frequency of opioid misuse and opioid use disorder among youth and adults in the United States |
Q36401889 | The association between frontal-striatal connectivity and sensorimotor control in cocaine users. |
Q35785618 | The association between insomnia and suicidal thoughts in adults treated for alcohol dependence in Poland |
Q57137191 | The association between lifetime polytobacco use and intention to quit among HIV-positive cigarette smokers |
Q40034864 | The association between neighborhood disorder, social cohesion and hazardous alcohol use: a national multilevel study. |
Q47231102 | The association between neighborhood socioeconomic disadvantage and high-risk injection behavior among people who inject drugs |
Q48071489 | The association between nonmedical use of prescription medication status and change in health-related quality of life: results from a Nationally Representative Survey |
Q35491054 | The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review |
Q91572569 | The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons |
Q44360018 | The association between parental alcohol-related behaviors and children's drinking |
Q38638817 | The association between parental history and delay discounting among individuals in recovery from addiction. |
Q35228275 | The association between parental risk behaviors during childhood and having high risk networks in adulthood |
Q45055508 | The association between personality disorders with alcohol use and misuse: A population-based twin study |
Q91233442 | The association between physical pain and cannabis use in daily life: An experience sampling method |
Q96616394 | The association between quantity, frequency and duration of cocaine use during the heaviest use period and DSM-5 cocaine use disorder |
Q91707956 | The association between racial and socioeconomic discrimination and two stages of alcohol use in blacks |
Q97085200 | The association between regular cocaine use, with and without tobacco co-use, and adverse cardiovascular and respiratory outcomes |
Q38649050 | The association between regular marijuana use and adult mental health outcomes |
Q58633816 | The association between religion/spirituality and 30 day crack/cocaine and marijuana use among female offenders |
Q103834911 | The association between short-term emotion dynamics and cigarette dependence: A comprehensive examination of dynamic measures |
Q93057769 | The association between smoke-free school policies and adolescents' anti-smoking beliefs: Moderation by family smoking norms |
Q45329935 | The association between substance use disorders and mortality among a cohort of Veterans with posttraumatic stress disorder: variation by age cohort and mortality type |
Q39480277 | The association between tobacco smoking and use of other psychoactive substances among Egyptian male students |
Q91828903 | The association between use of opiates, cocaine, and amphetamines during pregnancy and maternal postpartum readmission in the United States: A retrospective analysis of the Nationwide Readmissions Database |
Q37540492 | The association of alcohol intake with γ-glutamyl transferase (GGT) levels: evidence for correlated genetic effects |
Q38780494 | The association of prenatal cocaine exposure, externalizing behavior and adolescent substance use |
Q38825321 | The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample |
Q35714846 | The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt |
Q37328739 | The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment |
Q36803463 | The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women |
Q37067677 | The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary |
Q38402324 | The association of unemployment from age 21 to 33 with substance use disorder symptoms at age 39: The role of childhood neighborhood characteristics. |
Q39867861 | The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. |
Q51705895 | The attitudes of heroin users and matched non-users to drugs and drug users. |
Q37373642 | The behavioral economics of will in recovery from addiction |
Q68671017 | The beliefs and attitudes of a group of men in mid-life towards tobacco use |
Q90719476 | The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting |
Q67928670 | The blood alcohol curve as a function of time and type of beverage: methodological considerations |
Q52171033 | The brief abstinence test: voucher-based reinforcement of cocaine abstinence. |
Q38431215 | The built environment and alcohol consumption in urban neighborhoods. |
Q48039246 | The case for medical marijuana: an issue of relief. |
Q71736718 | The case of the Swedish methadone maintenance treatment programme |
Q39161296 | The cerebellum in drug craving. |
Q44786057 | The challenge of illicit drug addiction for general practice |
Q39733529 | The challenge of psychiatric comorbidity to the public services for drug dependence in Italy: A national survey. |
Q114190380 | The changes in retinal nerve fiber layer and macular thickness in Chinese patients with alcohol dependency |
Q48186010 | The changes in sulfhydryl compounds in plasma, liver and brain after acute and chronic ethanol administration in rats |
Q45999091 | The changing demographic of blunt smokers across birth cohorts. |
Q91339193 | The changing landscape of naloxone availability in the United States, 2011 - 2017 |
Q42672917 | The characteristics and risk factors for HIV infection among Beijing drug users in different settings |
Q43870789 | The clinical course of alcohol use disorders: using joinpoint analysis to aid in interpretation of growth mixture models |
Q35124187 | The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic |
Q39466523 | The clinical usefulness of agonist-antagonist analgesics in acute pain |
Q39466528 | The clinical usefulness of agonist-antagonistic opioid analgesics in chronic pain |
Q70578332 | The clinical-correctional interface in the treatment of drug offenders: the evidence from N.S.W. australia |
Q46594892 | The co-occurrence of smoking and drinking among young adults in college: national survey results from the United States |
Q47646223 | The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France |
Q44689212 | The comorbidity of alcohol dependence and affective disorders: treatment implications |
Q44905048 | The comorbidity of substance abuse and depressive symptoms in Costa Rican adolescents. |
Q43282951 | The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases |
Q37292214 | The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study |
Q41921956 | The continuum of fetal alcohol spectrum disorders in a community in South Africa: Prevalence and characteristics in a fifth sample |
Q36494950 | The continuum of fetal alcohol spectrum disorders in four rural communities in South Africa: Prevalence and characteristics |
Q99358052 | The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data |
Q44337133 | The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people |
Q24630787 | The cost of crime to society: new crime-specific estimates for policy and program evaluation |
Q102053189 | The cost of opioid use disorder and the value of aversion |
Q37331750 | The cost of treating addiction from the client's perspective: results from a multi-modality application of the Client DATCAP. |
Q43131867 | The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients |
Q36536506 | The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial |
Q57686829 | The cost-effectiveness of tailored, postal feedback on general practitioners’ prescribing of pharmacotherapies for alcohol dependence |
Q47615115 | The costs of crime associated with stimulant use in a Canadian setting |
Q52271239 | The course and outcome of drug addiction. A follow-up study of 178 cases in Madurai, South India. |
Q44263719 | The dangers of alcohol - the situation in the Federal Republic of Germany |
Q52270457 | The day-to-day criminality of heroin addicts in Baltimore--a study in the continuity of offence rates. |
Q67781897 | The decrease of superoxide dismutase activity and depletion of sulfhydryl compounds in ethanol-induced liver injury |
Q68103393 | The demographic distribution of drinking patterns in 1984 |
Q39180842 | The design of medical marijuana laws and adolescent use and heavy use of marijuana: Analysis of 45 states from 1991 to 2011. |
Q47357565 | The detoxification of high dose heroin addicts in Pakistan |
Q91608789 | The development and validation of a human screening model of tobacco abstinence |
Q51649264 | The development of a cocaine craving questionnaire. |
Q91421148 | The development of respondent-driven sampling (RDS) inference: A systematic review of the population mean and variance estimates |
Q44271760 | The development of suicide ideation and attempts: an epidemiologic study of first graders followed into young adulthood |
Q34771658 | The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study. |
Q46474837 | The developmental origin of adolescent alcohol use: findings from the Mater University Study of Pregnancy and its outcomes |
Q48956398 | The dexamethasone suppression test in chronic alcoholics with and without depression and its relationship to their hepatic status |
Q41313783 | The diabetic alcoholic: characteristics and treatment outcome |
Q34574338 | The diagnostic dilemma of pathological appearance and performance enhancing drug use |
Q74741310 | The differential effects of alcohol consumption and dependence on adverse alcohol-related consequences: implications for the workforce |
Q42093683 | The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats |
Q36003494 | The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task |
Q37448792 | The dimensionality of alcohol use disorders: results from Israel |
Q51174193 | The discriminative stimulus properties of ethanol and acute ethanol withdrawal states in rats. |
Q39840606 | The disease concept of alcoholism: a review |
Q44102616 | The diversion and injection of a buprenorphine-naloxone soluble film formulation |
Q47563437 | The dopamine D2 receptor gene: a genetic risk factor in substance abuse |
Q36494884 | The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference. |
Q47676574 | The dopamine transporter gene may not contribute to susceptibility and the specific personality traits of amphetamine dependence |
Q36536527 | The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users |
Q91028770 | The downstream effects of state tobacco control policies on maternal smoking during pregnancy and birth outcomes |
Q41519830 | The drinking habits of residents of a rehabilitation program with a controlled drinking option: a preliminary report |
Q41188256 | The drinking patterns of American and Polish university students: a cross-national study |
Q47820837 | The drug abuse problem in Peninsular Malaysia: parent and child differences in knowledge, attitudes and perceptions |
Q93631312 | The drug problem in the Federal Republic of Germany |
Q92887613 | The drug purity discounting task: Ecstasy use likelihood is reduced by probabilistic impurity according to harmfulness of adulterants |
Q52734459 | The drug use profile (DUP): an instrument for clinical and research evaluations for drug use patterns. |
Q70905533 | The drug-use patterns of helping-profession students in Brisbane, Australia |
Q43750183 | The drunken driver: a psychosocial study |
Q34352464 | The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland). |
Q52316732 | The dual-process model in young adults with a consistent binge drinking trajectory into adulthood. |
Q101119538 | The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 |
Q40791219 | The economic context of drug and non-drug reinforcers affects acquisition and maintenance of drug-reinforced behavior and withdrawal effects |
Q31799483 | The economic costs of heroin addiction in the United States |
Q34387048 | The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients |
Q46970547 | The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone |
Q48826483 | The effect of Heparegen and D-penicillamine on the activity of some ammonia metabolizing enzymes in liver and brain of rats intoxicated with ethanol |
Q50138551 | The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial |
Q44982022 | The effect of abstinence in alcoholics of erythrocyte gangliosides |
Q46913878 | The effect of acamprosate on alcohol and food craving in patients with alcohol dependence |
Q47416212 | The effect of alcohol dependence on automatic visuo-spatial perspective taking |
Q97439237 | The effect of alcohol level on male and female drivers: Important facts |
Q92194311 | The effect of alcohol on osteoporosis: A systematic review and meta-analysis |
Q48771725 | The effect of alcoholism on salsolinol and biogenic amines in human brain |
Q46535072 | The effect of buprenorphine and benzodiazepines on respiration in the rat. |
Q71035590 | The effect of chlormethiazole on serum cortisol concentrations in chronic alcoholics |
Q48301695 | The effect of chronic ethanol ingestion on brain lipid peroxide and glutathione levels in rats |
Q48359230 | The effect of chronic ethanol intake on brain NGF level and on NGF-target tissues of adult mice. |
Q48269467 | The effect of chronic maternal alcohol consumption on the development of central nervous system myelin subfractions in rat offspring |
Q52215302 | The effect of chronic naltrexone pretreatment on associative vs. non-associative morphine tolerance. |
Q48869561 | The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers |
Q43908079 | The effect of clonidine and related substances on voluntary ethanol consumption in rats |
Q36997176 | The effect of drinking goals at treatment entry on longitudinal alcohol use patterns among adults with alcohol dependence |
Q44668429 | The effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic system |
Q91770465 | The effect of economy type on demand and preference for cocaine and saccharin in rats |
Q52286397 | The effect of haloperidol and 6-hydroxydopamine on oral drug taking behavior in rats |
Q70666024 | The effect of hematin on the development of microsomal enzyme induction and physical dependence in mice following repeated oral propoxyphene administration |
Q50680889 | The effect of heroin dependence on resumption of heroin self-administration in rats. |
Q53403058 | The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. |
Q39768145 | The effect of individual, program, and neighborhood variables on continuity of treatment among dually diagnosed individuals |
Q77504461 | The effect of lamotrigine on naloxone-precipitated opiate withdrawal |
Q34751772 | The effect of maternal betel quid exposure during pregnancy on adverse birth outcomes among aborigines in Taiwan |
Q95644068 | The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US |
Q92414944 | The effect of methadone on the hypothalamic pituitary gonadal axis and sexual function: A systematic review |
Q37149617 | The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study |
Q43050936 | The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study |
Q72548171 | The effect of naftidrofuryl on ethanol-induced liver damage in chronic alcoholic patients |
Q51866177 | The effect of neuroleptics, tranquillizers, narcotics, antidepressants and anticonvulsive drugs on the alterations of mouse behaviour caused by acetaldehyde |
Q70369063 | The effect of paternal alcohol consumption on fetal development in mice |
Q42667562 | The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence |
Q38619321 | The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. |
Q36248958 | The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs |
Q57137163 | The effect of quinine in two bottle choice procedures in C57BL6 mice: Opioid preference, somatic withdrawal, and pharmacokinetic outcomes |
Q72533796 | The effect of repeated amphetamine administration on the proopiomelanocortin mRNA level in the rat pituitary: an in situ hybridization study |
Q41303999 | The effect of repeated withdrawal episodes on subsequent withdrawal severity in ethanol-treated rats |
Q40515923 | The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial |
Q44336126 | The effect of single and repeated ethanol administration of hypothalamic opioid systems activity --an in vitro release study |
Q33696256 | The effect of social anxiety on urge and craving among smokers with and without anxiety disorders |
Q38928821 | The effect of task difficulty on motor performance and frontal-striatal connectivity in cocaine users |
Q43867225 | The effect of the 'What Do You Drink' web-based brief alcohol intervention on self-efficacy to better understand changes in alcohol use over time: randomized controlled trial using ecological momentary assessment |
Q60653460 | The effect of the ecstasy ‘come-down’ on the diagnosis of ecstasy dependence |
Q44152881 | The effect of the timing and spacing of observations in longitudinal studies of tobacco and other drug use: temporal design considerations |
Q39995975 | The effect of two elementary school-based prevention interventions on being offered tobacco and the transition to smoking |
Q43192049 | The effectiveness of a school-based substance abuse prevention program: 18-month follow-up of the EU-Dap cluster randomized controlled trial |
Q34091426 | The effectiveness of brief intervention among injured patients with alcohol dependence: who benefits from brief interventions? |
Q44026541 | The effectiveness of drug abuse treatment: a meta-analysis of comparison group studies |
Q31870918 | The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. |
Q83288310 | The effectiveness of outreach case management in re-enrolling discharged methadone patients |
Q39444337 | The effectiveness of post-detoxication referrals: Effects on later detoxication admissions, drunkenness and criminality |
Q93122288 | The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review |
Q40472775 | The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. |
Q39555493 | The effectiveness of two intensities of psychosocial treatment for cocaine dependence |
Q52260277 | The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline. |
Q47697500 | The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats |
Q30490351 | The effects of HIV on P300 are moderated by familial risk for substance dependence: implications for a theory of brain reserve |
Q36248846 | The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. |
Q64917135 | The effects of Pavlovian cue extinction and ceftriaxone on cocaine relapse after abstinence. |
Q48037868 | The effects of Present Hedonistic Time Perspective and Past Negative Time Perspective on substance use consequences |
Q51110632 | The effects of a cold-water immersion stressor on the reinforcing and subjective effects of fentanyl in healthy volunteers. |
Q39295778 | The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocaine self-administration in rats |
Q90343744 | The effects of a working memory load on drinking-related decisions: The role of incentives, disincentives, and lifetime alcohol problems |
Q33169939 | The effects of acute and chronic ingestion of ethanol on the autonomic nervous system |
Q44094302 | The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers |
Q51104194 | The effects of alcohol history on the reinforcing, subjective and psychomotor effects of nitrous oxide in healthy volunteers. |
Q39212153 | The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. |
Q48868203 | The effects of alcohol withdrawal and acute doses of alcohol on the acid-base balance in mice and rats |
Q40164948 | The effects of alcohol, cannabis, and cigarette use on the initiation, reinitiation and persistence of non-medical use of opioids, sedatives, and tranquilizers in adults |
Q37518400 | The effects of alcohol-containing e-cigarettes on young adult smokers |
Q34621557 | The effects of chronic alcohol self-administration on serotonin-1A receptor binding in nonhuman primates. |
Q37656588 | The effects of chronic ethanol self-administration on hippocampal 5-HT1A receptors in monkeys. |
Q43570029 | The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys |
Q48367150 | The effects of cocaine and the amphetamines on brain and behavior: a conference report |
Q45348662 | The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial |
Q35876145 | The effects of continuing care on emerging adult outcomes following residential addiction treatment |
Q45089622 | The effects of delay of reinforcement and dose on the self-administration of cocaine and procaine in rhesus monkeys |
Q51657117 | The effects of dose and access restrictions on the periodicity of cocaine self-administration in the rat. |
Q35952033 | The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone |
Q44430852 | The effects of escalating doses of smoked cocaine in humans |
Q66972164 | The effects of ethanol and meperidine on auditory evoked potentials |
Q92246550 | The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial |
Q48967180 | The effects of food deprivation on the self-administration of psychoactive drugs |
Q35737181 | The effects of general and alcohol-specific peer factors in adolescence on trajectories of alcohol abuse disorder symptoms from 21 to 33 years |
Q72066753 | The effects of high and low doses of methadone on cigarette smoking |
Q71035567 | The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population |
Q43845717 | The effects of maternal drug dependence on neonatal mortality |
Q68085655 | The effects of moderate drinking and abstinence on serum and urinary beta-hexosaminidase levels |
Q39617959 | The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey |
Q112162178 | The effects of nicotine administration and drug cue on impulsivity |
Q36936174 | The effects of oral d-amphetamine on impulsivity in smoked and intranasal cocaine users |
Q50470311 | The effects of perceived quality on behavioral economic demand for marijuana: A web-based experiment |
Q40133486 | The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases |
Q35584841 | The effects of piracetam on heroin-induced CPP and neuronal apoptosis in rats |
Q48416275 | The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases |
Q51901625 | The effects of priming restrained versus disinhibited behaviour on alcohol-seeking in social drinkers |
Q60485526 | The effects of psychiatric comorbidity on response to an HIV prevention intervention |
Q34421435 | The effects of racemic D,L-methadone and L-methadone in substituted patients--a randomized controlled study |
Q50964385 | The effects of rearing condition on methamphetamine self-administration and cue-induced drug seeking. |
Q30276879 | The effects of resistance exercise on cocaine self-administration, muscle hypertrophy, and BDNF expression in the nucleus accumbens |
Q69416627 | The effects of smoked Marijuana on interpersonal distances in small groups |
Q47748378 | The effects of social contact on cocaine intake in female rats |
Q33914705 | The effects of social learning on the acquisition of cocaine self-administration |
Q34113858 | The effects of sponsorship in 12-step treatment of injection drug users |
Q44343723 | The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving |
Q39371164 | The effects of the therapeutic workplace and heavy alcohol use on homelessness among homeless alcohol-dependent adults |
Q38706700 | The effects of using answer sheets on reported drug use and data quality in a classroom survey: A cluster-randomized study. |
Q46200725 | The effects of varenicline on stress-induced and cue-induced craving for cigarettes |
Q36213637 | The efficacy of Familias Unidas on drug and alcohol outcomes for Hispanic delinquent youth: main effects and interaction effects by parental stress and social support |
Q43685933 | The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy |
Q92207231 | The efficacy of spiritual/religious interventions for substance use problems: A systematic review and meta-analysis of randomized controlled trials |
Q57137151 | The end of convergence in developmental patterns of frequent marijuana use from ages 18 to 30: An analysis of cohort change from 1976-2016 |
Q37640872 | The endogenous opioid system: a common substrate in drug addiction |
Q92244303 | The epidemiology of benzodiazepine misuse: A systematic review |
Q47249158 | The epidemiology of cocaine use in Spain |
Q35783203 | The epidemiology of fetal alcohol syndrome and partial FAS in a South African community |
Q90507450 | The epidemiology of opioid overdose in Flint and Genesee County, Michigan: Implications for public health practice and intervention |
Q92960674 | The etiology of DSM-5 alcohol use disorder: Evidence of shared and non-shared additive genetic effects |
Q41636663 | The etiology of problem drinking in the workplace |
Q93008283 | The event-level impact of one's typical alcohol expectancies, drinking motivations, and use of protective behavioral strategies |
Q52201682 | The expression of both amphetamine-conditioned place preference and pentylenetetrazol-conditioned place aversion is attenuated by the NMDA receptor antagonist (+/-)-CPP. |
Q39480270 | The extent of drug use among Egyptian male university students |
Q39480289 | The extent of nonmedical use of psychoactive substances among secondary school students in Greater Cairo |
Q44701184 | The external validity of results derived from ecstasy users recruited using purposive sampling strategies |
Q36164721 | The first 90 days following release from jail: findings from the Recovery Management Checkups for Women Offenders (RMCWO) experiment |
Q70905549 | The frequency of delirium tremens and chlormethiazole (Heminevrin) |
Q41522275 | The future of federal drug abuse research. How can we best maximize scarce resources? |
Q57729642 | The gap in marijuana prevalence between black and white adolescents has disappeared since 2011: The role of perceived risk of marijuana use |
Q43075979 | The genetic epidemiology of substance use disorder: A review |
Q52264195 | The genetic interface of addiction |
Q36997134 | The genetic relationship between cannabis and tobacco cigarette use in European- and African-American female twins and siblings |
Q36314812 | The genetics of alcohol dependence: advancing towards systems-based approaches |
Q38190139 | The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. |
Q35893566 | The global political economy of scheduling: the international-historical context of the Controlled Substances Act. |
Q91195619 | The grey future: Overgenerality of emotional future thinking in alcohol-use disorders |
Q37244439 | The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats. |
Q96018547 | The growing transition from lifetime marijuana use to frequent use among 12th grade students: U.S. National data from 1976 to 2019 |
Q44023961 | The growth of treatment research in alcohol and drug use disorders: a computerized literature search |
Q45234131 | The half-life of the 'teachable moment' for alcohol misusing patients in the emergency department |
Q27687440 | The hardening hypothesis: is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary |
Q37218679 | The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico |
Q42724125 | The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use. |
Q39860248 | The health benefits of moderate alcohol consumption: a review of the literature |
Q95651829 | The heterogeneous effect of marijuana decriminalization policy on arrest rates in Philadelphia, Pennsylvania, 2009-2018 |
Q43162019 | The highs and lows of my years at NIDA (1986-1992). |
Q43162027 | The history of a public science: How the Addiction Research Center became the NIDA Intramural Research Program |
Q42221571 | The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse |
Q52264302 | The iceberg of opium addiction an epidemiological survey of opium addiction in a rural community |
Q43625667 | The identification and management of drug-seeking behavior in a medical center |
Q40521710 | The identification of LSD-like hallucinogens using the chronic spinal dog |
Q67553724 | The image of self and of the environment in drug abusers: a comparative study using the TAT |
Q37621168 | The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults |
Q96031916 | The impact of Medicare Part D on opioid use among U.S. older adults |
Q40240663 | The impact of a Housing First randomized controlled trial on substance use problems among homeless individuals with mental illness |
Q46588017 | The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence |
Q44344420 | The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers |
Q47697281 | The impact of a stage tailored intervention on alcohol use trajectories among those who do not intend to change |
Q30407558 | The impact of active and passive peer influence on young adult smoking: an experimental study |
Q52689775 | The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study. |
Q39290095 | The impact of adolescent exposure to medical marijuana laws on high school completion, college enrollment and college degree completion |
Q47703672 | The impact of alcohol policies on alcohol-attributable diseases in Taiwan-A population-based study. |
Q37074829 | The impact of an alcohol harm reduction intervention on interpersonal violence and engagement in sex work among female sex workers in Mombasa, Kenya: Results from a randomized controlled trial |
Q39064035 | The impact of anticipated and unanticipated smoking opportunities on cigarette smoking and nicotine lozenge responses |
Q40982600 | The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study |
Q35613401 | The impact of borderline personality disorder on residential substance abuse treatment dropout among men. |
Q40008111 | The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone |
Q33644060 | The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients |
Q38742773 | The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis |
Q89845190 | The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study |
Q90515856 | The impact of co-occurring opioid misuse and PTSD on response inhibition |
Q36669895 | The impact of early school behavior and educational achievement on adult drug use disorders: a prospective study. |
Q33874564 | The impact of engagement in street-based income generation activities on stimulant drug use cessation among people who inject drugs |
Q40647261 | The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers |
Q35987538 | The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection |
Q45193444 | The impact of injecting drug use status on hepatitis C-related referral and treatment |
Q37463091 | The impact of lifetime drug use on hepatitis C treatment outcomes in insured members of an integrated health care plan |
Q83481347 | The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function |
Q46028367 | The impact of long-term moderate and heavy alcohol consumption on incident atherosclerosis among persons living with HIV. |
Q36249096 | The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting |
Q41234842 | The impact of marijuana decriminalization on California drivers |
Q102209695 | The impact of menthol flavoring in combusted tobacco on alternative product purchasing: A pilot study using the Experimental Tobacco Marketplace |
Q68249667 | The impact of methadone and drug-free treatment on criminal behavior |
Q80030516 | The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program |
Q91402447 | The impact of opioid use disorder on levels of educational attainment: Perceived benefits and consequences |
Q53601410 | The impact of personality and religion on attitude towards substance use among 13-15 year olds. |
Q91072392 | The impact of plain packaging and health warnings on consumer appeal of cannabis products |
Q99622433 | The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder |
Q60145905 | The impact of state medical marijuana legislation on adolescent marijuana use |
Q90366187 | The impact of the prescription opioid epidemic on young children: Trends and mortality |
Q51257105 | The impact of the prohibition of benzylpiperazine (BZP) "legal highs" on the availability, price and strength of BZP in New Zealand. |
Q51189023 | The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand. |
Q24656563 | The impact of two universal randomized first- and second-grade classroom interventions on young adult suicide ideation and attempts |
Q36689355 | The impact of violence on sex risk and drug use behaviors among women engaged in sex work in Phnom Penh, Cambodia |
Q39528560 | The impact on retention of expansion of an Australian public methadone program. |
Q35952296 | The impacts of marijuana dispensary density and neighborhood ecology on marijuana abuse and dependence. |
Q51425638 | The importance of a compound stimulus in conditioned drug-seeking behavior following one week of extinction from self-administered cocaine in rats. |
Q37282055 | The importance of age composition of 12-step meetings as a moderating factor in the relation between young adults' 12-step participation and abstinence |
Q91339366 | The importance of considering polysubstance use: lessons from cocaine research |
Q35914745 | The importance of family factors to protect against substance use related problems among Mexican heritage and White youth. |
Q47798089 | The importance of nutrition in aiding recovery from substance use disorders: A review. |
Q40444393 | The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students. |
Q46651929 | The increase in the association of education and cocaine use over the 1980s and 1990s: evidence for a 'historical period' effect |
Q36402197 | The incremental inpatient costs associated with marijuana comorbidity |
Q39618347 | The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine |
Q52262580 | The induction of oral ethanol self-administration by contingent ethanol delivery. |
Q93683331 | The influence of acute ethanol on the catecholamine system in man as reflected in cerebrospinal fluid and urine. A new condensation product, 1-carboxysalsolinol |
Q51807704 | The influence of antihistamine compounds on the oral intake of different addictive drugs. |
Q53040844 | The influence of brain catecholamines on 'drug taking behaviour' relative to oral self-administration of d-amphetamine by rats. |
Q34749316 | The influence of cannabis motives on alcohol, cannabis, and tobacco use among treatment-seeking cigarette smokers |
Q35915889 | The influence of depressive symptoms on alcohol use among HIV-infected Russian drinkers |
Q37668649 | The influence of discrimination on smoking cessation among Latinos |
Q52310969 | The influence of early lead exposure on morphine reinforcement in the rat |
Q72541331 | The influence of external factors on oral drugtaking behavior |
Q71865393 | The influence of familial and non-familial factors on the association between major depression and substance abuse/dependence in 1874 monozygotic male twin pairs |
Q47658891 | The influence of groups and alcohol consumption on individual risk-taking. |
Q48619747 | The influence of haloperidol and aminooxyacetic acid on etonitazene, alcohol, diazepam and barbital consumption |
Q48089749 | The influence of heroin abuse on glutathione-dependent enzymes in human brain |
Q36492527 | The influence of legal coercion on dropout from substance abuse treatment: results from a national survey |
Q45391269 | The influence of living along the U.S.-Mexico border on unintentional drug overdose death, New Mexico (USA), 2005-2009. |
Q37204952 | The influence of monetary punishment on cognitive control in abstinent cocaine-users |
Q50038109 | The influence of motives on alcohol- and sex-related behaviors among female college students |
Q92541781 | The influence of opioid dependence on salt consumption and related psychological parameters in mice and humans |
Q70524829 | The influence of p-chlorophenylalanine on different morphine effects |
Q30892590 | The influence of parental drinking on offspring's drinking motives and drinking: a mediation analysis on 9 year follow-up data |
Q44394299 | The influence of partner drug use and relationship power on treatment engagement |
Q40315044 | The influence of perceived neighborhood disorder on smoking cessation among urban safety net hospital patients. |
Q70163512 | The influence of pimozide, haloperidol, α-methyl-p-tyrosine and reserpine on the development of morphine dependence in rats |
Q39880096 | The influence of program mediators on eleventh grade outcomes for seventh grade substance users and nonusers. |
Q52267294 | The influence of thiamine deficiency and ethanol on rat brain catecholamines. |
Q39459611 | The inner city and drug use: initial findings from an epidemiological study |
Q35133392 | The interacting effect of depressive symptoms, gender, and distress tolerance on substance use problems among residential treatment-seeking substance users |
Q34033735 | The interaction of conduct problems and depressed mood in relation to adolescent substance involvement and peer substance use |
Q92789505 | The interaction of sociodemographic risk factors and measures of nicotine dependence in predicting maternal smoking during pregnancy |
Q50918160 | The interest in eight new psychoactive substances before and after scheduling. |
Q43224874 | The intergenerational transmission of tobacco smoking--the role of parents' long-term smoking trajectories |
Q52303163 | The international HIV/AIDS pandemic has been closely inter-twined with drug abuse and addiction from the time it began. Preface. |
Q57137118 | The interplay between externalizing disorders polygenic risk scores and contextual factors on the development of marijuana use disorders |
Q44994504 | The interplay between help-seeking and alcohol-related outcomes: divergent processes for professional treatment and self-help groups |
Q44896450 | The intravenous self-administration of antihistamines by rhesus monkeys |
Q41016602 | The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study |
Q37917043 | The irrelevance of research to government policies on drugs |
Q36198973 | The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study |
Q54339091 | The language barrier and institutional provincialism in science. |
Q37281788 | The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study. |
Q40386603 | The latent structure of alcohol misuse in young adults: Do taxometric results differ as a function of prior criminal history? |
Q36275182 | The latent structure of marijuana and cocaine use disorders: results from the National Longitudinal Alcohol Epidemiologic Survey (NLAES). |
Q91415787 | The legal regulation of drugs and role of government: Perspectives from people who use drugs |
Q40415606 | The level of response to alcohol in daughters of alcoholics and controls |
Q48545762 | The long-term effects of prenatal nicotine exposure on verbal working memory: an fMRI study of young adults |
Q40267376 | The long-term effects of school dropout and GED attainment on substance use disorders |
Q37588861 | The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. |
Q46743700 | The longitudinal association between substance use and delinquency among high-risk youth |
Q39724014 | The longitudinal associations between substance use, crime, and social risk among emerging adults: A longitudinal within and between-person latent variables analysis |
Q51839943 | The mGlu5 receptor antagonist MTEP attenuates opiate self-administration and cue-induced opiate-seeking behaviour in mice. |
Q47906290 | The mGlu5 receptor regulates extinction of cocaine-driven behaviours. |
Q45358941 | The magnitude and reliability of cue-specific craving in nondependent smokers |
Q40119935 | The major medical sequelae of opioid addiction |
Q40766153 | The male factor: Outcomes from a cluster randomized field experiment with a couples-based HIV prevention intervention in a South African township |
Q63313862 | The marginal effects of hazardous alcohol use on the probability of behavioral healthcare utilization among National Guard members |
Q91246774 | The maximum alcohol withdrawal syndrome score associates with worse clinical outcomes-A retrospective cohort study |
Q40156026 | The mediating effects of depressive symptoms and sleep quality on the relationship between the non-medical use of prescription drugs and suicidal behaviors among Chinese adolescents |
Q40791224 | The medical status of methadone maintenance patients in treatment for 11-18 years |
Q50657393 | The misuse of benzodiazepines among adolescents: psychosocial risk factors in a national sample |
Q47566322 | The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand |
Q36434454 | The moderating effect of parental illicit substance use disorders on the relation between adolescent depression and subsequent illicit substance use disorders |
Q90284031 | The moderating effect of perceived social support on the relation between heaviness of smoking and quit attempts among adult homeless smokers |
Q38554257 | The more drinking, the more fun; but is there a calculus of fun, and should it drive policy? |
Q33921417 | The more you drink, the harder you fall: a systematic review and meta-analysis of how acute alcohol consumption and injury or collision risk increase together |
Q38303351 | The morphine-binding site on human activated T-cells is not related to the mu opioid receptor |
Q114261732 | The most 100 cited papers in addiction research on cannabis, heroin, cocaine and psychostimulants. A bibliometric cross-sectional analysis |
Q48858290 | The motivation of alcohol dependents to undergo treatment |
Q30556629 | The musical substance of Charles R. Schuster, Ph.D. (1930–2011). |
Q52662978 | The national implementation of Contingency Management (CM) in the Department of Veterans Affairs: Attendance at CM sessions and substance use outcomes. |
Q43774567 | The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults |
Q36536957 | The natural history of efforts to stop smoking: a prospective cohort study |
Q71096963 | The need for a new design for evaluating alcoholism treatment programs |
Q36576210 | The need for evidence-based research ethics: a review of the substance abuse literature |
Q50437056 | The needle and the damage done: clinical and behavioural markers of severe femoral vein damage among groin injectors |
Q92731464 | The neural interface between negative emotion regulation and motivation for change in cocaine dependent individuals under treatment |
Q91885065 | The neural representation of the association between comorbid drug use disorders and childhood maltreatment |
Q47611030 | The neurobiology of alcohol abuse and alcoholism: building knowledge, creating hope |
Q35685525 | The neurobiology of cognitive control in successful cocaine abstinence. |
Q47720605 | The neurochemical consequences of methamphetamine self-administration in male and female rats |
Q38590656 | The non-medical use of prescription psychotropic drugs by school boys in greater Cairo |
Q39480305 | The non-medical use of psychoactive substances among male secondary school students in Egypt: an epidemiological study |
Q46100326 | The nonmedical use of prescription medicines among high school students: a cross-sectional study in Southern China |
Q39480295 | The nonmedical use of psychoactive substances by male technical school students in Greater Cairo: an epidemiological study |
Q46919093 | The nuts and bolts of gene array technology and its application to drug abuse research |
Q60632070 | The onset of heroin use and criminal behaviour: does order make a difference? |
Q92252115 | The optimization of methadone dosing whilst treating with rifampicin: A pharmacokinetic modeling study |
Q52308306 | The overexpression of Thioredoxin-1 suppressing inflammation induced by methamphetamine in spleen. |
Q41158842 | The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine |
Q100408331 | The performance of DSM-5 alcohol use disorder and quantity-frequency of alcohol consumption criteria: An item response theory analysis |
Q39168475 | The permissive role of glucocorticoids in the development of ethanol dependence and tolerance |
Q41507662 | The personal characteristics and life-style of the young drinker: the results of a survey of British adolescents |
Q35287300 | The pharmacokinetics of methamphetamine self-administration in male and female rats |
Q47658516 | The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats |
Q43728941 | The pharmacologic and expectancy effects of alcohol on social anxiety in individuals with social phobia. |
Q43619986 | The pharmacological activity of inhalation exposure to marijuana smoke in mice |
Q44668423 | The pharmacology of cocaethylene in humans following cocaine and ethanol administration |
Q44184667 | The pharmacology of drug abuse--a novel approach to drug education at San Quentin |
Q44443571 | The pharmacology of thebaine in the chronic spinal dog |
Q92720127 | The polymorphism of dopamine D2 receptor TaqIA gene is associated with brain response to drug cues in male heroin-dependent individuals during methadone maintenance treatment |
Q52074785 | The position of psychiatry in alcohol dependence. |
Q43188400 | The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration |
Q67492426 | The possible mechanism of action of ethanol on rat thymus |
Q36003086 | The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs |
Q35535833 | The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD. |
Q35665809 | The power of the proposition: frequency of marijuana offers, parental knowledge, and adolescent marijuana use. |
Q44349305 | The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? |
Q102377607 | The predictability of the Addiction Severity Index criminal justice assessment instrument and future imprisonment: A Swedish registry study with a national sample of adults with risky substance use |
Q103798439 | The predictive capacity of AUDIT and AUDIT-C among adolescents in a one-year follow-up study |
Q34510807 | The prevalence and clinical features of amphetamine-induced obsessive compulsive disorder |
Q37080021 | The prevalence and correlates of single cigarette selling among urban disadvantaged drug users in Baltimore, Maryland |
Q89845192 | The prevalence and impact of elevated anxiety sensitivity among hazardous drinking college students |
Q51724371 | The prevalence and self-reported consequences of cocaine use: an exploratory and descriptive analysis. |
Q37127803 | The prevalence of cannabis-involved driving in California |
Q46858941 | The prevalence of drinking and driving in the United States, 2001-2002: results from the national epidemiological survey on alcohol and related conditions |
Q35911194 | The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms |
Q103722816 | The prevalence, child characteristics, and maternal risk factors for the continuum of fetal alcohol spectrum disorders: A sixth population-based study in the same South African community |
Q36501904 | The prevention of HIV transmission in Hispanic adolescents |
Q39998590 | The profile of psychiatric symptoms exacerbated by methamphetamine use. |
Q36968077 | The prognostic implications of DSM-IV abuse criteria in drinking adolescents |
Q44998766 | The promise of PROMIS(®) for addiction |
Q48502970 | The provision of cell phones as a recruitment and retention strategy for people who inject drugs enrolling in a randomized trial |
Q40406912 | The proximal association between smoking and alcohol use among first year college students |
Q39862349 | The psychological benefits of moderate alcohol consumption: a review of the literature |
Q35068959 | The psychological impact of heavy drinking among the elderly on their co-residents: the 10/66 group population based survey in the Dominican Republic |
Q52267824 | The psychopathology of alcoholism. |
Q44403992 | The quantitative assessment of physical dependence on opiates |
Q46928854 | The reach of a youth-oriented anti-tobacco media campaign on adult smokers |
Q38929843 | The recovery of online drug markets following law enforcement and other disruptions |
Q42409477 | The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections |
Q104456570 | The reinforcement threshold and elasticity of demand for nicotine in an adolescent rat model of depression |
Q36164835 | The reinforcement threshold for nicotine as a target for tobacco control |
Q51559250 | The reinforcing effects of brief exposures to nitrous oxide in healthy volunteers. |
Q97597714 | The reinforcing effects of ethanol within the prelimbic cortex and ethanol drinking: Involvement of local dopamine D2 receptor-mediated neurotransmission |
Q48147520 | The reinforcing value of alcohol in a drinking to cope paradigm |
Q52318213 | The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. |
Q48035869 | The relation between risk-taking behavior and alcohol use in young adults is different for men and women |
Q60736714 | The relation of autonomic function to physical fitness in patients suffering from alcohol dependence |
Q88758587 | The relation of parent alcohol disorder to young adult drinking outcomes mediated by parenting: Effects of developmentally limited versus persistent parent alcohol disorder |
Q42598813 | The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs |
Q48937654 | The relationship between alcohol intoxication and power in real-life non-alcoholic couples |
Q50743001 | The relationship between alcohol use and injecting drug use: impacts on health, crime and wellbeing. |
Q45082907 | The relationship between alcohol use and other drug use among New York State college students |
Q35701473 | The relationship between cannabis involvement and suicidal thoughts and behaviors. |
Q43774559 | The relationship between cannabis use and other substance use in the general population. |
Q35954701 | The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). |
Q53536682 | The relationship between crystalline methamphetamine use and methamphetamine dependence. |
Q35203268 | The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India |
Q47575492 | The relationship between executive functions and emotion regulation in females attending therapeutic community treatment for substance use disorder |
Q40117573 | The relationship between group size, intoxication and continuing to drink after bar attendance |
Q70578344 | The relationship between hepatitis B surface antigen and antibody and continued drug use in narcotic dependency: a randomized controlled study |
Q52381686 | The relationship between impulsivity and methamphetamine use severity in a community sample. |
Q96126830 | The relationship between incarceration history and overdose in North America: A scoping review of the evidence |
Q98244559 | The relationship between insomnia and the intensity of drinking in treatment-seeking individuals with alcohol dependence |
Q34149087 | The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. |
Q51692774 | The relationship between observed signs of impairment and THC concentration in oral fluid. |
Q35231076 | The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample |
Q92520636 | The relationship between perceived stress and depression in substance use disorder treatment |
Q51972710 | The relationship between psychopathology and smoking cessation treatment response. |
Q92124840 | The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal |
Q33385914 | The relationship between recreational gambling and substance abuse/dependence: data from a nationally representative sample |
Q50993301 | The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. |
Q47192999 | The relationship between self-compassion and the risk for substance use disorder |
Q35173139 | The relationship between services delivered and substance use outcomes in New Mexico's Screening, Brief Intervention, Referral and Treatment (SBIRT) Initiative |
Q93140233 | The relationship between smoking cessation and binge drinking, depression, and anxiety symptoms among smokers with serious mental illness |
Q91824862 | The relationship between social inequalities, substance use and violence in border and non-border cities of northern Mexico |
Q35037944 | The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, India |
Q50927485 | The relationship between temporal discounting and the prisoner's dilemma game in intranasal abusers of prescription opioids. |
Q39435513 | The relationship between the UPPS-P impulsive personality traits and substance use psychotherapy outcomes: A meta-analysis |
Q46904306 | The relationship between the locomotor response to a novel environment and behavioral disinhibition in rats |
Q44349161 | The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use. |
Q33717964 | The relationship of DSM-IV personality disorders to nicotine dependence-results from a national survey |
Q69677294 | The relationship of cerebral atrophy and T1 in alcoholics: an MRI study |
Q52893957 | The relationship of counseling and self-help participation to patient outcomes in DATOS. |
Q36144625 | The relationship of cumulative and proximal adversity to onset of substance dependence symptoms in two American Indian communities |
Q36346768 | The relationship of dysthymia, minor depression, and gender to changes in smoking for current and former smokers: longitudinal evaluation in the U.S. population |
Q70459129 | The relationship of mean daily blood alcohol levels to admission MAST, clinic absenteeism and depression in alcoholic methadone patients |
Q40863292 | The relationship of pre-treatment Alcoholics Anonymous affiliation with problem severity, social resources and treatment history |
Q31870842 | The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients |
Q43075644 | The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes |
Q52921754 | The relationships of HIV status and HIV risky behavior with readiness for treatment. |
Q39212907 | The relationships of childhood trauma and adulthood prescription pain reliever misuse and injection drug use. |
Q67353194 | The relationships of recidivism to program evaluation |
Q37156564 | The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers |
Q36442331 | The relative and unique contributions of emotion dysregulation and impulsivity to posttraumatic stress disorder among substance dependent inpatients |
Q93171141 | The relative importance of perceived substance misuse use by different peers on smoking, alcohol and illicit drug use in adolescence |
Q41649577 | The relative validity of a chronological drinking record |
Q50780335 | The relevance of age at first alcohol and nicotine use for initiation of cannabis use and progression to cannabis use disorders. |
Q40800974 | The relevance of recent animal studies for the development of treatment procedures for alcoholics |
Q44747877 | The reliability and stability of a quantity-frequency method and a diary method of measuring alcohol consumption |
Q44993938 | The reliability and validity of the WHO student drug-use questionnaire among Nigerian students |
Q52274533 | The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. |
Q35752855 | The remote brief intervention and referral to treatment model: Development, functionality, acceptability, and feasibility |
Q40467778 | The residual neuropsychological effects of cannabis: the current status of research |
Q42762761 | The rise (and fall?) of drug discrimination research |
Q92754460 | The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects |
Q43162029 | The road from ADAMHA to NIH: Reflections on NIDA (1992-1994). |
Q40480633 | The role of 5-HT3 receptors in drug dependence |
Q34708991 | The role of Alcoholics Anonymous in mobilizing adaptive social network changes: a prospective lagged mediational analysis |
Q40530370 | The role of N-methyl-D-aspartate receptors in dopaminergic neuropathology produced by the amphetamines |
Q51611717 | The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse. |
Q98509862 | The role of access to integrated services at opioid agonist treatment sites in reaching 90-90-90 cascade in people who inject drugs in Ukraine: Country-level data |
Q49384047 | The role of acculturation and binge drinking on smoking status among Mexican Americans: Comparison by border residence |
Q33684454 | The role of adverse events and related safety data in the pre-market evaluation of drug abuse potential |
Q37307782 | The role of alcohol consumption in future classifications of alcohol use disorders |
Q34308754 | The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma Study |
Q39446837 | The role of alcohol use in antiretroviral adherence among individuals living with HIV in South Africa: Event-level findings from a daily diary study. |
Q94472462 | The role of alcohol-induced blackouts in symptoms of depression among young adults |
Q44592860 | The role of alcohol-related problematic events in treatment entry |
Q40480636 | The role of calcium channels in drug dependence |
Q35156598 | The role of cannabis use within a dimensional approach to cannabis use disorders. |
Q48721673 | The role of central serotoninergic neurotransmission in the morphine abstinence syndrome in rats |
Q54029322 | The role of conduct disorder in explaining the comorbidity between alcohol and illicit drug dependence in adolescence. |
Q44897038 | The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2. |
Q39627351 | The role of craving in AUDs: dimensionality and Differential Functioning in the DSM-5. |
Q91757109 | The role of craving in the treatment of alcohol use disorders: The importance of competing desires and pretreatment changes in drinking |
Q35952070 | The role of decision-making in cannabis-related problems among young adults |
Q37164972 | The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting |
Q42126435 | The role of discrimination in alcohol-related problems in samples of heavy drinking HIV-negative and positive men who have sex with men (MSM) |
Q40231995 | The role of distress intolerance in the relationship between childhood sexual abuse and problematic alcohol use among Latin American MSM. |
Q40480641 | The role of dopamine in drug abuse viewed from the perspective of its role in motivation |
Q43032717 | The role of drinking locations in university student drinking: findings from a national web-based survey |
Q36371241 | The role of dyad-level factors in shaping sexual and drug-related HIV/STI risks among sex workers with intimate partners |
Q91004177 | The role of emotion dysregulation in the relation of childhood trauma to heroin craving in individuals with heroin dependence |
Q51819657 | The role of food deprivation in the maintenance and reinstatement of cocaine-seeking behavior in rats. |
Q41699208 | The role of general parenting and cannabis-specific parenting practices in adolescent cannabis and other illicit drug use. |
Q37147515 | The role of human drug self-administration procedures in the development of medications |
Q94549439 | The role of impulsivity as predisposing behavioural trait in different aspects of alcohol self-administration in rats |
Q38708639 | The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study |
Q37197574 | The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients |
Q48711248 | The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus |
Q89744537 | The role of negative affect in the persistence of nicotine dependence among alternative high school students: A latent growth curve analysis |
Q35952351 | The role of neighborhood in urban black adolescent marijuana use. |
Q92391363 | The role of neurocognitive functioning, substance use variables and the DSM-5 severity scale in cocaine relapse: A prospective study |
Q39172033 | The role of pain intensity and smoking expectancies on smoking urge and behavior following experimental pain induction |
Q45160175 | The role of parental alcohol use, parental discipline and antisocial behaviour on adolescent drinking trajectories |
Q42982738 | The role of parental alcohol-specific communication in early adolescents' alcohol use. |
Q39176065 | The role of participants' self-selected future smoking goals in adolescent smoking cessation interventions. |
Q33648476 | The role of physical dependence in animal models of human alcoholism |
Q91564360 | The role of pubertal timing in the link between family history of alcohol use disorder and late adolescent substance use |
Q47844681 | The role of restraint omission in alcohol-related traffic fatalities. |
Q35903257 | The role of sexual expectancies of substance use as a mediator between adult attachment and drug use among gay and bisexual men. |
Q36701887 | The role of social networks and geography on risky injection behaviors of young persons who inject drugs |
Q89841641 | The role of social support on the effects of stress and depression on African American tobacco and alcohol use |
Q51419175 | The role of stimulated lipid peroxidation and impaired calcium sequestration in the enhancement of cocaine induced hepatotoxicity by ethanol. |
Q94683479 | The role of subjective responses in electronic cigarette uptake and substitution in adult smokers |
Q90000185 | The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose |
Q45989460 | The role of temperament in the relationship between early onset of tobacco and cannabis use: the TRAILS study. |
Q46812074 | The role of the early therapeutic alliance in predicting drug treatment dropout |
Q71500106 | The role of the hepatic microsomal electron-transport system in the development of metabolic tolerance from repeated oral methadone administration in mice |
Q88717491 | The role of the vasopressin system and dopamine D1 receptors in the effects of social housing condition on morphine reward |
Q92987469 | The roles of heavy drinking and drug use in engagement in HIV care among hospitalized substance using individuals with poorly controlled HIV infection |
Q35660928 | The roles of outlet density and norms in alcohol use disorder |
Q33174599 | The safety and value of naloxone as a therapeutic aid. |
Q43984088 | The scale for treatment integration of the dually diagnosed (STIDD): an instrument for assessing intervention strategies in the pharmacotherapy of mentally ill substance abusers |
Q36335939 | The scientific/clinical response to the cocaine epidemic: a MEDLINE search of the literature |
Q38776235 | The search for an elusive cutoff remains: Problems of binary classification of heavy drinking as an endpoint for alcohol clinical trials |
Q36248887 | The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats |
Q46181714 | The serotonin 2A receptor gene in alcohol dependence and tobacco smoking |
Q33716681 | The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. |
Q97597713 | The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice |
Q35017184 | The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine. |
Q46944269 | The simulation of addiction: pharmacological and neurocomputational models of drug self-administration |
Q113876983 | The situational contexts and subjective effects of co-use of electronic cigarettes and alcohol among college students: An ecological momentary assessment (EMA) study |
Q36827603 | The six-year outcome of alcohol use disorders in men: A population based study from India |
Q35226260 | The social context of homeless men's substance use |
Q37346301 | The social context of homeless women's alcohol and drug use. |
Q37917025 | The social relevance of epidemiological research in drug use, abuse and dependence: a position paper |
Q37499486 | The social shaping of health and smoking |
Q53416220 | The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis. |
Q38706703 | The spatial accuracy of geographic ecological momentary assessment (GEMA): Error and bias due to subject and environmental characteristics |
Q90133154 | The spatio-temporal distribution of naloxone administration events in rural Ohio 2010-16 |
Q94491362 | The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda |
Q97539598 | The state of the science in opioid policy research |
Q39459880 | The stimulants and hallucinogens under consideration: a brief overview of their chemistry and pharmacology |
Q36083418 | The street cost of drugs and drug use patterns: relationships with sex work income in an urban Canadian setting |
Q59282396 | The street prices of immediate- and extended-release tapentadol are lower than other schedule II opioid tablets/capsules |
Q46591372 | The structure of alcohol dependence in the community |
Q44189348 | The structure of cannabis dependence in the community |
Q48120304 | The structure of synaptosomal plasma membrane |
Q36705949 | The structure of the UPPS-R-Child impulsivity scale and its relations with substance use outcomes among treatment-seeking adolescents |
Q43803511 | The subjective effects of MDMA and mCPP in moderate MDMA users |
Q30586963 | The suspected association between methamphetamine ('ice') smoking and frequent episodes of alcohol intoxication: data from the 1993 National Household Survey on Drug Abuse |
Q36421427 | The temporal association between energy drink and alcohol use among adolescents: A short communication |
Q37971218 | The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses |
Q44620772 | The theory of planned behavior: precursors of marijuana use in early adolescence? |
Q37011213 | The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence |
Q52266799 | The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. |
Q40530376 | The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function |
Q40868924 | The trading of sex for money or drugs, sexually transmitted diseases (STDs), and HIV-related risk behaviors among multisubstance using alcoholic inpatients |
Q52265620 | The transfer of alcohol tolerance, and its relation to reinforcement. |
Q47199563 | The treatment mapping survey; a descriptive study of drug and alcohol treatment responses in 23 countries |
Q70910544 | The treatment of alcoholism in France |
Q40235510 | The treatment requests of alcoholics |
Q44707811 | The triggering effect of alcohol and illicit drugs on violent crime in a remand prison population: a case crossover study |
Q40368937 | The two-faceted nature of impulsivity in patients with borderline personality disorder and substance use disorder |
Q52082193 | The under-reporting of alcohol use: the role of organic mental syndromes. |
Q33582989 | The use of administrative data as a substitute for individual screening scores in observational studies related to problematic alcohol or drug use. |
Q34708873 | The use of anabolic androgenic steroids and polypharmacy: a review of the literature |
Q44934084 | The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. |
Q44070882 | The use of divalproex in alcohol relapse prevention: a pilot study |
Q30978827 | The use of electronic debit cards in longitudinal data collection with geographically mobile drug users |
Q48888391 | The use of flavor in cigarette substitutes |
Q27010380 | The use of neuroproteomics in drug abuse research |
Q98498888 | The use of person-centered language in scientific research articles focusing on alcohol use disorder |
Q119832652 | The use of person-centered language in scientific research articles focusing on opioid use disorder |
Q67553722 | The use of plasma levels to optimize methadone maintenance treatment |
Q40634290 | The use of psychoactive prescription drugs among DUI suspects |
Q39480248 | The use of psychoactive substances among Egyptian males working in the manufacturing industries |
Q39480256 | The use of psychoactive substances by female Egyptian university students, compared with their male colleagues on selected items |
Q47817673 | The use of social networking sites: A risk factor for using alcohol, marijuana, and synthetic cannabinoids? |
Q46779746 | The use of the mini-mental state examination in recruitment for substance abuse research studies |
Q46352373 | The use of tobacco products among Nigerian adults: a general population survey |
Q33360335 | The utility of indirect predictors of hepatitis C viremia |
Q46071378 | The utilization of health care services by children with Foetal Alcohol Syndrome in the Western Cape, South Africa |
Q46872174 | The validity and reliability of a brief measure of cocaine craving |
Q44070869 | The validity of drug use self-reports among hard core drug users in a household survey in Puerto Rico: comparison of survey responses of cocaine and heroin use with hair tests |
Q46651932 | The video assessment of simulated encounters (VASE): Development and validation of a group-administered method for evaluating clinician skills in motivational interviewing |
Q36962808 | The video assessment of simulated encounters-revised (VASE-R): reliability and validity of a revised measure of motivational interviewing skills |
Q39162976 | The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. |
Q90924170 | Themes of agency and communion and rehabilitation from substance misuse |
Q40741529 | Theoretical and observed subtypes of DSM-IV alcohol abuse and dependence in a general population sample |
Q66697404 | Theories of tolerance and dependence on ethanol: mechanistic approaches |
Q35850890 | Theory-based active ingredients of effective treatments for substance use disorders |
Q42691302 | Therapeutic community methods in methadone maintenance (Passages): an open clinical trial |
Q33880853 | Therapeutic infusions of ketamine: do the psychoactive effects matter? |
Q46606625 | Therapeutic thresholds in methadone maintenance treatment: a receiver operating characteristic analysis |
Q87287173 | Therapist-client relationships in a psychological therapy trial for psychosis and substance misuse |
Q45193433 | Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops |
Q31029486 | Thirsty heroin addicts show different fMRI activations when exposed to water-related and drug-related cues. |
Q54048194 | Thoughts about the relevance of neurochemistry, neurophysiology and neuropsychopharmacology to the social problems of drug abuse. |
Q104611952 | Three As of American Indian adolescent marijuana use: Availability, acceptability, and approval |
Q51996886 | Three clusters of male alcoholics. |
Q45004189 | Three-year changes in drinking patterns in Spain: a prospective population-based cohort study. |
Q58581274 | Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets |
Q43515119 | Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans |
Q70724460 | Thyroid status in chronic alcoholics |
Q70905552 | Thyroid status in patients with alcoholic liver disease |
Q52264384 | Tilidine abuse and dependence |
Q48785092 | Time based prospective memory deficits associated with binge drinking: evidence from the Cambridge Prospective Memory Test (CAMPROMPT). |
Q44874932 | Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice |
Q52431835 | Time course of breath acetaldehyde concentrations during intravenous infusions of ethanol in healthy men. |
Q73193612 | Time course of manganese superoxide dismutase concentrations in serum of alcohol-dependent patients during abstinence |
Q68275531 | Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans |
Q52275742 | Time of day of methadone consumption and illicit heroin use. |
Q42611291 | Time to first treatment interruption in the Chinese methadone maintenance treatment programme |
Q37204964 | Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone |
Q35997640 | Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors |
Q36797010 | Time-varying effects of a text-based smoking cessation intervention for urban adolescents |
Q90485664 | Time-varying effects of family smoking and family management on adolescent daily smoking: The moderating roles of behavioral disinhibition and anxiety |
Q36511764 | Time-varying effects of smoking quantity and nicotine dependence on adolescent smoking regularity |
Q90329442 | Timing of vape use among adolescents: Differences by family structure |
Q41082996 | To drink or not to drink? Assessing conflicting desires in dependent drinkers in treatment |
Q40017044 | Tobacco advertising, environmental smoking bans, and smoking in Chinese urban areas |
Q37186971 | Tobacco and cannabis co-occurrence: does route of administration matter? |
Q40171737 | Tobacco and e-cigarette use amongst illicit drug users in Australia |
Q91441418 | Tobacco control in France: Why missing the forest for the trees? |
Q54674873 | Tobacco control policy and socio-economic inequalities in smoking in 27 European countries. |
Q50503031 | Tobacco demand, delay discounting, and smoking topography among smokers with and without psychopathology |
Q41249626 | Tobacco smoking and cannabis use in a longitudinal birth cohort: evidence of reciprocal causal relationships |
Q57430015 | Tobacco smoking in relation to analgesic drug use in a national adult population sample |
Q38607385 | Tobacco toxicant exposure in cigarette smokers who use or do not use other tobacco products |
Q36859686 | Tobacco use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals: 2002-2010 |
Q43623500 | Tobacco use among HIV-infected individuals in a rural community in Yunnan Province, China |
Q92960688 | Tobacco use among lesbian, gay, bisexual and transgender young adults varies by sexual and gender identity |
Q91207298 | Tobacco use and the interplay of internalizing, externalizing and substance use problems: A latent class analysis of data from the Population Assessment of Tobacco and Health Study |
Q97640864 | Tobacco use and tobacco services in California substance use treatment programs |
Q49068799 | Tobacco use by narcoleptics and daytime sleep tendency |
Q58702349 | Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study |
Q43773050 | Tobacco, alcohol and cannabis use during pregnancy: clustering of risks |
Q44666828 | Tobacco, alcohol, cannabis and other illegal drug use among young adults: the socioeconomic context |
Q48746493 | Tolerance and cross tolerance to the accuracy- and rate-decreasing effects of mu opioids in rats responding under a fixed-consecutive-number schedule |
Q73571286 | Tolerance development to morphine-induced alterations of immune status |
Q48670872 | Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion |
Q67694340 | Tolerance to an effect of ethanol on post-tetanic potentiation in Aplysia |
Q70645388 | Tolerance to methadone lethality and microsomal enzyme induction in mice tolerant to and dependent on morphine |
Q51665432 | Tolerance to self-administration of cocaine in rats: time course and dose-response determination using a multi-dose method. |
Q52287300 | Tolerance to the behavioral effects of orally self-administered phencyclidine. |
Q45163155 | Tolerance to, and physical dependence on, ethanol: Why do we study them ? |
Q67017062 | Tolerance, dependence and lethality in morphine-dependent mice after repeated oral administration of methadone |
Q43884117 | Toluene inhalation produces regionally specific changes in extracellular dopamine |
Q45994167 | Too young to drink but old enough to drive under the influence: a study of underage offenders as seen in substance abuse treatment in Texas. |
Q30407769 | Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial. |
Q50697707 | Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial. |
Q104130514 | Topiramate-phentermine combinations reduce cocaine self-administration in humans |
Q73100890 | Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects |
Q68046823 | Total acidity, pH and ethanol contents in illicit liquor (Indian home made brew) |
Q90110148 | Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study |
Q35207377 | Toward DSM-V: mapping the alcohol use disorder continuum in college students |
Q34617902 | Toward a comprehensive developmental model of smoking initiation and nicotine dependence |
Q114190375 | Toward a typology of hallucinogen users in the United States |
Q30579736 | Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. |
Q38778361 | Toward precision smoking cessation treatment I: Moderator results from a factorial experiment |
Q39066430 | Toward precision smoking cessation treatment II: Proximal effects of smoking cessation intervention components on putative mechanisms of action |
Q94540269 | Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxone |
Q41896870 | Towards a typology of relapse: a preliminary report |
Q30275499 | Towards greater understanding of addiction stigma: Intersectionality with race/ethnicity and gender |
Q96588209 | Toxicological analysis of serious drug-related harm among electronic dance music festival attendees in New South Wales, Australia: A consecutive case series |
Q46682988 | Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids |
Q90904448 | Toxicological oral fluid results among Spanish drivers testing positive on on-site drug controls from 2013 to 2015 |
Q35809445 | Training and fidelity monitoring of behavioral interventions in multi-site addictions research |
Q39709233 | Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members |
Q48628398 | Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals |
Q60031026 | Trait, state, and place: The role of personality and environment in drug use |
Q44737952 | Trajectories in cigarette dependence as a function of anxiety: a multilevel analysis |
Q36164859 | Trajectories of adolescent alcohol use after brief treatment in an Emergency Department |
Q128556441 | Trajectories of alcohol and cannabis use among emerging adults with a history of unstable housing: Associations with functioning over a two-year period |
Q47799439 | Trajectories of alcohol, marijuana, and illicit drug use in a diverse sample of young men who have sex with men. |
Q98194332 | Trajectories of cannabis use and risk for opioid misuse in a young adult urban cohort |
Q36668074 | Trajectories of criteria of nicotine dependence from adolescence to early adulthood |
Q51349506 | Trajectories of energy drink consumption and subsequent drug use during young adulthood. |
Q90256492 | Trajectories of heroin use: A 15-year retrospective study of Mexican-American men who were affiliated with gangs during adolescence |
Q41728812 | Trajectories of injecting behavior in the Amsterdam Cohort Study among drug users |
Q60697170 | Trajectories of nonmedical use of prescription opioids in adolescents in primary care |
Q91195624 | Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone |
Q101378086 | Tramadol non-medical use in Four European countries: A comparative analysis |
Q44094300 | Tramadol post-marketing surveillance in health care professionals |
Q47311551 | Transcriptomic profiling of the ventral tegmental area and nucleus accumbens in rhesus macaques following long-term cocaine self-administration |
Q34267700 | Transdermal administration of nicotine |
Q30884222 | Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking |
Q34432000 | Transdermal nicotine alters some of marihuana's effects in male and female volunteers |
Q69367849 | Transferrin and mitochondrial aspartate aminotransferase in young adult alcoholics |
Q46852590 | Transition to injection drug use among street youth--a qualitative analysis |
Q47947696 | Transition to parenthood and substance use disorders: findings from a 30-year longitudinal study |
Q40170941 | Transitional patterns of self-administration following substitution of methadone or l-alpha-acetylmethadol (LAAM) for morphine in dependent rats |
Q96438776 | Transitioning from pharmaceutical opioids: A discrete-time survival analysis of heroin initiation in suburban/exurban communities |
Q34959452 | Transitioning opioid-dependent patients from detoxification to long-term treatment: efficacy of intensive role induction |
Q46392666 | Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation? |
Q89261454 | Transitions in the use of multiple substances from adolescence to young adulthood |
Q64970607 | Transitions through stages of alcohol involvement: The potential role of mood disorders. |
Q36586134 | Transitions to regular smoking and to nicotine dependence in women using cannabis |
Q35122009 | Transporting efficacious treatments from academia to community: barriers and opportunities |
Q43842919 | Trauma and substance cue reactivity in individuals with comorbid posttraumatic stress disorder and cocaine or alcohol dependence |
Q49311370 | Traumatic damage of the posterior cranial fossa in chronic alcoholism |
Q46807354 | Traumatic events and post-traumatic stress disorder in cocaine users entering private treatment |
Q36468291 | Traveling young injection drug users at high risk for acquisition and transmission of viral infections |
Q35545701 | Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial |
Q37168989 | Treated and untreated remission from problem drinking in late life: post-remission functioning and health-related quality of life |
Q47306587 | Treated delinquent boys' substance use: onset, pattern, relationship to conduct and mood disorders |
Q44049000 | Treating hepatitis C in methadone maintenance patients: an interim analysis |
Q36407380 | Treating paternal drug abuse using Learning Sobriety Together: effects on adolescents versus children |
Q37109681 | Treatment Cost Analysis Tool (TCAT) for estimating costs of outpatient treatment services |
Q70972530 | Treatment attitudes of recovered alcoholic counselors and nonalcoholic counselors |
Q92677453 | Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated |
Q38770875 | Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands |
Q68249641 | Treatment effectiveness as judged by successfully and unsuccessfully treated alcoholics |
Q50878939 | Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva. |
Q124802407 | Treatment for alcohol use disorders in seriously mentally ill adults using the ethyl glucuronide biomarker |
Q34417838 | Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy |
Q44350871 | Treatment for opioid use and outcomes in older adults: a systematic literature review |
Q91195632 | Treatment for substance use disorders in pregnant women: Motivators and barriers |
Q88515472 | Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial |
Q33700819 | Treatment interventions-looking towards the millennium |
Q46066128 | Treatment motivation in drug users: a theory-based analysis |
Q38561488 | Treatment needs and experiences of Australian women with alcohol and other drug problems |
Q35612485 | Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment |
Q35131764 | Treatment of adolescent tobacco smokers: issues and opportunities for exposure reduction approaches |
Q52298905 | Treatment of adolescents with a cannabis use disorder: main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. |
Q69899416 | Treatment of alcoholism in Kuwait: a prospective follow-up study |
Q33872639 | Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications |
Q51826988 | Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline. |
Q51913341 | Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. |
Q52304268 | Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands. |
Q51855687 | Treatment of dependence upon stimulants and hallucinogens. |
Q34443382 | Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo |
Q28257927 | Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review |
Q90444531 | Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas? |
Q71141883 | Treatment outcome in methadone detoxification: relationship to initial levels of illicit opiate use |
Q43119790 | Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study. |
Q51538773 | Treatment outcome of cocaine-alcohol dependent patients. |
Q48899306 | Treatment outcome: a neglected area of drug abuse research |
Q34980323 | Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts: a population-based approach |
Q36248807 | Treatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence |
Q44487818 | Treatment process components and heroin use outcome among methadone patients |
Q36421010 | Treatment programs in the National Drug Abuse Treatment Clinical Trials Network |
Q42616333 | Treatment retention and 1 year outcomes for residential programmes in England |
Q43270096 | Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability |
Q39163426 | Treatment seeking in cannabis dependence: The role of social cognition. |
Q35875486 | Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis |
Q41747062 | Treatment use, perceived need, and barriers to seeking treatment for substance abuse and mental health problems among older adults compared to younger adults |
Q38649047 | Treatment use, sources of payment, and financial barriers to treatment among individuals with opioid use disorder following the national implementation of the ACA. |
Q38376069 | Treatment utilization among persons with opioid use disorder in the United States. |
Q33998159 | Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. |
Q36923895 | Treatment-naive active alcoholics have greater psychiatric comorbidity than normal controls but less than treated abstinent alcoholics |
Q40277380 | Trends and characteristics of heroin overdoses in Wisconsin, 2003-2012. |
Q47754601 | Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015. |
Q39034490 | Trends and correlates of marijuana use among late middle-aged and older adults in the United States, 2002-2014. |
Q58121247 | Trends and correlates of perceived access to heroin among young adults in the United States, 2002-2016 |
Q98182398 | Trends and correlates of self-reported alcohol and nicotine use among women before and during pregnancy, 2009-2017 |
Q39497894 | Trends and correlates of substance use disorders among probationers and parolees in the United States 2002-2014. |
Q36317009 | Trends and socioeconomic differences in policy triggers for thinking about quitting smoking: Findings from the International Tobacco Control (ITC) Europe Surveys |
Q95823464 | Trends in LSD use among US adults: 2015-2018 |
Q33942500 | Trends in U.S., past-year marijuana use from 1985 to 2009: an age-period-cohort analysis |
Q48116107 | Trends in abuse and misuse of prescription opioids among older adults |
Q41495873 | Trends in adult exposure to secondhand smoke in vehicles: Findings from the 2009-2012 Canadian Tobacco Use Monitoring Survey |
Q60447009 | Trends in and correlates of medical marijuana use among adults in the United States |
Q92720138 | Trends in and correlates of tranquilizer misuse among adults who misuse opioids in the United States, 2002-2014 |
Q91056911 | Trends in and factors associated with the adoption of digital aids for smoking cessation and alcohol reduction: A population survey in England |
Q92244297 | Trends in binge drinking and alcohol abstention among adolescents in the US, 2002-2016 |
Q90751949 | Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016 |
Q39674155 | Trends in cannabis use disorders among racial/ethnic population groups in the United States. |
Q40548568 | Trends in cannabis-related ambulance presentations from 2000 to 2013 in Melbourne, Australia |
Q96343909 | Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018 |
Q68035097 | Trends in diagnosed drug problems among newborns: United States, 1979-1987 |
Q89680299 | Trends in drug use among electronic dance music party attendees in New York City, 2016-2019 |
Q41498652 | Trends in dual diagnosis of severe mental illness and substance use disorders, 1996-2010, Israel |
Q89078788 | Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016 |
Q33799020 | Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado |
Q92602236 | Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015-2017 |
Q91195610 | Trends in first-time treatment admissions for older adults with alcohol use disorder: Availability of medical and specialty clinical services in hospital, residential, and outpatient facilities |
Q38616085 | Trends in heroin and pharmaceutical opioid overdose deaths in Australia |
Q56348907 | Trends in incidence and risk markers of student emergency department visits with alcohol intoxication in a U.S. public university-A longitudinal data linkage study |
Q51410074 | Trends in incidence of neonatal abstinence syndrome in Canada and associated healthcare resource utilization. |
Q90378759 | Trends in inequalities of alcohol-related harms among Thai households: 2007-2017 |
Q38464264 | Trends in injection drug use behaviors over 10 years among street youth |
Q38617056 | Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act. |
Q91195594 | Trends in marijuana edible consumption and perceptions of harm in a cohort of young adults |
Q91318445 | Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016 |
Q47203593 | Trends in medical student use of tobacco, alcohol and drugs in an Irish university, 1973-2002. |
Q24655493 | Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys |
Q50860797 | Trends in opiate overdose deaths in Australia 1979-1995. |
Q47686692 | Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995. |
Q90507463 | Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016 |
Q40164746 | Trends in recreational poisoning in Newcastle, Australia, between 1996 and 2013. |
Q40190400 | Trends in registered medical marijuana participation across 13 US states and District of Columbia. |
Q46812330 | Trends in situational norms and attitudes toward drinking among whites, blacks, and hispanics: 1984-1995. |
Q99604397 | Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019 |
Q92575301 | Trends in the sequence of first alcohol, cannabis and cigarette use in Australia, 2001-2016 |
Q44247687 | Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States |
Q41599553 | Trends in tobacco consumption in three different birth cohorts of elderly of São Paulo, Brazil |
Q38653569 | Trends in typologies of concurrent alcohol, marijuana, and cigarette use among US adolescents: An ecological examination by sex and race/ethnicity. |
Q57729658 | Trends in use of and attitudes toward marijuana among youth before and after decriminalization: The case of California 2007–2013 |
Q41621809 | Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: results from National HIV Behavioral Surveillance 2005-2012. |
Q38729731 | Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States |
Q37071511 | Tri-city study of Ecstasy use problems: a latent class analysis. |
Q47394430 | Triazolam and ethanol effects on human matching-to-sample performance vary as a function of pattern size and discriminability |
Q51150519 | Triazolam as a discriminative stimulus in humans |
Q92269761 | Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking |
Q48717693 | Tryptophan levels in human cerebrospinal fluid after acute and chronic ethanol consumption |
Q38127511 | Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention |
Q38073059 | Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature |
Q36731691 | Turning k on its head: comments on use of an ED50 in delay discounting research |
Q90130176 | Tutorial in Biostatistics: The use of generalized additive models to evaluate alcohol consumption as an exposure variable |
Q46745635 | Twelve-month prevalence and changes in driving after drinking: United States, 1991-1992 and 2001-2002. |
Q46757626 | Twelve-year trend in treatment seeking for buprenorphine abuse in Finland |
Q38706707 | Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation. |
Q43774557 | Twenty-five year mortality of US servicemen deployed in Vietnam: predictive utility of early drug use. |
Q57477949 | Twin epidemics: The surging rise of methamphetamine use in chronic opioid users |
Q43560182 | Two decades of treatment seeking for substance use disorders in Saudi Arabia: trends and patterns in a rehabilitation facility in Dammam |
Q43803507 | Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine |
Q86706665 | Two perspectives on the legalization of medical marijuana in the United States |
Q41384467 | Two versions of dependence: D.S.M.-III and the alcohol Dependence Syndrome |
Q36234326 | Two-part random effects growth modeling to identify risks associated with alcohol and cannabis initiation, initial average use and changes in drug consumption in a sample of adult, male twins |
Q52270837 | Types and characteristics of addicts in the community. |
Q34188489 | Types of alcohol withdrawal syndrome and dexamethasone suppression test |
Q44298060 | Types of self-reported psychopathology in Dutch and American heroin addicts |
Q44809248 | Typologies of drug dependence: comparative validity of a multivariate and four univariate models |
Q35190131 | Typologies of recanting of lifetime cigarette, alcohol and marijuana use during a six-year longitudinal panel study |
Q33653346 | Typology of club drug use among young adults recruited using time-space sampling |
Q88728494 | Typology of new psychoactive substance use among the general Australian population |
Q38701860 | U.S. cannabis legalization and use of vaping and edible products among youth. |
Q93346622 | U.S. county prevalence of retail prescription opioid sales and opioid-related hospitalizations from 2011 to 2014 |
Q90125162 | U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018 |
Q43540771 | U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages |
Q92413980 | UPPS-P impulsive personality traits and adolescent cigarette smoking: A meta-analysis |
Q38967254 | UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis |
Q90097529 | US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress |
Q44360024 | Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results |
Q51488279 | Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. |
Q44150372 | Ultra-rapid screening for substance-use disorders: the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite). |
Q31799410 | Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes |
Q59355947 | Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder |
Q38125886 | Uncovering the epidemic of HIV among men who have sex with men in Central Asia |
Q46190971 | Under double influence: assessment of simultaneous alcohol and cannabis use in general youth populations |
Q38853734 | Underreporting of ecstasy use among high school seniors in the US. |
Q92804804 | Understanding Opioid Use Disorder (OUD) using tree-based classifiers |
Q44574555 | Understanding US addiction physicians' low rate of naltrexone prescription |
Q57137203 | Understanding alcohol motivation using the alcohol purchase task: A methodological systematic review |
Q91691926 | Understanding disparities in access to naloxone among people who inject drugs in Southeast Michigan using respondent driven sampling |
Q59192068 | Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings |
Q44339372 | Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis |
Q35156798 | Understanding subtypes of inner-city drug users with a latent class approach |
Q40265036 | Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter? |
Q46056113 | Understanding the importance of organizational and system variables on addiction treatment services within criminal justice settings |
Q89744543 | Understanding the increase in opioid overdoses in New Hampshire: A rapid epidemiologic assessment |
Q91848237 | Understanding the link between substance use and chronic pain: A qualitative study among people who use illicit drugs in Montreal, Canada |
Q38667275 | Understanding the prevalence of lifetime abstinence from alcohol: An ecological study |
Q33753065 | Understanding the role of cessation fatigue in the smoking cessation process. |
Q37964420 | Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact |
Q57815346 | Understanding the use of diverted buprenorphine |
Q34021900 | Unemployment and substance outcomes in the United States 2002-2010. |
Q47980780 | Unfairness sensitivity and social decision-making in individuals with alcohol dependence: a preliminary study |
Q30710117 | Unhealthy alcohol use in older adults: Association with readmissions and emergency department use in the 30 days after hospital discharge |
Q72257051 | Unidimensionality of alcohol dependence syndrome |
Q44774641 | Unidimensionality of alcohol dependence syndrome? |
Q37118078 | Unintended effects of training on clinicians' interest, confidence, and commitment in using motivational interviewing |
Q92602240 | Unintentional drug overdose deaths involving cocaine among middle-aged and older adults in New York City |
Q37739631 | Unintentional overdose and suicide among substance users: a review of overlap and risk factors |
Q39880847 | Universal school-based substance abuse prevention programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and marijuana use. |
Q90282559 | University students' self-reported reasons for abstinence from prescription and non-prescription stimulants and depressants |
Q46618330 | Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement |
Q36213552 | Unmet need for treatment for substance use disorders across race and ethnicity |
Q91327898 | Unmet substance use disorder treatment need among reproductive age women |
Q58400538 | Unobserved home induction onto buprenorphine: Outcomes at year 7 |
Q39549385 | Unrecognized drug dependence and withdrawal in the elderly |
Q68035092 | Unrecognized left ventricular dysfunction in an apparently healthy alcohol abuse population |
Q52304415 | Unrecorded alcohol in Rio de Janeiro: assessing its misusers through Respondent Driven Sampling. |
Q48093091 | Unseen scars: Cocaine patients with prior trauma evidence heightened resting state functional connectivity (RSFC) between the amygdala and limbic-striatal regions. |
Q44340315 | Unused opioid analgesics and drug disposal following outpatient dental surgery: A randomized controlled trial |
Q38082143 | Update on tamper-resistant drug formulations |
Q40101926 | Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators. |
Q42656367 | Uptake of paraphernalia from injecting equipment provision services and its association with sharing of paraphernalia among injecting drug users in Scotland |
Q90793406 | Urban-rural variation in the socioeconomic determinants of opioid overdose |
Q36420025 | Urge-specific and lifestyle coping strategies of alcoholics: relationships of specific strategies to treatment outcome |
Q46449738 | Urge-specific and lifestyle coping strategies of cocaine abusers: relationships to treatment outcomes |
Q39162974 | Urgency traits moderate daily relations between affect and drinking to intoxication among young adults |
Q68086289 | Urine analysis for benzodiazepines among opiate consumers |
Q92501308 | Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction |
Q68345297 | Urine toxicology as a predictor of continuation in outpatient alcoholism treatment |
Q57910003 | Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK |
Q67416074 | Use and abuse of non-narcotic analgesics |
Q33857553 | Use of a single alcohol screening question to identify other drug use |
Q68046857 | Use of alcohol, tobacco and illicit drugs amongst 13-year-olds in three areas of Britain |
Q42971595 | Use of anabolic androgenic steroids in substance abusers arrested for crime |
Q99574415 | Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study |
Q95651824 | Use of and perceptions about electronic nicotine delivery systems (ENDS) among people with mental health conditions or serious psychological distress, 2018 |
Q42724129 | Use of and reasons for using multiple other tobacco products in daily and nondaily smokers: Associations with cigarette consumption and nicotine dependence |
Q61602587 | Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART |
Q61602596 | Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART |
Q35124209 | Use of buprenorphine in pregnancy: patient management and effects on the neonate |
Q34118694 | Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use. |
Q36757250 | Use of evidence-based treatments in substance abuse treatment programs serving American Indian and Alaska Native communities |
Q72486637 | Use of gastric fistula rats for the study of sedative, hypnotic and antianxiety drugs |
Q123600451 | Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws |
Q41087634 | Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists |
Q35206845 | Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. |
Q90587176 | Use of marijuana exclusively for medical purposes |
Q41364775 | Use of moist smokeless tobacco (snus) and the risk of development of alcohol dependence: a cohort study in a middle-aged population in Sweden |
Q42138329 | Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment |
Q44967942 | Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study |
Q46524670 | Use of nicotine replacement therapy among never smokers in the 1999-2006 National Health and Nutrition Examination Surveys |
Q39261394 | Use of psychoactive substances among male secondary school pupils in Egypt: a study on a nationwide representative sample |
Q43981697 | Use of psychotropic drugs and addiction: approaches to epidemiologic research |
Q46489651 | Use of specialty substance abuse and mental health services in adults with substance use disorders in the community |
Q33968846 | Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California |
Q59784157 | Use of the Fagerström test to assess differences in the degree of nicotine dependence in smokers from five ethnic groups: The HELIUS study |
Q42971596 | Use patterns and self-reported effects of Salvia divinorum: an internet-based survey |
Q34167524 | Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China |
Q33957998 | Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study |
Q48458232 | Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). |
Q34558973 | Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO. |
Q38403738 | User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate. |
Q35489516 | Using NicAlert strips to verify smoking status among pregnant cigarette smokers |
Q93346616 | Using a data science approach to predict cocaine use frequency from depressive symptoms |
Q48888380 | Using a drinking motivation scale to predict degrees of problematic drinking |
Q36947094 | Using a factor mixture modeling approach in alcohol dependence in a general population sample |
Q34098382 | Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance |
Q115162915 | Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment |
Q44026553 | Using ambulance attendances to recruit people who have experienced non-fatal heroin overdose |
Q101163433 | Using arrest and prescription data to examine the relationship between intimate partner violence and opioid prescriptions in the United States, 2006-2012 |
Q36338434 | Using behavioral economics to predict opioid use during prescription opioid dependence treatment |
Q37593389 | Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. |
Q40741524 | Using cluster analysis of alcohol use disorders to investigate 'diagnostic orphans': subjects with alcohol dependence symptoms but no diagnosis |
Q47837831 | Using conditioned suppression to investigate compulsive drug seeking in rats |
Q50059999 | Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam |
Q33266632 | Using engineering control principles to inform the design of adaptive interventions: a conceptual introduction |
Q36328432 | Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients |
Q36971137 | Using eye-tracking to examine how embedding risk corrective statements improves cigarette risk beliefs: Implications for tobacco regulatory policy |
Q39470215 | Using geographic information systems to assess spatial patterns of drug use, selection bias and attrition among a sample of injection drug users |
Q44958384 | Using growth models to relate acquisition of nicotine self-administration to break point and nicotinic receptor binding |
Q42984122 | Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City |
Q39772096 | Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users |
Q46377567 | Using latent class analysis to identify participant typologies in a drug treatment court. |
Q46805293 | Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S. |
Q98776074 | Using machine learning for real-time BAC estimation from a new-generation transdermal biosensor in the laboratory |
Q36026242 | Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection |
Q37268646 | Using propensity scores to adjust for selection bias when assessing the effectiveness of Alcoholics Anonymous in observational studies |
Q44152872 | Using qualitative research to inform survey development on nicotine dependence among adolescents |
Q39376145 | Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS |
Q33777712 | Using structural equation modeling to understand prescription stimulant misuse: a test of the Theory of Triadic Influence. |
Q45193425 | Utility of lead-in period in cocaine dependence pharmacotherapy trials |
Q92960681 | Utility of routine alcohol screening for monitoring changes in alcohol consumption |
Q73405954 | Utility of the AUDIT for identification of hazardous or harmful drinking in drug-dependent patients |
Q35795201 | Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012. |
Q36597791 | Utilization of communication technology by patients enrolled in substance abuse treatment. |
Q58581281 | Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada |
Q37347124 | Utilization patterns and correlates of retention among clients of the needle exchange program in Baltimore, Maryland. |
Q46489643 | Utilizing Recovery Management Checkups to shorten the cycle of relapse, treatment reentry, and recovery |
Q44055720 | Utilizing a multimodal assessment strategy to examine variations of impulsivity among young adults engaged in co-occurring smoking and binge drinking behaviors |
Q50530990 | Utilizing a train-the-trainer model for multi-site naloxone distribution programs. |
Q36531009 | Utilizing dissemination findings to help understand and bridge the research and practice gap in the treatment of substance abuse disorders in Hispanic populations |
Q35660947 | Utilizing mHealth methods to identify patterns of high risk illicit drug use. |
Q91511703 | Utilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers |
Q28239347 | Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial |
Q30494648 | Validation of a measure to assess alcohol- and marijuana-related risks and consequences among incarcerated adolescents |
Q115162830 | Validation of a single question for the assessment of past three-month alcohol consumption among adolescents |
Q121651970 | Validation of a single question for the assessment of past three-month alcohol consumption among adolescents |
Q39611760 | Validation of a substance and alcohol use assessment instrument among orphans and vulnerable children in Zambia using Audio Computer Assisted Self-Interviewing (ACASI). |
Q36330457 | Validation of prescriber risk indicators obtained from prescription drug monitoring program data. |
Q98460926 | Validation of secondary data sources for enumerating marijuana dispensaries in a state commercializing marijuana |
Q44411001 | Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment |
Q52923638 | Validation of the Christo Inventory for Substance-misuse Services (CISS): a simple outcome evaluation tool. |
Q39359437 | Validation of the Michigan Alcoholism Screening Test (MAST) in an Italian urban population |
Q37118446 | Validation of the Spanish Addiction Severity Index Multimedia Version (S-ASI-MV). |
Q39952522 | Validation of the alcohol use item banks from the Patient-Reported Outcomes Measurement Information System (PROMIS). |
Q37138260 | Validation of the nicotine dependence syndrome scale (NDSS): a criterion-group design contrasting chippers and regular smokers |
Q61700344 | Validation of the substance use brief screen in primary care |
Q46535048 | Validation of the timeline follow-back in the assessment of adolescent smoking |
Q100422777 | Validation of transdermal alcohol concentration data collected using wearable alcohol monitors: A systematic review and meta-analysis |
Q40234390 | Validity and reliability of the Michigan alcoholism screening test: a review |
Q36817013 | Validity and reliability of the nicotine and marijuana interaction expectancy (NAMIE) questionnaire |
Q90130158 | Validity of ICD-based algorithms to estimate the prevalence of injection drug use among infective endocarditis hospitalizations in the absence of a reference standard |
Q92944482 | Validity of International Classification of Diseases codes in identifying illicit drug use target conditions using medical record data as a reference standard: A systematic review |
Q34511215 | Validity of a demand curve measure of nicotine reinforcement with adolescent smokers |
Q42624283 | Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors |
Q46362431 | Validity of patients' self-reported drug use as a function of treatment status |
Q31992499 | Validity of self-reported data, scientific methods and drug policy |
Q33851850 | Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. |
Q36619494 | Validity of the CAGE questionnaire for men who have sex with men (MSM) in China |
Q123600442 | Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use |
Q46707974 | Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. |
Q88299023 | Validity of the PARADISE24 questionnaire in people with substance use disorders: A measure to assess psychosocial difficulties |
Q36864898 | Validity of the longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. |
Q52002806 | Validity of the psychopathy checklist-revised in male methadone patients. |
Q45928469 | Validity of the timeline followback among treatment-seeking smokers in Germany. |
Q46161701 | Validity of three measures of antisociality in predicting HIV risk behaviors in methadone-maintenance patients |
Q37267352 | Valproate treatment and cocaine cue reactivity in cocaine dependent individuals |
Q46951604 | Value for money in drug treatment: economic evaluation of prison methadone |
Q99590254 | Vaping while high: Factors associated with vaping marijuana among youth in the United States |
Q48783598 | Vaporised nicotine and tobacco harm reduction for addressing smoking among people living with HIV: A cross-sectional survey of Australian HIV health practitioners' attitudes. |
Q43188062 | Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats. |
Q37282141 | Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial |
Q50088319 | Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial |
Q88959955 | Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial |
Q30484284 | Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking |
Q52270874 | Variability in opium dosage: observations from Laos, 1965-75. |
Q34049049 | Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria |
Q92323631 | Variables associated with low, moderate and high emergency department use among patients with substance-related disorders |
Q46696112 | Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients |
Q44340328 | Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. |
Q36421698 | Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers |
Q71099427 | Variation in length of time to development of alcoholism by family history of problem drinking |
Q38654314 | Variation in receipt of pharmacotherapy for alcohol use disorders across racial/ethnic groups: A national study in the U.S. Veterans Health Administration. |
Q96428698 | Variation in the degree of concentration of prescription opioid utilization using different measures |
Q46114125 | Variations by age and sex in alcohol-related problematic behaviour per drinking volume and heavier drinking occasion |
Q44345956 | Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics |
Q35733246 | Variations in opioid receptor genes in neonatal abstinence syndrome |
Q37471349 | Variations in social contexts and their effect on adolescent inhalant use: a latent profile investigation |
Q40877019 | Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014. |
Q59780931 | Verbal memory is impaired among HIV + female, but not HIV + male cocaine users |
Q91456734 | Very-low-nicotine-content cigarettes and dependence among non-daily smokers |
Q45337765 | Veterans administration hospital staff attitudes toward alcoholism |
Q90164894 | Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? |
Q38686176 | Victimization as a mediator of alcohol use disparities between sexual minority subgroups and sexual majority youth using the 2015 National Youth Risk Behavior Survey |
Q43890385 | Violence among individuals in substance abuse treatment: the role of alcohol and cocaine consumption |
Q36811006 | Violence among men and women in substance use disorder treatment: a multi-level event-based analysis. |
Q114190346 | Violence, policing, and systemic racism as structural barriers to substance use treatment amongst women sex workers who use drugs: Findings of a community-based cohort in Vancouver, Canada (2010–2019) |
Q38816806 | Violence, trauma and living with HIV: Longitudinal predictors of initiating crystal methamphetamine injection among sex workers |
Q36495145 | Visual and verbal learning deficits in Veterans with alcohol and substance use disorders |
Q34167675 | Visual cortex activation to drug cues: a meta-analysis of functional neuroimaging papers in addiction and substance abuse literature. |
Q48441562 | Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: a cross-sectional study of inpatients in Nepal |
Q72590571 | Vitamin d utilization status in chronic alcoholic patients |
Q48944199 | Volitional oral intake of nicotine in tupaias: drug-induced alterations |
Q52271009 | Volitional problems in carrying through a difficult decision: the case of drug addiction. |
Q94680735 | Voluntary wheel running protects against the increase in ethanol consumption induced by social stress in mice |
Q34612884 | Voucher incentives increase treatment participation in telephone-based continuing care for cocaine dependence |
Q35990490 | Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial |
Q52200770 | Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program. |
Q43842935 | Voucher-based reinforcement of opiate abstinence during methadone detoxification |
Q101378069 | Vouchers versus reminders to prevent dropout: Findings from the randomized youth drug abuse treatment project (youthDAT project) |
Q41598952 | WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. |
Q69914150 | WHO Symposium on Drug Dependence: Benefit-risk ratio assessment of agonist-antagonist analgesics. August 1986. Satellite meeting to the III World Conference on Clinical Pharmacology and Therapeutics |
Q34776984 | WISDM primary and secondary dependence motives: associations with self-monitored motives for smoking in two college samples. |
Q84222763 | WITHDRAWN: The influence of living along the U.S.-Mexico border on unintentional drug overdose death, New Mexico (USA), 2005-2009 |
Q37626399 | Walking the line: stimulant use during sex and HIV risk behavior among Black urban MSM. |
Q91886340 | Waterpipe tobacco smoking trends among middle and high school students in the United States from 2011 to 2017 |
Q38521031 | Waterpipe tobacco smoking: The critical need for cessation treatment. |
Q30634195 | Wavelet-transformed temporal cerebral blood flow signals during attempted inhibition of cue-induced cocaine craving distinguish prognostic phenotypes |
Q90467657 | Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorder: A mixed methods pilot study |
Q39227670 | Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA |
Q36049485 | What Oregon's parity law can tell us about the federal Mental Health Parity and Addiction Equity Act and spending on substance abuse treatment services |
Q35180409 | What adolescents enrolled in genomic addiction research want to know about conflicts of interest |
Q39895285 | What are the needs of alcohol dependent patients with a history of sexual violence? A case-register study in a metropolitan region |
Q89712142 | What are the reasons that smokers reject ENDS? A national probability survey of U.S. Adult smokers, 2017-2018 |
Q33837927 | What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews |
Q48891817 | What do opiate addicts and cigarette smokers mean by "craving"? A pilot study |
Q37430998 | What do you feel? Adolescent drug and alcohol users show altered brain response to pleasant interoceptive stimuli |
Q44283708 | What does it take to retain substance-abusing adolescents in research protocols? Delineation of effort required, strategies undertaken, costs incurred, and 6-month post-treatment differences by retention difficulty |
Q34552327 | What factors are associated with current smokers using or stopping e-cigarette use? |
Q38923394 | What is abnormal about addiction-related attentional biases? |
Q52289910 | What is addiction? Age-related differences in the meaning of addiction. |
Q92009747 | What is the cause of death, when alcohol dependent persons die prematurely? |
Q100524019 | What is the drug of choice of young festivalgoers? |
Q34152761 | What is the evidence for hardening in the cigarette smoking population? Trends in nicotine dependence in the U.S., 2002-2012. |
Q40633504 | What motivates adolescent smokers to make a quit attempt? |
Q44094311 | What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults |
Q38278116 | What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose |
Q46491043 | What were they thinking? Adolescents' interpretations of DSM-IV alcohol dependence symptom queries and implications for diagnostic validity. |
Q58633822 | What's in your medicine cabinet? Gender differences |
Q30278578 | Wheel running exercise attenuates vulnerability to self-administer nicotine in rats |
Q91869837 | When DAWN went dark: Can the Nationwide Emergency Department Sample (NEDS) fill the surveillance gap left by the discontinued Drug Abuse Warning Network (DAWN)? |
Q47666946 | When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest records |
Q44540531 | When drugs in the same controlled substance schedule differ in real-world abuse, should they be differentiated in labeling? |
Q43440180 | When goals diverge: Staff consensus and the organizational climate |
Q57660311 | When is a little knowledge dangerous?Circumstances of recent heroin overdose and links to knowledge of overdose risk factors |
Q47191315 | When parents supply alcohol to their children: Exploring associations with drinking frequency, alcohol-related harms, and the role of parental monitoring |
Q71035562 | Which detoxified alcoholic keeps the first clinic appointment? |
Q44335967 | Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse |
Q50704389 | Which parenting style is more protective against adolescent substance use? Evidence within the European context. |
Q91306988 | White matter connectometry among individuals with self-reported family history of drug and alcohol use disorders |
Q31053800 | White matter development and tobacco smoking in young adults: A systematic review with recommendations for future research |
Q47371831 | White matter disruptions in male cocaine polysubstance users: Associations with severity of drug use and duration of abstinence. |
Q115162795 | White matter microstructure differences in individuals with dependence on cocaine, methamphetamine, and nicotine: Findings from the ENIGMA-Addiction working group |
Q38908454 | White-matter crossing-fiber microstructure in adolescents prenatally exposed to cocaine |
Q39290138 | Who are the adolescents saying "No" to cannabis offers |
Q46535042 | Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. |
Q33740800 | Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management? |
Q40241233 | Who benefits from computer-based brief alcohol intervention? Day-to-day drinking patterns as a moderator of intervention efficacy |
Q90631206 | Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity |
Q47565152 | Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting. |
Q35082600 | Who is becoming hallucinogen dependent soon after hallucinogen use starts? |
Q44614488 | Who is most affected by prenatal alcohol exposure: Boys or girls? |
Q40470596 | Who receives cannabis use offers: A general population study of adolescents. |
Q99547727 | Who takes the trip? Personality and hallucinogen use among college students and adolescents |
Q63313867 | Whose post-traumatic stress affects drinking levels? Couple-dyad modeling of national guard service members and their partners |
Q39693713 | Why do controlled-drinking outcomes vary by investigator, by country and by era? Cultural conceptions of release and remission in alcoholism |
Q51603071 | Why publish three negative articles on carbamazepine as a medication for the treatment of cocaine dependence? |
Q40731110 | Wide array of T-cell subpopulation alterations in patients with alcohol use disorders. |
Q58146740 | Widening inequalities in smoking initiation and cessation patterns: A cohort and gender analysis in France |
Q91207287 | Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada |
Q50860313 | Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. |
Q51748352 | Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city. |
Q46489645 | Wine preference and related health determinants in a U.S. national sample of young adults |
Q90131526 | With socioeconomic status controlled, cigarette use is lower among American Indians/Alaska Natives than whites |
Q46218705 | Withdrawal exposure with withdrawal regulation training for smoking cessation: a randomized controlled pilot trial |
Q46177958 | Withdrawal seizures in black and white alcoholic patients: intellectual and neuropsychological sequelae |
Q45195642 | Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART). |
Q72217772 | Withdrawal symptoms from high dose benzodiazepines in poly drug users |
Q90616275 | Withdrawal symptoms predict prescription opioid dependence in chronic pain patients |
Q99622436 | Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada |
Q52207481 | Withdrawal-like effects of pentylenetetrazol and valproate in the naive organism: a model of motivation produced by opiate withdrawal? |
Q95651836 | Within- and between-person associations of neighborhood poverty with alcohol use and consequences: A monthly study of young adults |
Q34084908 | Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers |
Q35069601 | Within-day temporal patterns of smoking, withdrawal symptoms, and craving |
Q35557400 | Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice |
Q36328326 | Within-session communication patterns predict alcohol treatment outcomes |
Q52201236 | Within-session determination of dose-response curves for heroin self-administration in rats: Comparison with between-session determination and effects of naltrexone. |
Q34913732 | Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers |
Q46604402 | Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers |
Q92852183 | Within-treatment frequency of use versus abstinence as a predictor of longitudinal post-treatment follow-up assessments of drug use |
Q84129775 | Women and smoking: An interdisciplinary examination of socioeconomic influences. Proceedings from the College on Problems of Drug Dependence Mini-conference, April 9-10, 2008, Annapolis, MD, USA |
Q33584633 | Women and smoking: an interdisciplinary examination of socioeconomic influences |
Q37432924 | Women and smoking: understanding socioeconomic influences |
Q37516839 | Women and tobacco control policies: social-structural and psychosocial contributions to vulnerability to tobacco use and exposure |
Q37227555 | Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database |
Q70198379 | Women, alcohol dependence and crime |
Q37320902 | Women, smoking, and social disadvantage over the life course: a longitudinal study of African American women |
Q36601412 | Women-only and mixed-gender drug abuse treatment programs: service needs, utilization and outcomes |
Q46814456 | Work-family conflicts and drinking behaviours among employed women and men. |
Q45060527 | Working memory and affective decision-making in addiction: a neurocognitive comparison between heroin addicts, pathological gamblers and healthy controls |
Q36767176 | Working memory and impulsivity predict marijuana-related problems among frequent users |
Q33625059 | Working memory deficits predict short-term smoking resumption following brief abstinence |
Q34199927 | Xorphanol |
Q115255360 | Years of life lost due to alcohol-related mortality: A nationwide population study in Poland, 1999–2017 |
Q39883364 | Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015. |
Q34021960 | You are the danger: attenuated insula response in methamphetamine users during aversive interoceptive decision-making. |
Q60944592 | You can't do this job when you are sober: Heroin use among female sex workers and the need for comprehensive drug treatment programming in Kenya |
Q34980211 | Young adult cannabis users report greater propensity for risk-taking only in non-monetary domains |
Q58605679 | Young adult dual combusted cigarette and e-cigarette users' anticipated responses to a nicotine reduction policy and menthol ban in combusted cigarettes |
Q99242652 | Young adult e-cigarette use: A latent class analysis of device and flavor use, 2018-2019 |
Q39891172 | Young adult injection drug users in the United States continue to practice HIV risk behaviors |
Q103722820 | Young adults' intention to quit using JUUL |
Q40480810 | Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks. |
Q61037537 | Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons |
Q33924340 | Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons |
Q70905554 | Zinc concentrations in ethanol liquid diet formulations |
Q44337295 | Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects |
Q45100773 | Zipeprol: preclinical assessment of abuse potential |
Q42959610 | Zolpidem does not serve as reinforcer in humans subjected to simulated shift work |
Q68345305 | [Abnormal erythrocyte membrane gangliosides in alcoholism] |
Q69416643 | [Abnormal gangliosides in the plasma of alcoholics] |
Q52266338 | [Addiction and primary prevention] |
Q68749035 | [Biophysical membrane correlates of tolerance and dependence on alcohol] |
Q71736684 | [Future aspects of research and clinical practice in the area of alcoholism] |
Q52270667 | [Primary prevention in the area of drug addiction: perspectives, errors and fallacies] |
Q71389905 | [Psychotherapy with the unwilling patient] |
Q71736707 | [The alcohol and drug problem as a task of health education] |
Q52282605 | [The drug scene during the past 10 years of experience and inquiries] |
Q71845878 | [Validity of the method of alcohol administration by the pulmonary route in studies of the alcoholic syndrome in the rat] |
Q42557926 | alpha-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: pharmacological evaluation and interaction with methamphetamine |
Q43728935 | beta-carboline binding to imidazoline receptors |
Q36502036 | fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders |
Q47721022 | mGlu5-dependent modulation of anxiety during early withdrawal from binge-drinking in adult and adolescent male mice |
Q112645955 | microRNA regulation related to the protective effects of environmental enrichment against cocaine-seeking behavior |
Q44347755 | mu-, delta- and kappa-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats |
Q40285375 | β-Adrenergic receptor density in brains of ethanoldependent rats |
Q36295861 | γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers |
Q48620221 | γ-Aminobutyric acid-ergic analgesia: Implications for γ-aminobutyric acid-ergic therapy for drug addictions |
Q26991859 | μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology |
Q126900201 | “This show hits really close to home on so many levels”: An analysis of Reddit comments about HBO’s Euphoria to understand viewers’ experiences of and reactions to substance use and mental illness |
Search more.